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ABSTRACT 
Wright, Kyle J. Ph.D., Purdue University, December 2016. Synthesis and 
Performance of Novel Supramolecular Tools for Single-Particle Cryogenic 
Electron Microscopy and Drug and Gene Delivery. Major Professor: David H. 
Thompson. 
 
      High-resolution biomacromolecular structure elucidation is fundamentally important 
to structure-based drug design and basic research into complex biochemical processes. 
Cryo-EM is an emerging alternative to XRD and NMR that is complementary in many 
ways relative to XRD and NMR. Materials approaches to cryo-EM are anticipated to 
greatly facilitate the cryo-EM process, allowing progress toward a more high-throughput 
application of cryo-EM to address challenges in structural biology. 
      Various affinity-based approaches inspired by approaches previously introduced for 
2D crystallization were developed for facilitation of cryo-EM. A library of affinity 
lipopolymer constructs were synthesized consisting of lipopolymers of various PEG 
molecular weights conjugated to lipids displaying varied affinity or covalently-active 
moieties at their distal termini. Modified-EM grids with stabilized lipid coatings were 
then used to capture His6-T7 bacteriophage and His6-RplL from cell lysates, purified 
His8-GFPuv, and nanodisc embedded His6-MalFGK2. Graphene-oxide-NTA-based 
affinity grids were fabricated via covalent modification of graphene-oxide and monolayer 
xxviii 
fabrication on a Langmuir trough. These monolayers were characterized by AFM, SEM, 
and evaluated for specific capture of his-tagged protein targets. These materials were also 
used to capture his6-GroEL from clarified cell lysates and used to generate a cryo-EM 
dataset yielding a map with a gold standard resolution of 8.1 Å. A library of 
polyrotaxanes based on PEG, α-CD and various endcaps and rotaxanation methods was 
synthesized. Several of these compounds were further modified with NTA moieties to 
impart affinity interactions on the tubular polyrotaxane templates which might be used 
for isolation of proteins and assisted cryo-EM. The laterally- and rotationally-mobile 
NTA-CD ligating groups enabled the capture of his-tagged proteins of substantially 
different sizes and facilitated their imaging via AFM, cryo-TEM, and TEM. This material 
may greatly facilitate cryo-EM analysis of his-tagged proteins by concentrating them into 
large and readily detectable clusters that enables projection images of the protein 
structure in all possible 3D orientations.  
.      Several families of diblock copolymer-based drug and gene delivery systems were 
also developed utilizing organocatalytic ring-opening polymerization (ROP) catalyzed by 
common amidine and guanidine bases. A library of mPEG-b-polycarbonate pendant 
polymers was synthesized and evaluated as part of a non-viral gene delivery system. The 
diblock copolymers showed the ability to form nanoparticles, typically 100-250 nm in 
size, with slightly positive surface zeta-potentials, effectively condensed pDNA at N/P 
ratios above 10, and showed comparable transfection efficiencies to Lipofectamine-2000 
in HeLa Cells. Organocatalytic ROP was also utilized to synthesize small libraries of 
mPEG-b-poly(ε-caprolactone), mPEG-b-poly(trimethylene carbonate) and mPEG-b-
poly(lactide-co-glycolide) diblock copolymers including a novel collagen-binding 
xxix 
peptide-diblock copolymer conjugate (SILY-PEG-b-PCL) utilizing organocatalytic ROP 
from a heterobifunctional PEG derivative. A facile and widely applicable synthetic 
procedure for the synthesis of cyclic amino-acid-N-carboxyanhydride monomers for 
synthesis of polypeptides utilizing tetrahydrofuran (THF) as solvent was developed and 
used to synthesize a small library of some novel and previously reported NCA monomers 




MATERIALS APROACHES TO FACILITATION OF SINGLE PARTICLE CRYO-EM 
1.1 High-Resolution Biomacromolecular Structure Elucidation 
High resolution structural information is a valuable asset for studies of biological 
systems and processes including: cellular trafficking and infrastructure, enzymatic 
processes, interactions between multiprotein complexes and infectious particles1, as well 
as for structure-based, or rational, drug design efforts2. X-ray crystallography (XRD), and 
nuclear magnetic resonance (NMR)-based methods account for the majority of published 
biomacromolecular structures3 to date (Table 1.1). Although tens of thousands of protein 
structures have been solved at or near atomic resolution, there are many targets of interest 
as pharmaceutical leads or for basic research, such as integral membrane proteins (IMP), 
which have not been solved with sufficient resolution to enable structure-based drug 
design or adequate conformational information. 
Structure-based drug design and high-throughput screening are the main tools 
used for identification of new pharmaceutical lead compounds. High-throughput 
screening involves the production and testing of very large libraries of compounds 
against an appropriate cell type or disease model to determine bioactivity and efficacy. 
Once an active compound is discovered, the process may be further refined by testing 
against a library of structurally-related compounds. In the case of structure-based drug 
design2b, where approaches like molecular docking are used to design ligands and 
2 
estimate binding affinities,  high resolution structural information often dictates accuracy 
and validity of results or even the ability to engage in this effort at all. Bakheet et al.2a 
estimate that 57% of human drug targets are IMP’s (Figure 1.1). Thus, facilitation of 
novel structure-based drug design will require high resolution structural information on 
these types of biomacromolecules. 
 
 
Figure 1.1 Sub-Cellular Locations of Proteins. (A) Drug targets and (B) Non-drug 
targets2a. 
A thorough structural understanding of biological systems is highly advantageous 
and often essential for progress in theoretical or applied efforts relating to the system of 
interest. Dynamic processes and complex multiprotein interactions are particularly 
informed through high-resolution structural information.  For example, Chang et al.1 have 
elucidated information regarding the mechanism by which some viruses package and 
3 
release their genome during infection via asymmetric single-particle cryo-EM 
reconstruction. 
 




1.1.1 X-Ray Crystallography 
 XRD is currently the most widely used and cost-effective method for 
determination of protein structures (Table 1.1). The combination of electron density map 
information obtained from x-ray diffraction patterns of high quality protein crystals with 
known protein amino acid sequence allows for determination of the protein’s three-
dimensional structure (Figure 1.2A). X-ray crystallography (XRD) is based on 
observation of x-ray diffraction patterns from large well-ordered 3D crystals4. Protein 
crystals are typically grown from supersaturated solutions of the protein. Supersaturation 
is usually induced via addition of inorganic salts (e.g. (NH4)2SO4, NaCl, KCl, CaCl2, 
etc.), volatile organic solvents (e.g. ethanol, acetonitrile, acetone, etc.), or polymers (e.g. 
polyethylene glycol (PEG)) as precipitants to concentrate the protein solution. Crystal 
formation is limited to cases where strong intermolecular contacts can be made to form 
an extended lattice. Proteins often show complex phase diagrams, are highly sensitive to 
solution conditions (e.g. pH, salinity, temperature, etc.), and may be difficult to obtain in 
4 
high purity due to proteolytic degradation or limitations in removal of occult impurities. 
The protein crystallization process is often approached by varying experimental variables 
(e.g. pH, salinity, temperature, precipitant, humidity, etc.) systematically across a wide 
parameter space using different crystallization methods. Generally, the highest quality 
protein crystals, that is, those that are the most well-ordered, are obtained when the 
nucleation and crystal growth steps are kinetically well separated5. 
Proteins may also have a high degree of conformational flexibility, which can 
produce misfolded states. As a result, each molecule has regions on its surface that vary 
from particle to particle, which impedes stabilization from intermolecular contacts and 
impairs crystallization. This might be a result of a hinge between domains or other 
flexible motifs. Proteins are also typically difficult to concentrate under mild conditions 
and tend to form crystals that are fragile due to high water content. The larger and more 
structurally irregular the macromolecular complex is, the less likely it is that it will form 
crystals such that the contact area is large in comparison with the total area of the 




Figure 1.2 High Resolution Tools in Structural Biology7. (A) X-ray crystallography 
(XRD). (B) Nuclear magnetic resonance spectroscopy (NMR). (C) Single-particle cryo-
EM. 
Other molecules may be unstable to crystallization conditions or be more likely to 
precipitate due to denaturation. Lipid membranes are also likely to impede crystallization 
due to their dynamic nature. IMP’s and some viruses fall into this class. IMP’s are 
generally not amenable to crystallization and there is no guarantee that they will 
crystallize in their native conformation8. Often, crystallization efforts and structural 
studies of IMP’s may involve focusing on partial structures. Also, crystallization happens 
over an extended time span, thus, dynamic events that happen on short time scales do not 
lend themselves to study by XRD. In crystallography, many conditions are often 
investigated. This requires a large quantity of sample, which is often impractical. 
6 
Crystallization also requires a highly pure sample. Since many samples are not amenable 
to extensive purification, crystallization may be impossible. Furthermore, extensive 
handling of human infectious particles is highly undesirable, but unavoidable during 
crystallographic screening. 
 
1.1.2 Nuclear Magnetic Resonance (NMR) 
 NMR-based techniques involve multidimensional NMR either in solution, or in 
the solid-state9. Unlike XRD, NMR does not require crystallization and the sample is 
examined in solution. Protein-NMR relies on 2D Nuclear Overhauser Enhancement 
Spectroscopy (NOESY) to observe interactions between proximal hydrogen atoms of the 
polypeptide chain (less than 5 Å apart). Proteins isotopically labeled with 15N- and 13C-
enriched amino acids are used to aid resolutions of overlapping peaks in multi-
dimensional NOESY spectra. The combination of large numbers of NOE proximity 
relationships along with knowledge of the protein sequence allow for elucidation of the 
3D structure of the protein (Figure 1.2B). 
The foundations of NMR structural analysis rely on high quality NMR spectra 
recorded with good sensitivity and spectral resolution7b. These limitations become harder 
to overcome with increasing molecular weight). This is due to low sensitivity and line 
broadening due to rapid transverse spin relaxation and extensive signal overlap due to 
highly complex spectra. Most published structures of biomolecules studied by NMR have 
molecular weights less than 25 kDa9. Isotopic labeling has been employed to overcome 
7 
this problem10, but this process is very time-consuming and requires extensive 
biochemical manipulation11.  
NMR structural studies of biomolecules require a very concentrated sample 
(~1mM). This means that a large amount of highly purified material is required. This is 
impractical in many cases and highly concentrated solutions are incompatible with many 
targets due to aggregation or denaturation. Frequently, NMR is used as a complement to 
low resolution crystal structures. Artificial conditions and sample preparation mean that 
there is no guarantee of native conformation from NMR structures. 
 
1.1.3 Electron Microscopy 
 Electron microscopy is an emerging tool for the elucidation of high resolution 
structural information. Electron diffraction has long been successfully used to determine 
3D structures of 2D crystalline samples up to a resolution of 1.9 Å12. Cryo-electron 
microscopy in combination with single-particle 3D reconstruction, collectively referred to 
as cryo-EM, has played an increasingly important role in determination of 3D structures 
up to subnanometer resolution13. Currently the highest obtained resolution from cryo-EM 
is the 2.2 Å structure of E. coli β-galactosidase in complex with the cell-permeant 




Figure 1.3. 2.2 Å Structure of β-Galactosidase-PETG Reported by Bartesaghi et. al13a. 
Observation of multi-protein interactions is essential for fundamental 
understanding of biochemistry and cell biology, but, like IMP’s, structural studies of 
large macromolecular machines are rarely attainable using XRD or NMR-based methods. 
This is largely due to the size, irregular shape, and flexibility of these species.  For 
example, a large macromolecular protein machine, the proteasome14 has recently been a 
subject of structural study due to the link between the ubiquitin-proteasome pathway15 
and its relation to the mitotic cycle and oncogenesis16.  The intact complex, referred to as 
the 26S Proteasome, along with the ubiquitin-conjugating system comprises the 
ubiquitin-proteasome system16, which is the major extralysosomal pathway for 
intracellular protein degradation in eukaryotes.  Like IMP’s, large macromolecular 
complexes like the proteasome are impractical for study by XRD or NMR. Recently, 
efforts have focused on cryo-electron microscopy (cryo-EM)17. 
9 
1.2 Single-Particle Cryo-EM 
Three dimensional structure determinations based on cryogenic electron 
microscopy (cryo-EM) have become a common tool to structural biologists in recent 
years12, 18. The technique has become more viable for high-resolution structure 
elucidation due to advances in instrumentation19, experimental techniques, and improved 
software for single-particle reconstruction12, 20 that is more accessible and more powerful. 
As a result, the number of protein structures solved by cryo-EM has increased steadily 
since 2007 (Figure 1.4). 
 
 
Figure 1.4 Growth of Structures Solved by Cryo-EM. (A) Growth of structures solved by 
cryo-EM since 2007 based on PDB and EMDB entries. (B) Growth of structures 
submitted to the PDB since 2002 by resolution21. 
10 
 Cryo-EM tends to generate higher resolution structures when the target is high 
molecular weight or consists of symmetrical multi-protein subunits. As a result, many of 
the first cryo-EM structures were viral particles. These targets are generally challenging 
for XRD and are too large for NMR. As cryo-EM develops as a technique, access to 
high-resolution structural information on these targets is expected to reveal new insights 
for biology and drug design (Figure 1.5). 
 
Figure 1.5 Added Value of Cryo-EM in Structural Biology22. 
In cryo-EM, highly pure samples are preferable although, moderately pure 
samples are tolerable depending on imaging conditions due to particle selection during 
image processing. Generally, a cryo-EM based project begins with isolation and 
11 
purification of the particle of interest (Figure 1.6). Cryo-EM sample preparation involves 
the application of a solution of the purified particle to a TEM grid. This solution is 
wicked away, allowed to dry shortly, and then flash-frozen in a solution of liquid ethane 
cooled with liquid nitrogen forming a thin layer of vitreous ice containing imbedded 
particles (Figure 1.7). An advantage of cryo-EM is that a relatively small amount of 
sample is required to collect a significant amount of data. One can take several 
micrographs from a single grid which requires only about 5 µL of sample at moderate 
concentrations. Since samples are flash frozen, relatively delicate samples are applicable 
to cryo-EM since the particles are preserved in a layer of vitreous ice. Also, events that 
happen on small time-scales may be observed since flash-freezing of the sample 
effectively preserves a snapshot of molecular conformations at the time of freezing. 
These advantages are particularly desirable for observing interactions between 




Figure 1.6 Pipeline in Biological Cryo-EM. 
13 
 
Figure 1.7 Vitrification Process During Cryo-EM Sample Preparation. 
 This sample is then imaged under low dose conditions to prevent sample 
degradation due to radiation damage. Radiation damage is one of the major drawbacks of 
electron optics applied to organic and biological systems. Primary events result in the 
formation of reactive species such as free radicals, which then undergo a secondary 
chemical event that promotes structural denaturation. Accumulated electrons also lead to 
the phenomenon known as charging, in which areas of accumulated charge distort the 
electron optics and lead to aberrations.  
14 
In traditional transmission electron microscopy, stains are used to improve 
contrast. These stains are composed of heavy metal salts. This is because contrast is 
mostly due to phase contrast in EM, which increases with increasing Z (atomic number). 
Higher Z elements scatter electrons mote effectively, which leads to high contrast in areas 
where the high Z elements are localized. In cryo-EM, typically no stains are used 
although the technique has been applied23. An absence of staining is preferable, since 
staining can lead to deformation, and phase contrast from protein atoms is necessary if 
atomic-scale resolution is the ultimate goal of the study.  
 2D particle projection images are then analyzed using reconstruction software to 
derive a reconstructed 3D image of the particle. One limitation of cryo-EM is the large 
number of particles necessary for a high resolution 3D structure to be obtained. The 
number depends on the geometry, size, and conformational flexibility of the particle, but 
tens of thousands of particles may be required. For example, a 6 Å structure of the 
molecular chaperone GroEL was obtained from 39,085 particles selected from 42 
micrographs24.  
1.2.1 3D Reconstruction of Biomacromolecules and Complexes 
 Reconstruction strategies often involve geometrical averaging of particle 
orientations during 3D reconstruction, which simplifies the process. In fact, 3D 
reconstruction is generally more easily accomplished for highly symmetrical particles, 
but is theoretically applicable to any particle geometry (Figure 1.8).  Structural studies of 
the Epsilon-15 virus by cryo-EM have determined the viral capsid structure at 4.5 Å 
15 
imposing icosahedral symmetry25 while the structure was solved at 20 Å using an 
asymmetric approach26. Cryo-EM has been frequently employed for studies of virus 
structure due to the high symmetry of these particles. 
 
 
Figure 1.8 Importance of Symmetry in Cryo-EM. 20 Å asymmetric reconstruction24 and 
4.5 Å icosahedral reconstruction23 of Epsilon-15 virus. 
The 3D reconstruction process depends on the method and varies from different 
developers and software. Generally, particles are selected manually using an image 
processing program. Most reconstruction software packages contain all of the necessary 
tools for a reconstruction project. More recently, automated particle selection programs 
have been developed to simplify the process27. However, automated particle selection 
often falls short of manual particle selection because automated programs tend to pick 
anomalies, and distorted particles. Including anomalous particles in a reconstruction data 
set can dramatically limit the minimum attainable resolution of the reconstruction. This 
also points out that conformational flexibility is not desirable in cryo-EM studies. As a 
result, manual particle selection is sometimes necessary. For reconstruction to be 
successful, the particle needs to be represented by many particles in many different 
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rotational orientations. This can be an issue since it has been noted that some particles 
adopt preferred orientations during cryo-EM sample preparation. For example, the 
molecular chaperone GroEL is a barrel shaped protein and particle images of the protein 
on its side are much more prevalent in micrographs than images of the two ends of the 
protein23b, 28.  
 The particles are grouped into classes of similar orientation. The basic principle of 
3D reconstruction involves Fourier transform of the 2D projection images of the 3D 
particle. These 2D Fourier transforms can then be combined in Fourier space to produce 
the 3D Fourier-space representation of the phase contrast from cryo-EM imaging. This 
can then undergo Fourier inversion to give the real-space 3D reconstruction.   
 Cryo-EM has become more popular and more viable in recent years due to 
advances in electron microscope technology as well as reconstruction algorithms29 and 
software30. Development of software for reconstructions involving more diverse particle 
symmetries20c and more user friendly software20a, 20b, 30b are among the many 
developments of late in cryo-EM software development.  In particular, much effort has 
centered around accurate determination of the contrast transfer function (CTF) that 
corrects the 2D images for the experimental out of focus distance, accurate determination 
of the relative orientation of individual particles, and the use of larger particle sets. This 
has led to routine reconstructions of suitable targets at 10 Å resolution, which is expected 
to continue to improve to in the near future.  
 Cryo-EM shows a great deal of promise for biomacromolecular structure 
elucidation, especially at moderate resolution and hybrid methods, which combine EM-
based studies of fragile complexes with XRD or NMR analyses of individual components 
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are promising but laborious processes7a, 31.  In many ways cryo-EM is a complementary 
technique to XRD and NMR. It works well for large fragile targets, provides a very good 
mimic of the targets native environment, and studies require a very small amount of pure 
material. To push EM-based structure determination further, materials approaches need to 
be invented that can facilitate cryo-EM-based 3D reconstruction. 
1.3 Materials Approaches to Single-Particle Cryo-EM 
Materials methods have previously been applied to structural studies focusing on 
electron microscopy-based structure determination. The concept of interfacial templating 
was first applied to 2D crystallography and the techniques were later applied to cryo-EM 
to expand the scope of cryo-EM in terms of expanding practical targets for cryo-EM and 
allowing for observation of dynamic events that would not otherwise be observed under 
conventional cryo-EM sample preparation and imaging conditions. 
 
1.3.1 2D Crystallization of Proteins at Lipid Interfaces 
Electron diffraction has regularly been successfully used to determine 3D 
structures of 2D crystalline samples up to a resolution of 1.9 Å12. For compounds with 
convoluted topologies and internal degrees of freedom which are unable to form ordered 
diffraction-quality 3D crystals, 1D and 2D templating approaches have been developed 
by orienting the protein with respect to the interface and limiting 2D diffusion. 1D and 
2D substrates like lipid lamellar phases, lipid monolayers, and lipid cubic phases have 
been used to produce 2D crystals of both soluble proteins and IMP’s. These interfaces 
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provide large surface areas for protein adsorption, can be utilized with a wide variety of 
lipid conjugates allowing for tunable binding interactions, and are compatible with 
microfluidic interfaces.  
2D crystals grown at interfaces are only a single molecular layer in thickness, 
making them extremely challenging for analysis by conventional XRD. If the 2D crystals 
are analyzed by tilt-series electron crystallography, the reconstructed volume invariably 
contains the “missing cone” defect due to practical limitations of projecting the electron 
beam through the sample at high tilt angles. 1D substrates allow for analysis by helical 
reconstruction32, however, this method requires strict control of the 1D substrate 
diameter, which is often impractical and is dependent on the nature of the substrate.  
 
 
Figure 1.9 Lipid Monolayer Formation Using a Langmuir Trough33. (A) A typical 
Langmuir trough setup. (B) Pressure-area isotherm relationship to 2D lipid phase. 
 Most interfacial templating approaches have focused on lipid monolayer-based 
substrates5. Lipid monolayer-based approaches involve formation of a monolayer film at 
the air-water interface. This is typically accomplished by spreading an organic solution of 
the lipids on a Langmuir trough (Figure 1.9A). As the solvent evaporates, the lipids form 
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a monolayer at the air-water interface with the polar head groups orient toward the 
aqueous subphase and the hydrophobic lipid tails orient toward the air where they can 
interact through dispersion forces with the lipid chains of neighboring molecules. The 
monolayer film can then be compressed allowing for phase control of the lipid 
monolayer. As the monolayer is compressed, the lipids form 2D gas-, fluid-, or solid-state 
films at the air-water interface (Figure 1.9B). 
If the protein of interest is present in the aqueous subphase, it can become 
concentrated at the surface of the Langmuir trough if it possesses an affinity for the lipids 
of the substrate. Thus, the general consideration for 2D crystallization is the generation of 
an interface that can produce enrichment of the protein at the interface. The combined 
elevated protein concentration, enhanced protein alignment, and fluid dynamics of the 
film, which allows for lateral mobility, contribute to the formation of 2D crystals. By 
designing the lipid components to have specific interactions with the protein of interest, 
samples of lower purity may be acceptable for 2D crystallization. 
2D crystallization typically involves simple experimental protocols, and a wide 
range of monolayer compositions may be utilized to take advantage of specific tunable 
monolayer properties. 
 
1.3.2 Interfacial Templating 
The first effort of this type was reported by Kornberg34 and coworkers who used 
antibody-based affinity interactions to concentrate protein targets on affinity lipid 
monolayer surfaces (Figure 1.10A). In this example, a monolayer of DNP-modified 
phasphatidylethanolamine (PE) lipid (Figure 1.11A) in a mixed monolayer of 1:1 DNP-
20 
PE and PC was used to produce 2D crystals of anti-DNP IgG through the specific DNP-
antibody interaction. This ligand affinity technique was later adapted to structural 
characterization of RNA polymerase II through electrostatic interaction with cationic-
lipid-containing monolayers, 2D crystallization of streptavidin on monolayers containing 
biotinylated lipids, and 2D crystallization of DNA gyrase on monolayers containing an 
ATP-lipid conjugate5. Many different material interfaces have been employed utilizing 
interactions from electrostatics to coordination complexation to highly specific ligand-
receptor type interactions5, 35. Many of these interactions are based on methods developed 
for affinity purification of biomolecules36. 
 
 
Figure 1.10 Conceptual Models of 2D Crystallization: (A) The original Uzgiris and 
Kornberg model using an antigenic lipid (DNP-PE), to concentrate anti-DNP antibodies 
at the air-water interfaces34. (B) Application of IMAC chemistry to induce 2D 
crystallization of recombinant histidine-tagged proteins37. 
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Figure 1.11 Molecular Structures of Some Lipids Used for 2D Crystallization Studies. 
(A) some ligand-lipid conjugates utilized for ligand-specific immobilization and 
crystallization and (B) some NTA-lipids synthesized for IMAC-based immobilization 
and crystallization of histidine-tagged proteins. 
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The interfacial templating approach to 2D crystallization was later adapted to 
incorporate affinity interactions from immobilized metal affinity chromatography 
(IMAC) chemistry (Figure 1.10B). These approaches generally rely on affinity 
interaction between nitrilotriacetic acid- (NTA) or iminodiacetic acid- (IDA)-lipid 
conjugates with divalent metal ions (e.g. Ni(II), Cu(II), Co(II), etc.) and a genetically 
engineered histidine tag (his-tag) of the protein of interest. Thompson and coworkers37 
used a nitriloltriacetic acid (NTA) containing mixed monolayer to capture and orient N-
terminal his-tagged Moloney murine leukemia virus capsids forming 2D crystals for 2D 
electron crystallography. A similar approach was used to analyze HIV-1 capsid by 2D 
electron crystallography on NTA-lipid-containing surfaces38. Several NTA-containing 
lipids have been reported (Figure 1.11B). NTA forms a tetradentate complex with many 
divalent metal ions like Ni(II), Cu(II), etc.39 This leaves two vacant coordination sites for 
an oligo-histidine tag (his-tag) to bind (Figure 1.12).  Equilibrium constants KD of 10-7 M 
for the his6:protein:M2+ and 8x10-13 M for NTA:Ni2+ have been reported39-40. 
 
 
Figure 1.12 Binding Interaction of NTA:Ni2+:His6 in IMAC Chemistry41. 
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Zhou et al. introduced the site-hopping concept for 2D crystallization of his-
tagged proteins42. This concept involves substrates composed of acylated cyclodextrins 
(CD). These compounds formed stable monolayers exposing the CD cavity. CD cavities 
have varying binding affinity for various small molecular guests43. The second 
component of the system consists of an NTA-conjugate of a specific molecule possessing 
binding affinity for the CD cavity. By mixing the NTA-conjugate with the his-tagged 
protein of interest, a transient interaction with the monolayer is established. This 
approach may allow for more favorable kinetics of nucleation with respect to crystal 





Figure 1.13 Site-Hopping Concept for 2D Crystallization Using Acylated-Cyclodextrin-
Based Monolayers. (A) Site-Hopping concept for 2D Protein Crystallization. (B) 
Molecular structures of β-CD-lipid and some guest-NTA compounds. 
1.3.3 The Affinity Grid 
 As cryo-EM became a more reliable and high-resolution tool, it was natural that 
the 2D crystallization strategy was adapted to address sample requirements for cryo-EM. 
By using TEM grids modified with 2D monolayer surfaces, the same affinity interactions 
could be utilized to generate diffuse bound particles for cryo-EM as opposed to 2D 
crystals. This approach allows for single-step purification and grid preparation and may 
allow for cryo-EM analysis of challenging samples (e.g. low concentration, transient 
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intermediates, etc.) and ultimately allow cryo-EM to become a more high-throughput 
technique. 
1.3.3.1 Lipid Monolayer-Based Affinity Grids 
The first direct application of the techniques of interfacial templating developed 
and implemented for 2D crystallization were first applied to cryo-EM when Kelly et al. 
developed the concept of monolayer purification44 and the affinity grid45. The method 
involves the transfer of a mixed monolayer of lipids doped with a lipid with an NTA 
chelator head (Figure 1.14A) followed by capture and imaging of the adsorbed his-tagged 
proteins. An adaptation of this method utilizing a his-tagged adaptor protein bound to 
specific antibodies for the protein of interest has also been reported (Figure 1.14B)46. The 
affinity grids were reported to be shelf-stable for several months and able to capture and 
prepare samples for cryo-EM within minutes. 
These materials were used to capture his-tagged rpl3, the human homolog of the 
E. coli 50 S ribosomal subunit rplC with or without associated RNA depending on 
sample preparation protocols. Cryo-EM data obtained using the modified grids were used 
to generate reconstructions of the 50 S ribosomal subunit, the 70 S ribosome and the 30 S 
ribosomal subunit from images from the same sample. This demonstrates the utility of 
this approach for study of dynamic processes within living systems that would be 
unobtainable if the target of interest is subjected to conventional sample preparation, 
particularly chromatographic purification. These materials were also shown to be stable 
in the presence of glycerol and detergents. This property was exploited to capture his-
tagged aquaporin-9 (AQP9) from detergent-solubilized membrane fractions of sf9 insect 
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cells. This example demonstrates the utility of this approach for isolation of an IMP, a 
limitation for conventional cryo-EM. 
Although this approach has shown several advantageous properties for cryo-EM, 
there are still several limitations to this approach. The monolayers are relatively unstable 
and tend to degrade in film quality following consecutive washes. The close proximity of 
the NTA moiety to the 2D surface allows relatively little rotational mobility for targets 
that contain a single his-tag. This limitation may lead to orientational bias and overall 
lower possible resolution for targets with only a single his-tag. The presence of antibody 
may lead to lower resolution or conformational changes relative to the native protein 
structure. Furthermore, the low electrical conductivity of the lipid monolayer may lead to 
charging effects. In order to address these limitations, novel affinity grids composed of 
lipopolymers47 and based on graphene-oxide48 have been designed and evaluated for 
cryo-EM. More recently, Sharma et al49. used the affinity grid approach to show that 
PKC βII binds to the small ribosomal subunit (40S) and interacts with RACK1, a seven 
bladed β-propeller protein present on the 40S and binds to two different regions close to 
blades 3 and 4 of RACK1. This study was a step toward understanding the molecular 




Figure 1.14 The Affinity Grid Approach to Cryo-EM. (A) affinity grids approach based 
on IMAC chemistry45 and (B) alternate approach enabling capture of non-his-tagged 
proteins46. 
1.3.3.2 Antibody-Based Affinity Grids 
 In another interesting variant of the affinity grid concept, Yu et al. introduced the 
antibody-based affinity grid and the concept of cryo-SPIEM. This technique applied the 
traditional concept of solid-phase immune electron microscopy (SPIEM) to cryo-EM50. 
This approach involves direct non-covalent modification of carbon-coated TEM grids 
with antibodies. This approach was used to isolate and generate 3D reconstructions of 
native protein targets from pure samples and cellular lysates.  
 
1.3.4 Other Approaches 
In a particularly interesting example, Sigworth and coworker have developed a novel 
spherical reconstruction algorithm that allowed for determination of the BK potassium 
channel at 30 Å resolution as an IMP imbedded in a tethered proteoliposome formulation 
(Figure 1.15). This method allowed for moderate resolution reconstruction of an IMP, 
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which has previously eluded efforts by XRD by building off of an existing platform that 
had been developed to grow 2D streptavidin crystals at biotinylated lipid interfaces which 
can then be transferred to TEM grids51. The method highlights the flexibility of cryo-EM-
based reconstruction. 
The channel was reconstituted into liposomes doped with PEG-ylated lipids bearing a 
biotin at their termini. EM grids were prepared and a monolayer 2D crystal of 
streptavidin was transferred to the grid. The grids were then treated with the liposome 
formulation and imaged. Images were collected of the protein imbedded in the 
liposome29. This case required the development of a novel spherical reconstruction 







Figure 1.15 The Proteoliposome-Based Approach Developed by Sigworth et al27. 
Finally, Turberfield and coworkers52 recently have described the use of two-
dimensional DNA templates for site-specific scaffolding of G-protein-coupled membrane 
receptor complexes for SPA, however, the resolution possible with these templates is not 
yet known. 
1.4 Conclusions 
 High-resolution biomacromolecular structure elucidation is fundamentally 
important to structure-based drug design and basic research into complex biochemical 
processes. XRD and NMR account for the majority of the reported protein structures on 
the protein data Bank (PDB). Cryo-EM is an emerging alternative to XRD and NMR that 
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is complementary in terms of sample applicability relative to XRD and NMR. TEM grid 
modification approaches originally developed for 2D crystallization studies have been 
applied to cryo-EM to extend the breadth of the technique. The affinity grid concept 
based on IMAC chemistry and antibody interactions has been used to isolate cryo-EM 
samples directly from cellular lysates or purified samples. Further exploration of this 
approach should continue to allow for application of the cryo-EM technique to 
challenging samples and targets that may not be readily amenable to XRD, NMR, or 
traditional cryo-EM samples preparation techniques. This could allow for access to high-
resolution structural data on targets that are not currently accessible furthering molecular 
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CHAPTER TWO: 
DEVELOPMENT OF NON-FOULING AFFINITY LIPOPOLYMER-BASED 
AFFINITY GRIDS FOR SINGLE PARTICLE CRYO-EM 
 
2.1 Introduction 
Single-particle cryogenic electron microscopy (cryoEM) is a rapidly advancing 
method of protein structure elucidation that is now capable of producing structures with 
resolutions approaching 2.2 Å, provided that thousands of single particle images can be 
collected.1 At present, this is achieved by collecting and class averaging images from 
many different carbon-coated grid preparations that randomly adsorb and present the 
protein target in multiple orientations for cryoEM imaging. Since many protein target 
candidates exist in low copy number, may be highly labile, and/or are derived from 
infectious agents that are in low supply, there is significant motivation for the 
development of new sample preparation methods to improve the throughput and 
predictability of this technique. 
Lipid monolayers have been used to concentrate proteins at interfaces for structure 
determination, as first described by Uzgiris and Kornberg.2 Subsequent affinity 
monolayer developments explored a variety of affinity lipid-ligand interactions such as 
biotin-streptavidin, ATP lipid-ATP binding protein, Ni2+:nitrilotriacetic acid (NTA)-
hexahistidine-tagged (His6-tag) protein, or Cu2+:iminodiacetic acid-His6-tag protein.3 
Many of these efforts were focused on the development two-dimensional crystallization 
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methods using nitriloltriacetic acid (NTA)-modified lipid conjugates,4 with some cases 
showing the potential of NTA lipids for structure elucidation with resolutions in the 10 – 
25Å regime.4b 
NTA lipid monolayers were extended to the realm of single-particle cryo-EM by 
Walz and coworkers, with the structures for 50S ribosomal subunits,5 transferrin-
transferrin receptor complex,6 and human RNA polymerase II7 reported using a 
commercially available NTA lipid conjugate, 1,2-dioleoyl-sn-glycero-3-[((N-(5-amino-1-
carboxypentyl)iminodiacetic acid)succinyl] (DGS-NTA), in mixed monolayers with 1,2-
lauroyl-sn-glycero-3-phosphocholine (DLPC). This report also extended this technique to 
the retrieval of protein targets from cell lysates;6a, 7 however, the potential of the approach 
is currently limited by the low stability,5 non-specific fouling,6a and preferred orientation8 
limitations of DGS-NTA:DLPC monolayers. 
2.2 Design of Novel Non-Fouling Affinity Grids 
Herein, a novel system was developed to address these challenges by depositing non-
fouling PEG-lipid9 coatings containing common affinity ligands like NTA3, 4e, 4f, 10 onto 
TEM grids.11 These coatings are prepared by compression of lipid films generated using a 
Langmuir trough whose capture ligand surface density and PEG mushroom-brush 
conformational state can be controlled by initial film composition and applied surface 
pressures prior to deposition onto the EM grid. Brush conformation methoxypolyethylene 
glycol (mPEG) coatings are highly non-fouling,12 thereby enabling the application of cell 
lysates directly onto the grid and removal of the non-specifically bound material in 
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subsequent buffer washing steps (Figure 2.1). Since the moiety bearing the affinity 
interaction exists at terminus of the lipopolymer, it is anticipated that this approach will 
allow for increased rotational degrees of freedom allowing for the potential of decreased 
sample orientation bias. In addition to the reduced sample quantity demands required for 
cryoEM analysis, the shortened sample processing times also limit the opportunities for 
proteolytic degradation and/or protein unfolding of the His6-target that may occur during 
standard sample processing protocols.  
 
 
Figure 2.1 Conceptual Diagram Showing Lipopolymer-Based Affinity Grid Fabrication 
and Affinity Capture from Crude Cell Lysates. 
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Figure 2.2 Chemical Structures of Targeted Affinity Lipopolymer Library. (A) Targeted 
PEG molecular weights. (B) Lipid structures. (C) affinity moieties and reactive termini. 
A small library of affinity lipopolymer constructs was designed to maintain the 
essential monolayer purification capability while incorporating a surface PEG brush, to 
prevent non-specific adsorption, and a polymerizable lipid component which undergoes 
topochemical polymerization13 upon exposure to UV light forming a more stable 
substrate for affinity grid sample preparation. Structures of the targeted library are 
depicted in Figure 2.2. Like the original approach introduced by Walz14, our approach 
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consists of a mixed monolayer film consisting of two lipopolymer components. The first 
component is an mPEG-PE-lipid conjugate where the PE-lipid is either 1,2-(tricosa-
10’,12’-diynoyl)-sn-glycero-3-phosphoethanolamine (DTPE) or – 1,2-(distearoyl)-sn-
glycero-3-phosphoethanolamine (DSPE) and the mPEG is relatively low molecular 
weight (e.g. ~350-750 Da). This component is designed to function as the non-fouling 
brush component of the monolayer, preventing non-specific adsorption and typically 
composes 90-99 % of the molar lipid concentration of the monolayer. When DTPE is the 
lipid component, a topochemical polymerization13, 15, induced by UV light (Figure 2.3), 
may be utilized to produce a conjugated 2D polymer, which should be more stable than a 
lipid monolayer and may allow for charge dissipation during electron imaging, which 
may lead to defects16 and lower overall possible resolution during 3D reconstruction of 
affinity grid-based cryo-EM. 
 
 
Figure 2.3 Topochemical Polymerization of Diacetylenic Lipids13. 
The minor component of the lipopolymer-based affinity grid approach is similar, 
but is composed of a higher molecular weight polymer (2-5 kDa) whose persistence 
length is significantly longer than the major component. The lipids utilized are either 
DTPE or DSPE. The distal terminus of this component is designed to incorporate various 
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affinity chemistries and covalently-active functionalities to enable selective capture of a 
wide range of targets using the lipopolymer-based affinity grid concept. NTA and tris-
NTA are useful for capture of his-tagged proteins using IMAC17 chemistry, glutathione is 
a useful handle for affinity purification of glutathione-S-transferase- (GST)-tagged 
proteins18, biotin may be utilized to take advantage of its affinity interaction with avidin- 
or streptavidin-fusions19 or for characterizing IMP’s via the proteoliposome-based 
spherical reconstruction approach to cryo-EM introduced by Sigworth and Wang20. 
The proposed materials are designed to be formulated into monolayers using a 
Langmuir trough. Since the relative molar compositions of the monolayer are completely 
tunable, relative particle surface density can be tuned to yield optimal particle spacing for 
3D reconstruction and automated particle selection21. 
2.3 Synthesis and Characterization of Affinity Lipopolymer Constructs 
2.3.1 Synthesis of Functional mPEG Derivatives 
 A small library of functional mPEG derivatives (Scheme 2.1) was synthesized 
following modified protocols previously reported for end group modification of higher 
molecular weight bifunctional PEG22. mPEG of various molecular weight (~350-5,000 
Da) 1a-e was converted to the mesylate (2a-e) via treatment with methansulfonyl 
chloride in dichloromethane (DCM) in the presence of triethylamine with average yields 
of 90-99 %. The mesylates were converted to azide-terminal-mPEG (3a-e) via SN2 
displacement by sodium azide in N,N-dimethylformamide (DMF) in 83-95 % average 
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yield. Reduction using hydrogen gas (1 atm) and 10 mol % palladium on carbon (Pd/C) 
support in ethyl acetate (EtOAc) gave the terminal amine (4a-e) in 82-94 % average 
yields.  
Carboxyl-terminal mPEG were obtained via Jones oxidation of 1a-e, giving 5a-e 
in 89-94 % average yields. Conversion was determined via TLC analysis combined with 
staining with bromocresol green to verify oxidation. An alternative route to amine 
terminal mPEG through an aldehyde-terminal intermediate was also utilized. The 
aldehyde-terminal mPEG derivatives were obtained via Albright-Goldman oxidation of 
1a-e to give 6a-e in 89-94 % average yield. The aldehyde-terminal mPEG were then 
converted to the amine 7a-e via reductive amination mediated by sodium 
cyanoborohydride and ammonia in methanol in 90-98 % overall yield. Reported yields 
are given as percent recovery. Polymers were purified via extractions and precipitation 
into diethyl ether depending on the polymer molecular weight (PEG with molecular 
weight < ~2 kDa exists as an oil or liquid and cannot be precipitated). For lower 
molecular weight polymers, TLC and TLC staining was utilized to monitor conversion to 
determine optimal reaction times. The efficiency of conversion for Jones oxidation is 
near complete22b. Conversions reported for the Albright-Goldman and reductive 
amination protocols are 78-86 %22b.  
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Scheme 2.1 Synthesis of Functional mPEG Derivatives. 
2.3.2 Synthesis of mPEG-Lipid Conjugates 
 mPEG-lipid conjugates were synthesized via a two-step process (Scheme 2.2). 
Carboxyl terminal mPEG 5a was converted to the active N-hydroxysuccinimidyl ester 8 
mediated by N-ethyl-N’-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-
hydroxysuccinimide (NHS) in the presence of diisopropylethylamine (DIEA) in DMF. 
Compound 8 was obtained in 84.4 % yield. Direct coupling of the carboxyl-terminal 
polymer and PE lipid was not performed in order to avoid activation of the phosphate 
groups of the lipids. The lipid conjugates 9a-c were synthesized via NHS-displacement 
upon treatment of the active ester of PEG with the phosphoethanolamine lipid in the 
presence of base. After chromatographic purification, mPEG conjugates of DTPE (9a), 
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DSPE (9b) and DPPE (9c) were synthesized. The lipid conjugates were obtained in 
varying yields from 31.1-72.3 %.  
  
 
Scheme 2.2 Synthesis of mPEG-Lipid Conjugates. 
 2.3.3 Synthesis of Biotin-PEG-lipids 
Biotin terminal lipopolymers (11a-b) were synthesized via treatment of 
commercial heterobifunctional biotin-PEG-NHS 10 with the phosphoethanolamine lipid 
(Scheme 2.3). After chromatographic purification, conjugates of DTPE (11a) and DSPE 
(11b) were synthesized in 75.3 and 56.4 % yield, respectively. In this case, PEG 
molecular weight was (~2.0 kDa).  
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Scheme 2.3 Synthesis of Biotin-PEG-Lipids. 
2.3.4 Synthesis of Functional t-butyl-NTA and tris-NTA Derivatives 
A small library of functional t-butyl-protected NTA and tris-NTA derivatives 
were also prepared (Scheme 2.4). The protocols used to synthesize these materials were 
based on previously reported protocols with modification23. 
H-Lys(Z)-OH (12) was converted to the t-butyl ester 13 by transesterification of t-
butyl acetate catalyzed by perchloric acid in 78.7 % yield. Compound 13 was then 
dialkylated by t-butyl bromoacetate in the presence of DIEA in DMF to give Compound 
14 in 84.4 % yield after chromatographic purification. Compound 14 was debenzylated 
by reductive hydrogenation on palladium on carbon support to give Compound 15 in 99.7 
% yield. Carboxyl-NTA 16 was synthesized from Compound 15 via acylation by succinic 
anhydride in the presence of organic base in DCM in 99.7 % yield after chromatographic 
purification. Alkyne-NTA derivative 17 was synthesized from Compound 16 via EDC-
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mediated coupling with propargylamine in the presence of N-hydroxybenzotriazole 
(HOBt) and DIEA in DMF in 88.5 % yield after chromatographic purification. 
 
Scheme 2.4 Synthesis of Functional t-butyl-NTA Derivatives. 
Z-protected NTA derivative 18 was synthesized via direct dialkylation of 
Compound 12 by bromoacetic acid in aqueous sodium hydroxide solution to give 
Compound 18 in 96.3 % yield without chromatographic purification. Compound 18 may 
also be converted to the fully deprotected lysine-NTA derivative 19 via hydrogenation 
using palladium on carbon under 1 atm of hydrogen gas in aqueous solution in 96.3 % 
yield. 
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Scheme 2.5 Synthesis of Functional t-butyl-tris-NTA Derivatives. 
Z-protected tris-NTA 20 was synthesized by EDC coupling of Compounds 15 and 
18 in the presence of HOBt and DIEA in DMF in 88.4 % yield after chromatographic 
purification. Hydrogenation of 20 by Pd/C under 1 atm of hydrogen gas gave 21 in 97.6 
% yield. A similar functionalization strategy to generate carboxyl- and alkynyl-
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functional-NTA derivatives was also employed for tris-NTA. Compound 21 was 
converted to a carboxyl-functional derivative via acylation by succinic anhydride in the 
presence of base in DCM to give Compound 22 in 87.4 % yield after chromatographic 
purification. Compound 22 was then converted to an alkynyl derivative via EDC-
mediated coupling with propargylamine in the presence of HOBt and DIEA in DMF to 
give Compound 23 in 76.4 % yield after chromatographic purification (Scheme 2.5). 
 
Scheme 2.6 Synthesis of PNP-Activated t-butyl-Protected NTA and tris-NTA 
Derivatives. 
Reactive p-nitrophenyl carbamate derivatives of Compounds 15 and 21 were 
synthesized via treatment of the respective primary amines with p-nitrophenyl 
chloroformate in the presence of DIEA in DCM to give Compounds 24 and 25 in 44.8 % 
and 73.1 % yields, respectively, after chromatographic purification (Scheme 2.6). 
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2.3.5 Initial Synthesis of DTPE-PEG-NTA. 
Initial efforts to synthesize NTA-terminal lipopolymers were only moderately 
successful due to low overall yield and side reactions associated with DTPE. Commercial 
heterobifunctional PEG derivative 26 containing t-butyl carbamate (Boc) and N-
hydroxysuccinimidyl-ester termini was used to acylate DTPE in the presence of base in 
DCM under dark conditions. Lipopolymer conjugate 27 was obtained in 87.8 % yield 
after chromatographic purification. Removal of Boc was effected by treatment with 
trifluoroacetic acid (TFA) in DCM in the presence of triethylsilane as a cation scavenger 
to give 28 in 91.3 % yield. Treatment of 28 with p-nitrophenylcarbamate 24 in the 
presence of base in DCM gave Compound 29 in 26.9 % yield after chromatographic 
purification. Compound 29 was then treated with TFA and triethylsilane in DCM to give 
Compound 30 in 62.1 % yield. 
 
 
Scheme 2.7 Initial Synthesis of DTPE-PEG-NTA. 
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2.3.6 Synthesis of Thiol-Functional NTA and tris-NTA Derivatives. 
 When working with polymers, small changes in end group or conjugation of a 
small-molecule tend to cause little change in the retention-factor of the product relative to 
the starting material. Thus, reactions that are highly efficient are best. For synthesizing 
affinity lipopolymer constructs, a synthetic pathway was designed that utilized thiol-
maleimide chemistry as the final step in the pathway to conjugate various affinity 
moieties. Although thiol-containing derivatives of NTA have been synthesized and 
reported24 by groups in the past, the synthetic routes to these compounds are 
unnecessarily complicated, use starting materials uncommon to other NTA synthetic 
routes and the target compounds are quite hydrophobic since they have long alkyl chains 
as tethers between the NTA and thiol functionalities.  
 A simpler synthesis that utilizing t-butyl-protected-lysine-NTA derivative 15 and 
S-trityl-3-mercaptopropionic acid 32 as starting materials was devised where a global 
TFA-mediated deprotection could yield the fully deprotected 34 (Scheme 2.8). 3-
Mercaptopropionic acid 31 was trityl-protected via treatment with trityl chloride in DCM 
to give 32 in 93.2 % yield. Coupling between Compounds 15 and 32 was accomplished 
by EDC-mediated coupling in the presence of HOBt and DIEA in DMF to give 
Compound 33 in 53.4 % yield after chromatographic purification. Global deprotection 
was effected by treatment of Compound 33 with TFA in the presence of triethylsilane in 
DCM to give Compound 34 in 92.7 % yield. 
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Scheme 2.8 Synthesis of Thiol-NTA. 
 Following a similar strategy, with a global TFA-mediated deprotection as the final 
step a thiol-containing derivative of tris-NTA was synthesized. Tris-NTA is used for 
affinity interaction with his-tagged protein in the same way as NTA, but tris-NTA has 
much higher binding affinities for his-tags (nM) as compared to NTA (µM). 
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Scheme 2.9 Synthesis of Thiol-tris-NTA. 
 S-Trityl-L-cysteine (35) was dialkylated under basic conditions by bromoacetic 
acid in a mixture of water and methanol to give Compound 36 in 82.0 % yield. EDC-
mediated coupling between Compounds 36 and 15 in the presence of HOBt and DIEA in 
DMF gave Compound 37 in 76.1 % yield after chromatographic purification. Global 
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deprotection of Compound 37 by TFA in the presence of triethylsilane in DCM gave 
Compound 38 in 92.2 % yield. Both Compounds 34 and 38 were highly water soluble, 
making them suitable for aqueous conjugation reactions (Scheme 2.9).  
2.3.7 Synthesis of DSPE-PEG-Maleimide and DSPE-PEG-NTA. 
 A mild synthesis of NTA-containing lipopolymer was accomplished using thiol-
maleimide Michael-addition chemistry (Scheme 2.10). Commercial heterobifunctional 
PEG Compounds 39a-b containing maleimide- and N-hydroxysuccinimidyl ester- 
terminal functionalities was conjugated to DSPE in the presence of DIEA in chloroform 
to give Compounds 40a-b in 43.4 % and 30.1 %, respectively after chromatographic 
purification. Thiol-NTA derivative 34 was then conjugated to the lipopolymer via 
Michael-addition in the presence of triethylamine (TEA) in DMF to give 41a-b in 89.8 % 
and 53.3 % yields, respectively 
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Scheme 2.10 Synthesis of DSPE-PEG-Maleimide and DSPE-PEG-NTA. 
 An alternative synthetic pathway to DSPE-PEG-maleimide was also utilized, but 
the overall yield of 45.8 % over three steps was only slightly improved over the single-
step direct conjugation of the phosphoethanolamine-containing lipid to the 
heterobifunctional PEG derivative, maleimide-PEG-NHS (Scheme 2.11). This pathway 
utilized the Diels-Alder adduct formation between 2.5-dimethylfuran and maleimide25, 
which is subject to thermodynamic control. Compound 39a and 2.5-dimethylfuran were 
mixed at 40 °C to form the Diels-Alder adduct 42. Compound 42 was then conjugated to 
DSPE in the presence of DIEA in chloroform to give 43 in 75.8 % yield. The Retro-
Diels-Alder reaction was effected by heating isolated Compound 43 in toluene at 80 °C 
to give Compound 44 in 61.5 % yield.  
    55 
 
Scheme 2.11 Alternative Synthesis of DSPE-PEG-Maleimide Utilizing Diels-Alder as a 
Protection Strategy. 
2.3.8 Synthesis of DSPE-PEG-tris-NTA 
 A similar strategy for the synthesis of Compound 41 was employed to generate 
tris-NTA-terminal lipopolymer construct (Scheme 2.12). Compounds 40a-b were 
conjugated to thiol-containing tris-NTA construct 38 via Michael addition in the presence 
of TEA in DMF to give 45a-b in 87.7 % and 40.2 % yield, respectively. 
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Scheme 2.12 Synthesis of DSPE-PEG-tris-NTA. 
2.3.9 Synthesis of DSPE-PEG-Glutathione 
 A similar approach was used to generate a lipopolymer conjugate of glutathione. 
Glutathione-S-transferase (GST) binds glutathione with high affinity and can be 
engineered as a fusion protein with a target protein of interest26. Therefore, glutathione-
terminal lipopolymer constructs may be useful for cryo-EM analysis of protein targets 
that bind glutathione or can be engineered to be GST-tagged. Compound 40a was 
coupled to L-glutathione via Michael addition in the same manner as the thiol-NTA and 
thiol-tris-NTA derivatives. Compound 46 was obtained in 93.1 % yield. 
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Scheme 2.13 Synthesis of DSPE-PEG-Glutathione. 
2.4 Performance of PEG-NTA-Based Affinity Grids 
 Langmuir-Schaefer deposition of a mixed monolayer containing two synthetic 
polymerizable lipids – 1,2-(tricosa-10’,12’-diynoyl)-sn-glycero-3-phosphoethanolamine-
N (methoxypolyethylene glycolamide 350) (9a, mPEG350-DTPE) and either 1,2-
(tricosa-10’,12’-diynoyl)-sn-glycero-3-phosphoethanolamine-N-[(5-amido-1-
carboxypentyl)iminodiacetic acid]polyethylene glycolamide 2000) (30, NTA-PEG2000-
DTPE) or 1,2-distearoyl–sn-glycerol-3-phosphoethanolamine-N-[(5-amido-1-
carboxypentyl)iminodiacetic acid]polyethylene glycolamide 2000) (41a, NTA-PEG2000-
DSPE) – prior to treatment with a 10 min, 254 nm light exposure was used to prepare 
stabilized affinity monolayers supported on carbon coated EM grids. These grids were 
then used to capture His6-T7 bacteriophage and His6-RplL from cell lysates, as well as 
purified histidine-tagged green fluorescent protein (His8-GFP) and nanodisc embedded 
His6-MalFGK2. Findings indicate that polymerized NTA lipid monolayers are capable of 
capturing His6-protein targets in a manner that controls their areal densities, while 
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efficiently blocking non-specific adsorption and limiting film degradation upon 
prolonged detergent exposure. 
 
2.4.1 Affinity Lipopolymer Monolayer Formation and Characterization 
CHCl3 stock solutions of the lipid mixtures were prepared, spread at the air-water 
interface at 20 C, a 5 min incubation period allowed for evaporation of the solvent, and 
the films compressed at a rate of 10 Å2/molecule until collapse at 30 mN/m – 35 mN/m 
for the mixed monolayers and 40 mN/m for pure mPEG350-DTPE monolayers. The 
pressure-area isotherms shown in Figure 2.4 for 1:99 and 5:95 NTA-PEG2000-
DTPE:mPEG350-DTPE lipid mixtures displayed gradually increasing surface pressures 
upon film compression, except that the onset of surface pressure occurred at larger 
molecular areas as the NTA-PEG2000-DTPE composition in the film increased. We 
attribute this observation to the displacement of surface-adsorbed NTA-PEG2000 from 
the air-water interface as previously described27 for mixed mPEG2000-lipid monolayers. 
As this desorption process progresses, the majority component, mPEG350, undergoes a 
mushroom-brush regime transition upon compression to 30 mN/m while the NTA-
PEG2000 fraction remains in the mushroom configuration. The extension of the 
PEG2000 polymer mushroom conformation from the surface of the film can be 
calculated by Lo = αN(α/D)2/3, where Lo = the length of PEG graft, α = length of PEG 
monomer (3.5 Å), N = number of ethylene glycol units in the PEG chain (i.e., 45), and D 
= the distance between grafting sites. For a lipid film containing 1% NTA-PEG2000-
DTPE, the grafting site separation is estimated to be 47 Å and the Lo = 2.8 nm. Fully 
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compressed 5:95 NTA-PEG2000-DTPE:mPEG350-DTPE monolayers are estimated to 
have a grafting site separation of 9.4 Å and a NTA-PEG2000 graft extension of 8.2 nm. 
As the lipid film is compressed below 113 Å2/molecule, the mPEG350 fraction enters the 
brush regime, while the NTA-PEG2000 polymer chain accommodates further 
compression by extending farther away from the air-water interface in a concentration-
dependent manner. Consequently, a longer NTA-PEG was prepared for these studies 
since it would confer greater conformational freedom to the immobilized histidine-tagged 




Figure 2.4 Pressure-Area Isotherm for 1:99 (black) and 5:95 (red) NTA-PEG2000-
DSPE:mPEG350-DTPE Monolayers at 20 C. The mushroom to brush regime is 
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Since the lipid films typically collapsed at surface pressures above 30 mN/m, the 
monolayers were compressed to 30 mN/m prior to Langmuir-Schaefer (LS) transfer onto 
carbon-coated grids that were not subjected to glow discharge before LS deposition. This 
method produced transfer ratios between 0.89 – 0.97 for the LS deposition step. 
Photopolymerization of the lipid monolayer was initiated by placing the grids ~6 – 8 cm 
from a handheld UV lamp and irradiated for 10 min. Grid performance as a function of 
varied irradiation time suggested that a 10 min exposure was most favorable. 
After monolayer film transfer onto 400 mesh grids and staining with freshly 
prepared 1% UO2(OAc)2, TEM images revealed the presence of large continuous areas 
exceeding 900 m2 in size that were punctuated by much smaller zones of higher contrast 
(Figure 2.5). We infer from these findings that the large area regions were monolayer 
films with occasional, interspersed domains of bilayer and trilayer films arising from 
partial monolayer collapse during compression that were preserved by the 
photopolymerization process. Sufficiently large areas of the grid were coated by 
stabilized monolayer film structures to make them suitable for negative stain and cryoEM 
studies; however, the multi-layer sections of the film were helpful for monitoring the 
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Figure 2.5 Characterization of Affinity Lipopolymer Monolayers by TEM. (A) Negative 
Stain TEM Images of Grids Coated with 1:99 NTA-PEG2000-DSPE:mPEG350-DTPE 
Monolayers. (B) Some sections of the monolayer-coated grid display areas with stepwise 
contrast that is suggestive of monolayer (1L), bilayer (2L) and trilayer (3L) lipid films. 
Scale bar: 400 nm. 
2.4.2 Evaluation of Affinity Lipopolymer Non-Fouling Properties 
The anti-fouling properties of the mPEG350 brush layer within the stabilized 
monolayer coating was probed qualitatively using fluorescence microscopy analysis of 
His8-GFPuv adsorption onto these modified surfaces. Wide field and line scan 
fluorescence microscopy analysis revealed that glow discharged bare amorphous carbon 
surfaces possessed nearly 20-fold greater fluorescence intensities after exposure to His8-
GFPuv than grids bearing mPEG350 brush regime coatings (>8000 RFU and ~400 RFU, 
respectively; Figure 2.6). Our data shows that the fluorescence distribution was uniform 
over both types of surfaces, however, in rare instances there were small variations in 
fluorescence observed. In those cases, we attribute the areas of decreased fluorescence to 
grid regions with an incomplete carbon coating, whereas zones of substantially increased 
fluorescence were ascribed to incomplete LS transfer of the brush layer mPEG350-
DTPE. We infer from these findings that non-specific binding of protein on the brush 
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regime mPEG350-DTPE coated grids is much lower than that of glow discharged bare 
carbon films due to the combined effects of molecular weight, polymer hydration, 
excluded volume, elastic restoration, and grafting density on the surface that enhance the 
antifouling properties of the mPEG coating.12b, 28 In some cases, low molecular weight 
PEG polymers such as mPEG350 display greater antifouling properties than their higher 
molecular weight counterparts since the shorter PEG chains are better able to form a 
more densely packed layer.29 Based on these findings, we concluded that brush regime 
mPEG350-DTPE monolayers, deposited onto a carbon coated surface by LS transfer, 
would be a good candidate for blocking non-specific adsorption of macromolecules onto 
EM grid surfaces. To test this assumption, we conducted a comparative study between 
DLPC monolayers and mPEG350-DTPE stabilized monolayers, both deposited via LS 
transfer, using bare carbon grids as a control. 
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Figure 2.6 Fluorescence Microscopy of Uncoated and Stabilized Monolayer-Coated TEM 
Grids. Fluorescence microscopy analysis of EM grids exposed to 2.0 mg/mL His8-GFPuv 
for 2 min, followed by three MilliQ water rinses to remove unbound protein. (A) Bare 
carbon coated grids (glow discharged) and (B) 100% mPEG350-DTPE coated grids 
prepared by compression to the brush regime of mPEG350, LS transfer onto carbon 
coated grids, and photopolymerization as described in the Experimental Section. (C) Line 
scans of the regions highlighted in (A) and (B), showing CCD pixel intensity as a 
function of position along the grid using the same protein source, protein deposition time, 
rinsing conditions, and fluorescence imaging settings. Substantially lower His8-GFPuv 
fluorescence was found on the mPEG350-DTPE coated grids than in the bare carbon 
coated grids. The abrupt reduction in pixel intensity centered at 76 m in the bare carbon 
surface line scan is attributed to an absence of carbon coating on this section of the TEM 
grid. 
His8-GFPuv capture on grids bearing stabilized 1:99 and 5:95 Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE monolayers was first demonstrated by fluorescence 
microscopy. Wide-field fluorescence images (Figure 2.6) of Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE modified grids reveal a non-uniform, concentration-dependent 
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GFP fluorescence. Some spots of bright fluorescence, suggestive of GFP aggregation, 
were also observed. The observed pixel intensities in the fluorescence line scan analyses 
were higher for the grids bearing a 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE 
coating than the grids coated with a 1:99 monolayer. In both cases, the bound His8-
GFPuv could be removed from the grid surface after a brief 5 min exposure to either 500 
mM imidazole or 150 mM EDTA to remove Ni2+ from the His8:Ni2+:NTA complex to 
enable elution of the immobilized protein target from stabilized, Ni2+ activated 1:99 and 
5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayers. These findings indicate 
that His-tag targets can be captured in an NTA concentration-dependent manner, with 
higher NTA loadings producing greater target protein concentrations on TEM coated 
with stabilized, Ni2+-activated NTA-PEG2000-DTPE:mPEG350-DTPE monolayers. 
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Figure 2.7 Fluorescence Microscopy of TEM Grids Coated with Stabilized NTA-
PEG2000-DSPE:mPEG350-DTPE Monolayers. Fluorescence microscopy analysis of EM 
grids coated with 1:99 or 5:95 NTA-PEG2000-DSPE:mPEG350-DTPE after compression 
to the brush regime of mPEG350, LS transfer onto carbon coated grids, 
photopolymerization, and Ni2+ activation as described in the Experimental Section. The 
grids were then exposed to 2.0 mg/mL His8-GFPuv for 2 min, followed by three MilliQ 
water rinses to remove unbound protein. (A) Appearance of 1:99 coating before and (C) 
after 500 mM imidazole, pH 7.2 treatment. (B) Appearance of 5:95 coating before and 
(D) after 500 mM imidazole, pH 7.2 treatment. (E) Cartoon illustrating varying surface 
density of bound target with varying monolayer composition. (F) Line scans of the 
regions highlighted in (A) - (D), showing CCD pixel intensity as a function of position 
along the grid using the same protein source, protein deposition time, rinsing conditions, 
and fluorescence imaging settings. 
Purified His6-T7 bacteriophage (1011 – 1012 particles/mL) was used to probe the 
non-specific adsorption properties of DLPC and mPEG350-DTPE stabilized monolayer-
coated grids at higher resolution, with carbon coated, glow-discharged grids serving as a 
control. The sample precipitated on grids lacking modified DLPC or mPEG350 
monolayers (Figure 2.8A). We identified virus-like particles on these grids, as shown in 
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Figure 2.8A (inset); however, the poor sample quality produced on unmodified, glow-
discharged grids made accurate quantification of adsorbed virus particles impossible. 
Therefore, we only quantified virus adsorption onto DLPC and mPEG350 modified grids, 
as discrete particles could be discerned in both cases. DLPC coated grids were found to 
decrease the amount of T7 that was adsorbed to the grid relative to bare carbon grids 
(Figure 2.8B), indicating that interactions between T7 bacteriophage and the DLPC 
monolayer are not as favorable. Nonetheless, a significant amount of occult debris 
remained on the DLPC monolayer coated grids. Grids coated with mPEG350-DTPE 
stabilized monolayers; however, displayed a greatly reduced accumulation of both T7 and 
debris (Figure 2.8C). The appearance of the virus particles in these samples included 
round-like objects as well as more familiar hexagonal projections of the mature 
icosahedral form of the virus. The T7 phage particle here represents the immature form 
where an absence of mature capsid shell protein gives results in the rounded appearance 
of these particles.30 The low abundance of T7 phage particles in this image highlights the 
antifouling opportunities of these PEGylated surfaces. Quantitative comparisons of the 
T7 particle densities on DLPC and mPEG350 monolayers revealed an accumulation of 
~110 particle/1 μm2, and 5 particle/1 μm2, respectively. We infer from these findings that 
mPEG350-DTPE stabilized monolayers are the most effective toward blocking non-
specific adsorption of T7 bacteriophage (Figure 2.8D). Low magnification images of 
purified T7 deposited onto both DLPC and mPEG-DTPE stabilized monolayer coated 
grids reveal a substantially lower background in the case of mPEG350-DTPE coated 
grids (Figure 2.8E and 2.8F). 
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Figure 2.8 Comparative Performance of Uncoated (bare carbon, glow-discharge), DLPC, 
and mPEG350-DTPE Coated Grids Toward Non-Specific Protein Adsorption (i.e., 
lacking NTA groups to promote specific binding). The capacity of these grids to reject 
non-specific protein adsorption was tested by negative stain TEM analysis using His6-T7 
bacteriophage in purified form or within cell lysates. (A) Purified His6-T7 bacteriophage 
on glow-discharged bare carbon grid; (B) purified His6-T7 bacteriophage on 100% DLPC 
monolayer coated grid; (C) His6-T7 bacteriophage on stabilized 100% mPEG350-DTPE 
monolayer coated grid; (D) number of non-specific contaminants adsorbed from purified 
His6-T7 bacteriophage solution onto bare carbon grids (blue), DLPC coated grids (red), 
and mPEG350-DTPE coated grids (green) as determined by counting 60 randomly 
selected fields across 3 different grids for each grid type; (E) His6-T7 bacteriophage in 
cell lysate applied to 100% DLPC coated grid; and (F) His6-T7 bacteriophage in cell 
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2.4.3 Affinity Capture of His-Tagged Proteins Using Affinity Lipopolymers Grids 
After evaluating the capacity of these grids to inhibit non-specific adsorption, we 
next turned our attention to their ability to direct affinity-guided interactions with NTA-
modified grids. First, we used fluorescence microscopy to monitor His8-GFPuv capture on 
grids bearing stabilized 1:99 and 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE 
monolayers. Wide-field fluorescence images (Figure 2.7) of Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE modified grids reveal a non-uniform, concentration-dependent 
GFP fluorescence. Occasional spots of bright fluorescence, suggestive of GFP aggregation, 
were also observed. The observed average pixel intensities in the fluorescence line scan 
analyses were higher for the grids bearing a 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE coating than the grids coated with a 1:99 monolayer. In both cases, the bound His8-
GFPuv could be removed from the grid surface after a brief 5 min exposure to either 500 
mM imidazole or 150 mM EDTA to remove Ni2+ from the His8:Ni2+:NTA complex to 
enable elution of the immobilized protein target from stabilized, Ni2+ activated 1:99 and 
5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayers. These findings indicate 
that histidine-tagged targets can be captured in an NTA concentration-dependent manner, 
with higher NTA loadings producing greater target protein concentrations on TEM grids 
coated with stabilized, Ni2+-activated NTA-PEG2000-DTPE:mPEG350-DTPE 
monolayers. 
Affinity capture of His6-T7 bacteriophage from cell lysates was then tested by 
negative stain and cryoelectron microscopy using grids modified with mPEG350-DTPE 
stabilized monolayers, Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabilized 
monolayers, and Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabilized monolayers 
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rinsed with 500 mM imidazole after lysate exposure (Figure 2.9). In the presence of 
mPEG350-DTPE stabilized monolayers, we observed minimal binding of His6-T7 
bacteriophage and very low levels of debris from the lysate onto the grid (Figure 2.9A). 
Background adsorption of non-T7 phage debris is highlighted in the inset of this image. In 
some cases, T7 particles were not observed on the brush polymer surface even at low 
magnification, suggesting a complete blockage of non-specific adsorption. Grids bearing 
Ni2+-charged 1:99 NTA-PEG2000-DTPE:mPEG350-DTPE stabilized monolayers were 
capable of capturing His6-T7 bacteriophage from cell lysate while limiting the background 
adsorption of undesired non-target cellular components (Figure 2.9B). It is worth noting 
that T7 viral particles often give mixed results of negative-stain and positive-stained 
particles since uranyl salts may positively stain packaged nucleic acid within the capsid 
structure.31 Exposure of these samples to 500 mM imidazole led to greatly decreased 
surface adsorption of His6-T7 bacteriophage, suggesting that the interaction of phage 
particles with the supported NTA-lipid monolayer is Ni2+ specific (Figure 2.9C). We 
attribute the occurrence of the few remaining particles to either non-specific adsorption to 
uncoated grid regions or particles that are avidly bound due to multivalent interactions 
between the phage particles and the NTA-PEG grafted surface. To compensate for particle 
capture efficiency limitations in samples prepared for cryogenic imaging5 due to 
unfavorable kinetics and/or modest ligand-receptor affinities,32 we examined 1:99 and 5:95 
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabilized monolayer coated grids to 
determine whether the areal density of NTA ligands had a detectable influence on His6-T7 
bacteriophage capture efficiency. Using identical sample processing methods and 
incubation times, we qualitatively observed an increase in particle surface density with 
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increasing Ni2+:NTA-PEG2000-DTPE composition (unpublished data). Since this 
comparison was not performed in a side-by-side manner between 1:99 and 5:95 Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE stabilized monolayers with the same lysate, it is 
conceivable that these findings may be the result of different virus titers in the His6-T7 
bacteriophage preparations. Nonetheless, these findings are consistent with the His8-
GFPuv experiments described above (Figure 2.7) showing that higher surface 
concentrations of affinity capture lipid produces greater areal densities of immobilized 
target on the NTA-modified surface, with the 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE stabilized monolayer coated grids being more suitable for cryoEM sample 
preparation (Figure 2.9D). The immobilization of both mature and immature T7 phage 
from lysate samples (Figure 2.9F) highlights the potential of rapid purification using 
affinity grids for the study of dynamic processes, which may not be possible when 
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Figure 2.9 Effect of NTA Surface Density on His-T7 Bacteriophage Captured from Cell 
Lysates Using Negative Stain and Cryo-EM Analysis. (A) Negative stain TEM 
appearance of grid coated with stabilized 100% mPEG350-DTPE monolayer after 2 min 
exposure to cell lysate containing His-T7 bacteriophage; (B) same as in (A), except that 
the grid was coated with stabilized 1:99 Ni2+:NTA-PEG2000-DSPE:mPEG350-DTPE 
monolayer; (C) same as in (B), except that the grid was rinsed with 500 mM imidazole, 
pH = 7.4 after the 2 min lysate exposure step; and (D) cryoEM appearance of grid coated 
with stabilized 5:95 Ni2+:NTA-PEG2000-DSPE:mPEG-350-DTPE monolayer after 2 min 
exposure to cell lysate containing His-T7 bacteriophage. (E) Schematic of T7 
bacteriophage organization and structure. (F) Cryo-EM image of his-T7 bacteriophage 
revealing different stages of maturation. 
We next demonstrated the capture of the 50S E. coli ribosomal subunit,5 His6-
RplL, directly from cell lysates onto grids coated with Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE stabilized monolayers. Negative stain EM images of His6-RplL 
lysate deposited onto grids coated with mPEG350-DTPE stabilized monolayers showed 
no appreciable target-specific adsorption onto the grid (Figure 2.10A). After LS 
deposition of 1:99 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabilized monolayers 
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onto the grids, particles consistent with the size and various shapes of the 50S subunit 
were observed on the grid surface (Figure 2.10B). When 500 mM imidazole was added to 
samples containing the captured ribosomal particles on 1:99 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE stabilized monolayers, the previously adsorbed particles were 
eluted from the surface of the TEM grid (Figure 2.10C), consistent with the expectation 
that the interaction of His6-RplL with the surface of the grid is Ni2+ specific. Using the 
same sample preparation procedure, cryo-EM analysis revealed the capture of His6-RplL 
from E. coli lysates (Figure 2.10D) as crown-like projections in some images (Figure 
5D). These have frequently been reported and are attributed to the 50S ribosomal subunit. 
The earliest reported TEM images of ribosomes were small, featureless bumps on the 
grid surface;33 however, more powerful tools eventually led to the revelation of several 
features in the ribosomal units such as ‘crown-like’ and ‘duck-like’ projections for the 
50S and 30S subunits, respectively.34 Since the RplL protein carries the hexahistidine tag 
on the 50S subunit in our construct, we identified many more of these particles bound to 
the grid than the 30S subunit. Crown-like projections are clearly seen from the side view 
of the 50S particle with a central protuberance, a ridge, a stalk, and two groove-like 
features.  
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Figure 2.10 Affinity Capture of His-RplL from Cell Lysates onto Stabilized Ni2+:NTA-
PEG2000-DTPE:mPEG-350-DTPE Monolayer Coated Grids. (A) Negative stain TEM of 
grid coated with stabilized 100% mPEG350-DTPE after 2 min exposure to cell lysate 
containing His-RplL; (B) negative stain TEM of grid coated with 1:99 Ni2+:NTA-
PEG2000-DSPE:mPEG350-DTPE after 2 min exposure to cell lysate containing His-
RplL; (C) same as in (B), except that the grid was rinsed with 500 imidazole, pH=7.4 
after the 2 min exposure to cell lysate containing His-RplL; and (D): cryoEM image of 
grid coated with stabilized 5:95 Ni2+:NTA-PEG2000-DSPE:mPEG-350-DTPE 
monolayer after 2 min exposure to cell lysate containing His-RplL. 
 
 
A key design feature of these stabilized affinity coatings is their utilization of two 
different types of poly(ethylene glycol)-modified lipids, one high molar ratio brush layer 
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short segment to block non-specific adsorption and facilitate stabilization via 
photopolymerization (i.e., mPEG350-DTPE) and a second low molar ratio component to 
enable multiple orientations of the captured protein target to avoid preferred orientations 
at the monolayer interface and provide a more representative single particle 
reconstruction analysis data set. We tested this hypothesis by preparing dozens of TEM 
grids bearing stabilized Ni2+:NTA-PEG2000-DSPE:mPEG350-DTPE coatings that had 
been treated with His6-RplL containing lysates. CryoEM evaluation of these grids 
confirmed that the NTA-PEG2000 tether is capable of both capturing and presenting 
multiple orientations of the bound His6-RplL target as demonstrated by the overlay of the 
known 50S subunit and 70S complex structures in different rotational configurations onto 
the corresponding EM images shown in Figures 2.11A-D. 
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Figure 2.11 Cryo-EM Images and Conformational Overlay Showing Representative 
Views of His-tag RplL from Cell Lysates onto Stabilized 5:95 Ni2+-NTA-PEG2000-
DSPE:mPEG350-DTPE Monolayer Coated Grids. (A, B) Projections of different 
ribosomal large subunit (50S) orientations onto corresponding cryo-EM images; (C, D): 
projections of different full ribosomal (70S) particle orientations onto corresponding 
cryoEM images.  
Membrane scaffold proteins (MSP) have become an increasingly popular tool for 
stabilizing membrane protein dispersions since it provides a platform in which the local 
environment of solubilized membrane proteins resemble the natural environment of the 
lipid bilayer in cells.35 MSP are used to corral lipids and membrane proteins within disk-
like structures containing a lipid bilayer interior that can host reconstituted membrane 
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proteins for structure analysis by electron microscopy,36 protein modification studies,37 and 
protein activation analysis.38 We used the purified hexahistidine-tagged maltose 
transporter, His6-MalFGK2, solubilized in MSP lipid nanodisc, for evaluating their affinity 
capture properties on NTA-modified stabilized affinity grids. Although His-tag MSP can 
be used for affinity purification,39 we used a His6-MalFGK2 construct for nanodisc 
reconstitution to ensure that only nanodisc containing His6-MalFGK2 are surface 
immobilized. We found that mPEG350-DTPE stabilized monolayer coated grids treated 
with His6-MalFGK2 nanodisc appeared to have fewer particles bound to the grid surface 
(Figure 2.12A) than the grids coated with 1:99 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE stabilized monolayers (Figure 2.12B). Treatment of the His6-MalFGK2-immobilized 
grids with 500 mM imidazole produced a decrease in MSP nanodisc binding to the surface 
(Figure 2.12C), further suggesting that the interaction between nanodisc solubilized His6-
MalFGK2 and the NTA-modified surface is Ni2+ specific. High magnification images of 
nanodisc solubilized His6-MalFGK2 immobilized onto 5:95 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE stabilized monolayers (Figure 2.12D) reveal a set of disc-like 
features in the size range of other lipid nanodisc dispersions (7 – 13 nm in diameter).40 
Although the His6-MalFGK2 within the MSP nanodiscs is not directly observed due to its 
small size relative to the nanodiscs, the fact that these features elute with 500 mM imidazole 
strongly corroborates the assumption that they contain His6-MalFGK2. In addition, our 
images show predominantly top/bottom views of the particles, i.e., a disk-like appearance 
in TEM micrographs (Figure 2.12D), suggesting that a longer PEG spacer is needed to 
collect a greater number of side views for this solubilized target. 
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Figure 2.12 Affinity Capture of MSP Nanodisc Containing Purified His6-MalFGK2. (A) 
Negative stain TEM of stabilized 100% mPEG350-DTPE monolayer-coated grid after 
treatment with His-MalFGK2 in nanodiscs; (B) negative stain TEM of His-MalFKG2 in 
nanodisc captured on stabilized 1:99 Ni2+:NTA-PEG2000-DSPE:mPEG350-DTPE 
monolayer-coated grid; (C) same as in (B), except that the grid was rinsed with 500 mM 
imidazole, pH = 7.4 after the His-MalFGK2 in nanodisc exposure step; and (D) cryoEM 
of His-MalFGK2 in nanodisc captured on stabilized 5:95 Ni2+:NTA-PEG2000-
DSPE:mPEG-350-DTPE monolayer-coated grid. (E) Schematic of MSP nanodisc 3D 




2.4.4 Affinity Lipopolymer Grid Stability Against Detergent Exposure 
In order to test the durability of the stabilized monolayers toward detergent 
exposure, the modified grids were treated with either 0.03% Triton X-100 (CAC = 
0.015%), 0.014% Tween 20 (CAC = 0.0072%), or 0.5% CHAPS (CMC=0.49%) 
solutions for varying periods of time before TEM observation. Lipid monolayers 
adsorbed to solid substrates display better detergent resistance than lipid bilayers that are 
prone to disruption via lipid flip-flop.41 Initial encounter of detergents with the outer 
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bilayer leaflet results in fluidization and lipid flip-flop from the inner leaflet to the outer 
leaflet, eventually leading to complete solubilization of the bilayer structure.41b Inhibition 
of flip-flop due to adsorption of a highly compressed monolayer onto the solid carbon 
substrate inhibits flip-flop processes, leading to improved detergent resistance. 
Despite some evidence of enhanced detergent resistant of supported DLPC 
monolayers, prior attempts to produce TEM grids coated with mixed Ni2+:NTA-
DSG:DPLC monolayers showed that their exposure to harsher detergents such as Triton 
X-100, Tween-20, and CHAPS led to monolayer solubilization.5 We tested the detergent 
resistance of our stabilized Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayer 
coatings under conditions where DLPC monolayers failed by using 0.03% Triton X-100 
(CMC = 0.015%), 0.014% Tween 20 (CMC = 0.0072%), or 0.5% CHAPS (CMC = 
0.49%) at 5, 15, and 30 min exposures to the detergent solutions. Negative stain TEM 
observation of the coatings after detergent exposure indicated that stabilized Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE monolayer coatings remain intact after 30 minutes of 
incubation with Triton X-100, Tween-20, and CHAPS (Figure 2.13). In the case of Triton 
X-100, some holes in the monolayer were occasionally observed, but none were apparent 
in grids treated with Tween 20 or CHAPS. The capacity of these coatings to immobilize 
purified His6-T7 bacteriophage after detergent exposure for 20 min indicated that a 
modest reduction in phage binding to the grid occurred, however, the immobilized His6-
T7 bacteriophage particles were bound specifically as indicated by their ability to be 
removed by elution with 500 mM imidazole.  
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Figure 2.13 Negative Stain TEM Images of TEM Grids Coated with 1:99 NTA-
PEG2000-DSPE:mPEG350-DTPE After Exposure to Different Detergents. Negative 
stain TEM analysis of EM grids coated with 1:99 NTA-PEG2000-DSPE:mPEG350-
DTPE after compression to the brush regime of mPEG350, LS transfer onto carbon 
coated grids, photopolymerization, and exposure to different detergent solutions for 
varying periods of time prior to TEM analysis. (A – C): A 0.03% Triton X-100 solution 
(10 L) was placed in contact with the grids for (A) 5, (B) 15, or (C) 30 min. (D – F): A 
0.014% Tween 20 solution (10 L) was placed in contact with the grids for (D) 5, (E) 15, 
or (F) 30 min. (G – I): A 0.5% CHAPS solution (10 L) was placed in contact with the 
grids for (G) 5, (H) 15, or (I) 30 min. The scale bars in all images are 400 nm. A defocus 
of > 10 μm was used to improve visualization of the monolayer film coatings. 
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Fluorescence microscopy analysis of detergent-treated Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE monolayers revealed that the stabilized Ni2+ lipid monolayer 
coatings retained their ability to capture His8-GFPuv. Pixel intensity data was collected 
over the entire fluorescence image (Figure 2.14) to best represent the overall specific 
capture capacity of the coating, regardless of whether it had been detergent compromised 
or not. In the case of Triton X-100 exposed samples, the fluorescence was occasionally 
enhanced near the grid edges, possibly as a result of solubilized or damaged monolayer 
near the center of the grid holes that were unable to capture His8-GFPuv in those regions. 
We did not see this phenomenon with either CHAPS- or Tween 20-treated surfaces. These 
grids exhibited a uniform distribution of His8-GFPuv fluorescence over the grid holes until 
the surfaces were treated with 500 mM imidazole to displace the immobilized protein. 
Despite the limitations of these stabilized Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE 
monolayer coatings toward prolonged Triton X-100 exposure, our data indicates that 
histidine-tagged proteins can be reversibly immobilized even after detergent exposure. We 
infer from these findings that both the integrity of the stabilized lipid monolayer and the 
specific affinity capture of the grids remains intact after exposure to detergents that has 
proven detrimental to previously reported mixed Ni2+:NTA-DGS:DLPC monolayers.5 
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Figure 2.14 Effect of Detergent Exposure on 1:99 Ni2+:NTA-PEG2000-DSPE:mPEG350-
DTPE Stabilized Monolayer Affinity Grids as Determined by Fluorescence Microscopy 
Using His8-GFP as a probe for NTA Monolayer Retention. 
2.5 Conclusions 
A library of affinity lipopolymer constructs was synthesized consisting of 
lipopolymers of various PEG molecular weights conjugated to DTPE or DSPE as lipid 
anchors and NTA, tris-NTA, biotin and glutathione as affinity moieties or maleimide as a 
covalent functionality. This strategy is expected to be effective for specific capture of other 
targets of interest by varying the composition of the PEG terminus. Specific targets to 
expand the library include dibenzocycloctynyl and other specific ligands. This strategy 
may also be useful for screening of a molecular drug target by incorporating the drug target 
into the affinity lipopolymer constructs. 
Langmuir-Schaefer transfer of compressed, mixed lipid monolayers containing 
Ni2+:NTA-PEG2000:mPEG350 head groups in 1:99 and 5:95 molar ratios are capable of 
capturing His-tag protein targets from cell lysates with controllable areal densities and low 
degrees of non-specific protein adsorption. Photopolymerization of the mPEG350-DTPE 
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component in these monolayers by irradiating for 10 min at 254 nm produced EM grids 
with stabilized lipid coatings that were used to then used to capture His6-T7 bacteriophage 
and His6-RplL from cell lysates, purified His8-GFPuv, and nanodisc embedded His6-
MalFGK2. Our data indicate that the crosslinked lipid coating maintains the non-fouling 
properties of the monolayer and provides multiple orientations of the captured target on the 
surface, while also affording greater mechanical and detergent resistance than previously 
reported for EM grid-supported DLPC monolayers. 
2.6 Future Directions 
 To further advance this project, we are interested in the synthesis of novel 
lipopolymer constructs with terminal moieties which impart specificity for binding or 
covalent reaction with a specific target or class of targets. For instance, by generating a 
library of lipopolymer drug conjugates, a screening array could be constructed for 
simultaneous identification and structural characterization by cryo-EM. This could be a 
powerful new approach for drug discovery. As another example, dibenzocycloctynyl-
lipopolymer conjugate 47 could allow for selective capture of azide-containing targets. 
We are interested in exploring affinity grid performance with polymer conjugates of other 
types of lipids which may provide better monolayer performance. We are also interested 
in exploring the relation of parameters like PEG molecular weight, lipid composition and 
modification of other surfaces to affinity grid performance, as well.  
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Figure 2.15. Proposed Affinity Lipopolymer for Immobilization of Azide-Containing 
Targets, DSPE-PEG-DBCO. 
2.7 Experimental Methods 
All reactions were carried out under a blanket of N2 or argon gas. Reaction 
progress was monitored by thin-layer chromatography (TLC) analysis. TLC spots were 
visualized either by UV light (254nm), exposure by ninhydrin staining, staining with 
phosphomolybdic acid (PMA), staining by bromocresol green, or by staining with I2. 
Flash column chromatography was carried out using 230-400 mesh silica gel and 
analytical grade solvents. Solvents were purchased from Mallinckrodt/Baker and used 
without further purification unless noted. Toluene was purchased from Fisher. mPEG 
polymers were from Sigma-Aldrich and were purified before use via precipitation N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), Nε-
((benzyloxy)carbonyl)-l-lysine (H-Lys(Z)-OH) and H-Cys(Trt)-OH were purchased from 
Advanced Chemtech. Heterobifunctional PEG derivatives were purchased from JenKem 
Technology USA. 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) and 1,2-
(tricosa-10’,12’-diynoyl)-sn-glycero-3-phosphoethanolamine (DTPE) were purchased 
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from Avanti Polar Lipids.  All other chemicals were purchased from Sigma Aldrich and 
used without further purification. Dichloromethane (DCM), and toluene were distilled 
from CaH2. Triethylamine (TEA) was distilled from CaH2 and stored over BaO. 
Tetrahydrofuran (THF) was distilled from sodium-benzophenone ketyl. α-methoxy-
polyethylene glycol (mPEG350) was purchased from Sigma Aldrich and purified by 
azeotropic drying with toluene. Jones’ reagent (1.25 M in CrO3) was prepared by 
dissolving 17.5 g CrO3 in 125 mL water plus 16 mL conc. H2SO4.  
1H and 13C nuclear magnetic resonance (NMR) spectra were recorded on either a 
Bruker AV500HD (500MHz) or a Bruker ARX400 spectrometer (400 MHz). Chemical 
shifts are reported in ppm relative to the residual solvent peaks as internal standard 
2.7.1 Synthesis of Affinity Lipopolymer Constructs 
mPEG-mesylate (2a-e). mPEG was dried azeotropically with toluene several times and 
dried in vacuo for 18 hours. As a representative reaction, mPEG (6.00 g) was dissolved in 
DCM (85 mL) and triethylamine (1.5 equiv.) was added. The solution was cooled to 0 °C 
in an ice bath and methansulfonyl chloride (MsCl, 1.1 equiv.) was added dropwise over 
10 minutes. The reaction was stirred for an additional 30 minutes at 0 °C. The solution 
was transferred to a separatory funnel with an additional 50 mL DCM. The solution was 
washed with 100 mL ice water followed by 100 mL 5 % HCl solution. The organic 
solution was dried with anhydrous sodium sulfate and concentrated in vacuo. For mPEG 
< 2.0 kDa the oily residue was further dried in vacuo. For mPEG > 2.0 kDa, the oily 
residue was precipitated into cold diethyl ether (500-800 mL), filtered and dried in vacuo. 
Yield: (90-98 %); TLC: Rf= 0.66 (3:17 MeOH:DCM) for mPEG350. 
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mPEG-azide (3a-e). mPEG-mesylate 2a-e (6.69 g) was dissolved in DMF (150 mL) and 
sodium azide (10.0 equiv.) was added. The solution was stirred for 90 °C for 48 hours. 
DMF was evaporated in vacuo. The residue was dissolved in DCM ((200 mL), filtered 
and washed with deionized water (150 mL) twice. The aqueous washes were extracted 
with DCM (100 mL) twice each and the organic extracts were combined with the original 
organic solution and concentrated in vacuo. For mPEG < 2.0 kDa the oily residue was 
further dried in vacuo. For mPEG > 2.0 kDa, the oily residue was precipitated into cold 
diethyl ether (500-800 mL), filtered and dried in vacuo. Yield: (83-95 %); TLC: Rf= 0.63 
(3:17 MeOH:DCM) for mPEG350. 
mPEG-amine (4a-e). mPEG-azide 3a-e (5.52 g) was dissolved in ethyl acetate (50 mL) 
and 10% palladium on carbon (wet type) was added via spatula. The flask was equipped 
with a three-way adapter and a hydrogen balloon. The flask was evacuated and purged 
with hydrogen three times and stirred vigorously under 1 atm hydrogen atmosphere for 
24 hours at ambient temperature. The solution was gravity filtered through celite and 
concentrated in vacuo. For mPEG < 2.0 kDa the oily residue was further dried in vacuo. 
For mPEG > 2.0 kDa, the oily residue was precipitated into cold diethyl ether (500-800 
mL), filtered and dried in vacuo. Yield: (82-94 %); TLC: Rf= 0.06 (3:17 MeOH:DCM) 
for mPEG350. 
mPEG-carboxylic acid (5a-e). Jones oxidation was used to produce carboxylic acid-
terminal mPEG.  As a representative reaction, mPEG (5.00 g) was dissolved in 280 mL 
acetone. Jones’ Reagent (1.1 equiv) was added to a 500 mL round bottom flask and the 
mPEG solution was added to this flask dropwise over 1 h via addition funnel. The 
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resulting solution was stirred at 20 °C for 1 h before quenching the excess Jones reagent 
with a few mL of iPrOH. The resulting green precipitate was removed by decantation of 
the liquid solution. The volatiles were removed under reduced pressure and the residue 
dissolved in 150 mL H2O. The aqueous phase was extracted with DCM (4 x 120 mL). 
Depending of mPEG molecular weight, it may be necessary to add MeOH (100-200 mL) 
to effect phase separation. The organic layers were combined and dried over anhydrous 
Na2SO4, filtered, and evaporated under reduced pressure. For mPEG < 2.0 kDa, the oily 
residue was dried in vacuo. For mPEG > 2.0 kDa, the oily residue was precipitated into 
cold diethyl ether (500-800-mL), filtered and dried in vacuo.  TLC analysis was used to 
verify conversion using bromocresol green stain. Yield: (89-94 %); TLC: Rf= 0.26 (3:17 
MeOH:DCM) for mPEG350; 1H NMR for mPEG350 (400 MHz, CDCl3): δ 3.35 (s 3H), 
3.4-3.8 (m 30H), 4.01 (s 2H), 10.1-12.2 (br 1H). 
mPEG-aldehyde (6a-e). Albright-Goldman oxidation was used to oxidize terminal 
hydroxyl-moieties of mPEG to aldehyde groups. mPEG 1a-e was dissolved in a mixture 
of dimethyl sulfoxide (DMSO) and acetic anhydride (Ac2O) (5 mL of 3:2 DMSO:Ac2O 
for every 1 mmol of alcohol). This solution is prepared beforehand at least 24 hours 
before reaction. The solution was stirred for 24 hours at ambient temperature. The 
solution was concentrated in vacuo. For mPEG < 2.0 kDa the oily residue was further 
dried in vacuo. For mPEG > 2.0 kDa, the oily residue was precipitated into cold diethyl 
ether (500-800 mL) 2-3 times, filtered and dried in vacuo. Yield: (89-94 %). 
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mPEG-amine (7a-e). An alternative synthesis of amine-terminal mPEG was developed 
utilizing reductive amination. mPEG-aldehyde 6a-e (7.31 g), ammonium chloride (10.0 
equiv.) and potassium hydroxide (3.3 equiv) were dissolved in anhydrous MeOH (25 
mL). This solution was stirred for 30 min. A solution of sodium cyanoborohydride (10.0 
equiv.) in anhydrous MeOH (10 mL) was added and the solution was stirred under argon 
at ambient temperature for 24 hours. The solution was poured into 100 mL of deionized 
water and extracted with DCM (100 mL) four times. The organic extracts were dried over 
anhydrous sodium sulfate and concentrated in vacuo. For mPEG < 2.0 kDa the oily 
residue was further dried in vacuo. For mPEG > 2.0 kDa, the oily residue was 
precipitated into cold diethyl ether (500-800 mL), filtered and dried in vacuo. Yield: (90-
98 %); TLC: Rf= 0.04 (3:17 MeOH:DCM) for mPEG350. 
mPEG350-NHS (8). Compound 5a (274 mg, 0.753 mmol), and NHS (217 mg, 1.885 
mmol) were dissolved in 15 mL DCM and the resulting solution was cooled in an ice 
bath. EDC (173 mg, 0.902 mmol) was then added followed by DIEA (393 µL, 2.259 
mmol), and the solution was stirred while slowly warming from 4 to 20 °C over 18 hours. 
Volatiles were removed under reduced pressure and the residue was dissolved in 50 mL 
DCM. The organic filtrate was washed with 50 mL H2O twice before combining and 
extracting the aqueous phase with DCM (2 x20 mL). The combined organic phases were 
dried over anhydrous Na2SO4 before removing the solvent under reduced pressure and 
purifying the residue by flash chromatography on silica (3:17 MeOH:DCM). Yield: 230 
mg (84.4 %); TLC: Rf= 0.66 (3:17 MeOH:DCM); 1H NMR (400 MHz, CDCl3): δ 2.65 (s 
4H), 3.35 (s 3H), 3.4-3.8 (m 30H), 4.01 (s 2H). 
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mPEG350-DTPE (9a). Compound 3 (100 mg, 0.210 mmol) and DTPE (183 mg, 0.210 
mmol) were dissolved in DMF (5 mL) in a 100 mL round bottom flask covered in 
aluminum foil. DIEA (37 µL) was added and the solution was stirred at 20 C for 36 
hours in the dark under N2. The volatiles were removed under reduced pressure and the 
residue was purified by chromatography on silica (3:17 MeOH:DCM). Yield: 82 mg 
(31.1%); TLC: Rf= 0.29 (3:17 MeOH:DCM). 1H NMR (400 MHz, CDCl3): δ 0.88 (t 6H), 
1.25-1.35 (m 44H), 1.49 (m 8H), 2.22 (m 8H), 2.53 (br 2H), 2.61 (br 2H), 3.36 (s 3H), 
3.54-4.32 (m, 40H), 512 (br 1H), 7.64 (br 1H). 
mPEG350-DSPE (9b). Compound 3 (100 mg, 0.210 mmol) and DSPE (157 mg, 0.210 
mmol) were dissolved in chloroform (10 mL) in a 100 mL round bottom flask. DIEA 
(154 µL) was added and the solution was stirred at 20 °C for 36 hours under N2. The 
volatiles were removed under reduced pressure and the residue was purified by 
chromatography on silica (3:17 MeOH:DCM). Yield: 173.2 mg (81.6%); TLC: Rf= 0.24 
(3:17 MeOH:DCM). 1H NMR (400 MHz, CDCl3) δ 4.48 – 4.33 (m, 1H), 4.33 – 4.05 (m, 
4H), 3.91 – 3.69 (m, 5H), 3.64 (s, 52H), 3.37 (s, 6H), 3.07 (s, 2H), 2.95 (s, 2H), 2.71 (d, J 
= 48.6 Hz, 7H), 2.33 (s, 1H), 1.24 (s, 22H), 0.87 (t, J = 15.3 Hz, 6H). 
mPEG350-DPPE (9c). Compound 3 (61.0 mg, 0.13 mmol) and DPPE (100 mg, 0.14 
mmol) were dissolved in chloroform (5 mL) in a 100 mL round bottom flask. DIEA (92 
µL) was added and the solution was stirred at 20 °C for 36 hours under N2. The volatiles 
were removed under reduced pressure and the residue was purified by chromatography 
on silica (3:17 MeOH:DCM). Yield: 108.8 mg (72.3 %); TLC: Rf= 0.21 (3:17 
    89 
MeOH:DCM).  1H NMR (400 MHz, CDCl3) δ 5.20 (s, 1H), 4.36 (d, J = 13.7 Hz, 1H), 
4.16 (s, 1H), 4.01 (s, 2H), 3.94 (s, 3H), 3.65 (d, J = 13.0 Hz, 18H), 3.54 (d, J = 5.8 Hz, 
2H), 3.47 (s, 1H), 3.38 (d, J = 13.5 Hz, 3H), 2.86 (s, 1H), 2.27 (s, 3H), 1.56 (s, 4H), 1.23 
(s, 40H), 0.86 (t, J = 6.5 Hz, 6H). 
DTPE-PEG2K-biotin (11a). Biotin-PEG2K-NHS (10, 163 mg) and DTPE (52 mg) were 
combined in an oven-dried 100 mL round bottom flask equipped with a rubber septum 
and magnetic stir bar covered in aluminum foil. The solids were dissolve in 5 mL 
chloroform and 26 µL DIEA was added. The solution was stirred under nitrogen for 36 
hours. The volatiles were removed under reduced pressure and the residue was purified 
by chromatography on silica (1:4 MeOH:DCM). Yield:  146 mg (75.3 %); TLC: Rf= 0.38 
(1:4 MeOH:DCM).  1H NMR (400 MHz, CDCl3) δ 6.49 (s, 1H), 5.84 (s, 1H), 5.20 (s, 
1H), 4.52 (s, 1H), 4.35 (s, 3H), 4.07 (d, J = 57.5 Hz, 11H), 3.63 (s, 343H), 3.10 (d, J = 
32.1 Hz, 6H), 2.90 (d, J = 17.2 Hz, 3H), 2.82 – 2.55 (m, 4H), 2.52 – 2.03 (m, 19H), 1.68 
(s, 12H), 1.57 – 1.08 (m, 91H), 0.87 (s, 6H). 
DSPE-PEG2K-biotin (11b). Biotin-PEGK-NHS (10, 200 mg) and DSPE (66 mg) were 
combined in an oven-dried 100 mL round bottom flask equipped with a rubber septum 
and magnetic stir bar. The solids were dissolve in 10 mL chloroform and 34 µL DIEA 
was added. The solution was stirred under nitrogen for 36 hours. The volatiles were 
removed under reduced pressure and the residue was purified by chromatography on 
silica (1:4 MeOH:DCM). Yield: 150 mg (56.4  %); TLC: Rf= 0.43 (1:4 MeOH:DCM).  
1H NMR (400 MHz, CDCl3) δ 6.59 (s, 1H), 6.13 (s, 1H), 5.46 (s, 1H), 5.28 (s, 4H), 5.16 
(s, 1H), 4.56 – 4.43 (m, 1H), 4.41 – 4.24 (m, 2H), 4.11 (s, 2H), 3.97 (s, 5H), 3.62 (s, 
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207H), 3.13 (s, 1H), 2.99 (s, 2H), 2.93 – 2.81 (m, 1H), 2.81 – 2.57 (m, 1H), 2.36 – 2.06 
(m, 6H), 1.79 – 1.61 (m, 4H), 1.60 – 1.50 (m, 4H), 1.41 (d, J = 6.9 Hz, 8H), 1.35 (d, J = 
6.5 Hz, 5H), 1.23 (s, 55H), 0.96 – 0.73 (m, 6H). 
tert-Butyl N6-((benzyloxy)carbonyl)-L-lysinate (13). Nε-((benzyloxy)carbonyl)-L-
lysine (22.46 g, 80.11 mmol) was mixed with t-butyl acetate (270 mL) in a 500 mL round 
bottom flask and concentrated HClO4 (10.0 mL) added to this mixture, producing a clear 
solution. This solution was stirred for 24 hours before extracting with 120 mL 5% HCl 
nine times. The aqueous extracts were combined and the pH was adjusted to about 12 via 
addition of 33 % NaOH solution. The aqueous solution was extracted with diethyl ether 
(4 x 240 mL). The ether extracts were combined and dried over anhydrous MgSO4. The 
ether was then filtered and concentrated under reduced pressure and dried under a 50 m 
vacuum overnight giving a colorless oil. Yield: 21.20 g (78.7 %). 1H NMR (400 MHz, 
CDCl3): δ 1.30 (s 9H), 1.23-1.50 (m 8H), 2.99 (t 2H), 3.11 (t (1H), 4.91 (s 2H), 5.61 (br 
1H), 7.14-7.16 (m 5H). 13C NMR (101 MHz, CDCl3): δ 175.18, 156.34, 142.38, 136.60, 
128.31, 127.88, 108.60, 80.74, 77.46, 77.14, 76.82, 66.29, 54.66, 40.66, 34.36, 31.08, 
29.53, 27.90, 22.64. 
Di-t-Butyl 2,2'-((6-(((benzyloxy)carbonyl)amino)-1-(t-butoxy)-1-oxohexan-2-
yl)azanediyl)diacetate (14). Nε-Benzyloxycarbonyl-L-lysine-t-butyl ester (13, 13.921 g, 
41.38 mmol) was dissolved in DMF (80 mL) prior to the addition of t-butyl bromoacetate 
(18.34 mL, 24.21 g, 124.12 mmol) and DIEA (25.23 mL, 18.72 g, 144.85 mmol) by 
syringe. The solution was stirred under N2 at 70 °C for 96 hours. The solvent was 
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evaporated under reduced pressure and the residue was extracted with 200 mL of ethyl 
acetate and filtered. The ethyl acetate extract was purified by flash chromatography on 
silica (4:1 hexane:EtOAc) to give 14 as a slightly yellow oil. Yield: 27.37 g (84.4 %); 
TLC: Rf = 0.18 (4:1 hexane:EtOAc); 1H NMR (CDCl3): δ 1.25-1.50 (m 6H), 1.30 (s 
18H), 1.32 (s 9H), 3.04 (m 2H), 3.16 (t 1H), 3.33 (q 4H), 4.93 (s 2H), 5.39 (br 1H), 7.15-
7.19 (m 5H). 13C NMR (101 MHz, CDCl3) δ 172.07, 170.41, 156.32, 136.69, 128.15, 
127.79, 127.64, 80.70, 80.33, 77.54, 77.22, 76.90, 66.03, 64.91, 60.04, 53.62, 40.56, 
29.93, 29.02, 27.97, 27.86, 27.73, 22.80, 20.71, 13.97. 
Di-t-butyl 2,2'-((6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)azanediyl)diacetate (15). 
Compound 14 (9.84 g, 17.4 mmol) was dissolved in MeOH (90 mL) in a 500 mL round 
bottom flask. To this solution was added 40 mg of 10% Pd/C. The flask was evacuated 
and purged with H2 three times and then stirred for 12 hours under 1 atm H2. The 
heterogeneous solution was then filtered through a pad of Celite, with further washing of 
the Celite cake with 50 mL MeOH. The filtrate was concentrated under reduced pressure 
to give 15 as a clear oil. Yield: 7.52 g (99.7 %); TLC: Rf = 0.02 (4:1 hexane:EtOAc); 1H 
NMR (CDCl3): δ 1.29 (s 18H), 1.30 (s 9H) 1.1-1.5 (m 6H), 2.63 (t 2H), 3.16 (t 1H), 3.30 
(q 4H), 3.96 (br 3H)13C NMR (101 MHz, CDCl3) δ 172.05, 170.46, 80.78, 80.42, 77.41, 
77.09, 76.77, 64.94, 53.52, 49.54, 40.90, 31.09, 30.09, 27.95, 27.87, 22.91. 
4-((5-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)-6-(tert-butoxy)-6-oxohexyl)amino)-4-
oxobutanoic acid (16). Compound 15 (1.00 g, 2.32 mmol) and succinic anhydride (0.418 
g, 4.18 mmol) were combined in an oven-dried 250 mL round bottom flask equipped 
with a rubber septum and magnetic stir bar. The solids were dissolved in DCM (20 mL) 
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and TEA (1.62 mL, 11.61 mmol) was added. The reaction was stirred at ambient 
temperature for 18 hours. The solution was concentrated and dissolved in 50 mL ethyl 
acetate. This solution was washed with 5% HCl (30 mL) twice. The organic phase was 
concentrated and purified by flash chromatography using a gradient of 1:1 hexane ethyl 
acetate to 1:1 hexane ethyl acetate. The pure fractions were combined and dried in vacuo 
to give 16 as a colorless oil. Yield: 1.15 g (93.6 %); TLC: Rf = 0.28 (1:1 hexane:EtOAc). 
1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 114.3 Hz, 2H), 6.96 (s, 1H), 3.46 – 3.24 (m, 
6H), 3.23 – 2.97 (m, 3H), 2.54 (t, J = 6.4 Hz, 2H), 2.44 (d, J = 6.1 Hz, 2H), 1.79 – 1.46 
(m, 3H), 1.34 (d, J = 6.2 Hz, 29H), 1.28 (d, J = 6.3 Hz, 3H). 
Di-tert-butyl 2,2'-((1-(tert-butoxy)-1-oxo-6-(4-oxo-4-(prop-2-yn-1-
ylamino)butanamido)hexan-2-yl)azanediyl)diacetate (17). Compound 16 (1.15 g, 2.17 
mmol) and propargylamine (131 mg, 2.38 mmol) and HOBt (322 mg, 2.38 mmol) were 
combined in an oven-dried 250 mL round bottom flash equipped with a rubber septum 
and magnetic stir bar. The solids were dissolved in DMF (8 mL) and EDC (457 mg, 2.38 
mmol) was added followed by DIEA (1.15 mL, 6.50 mmol). The reaction was stirred for 
24 hours at ambient temperature. The solution was diluted with 90 mL DCM and washed 
with 5 % HCl (50 mL) twice. The organic phase was dried over anhydrous sodium sulfate 
and concentrated in vacuo. The residue was purified via flash chromatography using a 
gradient of 4:1 hexane:EtOAc to 1:1 hexane:EtOAc. Pure fractions were combined and 
dried in vacuo to give Compound 17 as a clear oil. Yield: 1.09 g (88.5 %); TLC: Rf = 
0.35 (1:1 hexane:EtOAc). 1H NMR (400 MHz, CDCl3) δ 8.03 (s, 1H), 7.12 (d, J = 4.9 
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Hz, 1H), 3.48 – 3.26 (m, 5H), 3.26 – 3.06 (m, 3H), 2.94 (s, 1H), 2.52 (dd, J = 15.3, 10.9 
Hz, 3H), 1.91 – 1.66 (m, 1H), 1.66 – 1.48 (m, 4H), 1.36 (d, J = 6.1 Hz, 34H). 
2,2'-((5-(((Benzyloxy)carbonyl)amino)-1-carboxypentyl)azanediyl)diacetic acid (18). 
Compound 12 (10.00 g, 35.67 mmol) was dissolved in 1.5 M NaOH and cooled to 0 °C 
in an ice bath. Bromoacetic acid was also dissolved in 67 mL of 1.5 M NaOH and cooled 
to 0 °C in an ice bath. The bromoacetic acid solution was added to the solution of 
Compound 12 and the solution was allowed to warm to ambient temperature and stirred 
for an additional 24 hours. The solution was heated to 50 ᵒC and stirred for 2 hours. The 
solution was cooled back to 0 °C and the pH was adjusted to 2-3 using conc. HCl. The 
precipitate was filtered and dried in vacuo to give Compound 18 as a white crystalline 
solid. Yield: 11.67 g (82.6 %). 1H NMR (400 MHz, DMSO-d6) δ 12.51 (s, 0H), 7.68 – 
7.06 (m, 6H), 4.98 (s, 2H), 3.55 – 3.38 (m, 4H), 3.31 (t, J = 7.4 Hz, 1H), 2.94 (s, 2H), 
2.53 – 2.40 (m, 0H), 1.58 (s, 1H), 1.52 (s, 1H), 1.46 – 1.30 (m, 3H), 1.25 (s, 1H). 13C 
NMR (101 MHz, DMSO) δ 190.15, 174.86, 174.14, 156.95, 138.18, 129.22, 128.60, 
76.17, 65.99, 65.20, 54.27, 40.56, 40.35, 40.14, 30.20, 23.88. 
2,2'-((5-Amino-1-carboxypentyl)azanediyl)diacetic acid (19). Compound 18 (2.90 g, 
2.27 mmol) was dissolved in deionized water (50 mL) and 10 mL 1.5 M NaOH was 
added to dissolve the material in an oven-dried 250 mL round bottom flask. Palladium on 
carbon was added and the flask was equipped with a three-way adapter and a hydrogen 
balloon. The flask was evacuated and purged with hydrogen. The reaction was stirred 
vigorously under 1 atm hydrogen for 12 hours. The heterogeneous solution was filtered 
through Celite to remove catalyst and the pH was adjusted to 2 via addition of conc. HCl 
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and the white precipitate was concentrated using a rotary evaporator and isolated via 
filtration. Compound 19 was obtained as a white crystalline solid. Yield: 1.92 g (96.9 %). 
1H NMR (400 MHz, D2O) δ 3.21 – 2.91 (m, 1H), 2.85 (t, J = 6.9 Hz, 0H), 2.45 (t, J = 7.0 
Hz, 0H), 1.43 (q, J = 7.4 Hz, 0H), 1.39 – 1.23 (m, 0H), 1.23 – 0.97 (m, 0H). 
Z-Lys-tris-NTA-OtBu (20).  Compounds 15 (15.531 g, 36.07 mmol), 18 (2.67 g, 7.23 
mmol) and HOBt (4.38 g, 32.46 mmol) were added to an oven-dried 250 mL round 
bottom flask equipped with a rubber septum and a magnetic stir bar. The contents were 
dissolved in DMF (240 mL) and cooled down to 0 °C in an ice bath. EDC (8.30 g, 43.29 
mmol) was added followed by DIEA (12.57 mL, 72.14 mmol) and the solution was 
allowed to warm to ambient temperature and stirred for 72 hours. The solution was 
diluted with EtOAc and filtered then concentrated and purified via flash chromatography 
using 5:95 MeOH:DCM giving Compound 20 as a yellow oil. Yield: 2.57 g (88.4 %); 
TLC: Rf = 0.40 (5:95 MeOH:DCM). 1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 18.4 Hz, 
3H), 7.32 – 7.15 (m, 5H), 5.24 (s, 1H), 4.98 (s, 2H), 3.44 – 3.32 (m, 11H), 3.30 (d, J = 
5.0 Hz, 2H), 3.27 (d, J = 4.5 Hz, 2H), 3.23 – 3.01 (m, 13H), 2.97 (d, J = 6.9 Hz, 1H), 
1.73 (s, 1H), 1.63 – 1.50 (m, 7H), 1.50 – 1.40 (m, 13H), 1.40 – 1.11 (m, 99H). 13C NMR 
(126 MHz, CDCl3) δ 172.20, 172.15, 171.42, 170.65, 170.62, 170.10, 156.44, 136.70, 
128.36, 127.89, 81.00, 80.64, 77.43, 76.92, 66.29, 64.94, 57.97, 56.19, 53.70, 41.86, 
40.49, 39.16, 30.13, 29.87, 29.48, 29.18, 28.62, 28.06, 24.34, 24.13, 23.28, 23.00. 
H2N-Lys-tris-NTA-OtBu (21). Compound 20 (0.420 g, 0.26 mmol) was dissolved in 
MeOH (50 mL) in a 250 mL round bottom flask. To this solution was added 10% Pd/C. 
The flask was evacuated and purged with H2 three times and then stirred for 12 hours 
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under 1 atm H2. The heterogeneous solution was then filtered through a pad of Celite, 
with further washing of the Celite cake with 50 mL MeOH. The filtrate was concentrated 
under reduced pressure to give 21 as a clear yellow oil. Yield: 0.380 g (97.6 %); TLC: Rf 
= 0.03 (EtOAc). 
HO2C-Lys-tris-NTA-OtBu (22). Compound 21 and succinic anhydride were combined 
in an oven dried 50mL round bottom flask equipped with a rubber septum and a magnetic 
stir bar. DCM (5 mL) was added and TEA (37 µL) was added via syringe. The solution 
was stirred for 18 hours at ambient temperature. The contents were concentrated and 
purified via flash chromatography using 5:95 MeOH:DCM as eluent to give Compound 
22 as a slightly yellow oil. Yield: 0.146 g (87.4 %); TLC: Rf = 0.39 (5:95 MeOH:DCM). 
1H NMR (400 MHz, CDCl3) δ 3.42 (s, 1H), 3.24 (d, J = 15.3 Hz, 1H), 1.51 (d, J = 10.5 
Hz, 4H), 1.44 (d, J = 6.4 Hz, 21H). 
Alkyne-Lys-tris-NTA-OtBu (23). Compound 22 (139 mg, 0.09 mmol), HOBt (58.6 mg, 
0.43 mmol), and propargylamine (56 µL, 0.87 mmol) were combined in an oven dried 50 
mL round bottom flask equipped with a magnetic stir bar and rubber septum. DCM 
(5mL) was added and the solution was cooled to 0 °C in an ice bath. EDC (83 mg, 0.43 
mmol) was added followed by DIEA (77µL, 0.43 mmol) and the solution was allowed to 
warm to ambient temperature and stirred for 24 hours. The contents were concentrated 
and purified via flash chromatography using 5:95 MeOH:DCM as eluent to give 
Compound 22 as a slightly yellow oil. Yield: 0. g (76.4 %); TLC: Rf = 0.32 (5:95 
MeOH:DCM). 1H NMR (400 MHz, CDCl3) δ 8.13 (d, J = 12.8 Hz, 1H), 7.65 (s, 1H), 
7.56 (s, 1H), 7.36 – 7.04 (m, 3H), 4.14 – 3.86 (m, 2H), 3.60 (d, J = 3.5 Hz, 2H), 3.60 – 
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3.33 (m, 17H), 3.33 – 2.98 (m, 18H), 2.84 (s, 4H), 2.49 (s, 2H), 2.37 – 2.09 (m, 3H), 1.96 
(s, 2H), 1.87 – 0.98 (m, 150H), 0.96 – 0.60 (m, 6H). 
Di-tert-butyl-2,2'-((1-(tert-butoxy)-6-(((4-nitrophenoxy)carbonyl)amino)-1-
oxohexan-2-yl)azanediyl)diacetate (24). p-Nitrophenyl chloroformate (PNP-Cl, 0.552 g, 
2.74 mmol) was dissolved into 20 mL DCM in a 100 mL round bottom flask equipped 
with a stir bar and addition funnel and was cooled to 4 °C in an ice bath. Compound 15 
(0.983 g, 2.28 mmol) in 20 mL DCM was added to the addition funnel. The system was 
evacuated and flashed with nitrogen gas. The solution of 15 was added over a one hour 
period at 4 °C and stirred for an additional 12 hours warming to room temperature. The 
solution was concentrated in vacuo and purified by flash chromatography using 4:1 
hexane:EtOAc as eluent. Yield: 0.609 g (44.8 %).; TLC: Rf= 0.24 (4:1 hexanes:EtOAc); 
1H NMR (CDCl3): δ 1.38 (s 18H), 1.40 (s 9H), 1.18-1.59 (m 6H), 3.18-3.29 (m 3H), 3.40 
(q 4H), 6.09 (br 1H), 7.24 (d 2H, J = 9 Hz), 8.14 (d 2H, J = 9 Hz); MS (ESI+). Expected: 
596.68 [M+H]; Found 596.59 ([M+H], 618.54 [M+Na]. 
PNP-tris-NTA-OtBu (25). PNP-Cl (0.060 g, 0.30 mmol) was dissolved into 15 mL 
DCM in a 100 mL round bottom flask equipped with a stir bar and addition funnel and 
was cooled to 4 °C in an ice bath. Compound 21 (0.372 g, 0.25 mmol) in 10 mL DCM 
was added to the addition funnel. The system was evacuated and flashed with nitrogen 
gas. The solution of 21 was added over a one-hour period at 4 °C and stirred for an 
additional 12 hours warming to room temperature. The solution was concentrated in 
vacuo and purified by flash chromatography using EtOAc as eluent. Yield: 0.302 g (73.1 
%).; TLC: Rf= 0.31 (EtOAc); 1H NMR (CDCl3): δ 1.35 (s 54H), 1.38 (s 27H), 110-1.68 
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(m 18H), 3.09-3.37 (m 9H), 3.42 (q 12H), 6.14 (br 3H), 7.24 (d 2H, J = 9 Hz), 8.13 (d 
2H, J = 9 Hz); MS (ESI+). Expected: 1665.01 [M+H]; Found 1666.45 ([M+2H], 1667.44 
([M+3H]), 1689.39 [M+Na]. 
NHBoc-PEG2000-DTPE (27). NHS-PEG2K-NHBoc (26, 190 mg, 0.095 mmol) and 
DTPE (82.8 mg, 0.095 mmol) were dissolved in DCM (10 mL) in a 25 mL round bottom 
flask with stir bar. DIEA (83 µL, 0.474 mmol) was added and the flask was evacuated, 
flushed with nitrogen and covered with aluminum foil. The solution was stirred at 
ambient temperature for 48 hours in the dark. Volatiles were evaporated and purified by 
flash chromatography on silica using an eluting system of DCM and MeOH starting with 
95:5 then 90:10 then 85:15. Fractions containing product were combined and dried in 
vacuo to give 27. Yield: 0.209 g (87.8 %).; TLC: Rf= 0.72 (80:20 DCM:MeOH); 1H 
NMR (CDCl3): δ 0.88 (m 6H), 1.23-1.49 (m 50H), 1.42 (s 9H), 2.21 (m 8H), 2.66 (t 4H), 
3.26-3.96 (m 180 H), 4.11-4.12 (m 2H), 4.33-4.36 (m 2H), 5.17 (br 1H). 
NH2-PEG2000-DTPE (28). Compound 27 (209 mg, 0.076 mmol) and triethylsilane (200 
µL, 1.25 mmol) was dissolved in 30 % TFA in DCM solution (20 mL) and stirred for 1.5 
hours under ambient temperature and atmosphere. Volatiles were removed in vacuo and 
the residue was evaporated with 15 mL DCM twice more. The product was dried in 
vacuo and used without further purification. Yield: 0.191 g (91.3 %).; TLC: Rf= 0.56 ( 
80:20 DCM:MeOH). 
NTA-(OtBu)3-PEG2000-DTPE (29). Compound 28 (95.5 mg, 0.034 mmol) and 
Compound 24 (205 mg, 0.344 mmol) were dissolved in DCM (5 mL) in a 25 mL round 
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bottom flask with stir bar covered in aluminum foil. The flask was evacuated and flushed 
with nitrogen. DIEA (60 µL, 0.348 mmol) was added and the solution stirred for 48 hours 
at ambient temperature under a nitrogen atmosphere in the dark. Volatiles were 
evaporated under reduced pressure and the product was purified by flash chromatography 
on silica using a gradient of DCM:MeOH as eluent starting with 90:10 moving to 85:15 
then finally 80:20. Fractions containing product were pooled, concentrated and dried in 
vacuo to give Compound 29. Yield: 29.0 mg (26.9 %).; TLC: Rf= 0.65 (80:20 
DCM:MeOH). 
NTA-PEG2000-DTPE (30). Compound 29 (29 mg, 0.009 mmol) and triethylsilane (100 
µL, 0.625 mmol) were dissolved in 30% TFA in DCM solution (10 mL) in a 25 mL 
round bottom flask with stir bar covered in aluminum foil. The solution was stirred under 
ambient temperature and atmosphere for 1.5 hours in the dark. Volatiles were evaporated 
and the residue was dissolved in 5mL PBS buffer (pH = 7.2) plus 5 mL MeOH. The 
solution was extracted with CHCl3 (3x8 mL). The organic extracts were dried over 
anhydrous Na2SO4, filtered, concentrated and dried in vacuo to give Compound 30. 
Yield: 18.0 mg (62.1 %).; TLC: Rf= 0.01 (80:20 DCM:MeOH). 
S-Trityl-3-mercaptopropionic acid (32). 3-Mercaptopropionic acid (31, 6.00 g, 56.5 
mmol) was dissolved in DCM (50 mL) in a 250 mL round bottom flask. Trityl chloride 
(17.34 g, 62.2 mmol) in DCM (30 mL) was added dropwise to this solution over 1 hour 
before stirring for an additional 12 h. The white precipitate was filtered and washed with 
diethyl ether (2 x 50 mL) and dried under a 50 m vacuum to give a fine white powder. 
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Yield: 18.25 g (93%); 1H NMR (400 MHz, CDCl3): δ 2.25 (t, 2H, J = 8 Hz), 2.47 (t, 2H, 
J = 8 Hz), 7.2-7.3 (m, 9H), 7.43 (d, 6H). 
Di-t-butyl 2,2'-((1-(t-butoxy)-1-oxo-6-(3-(tritylthio)propanamido)hexan-2-
yl)azanediyl)diacetate (33). Compound 32 (1.46 g, 4.19 mmol) and Compound 15 (1.80 
g, 4.19 mmol) were dissolved in DMF (100 mL) in a 250 mL round bottom flask. This 
solution was cooled on an ice bath before addition of EDC (0.962 g, 5.02 mmol), HOBt 
(0.678 g, 5.02 mmol), and 1.86 mL of DIEA (1.35 g, 10.4 mmol). The solution was 
stirred under Ar for 48 hours while allowing the mixture to gradually warm from 4  20 
C. The DMF was evaporated under reduced pressure and the residue was dissolved in 
EtOAc (80 mL). This solution was washed with H2O (2 x 100 mL) before combining the 
aqueous phases and back extracting with EtOAc (100 mL). The EtOAc layers were 
combined and dried over anhydrous Na2SO4. The solvent was evaporated and the residue 
purified by flash chromatography on silica using 1:1 hexane:EtOAc as eluent yielding 33 
as a colorless oil. Yield: 1.70 g (53.4 %).; TLC: Rf= 0.54 (1:1 hexane:EtOAc); 1H NMR 
(CDCl3): δ 1.22-1.61 (m 6H), 1.39 (s 18H), 1.43 (s 9H), 2.09 (t 2H), 2.46 (t 2H), 3.11 (m 
2H), 3.25 (t 1H), 3.43 (m 4H), 5.98 (br 1H), 7.14-7.4 (m 15H). 13C NMR (126 MHz, 
CDCl3) δ 172.39, 170.92, 170.73, 144.77, 129.59, 127.88, 126.61, 81.10, 80.73, 77.39, 
77.14, 76.88, 66.66, 64.92, 53.91, 39.19, 35.36, 29.83, 28.41, 28.23, 28.16, 27.77, 22.89.; 
MS (ESI+). Expected: 762.02 [M+H]; Found 762.71. 
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2,2'-((1-Carboxy-5-(3-mercaptopropanamido)pentyl)azanediyl)diacetic acid (34). 
Compound 33 (0.800 g, 1.05 mmol) was dissolved in DCM (10 mL), followed by 
addition of Et3SiH (0.367 g, 3.16 mmol) and 2-mercaptoethanol (.246 g, 3.15 mmol). 
This solution was cooled on an ice bath before addition of TFA (15 mL) dropwise over 
10 min. The solution was stirred for 1 h at 4 C before removal of the volatiles under 
reduced pressure. Diethyl ether (20 mL) and 4 drops of concentrated HCl were added to 
the residue before decanting the organic phase and repeating the process two more times. 
Toluene (30 mL) was then added to the residue and evaporated under reduced pressure 
three times to give Compound 34 as a white powder. Yield: 0.327 g (92.7 %); 1H NMR 
(500 MHz, DMSO-d6) δ 3.50 (q, J = 16.6, 15.4 Hz, 4H), 3.34 (d, J = 7.3 Hz, 1H), 2.99 (s, 
2H), 2.92 – 2.76 (m, 1H), 2.70 – 2.55 (m, 2H), 2.47 (d, J = 13.4 Hz, 2H), 2.33 (d, J = 7.1 
Hz, 1H), 2.27 – 2.06 (m, 1H), 1.70 – 1.45 (m, 2H), 1.36 (s, 3H), 1.23 (d, J = 15.3 Hz, 
3H), 1.13 (t, J = 17.8 Hz, 1H). 13C NMR (126 MHz, DMSO) δ 174.15, 173.35, 170.40, 
64.75, 53.73, 40.28, 39.95, 39.61, 38.74, 31.17, 29.56, 29.25, 23.54, 20.44. 
2,2'-((1-Carboxy-2-(tritylthio)ethyl)azanediyl)diacetic acid (36). H-Cys(Trt)-OH (1.00 
g, 4.73 mmol) was dissolved in 30 mL 1.5 KOH in MeOH in a 100 mL round bottom 
flask. Bromoacetic acid (2.760 g, 19.86 mmol) was dissolved in 10 mL 1.5 M KOH in 
MeOH and 10 mL deionized water. The two separate solutions were cooled to 0 °C in an 
ice bath and the bromoacetic acid solution wat added to the solution of H-Cys(Trt)-OH 
and the solution was stirred at ambient temperature for 48 hours under argon. The 
solution was stirred at 50 °C for 3 hours. The solution was concentrated in vacuo and 
precipitated via the addition of conc. HCl. The precipitate was filtered and recrystallized 
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from acidic water. Yield:2.27 g (82.0 %); 1H NMR (500 MHz, DMSO-d6) δ 7.30 (d, J = 
3.7 Hz, 12H), 7.28 – 7.00 (m, 4H), 3.32 – 3.09 (m, 4H), 2.87 (t, J = 7.5 Hz, 1H), 2.82 (s, 
0H), 2.55 (dd, J = 13.0, 6.9 Hz, 1H), 2.51 – 2.45 (m, 1H), 2.32 (dd, J = 13.0, 8.1 Hz, 1H). 
13C NMR (126 MHz, DMSO) δ 173.88, 173.15, 144.96, 129.63, 128.47, 127.14, 66.61, 
65.93, 54.40, 40.46, 40.13, 39.96, 39.46, 32.73. 
Trt-Cys-tris-NTA-OtBu (37). Compound 36 (0.511 g, 1.07 mmol), Compound 15 
(2.295 g, 5.33 mmol) and HOBt (0.735 g, 4.80 mmol) were combined in an oven-dried 
100 mL round bottom flask equipped with a magnetic stir bar and rubber septum. The 
contents were dissolved in 25 mL DMF and cooled to 0 °C in an ice bath. EDC (1.226 g, 
6.40 mmol) followed by DIEA (1.857 mL, 10.66 mmol) were added and the solution was 
allowed to warm to room temperature and stir for 36 hours at ambient temperature. The 
solution was concentrated in vacuo and the residue was purified by flash chromatography 
using a gradient of 1:1 hexane:EtOAc to 3:7 hexane:EtOAc to give Compound 37 as a 
slightly yellow oil. Yield: 1.392 g (76.1 %).; TLC: Rf= 0.42 (1:1 hexane:EtOAc); 1H 
NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.1 Hz, 6H), 7.19 (t, J = 7.6 Hz, 7H), 7.13 (t, J = 
7.3 Hz, 3H), 3.45 – 3.29 (m, 13H), 3.25 – 3.15 (m, 6H), 1.55 (d, J = 6.8 Hz, 8H), 1.48 – 
1.26 (m, 96H). 13C NMR (126 MHz, CDCl3) δ 172.22, 171.14, 170.62, 170.55, 144.47, 
127.90, 126.71, 81.03, 80.66, 80.48, 77.42, 77.17, 76.91, 67.24, 65.85, 65.30, 64.95, 
55.69, 53.67, 53.56, 39.36, 39.19, 34.62, 31.57, 31.45, 30.35, 29.88, 29.43, 28.17, 28.08, 
23.49, 23.06. 
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11-(2-((5-(Bis(carboxymethyl)amino)-5-carboxypentyl)amino)-2-oxoethyl)-2,20-
bis(carboxymethyl)-10-(mercaptomethyl)-9,13-dioxo-2,8,11,14,20-
pentaazahenicosane-1,3,19,21-tetracarboxylic acid (38). Compound 37 (1.392 g, 0.81 
mmol) was dissolved in DCM (20 mL) and triethylsilane (1.94 mL, 12.16 mmol) was 
added. TFA (20 mL) was added and the solution was stirred at ambient temperature for 
1.5 hours under a stream of nitrogen. Volatiles were removed in vacuo. DCM (80 mL) 
was added and evaporated in vacuo to remove excess TFA. The residue was trititurated 
with diethyl ether to remove triphenylmethyl by-products. The residue was suspended in 
deionized water and lyophilized to give Compound 38 as a white powder. Yield: 0.725 g 
(92.2 %).; 1H NMR (500 MHz, DMSO-d6) δ 3.63 – 3.41 (m, 12H), 3.36 (dt, J = 13.0, 6.5 
Hz, 5H), 3.29 – 3.15 (m, 3H), 3.15 – 2.94 (m, 6H), 2.77 – 2.61 (m, 1H), 1.71 – 1.57 (m, 
3H), 1.52 (d, J = 8.4 Hz, 4H), 1.47 – 1.31 (m, 11H), 1.30 – 1.16 (m, 4H). 13C NMR (126 
MHz, DMSO) δ 174.14, 173.38, 65.37, 64.81, 55.83, 53.76, 40.47, 40.30, 40.13, 39.97, 
39.80, 39.63, 39.46, 38.87, 29.58, 29.26, 28.20, 23.59, 15.63. 
Maleimide-PEG-DSPE (40a). DSPE (0.072 g, 0.096 mmol) and NHS-PEG2K-
maleimide (39a, 0.200 g, 0.095 mmol) were dissolved in CHCl3 (15 mL) in a 50 mL 
round bottom flask with stir bar and DIEA (0.062g, 0.480) mmol was added via syringe. 
The flask was evacuated and flushed with nitrogen and stirred for 72 hours at ambient 
temperature. The volatiles were evaporated under reduced pressure and the residue 
purified by flash chromatography on silica using a gradient starting with 85:15 
DCM:MeOH and increasing in polarity to 80:20 DCM:MeOH. Yield: 0.118 g (43.4 %).; 
TLC: Rf= 0.48 (4:1 DCM:MeOH); 1H NMR (CDCl3): δ 0.84 (t 6H), 1.15-1.40 (m 64H), 
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2.24 (m 4H), 2.48 (t 2H) 2.99 (m 2H), 3.37-4.10 (m 180 H), 3.80-3.96 (m 4H), 4.12 (m 
2H), 4.34 (d 2H), 5.17 (m 1H), 6.27 (br 1H), 6.67 (s 1H), 7.38 (br 1H). 
Maleimide-PEG-DSPE (40b). DSPE (0.094 g, 0.13 mmol) and NHS-PEG3.4K-
maleimide (39b, 0.400 g, 0.12 mmol) were dissolved in CHCl3 (10 mL) in a 50 mL round 
bottom flask with stir bar and DIEA (0.074 g, 0.57 mmol) was added via syringe. The 
flask was evacuated and flushed with nitrogen and stirred for 72 hours at ambient 
temperature. The volatiles were evaporated under reduced pressure and the residue 
purified by flash chromatography on silica using a gradient starting with 85:15 
DCM:MeOH and increasing in polarity to 80:20 DCM:MeOH. Yield: 0.146 g (30.1 %).; 
TLC: Rf= 0.49 (4:1 DCM:MeOH); 1H NMR (400 MHz, CDCl3) δ 4.00 – 3.87 (m, 1H), 
3.61 (s, 25H), 3.52 – 3.45 (m, 1H), 2.34 – 2.16 (m, 1H), 1.61 – 1.48 (m, 1H), 1.39 (d, J = 
6.9 Hz, 1H), 1.33 (d, J = 6.6 Hz, 1H), 1.21 (s, 9H), 0.84 (t, J = 6.8 Hz, 1H). 
NTA-PEG2K-DSPE (41a). Compounds 40a (20.0 mg, 0.007 mmol) and 34 (18.0 mg, 
0.051 mmol) were dissolved in DMF (4 mL) in a 25 mL round bottom flask with stir bar. 
TEA (15.0 µL, 0.119 mmol) was added and the flask was evacuated and flushed with 
nitrogen. The solution was stirred at 40 °C for 24 hours monitoring the consumption of 
starting material by TLC. Volatiles were removed in vacuo at 45 °C and the residue was 
dissolved in 6 mL PBS buffer (pH = 7.2) plus 4 mL MeOH. This solution was extracted 
with CHCl3 (3x15 mL). The organic extracts were combined and dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo to give 41a. Yield: 21.2 mg (a: 89.8 %; b: 
53.3 %).; TLC: Rf= 0.0 (4:1 DCM:MeOH); 1H NMR (CDCl3): δ 0.84 (t 6H), 1.15-1.40 
(m 64H), 2.25 (s 4H), 2.28-2.32 (m 2H), 2.48-2.53 (m 2H), 2.75-2.78 (m 4H), 2.48-3.7 
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(m 180H), 3.70 (s 4H), 3.88 (br 2H), 4.00 (br 2H), 4.16 (br 2H), 4.37-4.40 (br 1H), 5.30 
(s 1H), 6.96 (s 1H). 
NTA-PEG3.4K-DSPE (41b). Compounds 40b (49.0 mg, 0.01 mmol) and 34 (21.0 mg, 
0.05 mmol) were dissolved in DMF (5 mL) in a 25 mL round bottom flask with a stir bar. 
TEA (16.4 µL, 0.09 mmol) was added and the flask was evacuated and flushed with 
nitrogen. The solution was stirred at 40 °C for 24 hours monitoring the consumption of 
starting material by TLC. Volatiles were removed in vacuo at 45 °C. the residue was 
dissolved in 6 mL PBS buffer (pH = 7.2) plus 4 mL MeOH. This solution was extracted 
with CHCl3 (3x15 mL). The organic extracts were combined and dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo to give 41b. Yield: 28.6 mg (53.3 %); 1H 
NMR (500 MHz, CDCl3) δ 7.26 (s, 1H), 4.02 (d, J = 12.0 Hz, 1H), 3.82 – 3.74 (m, 1H), 
3.63 (s, 55H), 3.54 – 3.46 (m, 1H), 2.50 (d, J = 29.9 Hz, 1H), 2.30 (d, J = 7.9 Hz, 1H), 
2.24 (s, 1H), 1.70 – 1.65 (m, 1H), 1.59 (s, 3H), 1.43 (s, 2H), 1.37 (s, 3H), 1.24 (s, 18H), 
0.87 (s, 6H). 
NHS-PEG2K-MAL-2/5-dimethylfuran adduct (42). NHS-PEG2K-maleimide (0.200 g, 
0.10 mmol) was added to an oven-dried 50 mL round bottom flask equipped with a 
magnetic stir bar and rubber septum. The solid material was dissolved in toluene (10 mL) 
and 2.5 dimethylfuran (2.50 mL g, 23.14 mmol) was added. The solution was heated to 
40 °C and stirred under nitrogen for 12 hours. The solution was concentrated, precipitated 
into 200 mL diethyl ether and filtered to give Compound 42 as a white powder. Yield: 
151.7 mg (98.2 %); 1H NMR (400 MHz, CDCl3) δ 6.23 (s, 1H), 6.10 (s, 1H), 4.43 (s, 
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2H), 3.55 (s, 182H), 3.37 (s, 2H), 3.30 (s, 1H), 3.12 (s, 1H), 2.78 (s, 4H), 2.73 (s, 4H), 
2.29 (s, 2H), 2.20 (d, J = 8.2 Hz, 1H), 2.10 (s, 1H), 1.68 (s, 3H), 1.59 (s, 2H). 
DSPE-PEG2K-MAL-2/5-dimethylfuran adduct (43). Compound 42 (0.200 g, 0.10 
mmol) and DSPE (0.079 g, 0.11 mmol) were dissolved in chloroform (5 mL) in an oven-
dried 50 mL round bottom flask equipped with magnetic stir bar and rubber septum. 
DIEA (95 µL, 0.53 mmol) was added and the solution was stirred for 72 hours at ambient 
temperature. The volatiles were evaporated under reduced pressure and the residue 
purified by flash chromatography on silica using a gradient starting with 85:15 
DCM:MeOH and increasing in polarity to 80:20 DCM:MeOH. Yield: 0.182 g (75.8 %).; 
TLC: Rf= 0.17 (95:5 DCM:MeOH); 1H NMR (400 MHz, CDCl3) δ 4.12 (dd, J = 11.9, 6.7 
Hz, 1H), 3.98 – 3.87 (m, 5H), 3.79 (dd, J = 8.5, 5.0 Hz, 1H), 3.61 (s, 182H), 3.46 – 3.42 
(m, 2H), 3.38 (q, J = 5.8 Hz, 3H), 3.18 (s, 1H), 3.00 (s, 2H), 2.78 (s, 1H), 2.62 (s, 1H), 
2.29 – 2.16 (m, 4H), 1.74 (s, 1H), 1.65 (s, 1H), 1.54 (q, J = 9.3, 8.0 Hz, 4H), 1.39 (d, J = 
7.3 Hz, 7H), 1.33 (d, J = 6.7 Hz, 7H), 1.21 (s, 61H), 0.84 (t, J = 6.8 Hz, 6H). 
DSPE-PEG2K-MAL (44). Compound 43 was dissolved in toluene (20 mL) and heated 
at 80 °C for 12 hours under argon. The solution was concentrated in vacuo and 
redissolved in DCM (40 mL). This solution was filtered through a pad a Celite and 
activated carbon. The product 44 was precipitated into diethyl ether (200 mL), filtered 
and dried in vacuo. Yield: 0.112 g (61.5 %).; TLC: Rf= 0.69 (4:1 DCM:MeOH); 1H NMR 
(400 MHz, CDCl3) δ 7.40 (s, 1H), 7.26 (s, 2H), 6.68 (s, 1H), 6.33 (s, 1H), 5.20 (s, 1H), 
4.35 (d, J = 10.8 Hz, 1H), 4.18 – 4.09 (m, 1H), 3.97 (s, 4H), 3.80 (d, J = 7.5 Hz, 2H), 3.61 
(s, 182H), 3.44 (s, 2H), 3.38 (s, 3H), 3.00 (s, 2H), 2.58 – 2.43 (m, 2H), 2.24 (s, 3H), 1.55 
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(s, 4H), 1.42 (t, J = 7.8 Hz, 7H), 1.35 (d, J = 6.6 Hz, 7H), 1.22 (s, 48H), 0.85 (t, J = 6.6 
Hz, 6H). 
Tris-NTA-PEG2000-DSPE (45a). Compounds 40a (20.0 mg, 0.01 mmol) and 38 (48.0 
mg, 0.05 mmol) were dissolved in DMF (5 mL) in a 25 mL round bottom flask with a stir 
bar. TEA (35 µL, 0.22 mmol) was added and the flask was evacuated and flushed with 
nitrogen. The solution was stirred at 40 °C for 24 hours monitoring the consumption of 
starting material by TLC. Volatiles were removed in vacuo at 45 °C. the residue was 
dissolved in 6 mL PBS buffer (pH = 7.2) plus 4 mL MeOH. This solution was extracted 
with CHCl3 (3x15 mL). The organic extracts were combined and dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo to give 45a. Yield: 23.6 mg (87.8 %); 1H 
NMR (400 MHz, CDCl3) δ 6.95 (s, 2H), 5.30 (s, 1H), 5.22 (t, J = 5.6 Hz, 1H), 4.12 (s, 
1H), 4.00 (s, 3H), 3.87 (s, 2H), 3.82 (d, J = 6.8 Hz, 3H), 3.64 (s, 182H), 3.49 – 3.43 (m, 
4H), 3.40 (s, 3H), 3.08 (s, 7H), 2.98 – 2.87 (m, 6H), 2.81 – 2.72 (m, 8H), 2.52 (d, J = 6.8 
Hz, 4H), 2.36 – 2.26 (m, 6H), 2.24 (s, 5H), 1.88 (s, 2H), 1.65 – 1.48 (m, 11H), 1.46 – 
1.40 (m, 3H), 1.29 (d, J = 32.8 Hz, 81H), 0.86 (d, J = 7.1 Hz, 16H). 
Tris-NTA-PEG3.4K-DSPE (45b). Compounds 40b (49.0 mg, 0.01 mmol) and 38 (57.0 
mg, 0.06 mmol) were dissolved in DMF (5 mL) in a 25 mL round bottom flask with stir 
bar. DIEA (16.4 µL, 0.09 mmol) was added and the flask was evacuated and flushed with 
nitrogen. The solution was stirred at 40 °C for 24 hours monitoring the consumption of 
starting material by TLC. Volatiles were removed in vacuo at 45 °C and the residue was 
dissolved in 6 mL PBS buffer (pH = 7.2) plus 4 mL MeOH. This solution was extracted 
with CHCl3 (3x15 mL). The organic extracts were combined and dried over anhydrous 
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Na2SO4, filtered and concentrated in vacuo to give 45b. Yield: 24.3 mg (40.2 %); 1H 
NMR (500 MHz, CDCl3) δ 6.93 (s, 4H), 5.36 (dt, J = 10.7, 5.2 Hz, 1H), 5.21 (t, J = 5.2 
Hz, 1H), 4.35 (d, J = 11.8 Hz, 1H), 4.15 (dd, J = 11.3, 7.0 Hz, 2H), 4.09 – 3.94 (m, 6H), 
3.87 (s, 3H), 3.83 – 3.77 (m, 3H), 3.64 (s, 309H), 2.71 (s, 1H), 2.49 (s, 4H), 2.29 (d, J = 
7.5 Hz, 9H), 2.24 (s, 7H), 1.88 (s, 3H), 1.59 (s, 20H), 1.51 – 1.43 (m, 13H), 1.37 (s, 35H), 
1.25 (s, 146H), 0.90 – 0.80 (m, 50H). 
Glutathione-NTA-PEG2K-DSPE (46). Compound 40b (20.0 mg, 0.01 mmol) and L-
glutathione (15.4 mg, 0.05 mmol) were dissolved in DMF (5 mL) in a 25 mL round 
bottom flask with a stir bar. DIEA (16.4 µL, 0.09 mmol) was added and the flask was 
evacuated and flushed with nitrogen. The solution was stirred at 40 °C for 24 hours 
monitoring the consumption of starting material by TLC. Volatiles were removed in 
vacuo at 45 °C and the residue was dissolved in 6 mL PBS buffer (pH = 7.2) plus 4 mL 
MeOH. This solution was extracted with CHCl3 (3x15 mL). The organic extracts were 
combined and dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give 
Compound 46. Yield: 20.3 mg (93.1 %); 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.8 
Hz, 2H), 7.19 (d, J = 6.9 Hz, 1H), 6.95 (s, 1H), 5.20 (s, 1H), 4.20 – 4.08 (m, 1H), 4.00 (d, 
J = 5.7 Hz, 5H), 3.64 (s, 182H), 3.05 (s, 1H), 2.50 (s, 3H), 2.36 – 2.16 (m, 6H), 1.71 – 
1.50 (m, 9H), 1.31 (d, J = 50.7 Hz, 81H), 1.02 – 0.63 (m, 31H). 
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2.7.2 Cell Lysate Preparation 
The ASKA library, a complete E. coli K-12 ORF archive in which over 4000 
bacterial proteins have been cloned into pCA24N expression vectors, was used. Each 
protein coding ORF has an N-terminal His6 and a C-terminal green fluorescence protein 
(GFP); each protein coding ORF is also available without the GFP fusion (which are the 
strains used in these studies). Cells containing the RplL gene overexpression vector were 
grown to OD = 0.6 in 100 mL of LB broth using a 37 °C shaker/incubator and induced 
with a final concentration of 1.0 mM IPTG before allowing to grow for an additional 4 h. 
After centrifugation, the supernatant was discarded before resuspending the cell pellet in 
lysis buffer (20 mM Tris, 10 mM MgCl2, 100 mM KCl, pH=7.4, 100 µg aprotinin, 174 
µg PMSF, 500 µg lysozyme) and incubation for 20 min. The cell membranes were 
disrupted by sonication (35 pulses, 1 sec/pulse at 75 W) before centrifugation of the 
suspension at 11,000 g for 10 min. The supernatant containing His6-RplL was diluted 10-
fold before application to the TEM grid for analysis.  
Purified C-terminal His6-tag gp10 (capsid protein) of T7 bacteriophage was 
typically produced at a concentration of ~1 x 1012 particles/mL. BL21 bacteria cells in 1 
mL of LB media were grown to OD = 0.8 before addition of T7 bacteriophage (1.0 µL, 
1.0X1012 particles/mL) to the culture and shaking at 37 °C for 1 h. After centrifugation of 
the cells, the supernatant was used directly for TEM grid analysis. 
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2.7.3 His8-GFP Purification 
A glycerol stock of E. coli cells, transformed with the His8-GFPuv pT7-7 plasmid, 
was shaken at 37 C overnight before addition to 250 mL of LB media with shaking at 37 
C until an OD600 of 0.7 was reached. Then, a 1.0 M stock solution of isopropyl-β-D-
thiogalactopyranoside (IPTG) was added, bringing the final concentration to 1.0 mM, 
before shaking continually at 37 C for an additional 5 h. The cells were then centrifuged 
at 11,000 g for 10 min, the supernatant discarded, and the pellet re-suspended in 10 mL 
of lysis buffer (50 mM NaH2PO4, 100 mM NaCl, pH = 8.0, 100 µg aprotinin, 174 µg 
phenylmethanesulfonyl fluoride (PMSF), and 500 µg of lysozyme). The suspension was 
allowed to stand for 20 min before the cell membranes were disrupted using 3 rounds of 
sonication (35 pulses of probe sonication, 1 sec/pulse at 75 W with 1 sec rest/pulse) and 
the debris pelleted by centrifugation at 11,000 g for 30 min. The supernatant was 
incubated with 100 µL of Ni-NTA agarose beads and gently rotated for 4 h. The beads 
were pelleted using a bench top centrifuge operating at 5,000 g for 2 min. The 
supernatant was discarded and the pellet was washed with PBS buffer containing 
imidazole (50 mM NaH2PO4, 100 mM NaCl, 10 mM imidazole, pH = 8.0). The same 
spin and wash sequence was repeated with 15 mM, 20 mM, and 30 mM imidazole in 
PBS. The protein was eluted from the resin after a final spin, discarding of supernatant, 
and incubation with 500 mM imidazole in PBS for 4 h. The removal of imidazole was 
achieved by dialyzing the eluted protein against PBS (50 mM NaH2PO4, 100 mM NaCl, 
10 mM imidazole, pH = 8.0) overnight using a 10,000 MWCO Slide-A-Lyzer. The 
protein was characterized using 12.5% acrylamide SDS-PAGE gel electrophoresis. 
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2.7.4 Purified Maltose Transporter Solubilized in Lipid Nanodisc 
The methods used to purify and insert His6-MalFGK2 maltose transporter in lipid 
nanodiscs derived from membrane scaffolding proteins (MSP) followed those described 
in a previously reported protocol.42 
2.7.5 TEM Grid Carbon Coating Procedure 
A Formvar solution was prepared by dissolving 100 mg Formvar powder in 50 
mL DCM. Copper grids (400 mesh) were purchased from Ted Pella and sonicated in 
acetone for 30 min before drying overnight in a dust free environment. Glass microscope 
slides were freshly cleaned with detergent, rinsed exhaustively with distilled water, dried 
overnight in a vacuum oven, and stored in a dust free environment until coated with 
Formvar solution for 30 seconds by partial immersion before drying for 5 min. The edges 
of the glass slides then were scrapped with a razor before floating the Formvar film on 
water by submersion of the glass slide into a darkly tinted Pyrex glass dish. The pre-
cleaned copper grids were placed atop the floating Formvar film (15 - 20 grids, shiny side 
down) and picked up with a pre-cleaned glass slide before transfer to a Petri dish to dry 
overnight. Then, a carbon film was evaporated onto the glass slide with the TEM grids 
facing up before removal of the Formvar film by placement of the grids on top of filter 
paper soaked with CHCl3 in a glass Petri dish for 30 min. Finally, the filter paper was 
removed and the grids dried overnight in a dust free environment before transfer to a 
standard TEM grid storage box. 
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2.7.6 Langmuir-Schaefer Film Deposition onto TEM Grids 
Stock solutions of two lipid mixtures (1:99 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE and 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE) were 
prepared in CHCl3 at 2.0 mg/mL and stored at -80 °C. Each of these were spread via 10 
L microsyringe at the air-water interface of a KibronTrough S and compressed to a 
final surface pressure of 30 mN/m (i.e., ~59 Å2/molecule for 1:99 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE monolayers and ~66 Å2/molecule for 5:95 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE monolayers). The compressed lipid monolayers were deposited 
onto TEM grids by Langmuir-Schaefer transfer using tabbed TEM grids (Ted Pella) to 
enable grid approach at 180 (and the transfer forceps at 90) relative to the air-water 
interface and the LS film immediately blotted with filter paper. (n.b.: Standard TEM grids 
and forceps produced extensive disruption of the interface during the LS transfer step, 
making it impossible to determine accurate grid transfer ratios under these conditions.) 
The supported monolayer films were then polymerized for 10 min using a handheld 
8W/m2 254 nm lamp that was placed 6-8 cm above the grid surface before transfer to a 
standard TEM grid box for later use. 
2.7.7 Fluorescence Microscopy 
Sessile drops of His8-GFPuv solution (3.5 µL, 2.0 mg GFP/mL in PBS) were 
deposited onto 1:99 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE, 5:95 Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE, 100% mPEG350-DTPE, or bare carbon coated grid 
surfaces for 2 min, followed by removal of excess sample using a microsyringe. Grids 
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were then washed 3 times with 20 µL drops of Tris buffer before removal of the excess 
solution via microsyringe. For elution of Ni2+:NTA-bound T7 bacteriophage from the 
surface of the grid, 500 mM imidazole was deposited on the grid surface for 5 min before 
washing twice with 20.0 µL of PBS. After preparation, the TEM grid was sandwiched 
between a microscope slide and coverslip and sealed with nail polish before recording the 
fluorescence images. 
2.7.8 Negative Staining Procedure 
T7 bacteriophage and RplL cell lysate samples were prepared by incubating a 5.0 
µL drop of cell lysate on the grid surface for 2.0 min before gentle removal by 
microsyringe. The grids were then washed 6 times with 20 µL drops of Tris buffer 
followed by a final wash with 20 µL of distilled water. A 5 µL drop of 2% uranyl acetate 
was placed on the grid for 1 min before removal of the excess solution with a wedge of 
filter paper. Ni2+:NTA-immobilized samples were eluted from the grids by adding 5 µL 
of 500 mM imidazole in Tris buffer immediately after sample deposition (i.e., instead of 
6 Tris buffer washes). Nanodisc solubilized His6-MalFGK2 and purified his6-T7 
bacteriophage samples were prepared in the same manner as the cell lysate samples, 
except that the incubation time of the samples on DLPC and mPEG350-DTPE modified 
grids was increased to 3 min.  Negatively stained samples were imaged using a Tecnai 
TF20 transmission electron microscope operating at 200 kV. 
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2.7.9 Preparation of Frozen Hydrated Samples for Cryo-EM 
TEM grids modified with stabilized 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE monolayers were treated with His-tag protein samples as described above for 
negative-staining. After application of the protein solution, the excess sample was 
removed by blotting the grids twice for 3 secoonds with an offset of -1 at 80 % humidity 
using a Vitrobot (FEI Company). The grids were then cryo-fixed by plunging into liquid 
ethane and imaged at 200 kV on an FEI CM200 transmission electron microscope using 
low-dose techniques. Images were recorded using a Gatan Ultrascan CCD. 
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DEVELOPMENT OF GRAPHENE-OXIDE-BASED AFFINITY GRIDS FOR SINGLE-
PARTICLE CRYO-EM 
3.1 Introduction 
Single particle cryo-EM analysis (SPA) is a rapidly growing method for elucidating 
structure of biological materials at near atomic resolution1 due to recent advances in 
instrumentation and computational algorithms2. One aspect of the SPA process that is not 
well optimized, however, is sample preparation. Furthermore, materials approaches to 
modification of traditional TEM grid surfaces can dramatically increase the relative scope 
of the technique3. Traditionally, proteins targeted for structural analysis must be 
overexpressed and subjected to time-consuming purification and concentration steps, 
sometimes under harsh conditions that disrupt protein-protein interactions of interest. 
Recently, there have been efforts reported that seek to address these limitations, either by 
improving grid rigidity to reduce beam-induced motion4 or by effecting on-grid 
purification with ‘affinity grids’3c, 5 that employ metal chelating lipids that were 
originally developed for two-dimensional protein crystallization at the lipid-water 
interface6. The latter approach seeks to selectively capture biological target molecules 
from complex mixtures such as cell lysates as an integral part of the TEM sample 
preparation process3c, 7. 
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Although lipid monolayer affinity grids have shown some success in producing 
samples for cryo-EM reconstruction at 20 Å resolution5a, robust performance of the 
reported grid coatings may be limited by film instability and non-uniformity under the 
evaporative casting methods that have been reported. Additionally, these lipid films 
require a thin polymer layer or a holey carbon substrate layer to provide mechanical 
support of the deposited film. The electrical conductivity of monolayer graphene is six 
orders of magnitude higher than amorphous carbon, and although the level of 
conductivity in graphene decreases with the extent of oxidation, it has been shown to 
recover much of this conductivity upon reduction with H2 plasma9. Additionally, unlike 
unsupported lipid monolayers, the elasticity of graphene makes it ideal to resist 
permanent deformation due to mechanical transfer techniques from the material-water 
interface. Our interest in utilizing graphene-based affinity substrates is focused on 
exploiting the superior mechanical strength and conductivity it offers. By conferring 
better target specificity to this substrate, affinity graphenic substrates have the potential to 
offer both improved stability and resistance to non-specific adsorption such that direct 
capture from cell lysates may be feasible. 
3.2 Design of Graphene-Oxide-NTA-Based Affinity Grids 
We sought to address the limitations of lipid monolayer coated affinity grids by 
employing a GO derivative that minimizes background signal due to the single atom 
thickness and improved conductivity as a way to combat sample charging and instability 
during image capture8. Here we demonstrate the utility of affinity grids using Langmuir-
Schaefer (LS) transfer of GO monolayer sheets that have been functionalized with 
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covalently linked N, N-dicarboxymethyllysine (GO-NTA). Using these affinity grids, 
we were able to selectively capture both His6-T7 bacteriophage and His6-GroEL. When 
the prepared grids were further modified with bovine serum albumin (BSA), a common 
antifouling agent that limits non-specific adsorption of non-targeted cellular debris, we 
were able to selectively capture these proteins directly from bacterial lysate while 
avoiding deposition of non-target proteins (Figure 3.1).  
 
 
Figure 3.1 Conceptual Diagram of Sample Preparation Using a GO-NTA-Modified TEM 
Grid. (i) GO-NTA monolayer deposition onto TEM grid via L-S transfer; (ii) activation 
of NTA with Ni2+; (iii) blocking of non-specific reaction and/or adsorption sites with 4-
aminobenzoic acid (PABA) and bovine serum albumin (BSA); (iv) incubation of clarified 
lysate with blocked grid; (v) washing of non-target molecules from grid, followed by 





3.3 Synthesis and Characterization of GO-NTA 
GO was produced from graphene using Hummer’s method8. Activation of the GO 
carboxylic acid groups with SOCl2 prior to reaction with the tris-t-butyl ester of lysine 
NTA (15) gave GO-NTA-(O-t-Bu)3. TFA deprotection of this intermediate gave GO-
NTA (51) (Scheme 3.1). Fourier transfer infrared spectroscopy was used to monitor these 
reactions as shown in Figure 3.29. The spectra of GO displayed a broad absorption at 
3236 cm-1 (O-H stretch) and a sharper absorption at 1648 cm-1 (C=O stretch)16. The 
NTA-GO tris-t-butyl ester displayed an additional absorption at 2933 cm-1 (C-H stretch) 
due to the incorporation of the lysine and t-butyl moieties. Following treatment of NTA-
GO tris-t-butyl ester with TFA, the presence of the aliphatic C-H stretching was greatly 
reduced, indicating successful deprotection of the NTA chelator substituents10. 
 
3.3.1 Synthesis of Graphene-Oxide-NTA 
GO was synthesized using an improved Hummers’ method8 that is easier to 
execute, is higher yielding, and does not evolve toxic gases (Scheme 3.1). This method 
involves oxidation of bulk graphite powder by potassium permanganate in the presence 
of sulfuric acid and phosphoric acid. It has been reported that there is no decrease in 
conductivity in the final product between the original and improved method, making it an 
attractive route for large scale production of GO. 
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Scheme 3.1 Synthesis of GO-NTA. 
Activation of the GO carboxylic acid groups with SOCl2 prior to reaction with the 
tris-t-butyl ester of lysine NTA (15) gave GO-NTA-(O-t-Bu)3. TFA deprotection of this 
intermediate gave GO-NTA (Scheme 3.1).  
 
3.3.2 FT-IR Analysis of GO Derivatives 
Fourier transfer infrared spectroscopy was used to monitor these reactions as 
shown in Figure 3.29. The spectra of GO displayed a broad absorption at 3236 cm-1 (O-H 
stretch) and a sharper absorption at 1648 cm-1 (C=O stretch)8. The NTA-GO tris-t-butyl 
ester displayed an additional absorption at 2933 cm-1 (C-H stretch) due to the 
incorporation of the lysine and t-butyl moieties. 
Previous work has shown that the typical GO sheet absorption band at ~240 nm is 
shifted to ~270 nm when the GO sheets are dispersed in aqueous solution. The origin of 
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this hypsochromic shift is due to n-π* electronic transitions arising from the C=O bonds 
introduced by oxidation11. GO-NTA samples prepared in this manner exhibited a major 
absorption peak at ~280 nm, in good agreement with these reports. 
 
Figure 3.2 FTIR Analysis of GO, GO-NTA-tris-t-butyl Ester and GO-NTA 
 Following treatment of NTA-GO tris-t-butyl ester with TFA, the presence of the 
aliphatic C-H stretching was greatly reduced, indicating successful deprotection of the 
NTA chelator substituents10. 
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3.3.3 Synthesis of Pyrene-NTA 
In a similar approach, we sought to use hydrophobic interactions between pyrene-
NTA conjugate and graphene-coated TEM grids to generate a novel affinity grid surface. 
We were interested in taking advantage of existing commercial graphene-functionalized 
TEM grid technologies, as well as novel exfoliated graphene-coated grids, to utilize 
affinity interactions for monolayer purification. To this end, a pyrene-functionalized NTA 
derivative 53 was synthesized via two step sequence (Scheme 3.2). 
 
 
Scheme 3.2 Synthesis of Pyrene-NTA. 
Pyrene-NTA was synthesized via EDC-mediated coupling reaction between 15 
and 4-pyrenebutyric acid (51) to yield 52 in 90.5 % yield after chromatographic 
purification. Deprotection using TFA was used to give Compound 53 in 93.2 % yield. 
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3.3.4 Synthesis of Triethoxysilyl-NTA 
To enable affinity modification of glass surfaces with NTA ligand for affinity 
purification, a triethoxysilyl-NTA derivative was designed and synthesized. This material 
is designed to be used for modification of glass surfaces followed by treatment of the 
modified surface with TFA to deprotect the t-butyl ester protecting groups. 
Scheme 3.3 Synthesis of Triethoxysilyl-NTA. 
To this end, Compound 15 was coupled to 3-(triethyxysilyl)propyl isocyanate (54) in 
THF to give the target Compound 55 in 77.3 % yield after chromatographic purification 
(Scheme 3.3).  
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3.4 Fabrication and Evaluation of GO-NTA-Based Affinity Grids 
Most reports of Langmuir dispersions of GO at the air-water interface focus on 
surfactant-assisted dispersion methods to stabilize GO sheets dispersed in water12. 
Treatment of GO with surfactants in these cases; however, biases the interfacial activity 
towards water-surfactant activity rather than GO-NTA activity due to their high relative 
abundance. The planar structure and functional group distribution on GO-NTA confers 
edge amphiphilicity due to the distribution of hydrophilic carboxyl, ketone, aldehyde, 
amide, and alcohol groups around the periphery of the hydrophobic aryl GO-NTA core 
(Figure 3.2)13. Since GO-NTA becomes increasingly hydrophobic as displacement 
toward the core from the GO-NTA edge increases, larger sheets will tend to be more 
hydrophobic and migrate to the air-water interface, whereas smaller more hydrophilic 
GO-NTA sheets are displaced into the aqueous subphase by the larger GO-NTA sheets14. 
 
3.4.1 GO-NTA Monolayer Formation 
Previously, it was thought that the use of surface-active agents was needed to disperse 
GO sheets. More recent work; however, has shown that GO layers form at the air-water 
interface in the absence of surfactant molecules15. Brewster angle microscopy studies 
have shown that the interfacial refractive index of GO solutions change after a few hours 
of stirring pure GO dispersions in water16. This suggests a time-dependent mechanism for 
GO absorption at the air-water interface, with slower interfacial adsorption rates 
attributable to slower diffusion rates of large graphene sheets relative to typical surfactant 
molecules used for studies of the air-water interfaces. To increase the amount of surface-
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active graphene sheets present at the air-water interface while circumventing hours of 
stirring, studies using rising gas bubbles of CO2 and N2 as a way of transporting these 
sheets to the surface have proven successful14. These studies show that GO can migrate to 
the air-water interface, while other work suggests that the surface activity of GO sheets in 
water can be increased using volatile, polar protic solvents to enable their manipulation 
using Langmuir compression15. 
 
3.4.2 Characterization of GO-NTA Affinity Monolayers 
Compression of the GO-NTA material at the interface gave a characteristic surface 
pressure-area isotherm (Figure 3.3), suggesting a progression from isolated GO-NTA 
sheets to close edge-to-edge packing of GO-NTA sheets, followed by folding, wrinkling, 
and sliding of the nearest neighbor GO-NTA sheets atop one another upon further 
compression17, in a manner analogous to pressure-induced collapse of Langmuir 
phospholipid monolayer films15. Repulsive electrostatic interactions and attractive van 
der Waals forces compete as GO-NTA sheets come into close contact. 
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Figure 3.3 Spreading Behavior of GO-NTA Using a Langmuir Trough. A) Cartoon 
depicting LS-transfer of GO-NTA surfaces onto TEM grids. B) Typical surface pressure-
area isotherm for GO-NTA. C) GO-NTA monolayer subjected to several compression-
decompression cycles on the Langmuir trough. 
Previous work with GO monolayers has suggested that over-compression of GO 
causes irreversible coagulation above ~15 mN/m15 due to the increasing participation of 
attractive van der Waals interactions once the repulsive electrostatic interactions between 
sheet edges has been overcome by lateral compression. Transfer of these films onto 
silicon substrates at multiple surface pressures enabled the transfer of single layer GO 




3.4.2.1 Fluorescence Microscopy Analysis of GO-NTA 
Epifluorescence microscopy, AFM, and SEM was employed to determine the 
thickness and lateral distribution of GO-NTA sheets deposited onto solid substrates by L-
S transfer from the air-water interface18. In particular, epifluorescence microscopy of 
Fluorescein-modified-PABA-GO-NTA (F-PABA-GO-NTA) monolayers proved useful 
because opacity of the graphene-based sheet is directly related to its thickness as revealed 
by analysis of monolayer-coated grid and negative control bare Cu TEM grid samples 
that showed significantly greater fluorescence intensity for grids coated with F-PABA-
GO-NTA (Figure 3.4). 
 
 
Figure 3.4 Analysis of F-PABA-GO-NTA Films by (A) Fluorescence Spectroscopy and 
(B) Epifluorescence Microscopy. Fluorescence spectra were measured for the supernatant 
(A, red spectrum) and the pellet (A, blue spectrum) after reaction of PABA-GO with 
aminofluorescein. (B) Epifluorescence image of F-PABA-GO-NTA film on TEM grid 
across the region indicated by the line in the epifluorescence image. 
We then evaluated drop casting and L-S transfer deposition methods for the 
production of the thinnest films possible, while yielding films with the highest density of 
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NTA capture ligands. Drop casting18-19, followed by slow evaporation of solvent, resulted 
in a fluorescence signal that completely spanned the holes of Formvar-coated 400 mesh 
Cu grids (data not shown). Slow solvent evaporation enables GO sheets to settle on top of 
one another to form a multi-layered film covering the TEM grid holes. Although 
successful, our findings suggest that drop casting typically yields sheets that are too thick 
and heterogeneous for protein structure elucidation applications by cryoEM. L-S transfer 
in the presence of 2-propanol (IPA) proved successful for depositions onto 1500 mesh 
grids, both with and without Formvar coating; however, L-S transfers with pure water 
resulted in thicker heterogeneous coatings over a limited area of the holes. L-S transfer 
onto Si wafers under identical conditions confirmed the presence of multilayered films 
(Figure 3B & D). We were not able to fabricate functional coatings with 400 mesh grids 
using L-S transfer, a finding we attribute to the mismatch between the average GO-NTA 
sheet size of ~16 μm x 16 μm and the 37 μm x 37 μm grid holes of these grids. It is worth 
noting that the GO-NTA sheet size can vary as a function of oxidation reaction duration 
and sonication time employed during GO synthesis20. 
3.4.2.2 AFM Analysis of GO-NTA 
To gain further insight into the structure of these GO-NTA films, SEM and AFM 
analyses were performed after compression to 15 mN/m and L-S transfer of GO-NTA 
monolayer sheets onto Si wafers. To prepare Si wafers for L-S transfer, ~2.25 cm2 wafers 
were cut and glued (bottom side) onto a transfer tube. The surface pressure was 
maintained until the Si wafer contacted the monolayer; the film was then recompressed to 
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15 mN/m after the L-S transfer step. The area difference before and after L-S transfer 
indicated transfer efficiencies of 75 – 85%. 
 
 
Figure 3.5 Characterization of GO-NTA Surfaces. (A) Pressure-area isotherm for GO-
NTA sheets at the air:water interface, dispersed at 67 ng/mL in water at 20 °C. GO-NTA 
sheets compressed at a rate of 500 mm2/min. (B) SEM images taken 1.0 keV, with 5 μm 
scale bar and (C) AFM images of GO-NTA after LS-transfer onto Si wafers from a 
subphase of pure H2O (5 μm scale bar). (D) SEM images taken at 0.5 keV (5 μm scale 
bar) and (E) AFM of GO-NTA after LS-transfer onto Si wafers from a subphase of 
IPA/H2O (5 μm scale bar). (F) TEM image of GO-NTA monolayers after LS transfer 
from a subphase of IPA/H2O onto TEM grids; Inset: Selected area electron diffraction 
analysis of GO-NTA monolayer. 
 
Image analysis of the coated Si wafers revealed the presence of GO-NTA 
monolayer sheets transferred from IPA-containing subphases with ~1.3 nm thicknesses 
that were relatively uniform (Figure 3D & E), in good agreement with previously 
reported values for single layer GO21. In the absence of IPA; however, data from SEM 
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and AFM experiments revealed GO-NTA films comprised of overlapping sheets and 
undesirable layer thickness variations (Figure 3.5 B & C). 
3.4.2.3 SEM and SAED Analysis of GO-NTA 
Selected area electron diffraction analysis of GO-NTA L-S films deposited onto 
bare 2000 mesh grids from the air-IPA/H2O interface revealed a hexagonal diffraction 
pattern, indicative of a single layer of graphenic material (Figure 3.5 F). The measured 










3.4.3 Affinity Capture of His6-T7 Phage Using BSA and PABA as Antifouling Agents 
The capacity of GO-NTA coated grids to capture his6-T7 bacteriophage (his6-T7) 
by affinity interaction was examined first by negative-stain TEM. After a 2 min exposure 
of purified his6-T7 on GO-NTA modified 1500 mesh grids, dense clusters of phage 
particles were found on the GO-NTA surface in the absence of Ni2+ (Figure 3.7 A). 
Paradoxically, we observed fewer phage particles after charging the GO-NTA grids with 
Ni2+ (Figure 3.7 B). We attribute these findings to non-specific and random covalent 
coupling of lysine residues with epoxide and aldehyde residues on the GO sheets that are 
inactivated upon exposure to the metal ion22. To obviate this problem, we chemically 
deactivated these functional groups by treatment of GO-NTA with 4-aminobenzoic acid 
(PABA) after L-S transfer. The resulting PABA-GO-NTA grids showed a reduction in, 
but incomplete abrogation of, non-specific His6-T7 binding under the same incubation 
conditions (Figure 3.7 C). When activated with Ni2+, PABA-GO-NTA grids revealed a 
higher density of phage particles due to engagement of the NTA:Ni2+:his6 affinity 




Figure 3.7 Micrographs of Negatively Stained His6-T7 Bacteriophage Using Various 
TEM Grid Coatings: (A, B) GO-NTA; (C, D) PABA-GO-NTA; and (E–H) BSA-PABA-
GO-NTA. Negative controls (A, C, E) demonstrate no capture of purified phage when 
Ni2+ is absent, whereas coatings treated with Ni2+ (B, D, F) show capture of purified 
phage. Affinity capture of phage from lysate (G) can be reversed by incubation of (G) 
with 500 mM imidazole (H) that removes the Ni2+ from the coating and abrogates the 
affinity interaction between the phage and the grid surface. 
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To further enhance the anti-fouling properties of this material, we incubated the 
PABA-GO-NTA grids with BSA immediately before the affinity capture step. Under 
these conditions, BSA appears to complete the blockade of non-specific viral particle 
adsorption (Figure 3.7 E), suggesting that BSA inhibits non-specific binding more 
effectively than PABA modification. After Ni2+ activation of the BSA-blocked PABA-
GO-NTA surfaces, we observed a recovery in his6-T7 binding to the grids (Figure 3.7 F). 
To further demonstrate the Ni2+ dependence of this interaction, we treated the grid with 
500 mM imidazole, leading to the elution of his6-T7 from the grid (data not shown). 
Taken together, these findings demonstrate the importance of deactivating highly reactive 
chemical functionalities on the surface of GO prior to use in affinity capture experiments. 
 Next, we sought to capture his6-T7 directly from clarified E. coli lysate. The 
engineered His-tag does not interfere with his6-T7 infectivity, thereby enabling the 
infection of BL21 cells and viral replication in vitro. A negative control experiment 
demonstrated that Ni2+-free BSA-PABA-GO-NTA grids resulted in little or no capture of 
phage and minimal background adsorption from non-targeted cellular material (Figure 
S4); however, Ni2+ activation prompted selective his6-mediated binding of bacteriophage 
to the grid surface (Figure 3.7 G). As an additional control, the grid was washed with 500 
mM imidazole after Ni2+, but prior to incubation with lysate, to demonstrate that 
imidazole stripping of the metal ion results in the abrogation of his6-T7 binding (Figure 
3.6 H). These results indicate that BSA-PABA-GO-NTA coated grids are able to 
effectively purify his6-T7 directly from clarified lysate on the grid using the reversible 
NTA:Ni2+:his6 affinity interaction. 
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3.4.4 Affinity Capture of His6-GroEL from Lysate Using BSA-PABA-GO-NTA Affinity 
Grids 
 
The performance of antifouling BSA-PABA-GO-NTA coatings for high-
resolution single particle reconstruction analysis was then evaluated by performing on-
grid affinity capture of his6-GroEL from E. coli lysates. As observed for His6-T7 capture, 
specific binding of his6-GroEL occurred only with Ni2+-activated (Figure 3.8 B), but not 
Ni2+-free (Figure 3.8 A) or 500 mM imidazole treated grids (Figure 3.8 C).  
 
 
Figure 3.8 Micrographs of His6-GroEL Lysate Affinity Capture Using BSA-PABA-GO-
NTA TEM Grid Coating. Micrographs (A–C) are negatively stained. (A) Negative 
control showing no capture of his6-GroEL when Ni2+ is absent. (B) Affinity coating 
activated with Ni2+ displays specific capture of his6-GroEL from lysate. Treatment of the 
grid in (B) with 500 mM imidazole (C) leads to Ni2+ stripping from the coating and 
abrogation of his6-GroEL capture. (D) Representative cryo-EM image of affinity 
captured his6-GroEL from lysate. 
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Next, we obtained cryo-EM images of his6-GroEL deposited onto BSA-PABA-
GO-NTA coated grids (Figure 3.8 D). Initial attempts at his6-GroEL capture and 
cryofixation on 1500 mesh grids coated with BSA-PABA-GO-NTA generated 
unacceptably thick sample vitrification; however, high quality samples of his6-GroEL 
captured from lysate were afforded by BSA-PABA-GO-NTA films deposited by L-S 
transfer onto lacey carbon-supported 400 mesh copper grids. 
 
3.4.5 Single-Particle Analysis of His6-GroEL 
EMAN 2.123 was used for single particle analysis of his6-GroEL deposited onto BSA-
PABA-GO-NTA coated grids since this protein target is often used for gauging workflow 
performance and data processing robustness24. The reconstruction effort followed the 
usual steps from within the application, except that the particles were manually picked. 
Background signal contributions by the BSA blocking layer may also have contributed to 
the difficulties encountered during attempts at automated particle picking. Nonetheless, 
5363 particles were hand-picked from 217 micrographs and the particles rapidly 
converged into coherent classes displaying high contrast (Figure 3.9 A). 
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Figure 3.9 Single-Particle Analysis of his6-GroEL Captured from Lysate. (A) Class 
averages of his6-GroEL images captured from BSA-PABA-GO-NTA coated grids that 
were used to build the initial model; (B) Top and (C) side views of refined his6-GroEL 
EM map at 8.1 Å resolution (gold standard, 0.143 criteria); (D) Fourier Shell 
Correlations: gold standard using conservative masking (black), and cross-validation 
between published GroEL map EMD-5001 and our map (red); (E) Top and (F) side views 
of overlay with our his6-GroEL EM map (blue) and EMD-5001 (yellow). 
 
 
Of 50 total class averages, 12 were chosen to produce an initial model with imposed D7 
symmetry (Figure 3.9 A). After 12 refinement iterations with an angular sampling of 1.76 
degrees, we were able to produce a gold standard (0.143 criteria) density map having 8.1 
Å resolution using conservative masking (Figures 3.9 B-D). There were visible nodes in 




To verify the accuracy of our model, we performed a comparison with published 4.2 Å 
resolution cryo-EM map EMD-500124c that was also produced by EMAN using D7 
symmetry. Chimera25 was used to fit the volumes before calculating the FSC, yielding a 9 
Å resolution using 0.5 criteria (Figure 3.9 D-F). 
A substantial difference between our map and the published structure was 
observed, wherein additional electron density within the inner pore of the protein was 
found in the case of our his6-GroEL map. We attribute this finding to the extended amino 
acid sequences at the N- and C-termini (i.e., MRGSHHHHHHTDPALRA and GLCGR, 
respectively) of our his6-GroEL construct derived from the ASKA Library. 
Wild type N- and C-termini of the protomers are located at the surface of the inner 
pore lining the assembled tetradecameric complex. Thus, the 14 engineered subunits 
comprising our His6-GroEL complex yield an additional 308 residues that occupy the 
pore, of which 84 are histidines. Given the large number of potential metal chelation 
regioisomers and topoisomers, as well as the high potential for conformational flexibility 
in the N- and C-terminal sequences, we believe that this density is unlikely to adopt a 
defined structure and instead appears as a filled “droplet” within each ring. Also, there is 
a noticeable decrease in density in the flexible apical region that suggests less structural 
coherency. We infer from these findings that the additional pore residues, along with 
NTA chelation, may create dynamic distortions to the structure of GroEL that could vary 
for each particle, reducing coherency and map density at the apical ends. Further 
experiments that vary the length and number of his-tag linkers per particle may allow for 
a better model convergence with improved resolution, and potentially improved 
resemblance to wild type GroEL. 
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3.5 Conclusions 
Our findings show that a new functionalized GO-NTA monolayer sheet can be 
used as a coating to facilitate on-grid affinity purification from clarified cell lysates for 
negative stain TEM and cryo-EM single particle reconstruction analysis. GO sheets were 
successfully functionalized with lysine-NTA affinity ligands and compressed monolayer 
films at the air-water interface were prepared by employing an IPA/H2O mixture to lower 
surface tension before L-S transfer onto EM grids. SEM, AFM, fluorescence 
spectroscopy, and TEM analysis of these films suggests that single monolayer sheets of 
GO-NTA can be transferred onto Si wafers, bare copper grids, and holey carbon grids 
using this method. Since GO films are thinner than amorphous carbon substrates and 
offer better electron dissipation than lipid-based affinity grids, we believe these two 
benefits will yield improved contrast for cryo-EM image acquisition of biological 
molecules. 
Two blocking techniques, PABA coupling and BSA adsorption, were needed to 
deactivate the reactive GO surface towards non-specific adsorption of occult impurities 
present in complex samples such as cell lysates. Our data shows that further 
investigations into blocking agents that minimize background noise and improve 
cryofixation reliability are needed. Nonetheless, this grid coating approach showed good 
specificity for capture of His-tagged T7 bacteriophage and GroEL from highly complex 
cell lysates, while limiting background adsorption of non-targeted cellular material. 
The utility of these grids for on-grid purification from cell lysates and single 
particle reconstruction was demonstrated using His6-GroEL. Capture of this target onto 
the surface of GO-NTA affinity grids from clarified cell lysates was then used as the key 
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step to enable selection of 5363 particles for reconstruction analysis, yielding a map with 
a gold standard resolution of 8.1 Å. The presence of additional His-tag and linker amino 
acids in our engineered GroEL was distinctly visible in our density map, but our final 
map could still be fit to a published high-resolution EM map to 9 Å resolution using 0.5 
criteria. We conclude based on these findings that affinity capture-based graphenic 
materials offer great potential for simplified and accelerated cryo-EM sample preparation 
for high-resolution structure elucidation. These coatings possess many advantages over 
NTA-lipid-modified grids5a, 5b or other grid coatings that lack protection from non-
specific binding4, thereby offering substantial improvements in sample preparation time 
and reduced sample volumes needed to acquire high resolution structural information of a 
given protein target and, potentially, its interaction partners. 
3.6 Experimental Methods 
All reactions were carried out under a blanket of N2 gas. Reaction progress was 
monitored by thin-layer chromatography (TLC) analysis. TLC spots were visualized 
either by UV light (254nm), exposure by ninhydrin staining (100 mL n-BuOH, 3 mL 
Accor, 0.3 g ninhydrin), or by staining with I2. Flash column chromatography was carried 
out using 230-400 mesh silica gel and analytical grade solvents. 1H and 13C nuclear 
magnetic resonance (NMR) spectra were recorded on either a Bruker AV500HD 
(500MHz) or a Bruker ARX400 spectrometer (400 MHz). Chemical shifts are reported in 
ppm relative to the residual solvent peaks as internal standard. Flake graphite (F516, 200-
300 mesh) was obtained from Asbury Carbons Inc. EDC, HOBt, and DIEA were 
purchased from Advanced Chemtech. DCM, toluene, and acetonitrile (ACN) were 
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distilled from CaH2. Tetrahydrofuran (THF) was distilled from sodium benzophenone 
ketyl. All other reagents were purchased from Sigma Aldrich and used without further 
purification. 
3.6.1 GO-NTA Synthesis 
GO (49). A 9:1 mixture of H2SO4 and H3PO4 (130 mL total volume) was stirred 
with 1 g of graphite flakes (48, F516 flake graphite, 200-300 mesh, Asbury Carbons, 
Inc.) and KMnO4 (6.0 g, 6.0 wt. equiv.). The reaction began with heating to ~40 °C and 
proceeded with further heating and stirring at 50 °C for 12 hours before cooling to 20 °C 
and pouring the reaction mixture into 120 mL of ice cold-water with 1 mL 30% H2O2. 
Next, this suspension was passed through a metal U.S. Standard testing sieve (W.S. 
Tyler, 300 μm) and then passed through a glass wool plug to filter larger particulates. The 
filtrate was then centrifuged at 4,000 rpm for 4 h, the supernatant discarded, and the 
pellet washed twice with a 1:1:1 volumetric ratio of H2O, 30% HCl, and EtOH before 
passing the material through the testing sieve and centrifuging the filtrate at 4,000 rpm 
for 4 h to pellet the aggregated material. The supernatant was precipitated with Et2O (200 
mL) and filtered through a 0.45 μm PTFE membrane to gather the solid. The final 
material was dried under a 15 m vacuum for 12 h, yielding 49 (1.8 g). 
GO-NTA (50). GO (49, 335 mg) was stirred in a mixture of SOCl2 (60 mL) and 
DMF (1.5 mL) at 70 °C for 72 hours before evaporating the SOCl2 and DMF and 
washing the residue with dry DCM (3 x 50 mL). Toluene (50 mL) and Et3N (3 mL) were 
then added and the mixture stirred for 30 min. Tris(O-t-butyl)-N,N-
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dicarboxymethyllysine ester (15, 533 mg) was then added and the mixture stirred at 70 ˚C 
for 72 hours before washing with THF and H2O (9,000 rpm for 15 min, 3 times for each 
solvent), then vacuum drying at 60 ˚C for 24 h. TFA (10 mL) in DCM (30 mL) was 
added to the dried t-butyl-NTA ester intermediate (180 mg) and stirred at 60 ˚C for 5 h 
before washing with THF and H2O (11,000 rpm x 15 min, 3 times for each solvent)11, 26. 
3.6.2 Synthesis of Pyrene-NTA 
Di-tert-butyl 2,2'-((1-(tert-butoxy)-1-oxo-6-(4-(pyren-1-yl)butanamido)hexan-2-
yl)azanediyl)diacetate (52). 1-Pyrenebutyric acid (51, 0.198 g, 0.69 mmol) Compound 
15 (0.296 g, 0.69 mmol) and HOBt were combined in an oven-dried 50 mL round bottom 
flask equipped with a magnetic stir bar. DMF (5 mL) was added followed by EDC (0.145 
g, 0.76 mmol). The contents were swirled to dissolve the solids and the flask sealed with 
a rubber septum and filled with argon gas. The reaction was stirred at ambient 
temperature for 30 minutes. DIEA (0.444 g, 3.43 mmol) was added via syringe and the 
reaction was stirred for an additional 36 hours at ambient temperature. Volatiles were 
evaporated and the residue was purified by flash chromatography using 2:3 
EtOAc:hexane as eluent. Compound 52 was obtained as a slightly yellow oil. (0.447 g, 
90.5 %). Rf 2:3 EtOAc:hexane 0.29. 1H-NMR (500 MHz, CDCl3) δ 8.25 (d, J = 9.2 Hz, 
1H), 8.15 – 8.06 (m, 2H), 8.06 – 7.99 (m, 2H), 7.99 – 7.86 (m, 3H), 7.80 (d, J = 7.8 Hz, 
1H), 6.19 (s, 1H), 3.56 – 3.39 (m, 4H), 3.37 – 3.23 (m, 4H), 3.18 (s, 1H), 2.28 (t, J = 7.3 
Hz, 2H), 2.23 – 2.10 (m, 2H), 1.63 (s, 2H), 1.53 (s, 3H), 1.43 (s, 11H), 1.40 (s, 17H). 13C 
NMR (126 MHz, CDCl3) δ 172.84, 172.43, 170.78, 136.15, 131.36, 130.89, 129.82, 
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128.73, 127.46, 127.28, 126.57, 125.76, 125.02, 124.76, 123.47, 81.12, 80.73, 77.48, 
77.23, 76.97, 64.90, 53.98, 39.19, 35.98, 32.92, 29.81, 28.42, 27.57, 22.90. 
 
2,2'-((1-Carboxy-5-(4-(pyren-1-yl)butanamido)pentyl)azanediyl)diacetic acid (53). 
Compound 52 (0.447 g, 0.638 mmol) was dissolved in DCM (20 mL) and triethylsilane 
(0.371 g, 3.191 mmol) was added. TFA (20 mL) was added and the solution turned a 
slight clear black color. The solution was stirred at ambient temperature for 1.5 hours 
under a slight argon flow. After about 40 minutes, the reaction turned a slight 
beige/yellow color. After 1.5 hours, the solution was concentrated in vacuo. The residue 
was combined with DCM (80 mL) and evaporated twice to remove left over TFA. The 
residue was dissolved in deionized water and lyophilized to give Compound 53 as a 
yellow powder. (0.317 g, 93.2 %). 1H NMR (500 MHz, DMSO-d6) δ 12.54 (s, 2H), 8.36 
(d, J = 8.9 Hz, 1H), 8.26 (d, J = 7.1 Hz, 2H), 8.20 (d, J = 6.1 Hz, 2H), 8.10 (d, J = 9.2 Hz, 
2H), 8.04 (t, J = 7.1 Hz, 1H), 7.92 (d, J = 7.4 Hz, 1H), 7.78 (s, 1H), 3.60 (s, 4H), 3.48 (d, 
J = 13.4 Hz, 5H), 3.29 (s, 4H), 3.02 (s, 2H), 2.48 (s, 4H), 2.20 (s, 2H), 1.99 (s, 2H), 1.56 
(d, J = 49.6 Hz, 2H), 1.36 (d, J = 23.3 Hz, 6H), 1.12 (d, J = 26.8 Hz, 1H), 0.88 (s, 1H). 
13C NMR (126 MHz, DMSO) δ 174.32, 173.53, 172.10, 137.06, 131.34, 130.89, 129.75, 
128.61, 128.00, 127.91, 127.66, 126.94, 126.58, 125.38, 125.24, 124.69, 124.61, 123.98, 




3.6.3 Synthesis of Triethpxysilyl-NTA 
tert-Butyl 16-(2-(tert-butoxy)-2-oxoethyl)-15-(tert-butoxycarbonyl)-4,4-diethoxy-9-
oxo-3-oxa-8,10,16-triaza-4-silaoctadecan-18-oate (55). Compound 15 (0.102 g, 0.237 
mmol) was dissolved in THF (2 mL) in an oven-dried 25 mL round bottom flask 
equipped with a rubber septum and magnetic stir bar. The solution was evacuated and 
purged with argon before cooling to 0 °C in an ice bath and addition of 3-
(triethoxysilyl)propyl isocyanate (54) via syringe dropwise over 3 minutes. The solution 
was allowed to warm to ambient temperature and stirred for an additional 18 hours. The 
volatiles were evaporated in vacuo and the residue was purified by flash chromatography 
using 95:5 DCM:MeOH as eluent to give Compound 55 as a colorless oil. (0.142 g, 77.3 
%). 1H NMR (500 MHz, Chloroform-d) δ 3.74 (q, J = 7.0 Hz, 6H), 3.47 – 3.32 (m, 4H), 
3.29 – 3.21 (m, 1H), 3.21 – 3.13 (m, 1H), 3.09 (d, J = 3.7 Hz, 3H), 1.59 (d, J = 6.4 Hz, 
3H), 1.55 – 1.47 (m, 3H), 1.39 (d, J = 4.3 Hz, 27H), 1.15 (t, J = 7.0 Hz, 10H). 13C NMR 
(126 MHz, CDCl3) δ 172.48, 170.85, 158.61, 81.08, 80.83, 76.83, 64.89, 58.29, 54.00, 
42.88, 39.68, 29.57, 28.58, 28.16, 23.79, 22.51, 18.26, 7.63. 
3.6.4 GO-NTA Exfoliation 
The GO-NTA 50 sheets were ultrasonically exfoliated at 1 mg/mL by suspension 
of the powder in 5:1 MeOH:H2O using probe sonication at 150 watts for five cycles (45 s 
sonication followed by 45 s of rest in each cycle). The product was centrifuged at 1200 g 
for 10 min, after which the supernatant of exfoliated GO-NTA sheets was removed from 
the sediment of aggregated sheets and subjected to another 5 rounds of sonication. A final 
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centrifugation at 1200 g for 10 min was performed prior to removal of the supernatant to 
yield a GO-NTA solution that was stored for subsequent grid coating experiments. 
3.6.5 Langmuir Trough Setup 
Exfoliated GO-NTA was deposited at the air-water interface of a Kibron Trough 
via a syringe pump fitted with a 20 mL syringe. The GO-NTA dispersion was loaded into 
the syringe and slowly introduced at the air-water interface at a rate of 100 L/min until 
the surface pressure reached 15 mN/m. The film was then allowed to relax for 5 min, 
followed by slow compression of the film to 15 mN/m. IPA was then added to the 
subphase and the film transferred to either Si wafers, bare 1500 mesh TEM grids, or 
holey carbon grids by Langmuir-Schaefer (L-S) transfer. 
3.6.6 4-Aminobenzoic Acid (PABA) Modification of GO-NTA 
GO-NTA (1 mg/mL) was partially deactivated by adding PABA (30 mg) to a 10 
mL GO-NTA dispersion. This mixture was probe sonicated at 150 W for 30 sec of 
continuous sonication, followed by shaking for 24 h on a rotary mixer. The PABA-GO-
NTA was then exfoliated and washed as described above for GO-NTA exfoliation. 
3.6.7 Fluorescein Modification of GO-NTA 
Fluorescein modification of GO-NTA was performed by adding 2 mg of 
aminofluorescein to an aqueous solution of PABA-GO-NTA (10 mL at 1 mg/mL). This 
mixture was probe sonicated for 30 s at 150 W of continuous sonication and then placed 
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on a rotary mixer in the dark for another 24 h. The material was then centrifuged to pellet 
the GO species before re-suspending in water, addition of 5:1 MeOH:H2O, re-pelleted, 
and decanted a total of 10 times before exfoliation of the Fluorescein-PABA-GO-NTA 
(F-PABA-GO-NTA) product as described above for GO-NTA. 
3.6.8 Bovine Serum Albumin (BSA) Modification of GO-NTA 
Following L-S transfer of GO-NTA or PABA-GO-NTA onto EM grids and 
overnight drying in a desiccator, the grids were placed on a strip of Teflon before 
addition of BSA (10 μL of 0.1 mg/mL) and incubation for 5 min, followed by 3 x 20 μL 
double deionized H2O washes. The modified grids were then stored in a desiccator until 
use. 
3.6.9 Fluorescence Microscopy Sample Preparation 
F-PABA-GO-NTA was deposited onto 1500 mesh grids in the dark by L-S 
transfer as described above. After transfer, the grids were allowed to dry in the dark for 1 
d before sandwiching them between a glass and cover slip with 5 μL of double deionized 
H2O and the sandwich sealed with nail polish. The glass slide was then mounted on a 





3.6.10 GO Concentration Measurements 
The concentrations of the GO-NTA dispersions were measured at different steps 
of the synthesis by monitoring the UV-vis spectra of the products. The extinction 
coefficient data used for one batch of GO-NTA is shown (Figure S1A). Since each batch 
of GO-NTA has minor differences in concentration, each preparation was evaluated for 
its own experimentally determined extinction coefficient for subsequent concentration 
measurements. Standard solutions used to determine the extinction coefficients were 
prepared by dispersing a weighed amount of dry GO-NTA into known volumes of 5:1 
MeOH:H2O and measuring the absorbance at 280 nm across a series of dilutions with 5:1 
MeOH:H2O. The extinction coefficient was derived from the slope of these 
concentration-dependent absorption plots. 
3.6.11 GO-NTA Grid Treatment with Purified His6-T7 Phage 
Purified C-terminal gp10 His6-T7 bacteriophage was initially prepared at a 
concentration of 1012 particles/mL, with dilution to 1010 particles/mL in HEPES buffer 
(pH = 7.4) before application to the affinity grid surface. GO-NTA modified grids were 
placed on a Teflon strip, 1 mM NiSO4 (10 μL) added and the grids incubated for 5 min 
before washing with double deionized H2O (2 x 20 μL) and HEPES buffer (1 x 20 μL). 
Purified phage (3.5 μL) was then applied to the surface and incubated for 2 min before 
washing with HEPES (2 x 20 μL), double deionized H2O (1 x 20 μL), and staining with 
2% uranyl acetate (5 μL). 
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3.6.12 GO-NTA Grid Treatment with His6-T7 Phage Lysate 
BL21 bacterial cells in 1 mL of LB media were grown to an OD of 0.8 before 
adding 1.0 µL of His6-T7 bacteriophage (1 x 1012 particles/mL) to the media and shaking 
the culture for 1 h. After bench top centrifugation of the cells, the supernatant was 
withdrawn for use in His6-T7 bacteriophage particle capture studies. The grids were Ni2+-
activated as described above, except that His6-T7 lysate (5 μL) was applied to the surface 
before incubation for 2 min. The grids were then washed with HEPES (2 x 20 μL), 
double deionized H2O (1 x 20 μL), and then stained with 2% uranyl acetate (5 μL). 
3.6.13 GO-NTA Grid Treatment with His6-GroEL Lysate 
The ASKA Library was used to express N-terminal His6-GroEL. Cells containing 
N-His6-GroEL gene overexpression vector were grown to OD = 0.6 (in 100 mL of LB 
broth using a 37 ˚C shaker/incubator) and induced with a final concentration of 1.0 mM 
IPTG, before allowing the cells to grow for an additional 4 h. After centrifugation and 
removal of the supernatant, the cell pellet was re-suspended in lysis buffer (20 mM 
HEPES, 100 mM NaCl, pH = 7.4, 100 µg aprotinin, 174 µg phenylmethanesulfonyl 
fluoride (PMSF), and 500 µg of lysozyme) and allowed to sit for 20 min. Further 
disruption of the cell membranes was effected by 110 W probe sonication (35 pulses at 1 
second/pulse), followed by centrifugation at 11,000 g for 10 min. The supernatant 
containing His6-GroEL was diluted 10-fold and assayed for affinity binding using the 
Ni2+-activation procedure described above, except that N-His6-GroEL lysate (5 μL) was 
applied to the surface and incubated for 2 min. The grids were then washed and stained 
with 2% uranyl acetate as described above. 
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3.6.14 Affinity Capture of His6-GroEL from Lysate onto BSA-PABA-GO-NTA Affinity 
Grids for Cryo-EM Imaging 
 
Samples were prepared as described above for negative stain TEM imaging, 
except that BSA-PABA-GO-NTA modified grids were exposed to His6-GroEL lysate, 
after which the excess solution was removed by blotting twice for 6 s per blot using an 
offset setting of -1 at 80% humidity using a Vitrobot device (FEI Company). The grids 
were then plunged into liquid ethane for cryofixation and imaged at 300 kV on an FEI 
Titan Krios equipped with a Gatan K2 Summit direct electron detection camera using 
low-dose techniques. Integrated microscope automation software Leginon27 was used to 
acquire a large set of micrographs at 11,000x magnification with an exposure time of 7.6 
sec. 
3.6.15 Single-Particle Analysis of His6-GroEL 
Direct electron detector movie frames were processed in Appion28 to produce a 
set of averaged, motion-compensated micrographs to be used in subsequent steps. The 
micrographs had a 1.32 Å2/pixel resolution across a 4096 Å x 4096 Å array. EMAN 2.1 
software31 was used for reconstruction of 5363 particles that were manually picked from 
217 micrographs using a box size of 256. Automatic contrast transfer function (CTF) 
estimation and structure factor were determined from the incoherent sum of particles 
using e2ctf and phase-flipped to generate high-pass CTF-corrected particle stacks. 
Defocus was estimated to range between 0.4 μm – 4 μm, but 55% of the particles were 
defocused between 2 μm – 3 μm which resulted in a somewhat jagged CTF slope. 
Particles were binned 2X for class averaging and 12 classes were chosen to create an 
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initial model with imposed D7 symmetry. The classes contained a mix of top and side 
views. In the refinement steps, the input set of particles was divided into even/odd halves, 
each containing 2682 particles. Two independent refinements were generated, producing 
a gold standard of 8.1 Å (using 0.143 criteria) after 12 iterations over two refinements 
with an angular sampling of 1.76 degrees. Additionally, we performed Fourier shell 
correlation against an existing high-resolution cryo-EM map, EMD-500134. The maps 
were rotated and translated using Chimera35 to fit the volumes together. The correlation 
of our model against EMD-5001 (4.2 Å) gave an approximate resolution of 9 Å. 
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DEVELOPMENT OF AFFINITY POLYROTAXANE CONSTRUCTS FOR SINGLE 
PARTICLE CRYO-EM 
4.1 Introduction 
There are great opportunities for the design of new organic materials as tools for 
the elucidation of protein structure1, particularly in cases where traditional structure 
determination methods are ineffective or impractical. A host of different materials and 
approaches for interfacial templating have been developed including affinity lipids2, 
facial amphiphiles3, conformationally-restricted amphiphiles4, nanodiscs5, lysolipid-
guided cubic phase formation6, symmetry-guided chelation7, and polymer nucleants8. 
Some of these agents are directed toward the accelerated production of protein crystals 
for x-ray diffraction (XRD) analysis, while others are intended to facilitate single particle 
analysis (SPA) by cryoelectron microscopy (cryo-EM). 
XRD and NMR based methods account for the vast majority of high-resolution 
protein structures to date9, however, these methods are exceptionally challenging for the 
analysis of integral membrane protein (IMP), multiprotein complex structures, and other 
biomacromolecular assemblies, such as viral particles. Cryo-EM has become an 
increasingly powerful method for determining the three-dimensional structures of 
proteins and their assemblies via SPA10. Recently, the technique has been used to 
determine protein structural information at 2.2 Å resolution11. Cryo-EM, unlike other 
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electron microscopy techniques, does not require staining or embedding in non-
physiological media. A key challenge for structure determination via cryo-EM is that the 
method requires the collection of more than 30,000 images of the target structure to 
enable image reconstruction at near atomic resolution. Since protein concentrations used 
for SPA are typically in the μg-mg/mL range, data collection is a laborious and time-
consuming process under these conditions because there are typically a limited number of 
particles in the field of view at the magnification (18,000-24,000x) required to image the 
nano-scale targets. Thus, accelerated SPA by cryo-EM requires the development of 
materials and methods that increase the probability of finding the target particles in the 
vitrified sample. 
One method of overcoming this challenge is through the use of automated 
methods12. Alternative strategies seek to concentrate proteins at material interfaces for 
structural analysis. The first effort of this type was reported by Kornberg13 and coworkers 
who used antibody-based affinity interactions to concentrate protein targets on affinity 
lipid monolayer surfaces. 
The desire for more general methods to promote specific monolayer-protein 
interactions eventually led to the development of NTA-modified lipids that are capable of 
binding recombinant proteins bearing six or more repeating histidine residues (i.e. his-
tag). Thompson and coworkers first demonstrated the ability of NTA-lipids to facilitate 
the two-dimensional crystallization and structural determination of his-tagged Moloney 
leukemia virus capsid (his6-MoCA) at the air-water interface14.  Negative-stain TEM was 
used to determine the his6-MoCA structure at 9.5 Å resolution. More recently, this 
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method has been adapted and used by Walz15 and coworkers for the elucidation of the-
transferrin receptor complex and the human rp13 ribosomal complex. 
A disadvantage of the lipid-monolayer approach, however, is that two-
dimensional crystals or adsorbates can only be used to produce projection maps of the 
target structure unless a tilt series of images is collected to produce a three-dimensional 
structure with a “missing cone” due to sample tilting limitations beyond ~60˚. The lipid-
tubule method16 was developed to overcome these difficulties by using liquid-phase 
galactosylceramide lipid tubule templates that have been doped with low molar ratios of 
affinity lipids to promote specific interactions with the lipid template surface. These 
materials enable specific adsorption of proteins such that a single TEM image reveals all 
orientations of the adsorbed molecules, thereby eliminating the need for tilt-series 
imaging or multiple constructs of the protein with the affinity tag placed at different 
protein loci. This approach enabled the rapid elucidation of perfringolysin 0 at ~25 Å 
resolution17. The major limitation of this approach is that a highly consistent tubule 
diameter is required for high-resolution re-construction. 
4.2 Design of Novel NTA-Modified Polyrotaxanes for Cryo-EM 
These challenges led us to develop a family of polyrotaxane (PR) materials, a 
class of supramolecular structures where one or more macrocycles are threaded onto a 
linear polymer that has been subsequently end-capped with bulky substituents to prevent 
dethreading of the macrocycle(s)18. The term rotaxane is derived from Latin for wheel 
and axle. The supramolecular materials consist of three main components: the 
macrocycle or “wheel” which is usually a cyclic molecule (e.g. cyclodextrin, crown-
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ether, etc.), the axle, which is usually a linear polymer bearing an affinity for the 
macrocycle interior, and the endcap which is a bulky molecule (larger than the diameter 
of the macrocycle) which can be conjugated to the axle termini. If the endcap is smaller 
than the diameter of the macrocycle, the material is referred to as a pseudorotaxane or 
pseudopolyrotaxane. The kinetic and thermodynamic properties of the rotaxanation 
process are determined by the non-covalent interactions between the macrocycle and 
linear polymer and interactions between macrocycles of adjacent rotaxanes19.  
 




Cyclodextrins are commercially-available, water-soluble20, well-defined, 
biocompatible, easily-modified and available in different cavity diameters (Table 4.1). 
CD’s also may protect their threaded axle from degradation after threading21. 
Cyclodextrins (CD) have been utilized for polyrotaxanes synthesis and applications 
extensively22. Cyclodextrins (Figure 4.1) are cyclic oligosaccharides of glucose referred 
to as α-cyclodextrin (α-CD, 6 units), β-cyclodextrin (β-CD, 7 units) and γ-cyclodextrin 
(γ-CD, 8 units). α-CD and γ-CD exhibit very high water solubility with β-CD only having 
moderate solubility. CD-based polyrotaxanes are capable of producing a wide variety of 
molecular architectures.  
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Figure 4.1 Molecular Structures of Cyclodextrins. 
Similarly, many different axle components have been utilized for rotaxane 
synthesis. These materials are generally polymeric in nature with linear polymers being 
the most heavily utilized. The axle may be any component with a cross-section smaller 
than the macrocycle cavity and a length greater than that of the macrocycle.  
Polyrotaxanes are generally synthesized by either threading, followed by 
endcapping, clipping, or slippage. Of these, threading, followed by endcapping is the 
most common (Figure 4.2).  The endcapping process is formally referred to as 
rotaxanation. Cyclodextrin-based polyrotaxanes are the most widely-studied PR 
derivatives for biomedical and life science applications. They have been used as 
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transfection reagents22c, 23, as therapeutic agents22a, for modulation of ligand-protein 
interactions24, etc.21, 25. 
 
 
Figure 4.2 Summary of Polyrotaxane Architectures and Syntheses19. (A) Different CD-
based polyrotaxane architectures (B) Methods of forming main-chain type polyrotaxanes. 
These structures possess several uniquely advantageous properties resulting from 
the non-covalent interactions between polymer axle and macrocycle, such as free lateral 
and rotational mobility of the threaded macrocycles so that they can adapt to the steric 
demands of the adsorbate, facile preparation from inexpensive precursors, and uniform 
diameters that are defined by the macrocycle. The great structural diversity possible with 
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these materials26 has led to a number of proposed applications, including their use as 
carriers for drug and gene delivery27. There are few reports in the literature, however, of 




Figure 4.3 Conceptual Diagram of His-Tagged Protein Adsorption onto NTA-Modified-
Polyrotaxane Scaffolds. Polyrotaxanes bearing multiple laterally-and rotationally-mobile-
Lys-NTA-α-CD’s facilitate adsorption of his-tagged proteins. The relatively small 
protein, his6-GFP, (31 kD) yields a complex with a high degree of α-CD mobility, 
enabling favorable CD-CD and GFP-GFP interactions. Comparatively large protein 
assemblies (e.g. his6-gp10 connector polypeptide, 440 kD) lead to complexes with more 
constrained α-CD mobility due to molecular crowding of the bound proteins. In both 
cases, adsorbed proteins are presented in all possible orientations due to the dynamic 
mobility of the threaded Lys-NTA-α-CD to which they are chelated. 
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In the present study, the development of an approach that is conceptually similar 
to the NTA-lipid tubule template method that would retain the specific recognition and 
lateral diffusion properties of the lipid-tubule approach in a more chemically robust 
format is described. This strategy utilizes the principle of NTA:Ni2+:polyhistidine 
recognition on a polyrotaxane template that bears multiple laterally- and rotationally-
mobile lysine-N,N-di(carboxylmethyl)-α-cyclodextrins (LysNTA-α-CD) to concentrate 
his-tagged proteins on a spatially well-defined scaffold for single particle analysis by 
cryo-EM. 
These materials are designed to have good solubility in biological buffers and 
facilitate SPA of his-tagged proteins since: (1) like the lipid tubule approach, each TEM 
image reveals all 3D orientations of the adsorbed protein; (2) data collection is expedited 
by protein concentration at the polyrotaxane surface rather than being randomly 
distributed in solution; (3) polyrotaxanes offer a constant diameter template at the 
threaded cyclodextrin core; and (4) the rod-like polyrotaxane morphology should 
suppress information loss due to protein-protein overlap and secondary scattering events 
in projection EM images that is much more likely using a conventional polymer 





4.3 Synthesis and Characterization of NTA-Modified Polyrotaxanes 
4.3.1 Synthesis of Homobifunctional PEG Derivatives 
In a similar fashion described in Chapter 1 for mPEG derivatives, a small library 
of homobifunctional PEG derivatives was synthesized (Scheme 4.1) following modified 
protocols previously reported for end group modification of PEG29. PEG of various 
molecular weight (~2000-35,000 Da) 56a-e was converted to the mesylate (57a-e) via 
treatment with methansulfonyl chloride in dichloromethane (DCM) in the presence of 
triethylamine with average yield of 89-95 %. The mesylates were converted to bis-azide-
terminal-PEG (58a-e) via SN2 displacement by sodium azide in N,N-dimethylformamide 
(DMF) in 90-98 % average yield. Reduction using hydrogen gas (1 atm) and 10 mol % 
palladium on carbon (Pd/C) support in ethyl acetate (EtOAc) gave the terminal amine 
(59a-e) in 88-96 % average yield.  
 
Scheme 4.1 Synthesis of Homobifunctional PEG Derivatives. 
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Carboxyl-terminal PEG were obtained via Jones oxidation of 56a-e giving 60a-e 
in 88-94 % average yield. Conversion was determined via TLC analysis combined with 
staining with bromocresol green to verify oxidation. An alternative route to amine 
terminal PEG through an aldehyde-terminal intermediate was also utilized. The aldehyde-
terminal PEG derivatives were obtained via Albright-Goldman oxidation of 56a-e to give 
61a-e in 89-94 % average yield. The aldehyde-terminal PEG were then converted to the 
amine 62a-e via reductive amination mediated by sodium cyanoborohydride and 
ammonia in methanol in 91-97 % overall yield. Reported yields are given as percent 
recovery. Polymers were purified via extractions and precipitation into diethyl ether. The 
efficiency of conversion for Jones oxidation is near complete29b. Conversions reported for 
the Albright-Goldman and reductive amination protocols are 78-86 %29b.  
 
Scheme 4.2 Synthesis of Amine-Terminal PEG via CDI-Coupling. 
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 Additionally, in order to generate a third PEG-bis-amine with a different synthetic 
methodology, Compounds 63a-e were synthesized via coupling of ethylenediamine to the 
terminal hydroxyl groups of PEG via CDI-mediated coupling, in the presence of 
triethylamine, forming an N’-2-aminoethylcarbamate terminus. Compounds 63a-e were 
obtained in 91-97 % average yield). Similarly, in order to generate a tetrafunctional PEG-
amine capable of accommodating two endcaps per terminus, tris(2-aminoethyl)amine was 
coupled to terminal hydroxyl groups of PEG via CDI-coupling in the presence of 
triethylamine. Compounds 64a-e were obtained in 89-95 % average yield. 
 
Scheme 4.3 Synthesis PEG-bis-MBPA. 
 Additionally, bis-tertiary bromide terminal PEG was synthesized by direct 
esterification of PEG (56a-e) with 2-methyl-2-bromopropionic acid (Scheme 4 .3) 
mediated by EDC and DMAP in a solution of DCM and pyridine. Compounds 65a-e 
were obtained in 92-98 % yield. 
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4.3.2 Synthesis of TNB-Capped Polyrotaxanes 
A small library of TNBS-capped polyrotaxanes composed of PEG and α-CD as 
the axle and macrocycle, respectively, was synthesized by threading α-CD and PEG in 
aqueous solution followed by rotaxanation via reaction of 2,4,6-trinitrobenzenesulfonic 
acid (TNBS) with PEG-bis-amine (59a-d). The polyrotaxanes (66a-d) were isolated by 
exploiting the poor aqueous solubility of the polyrotaxanes compared to the high 
solubility of both PEG and α-CD by a centrifugal purification process followed by 
dialysis (Scheme 4.4). 
 
Scheme 4.4 Synthesis of TNB-Capped Polyrotaxanes from 59. 
 The polyrotaxanes were characterized via 1H-NMR to determine the number of 
CD’s, threading efficiency and estimated molecular weight (Table 4.2). The yields were 
highest for the PEG of low molecular weight. Threading efficiency was also generally 




Table 4.2 Characterization of TNB-Capped Polyrotaxanes from 59. 
 
 
Similarly, polyrotaxanes were synthesized from Compounds 63a, 63c, 63e via 
threading of the PEG and α-CD in water followed by rotaxanation via substitution 
reaction of TNBS with terminal amino functionalities of PEG. The compounds were 
purified by centrifugal washing and dialysis. 
 
Scheme 4.5 Synthesis of TNB-Capped Polyrotaxanes from 63. 
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The polyrotaxanes were characterized via 1H-NMR to determine the number of 
CD’s, threading efficiency and estimated molecular weight (Table 4.3). Yields were 
generally high and relatively consisted for the different molecular weights of PEG. This 
suggests that rotaxanation efficiency may be better for Compounds 67a, 67c, and 67e 
relative to Compounds 66a-d due to greater end group fidelity in Compound 63 relative 
to Compound 59. This further suggests that generating PEG-bis-amine by direct coupling 
mediated by CDI with ethylenediamine is a better strategy relative to the three step 
synthesis used to generate 59.  
Table 4.3 Characterization of TNB-Capped Polyrotaxanes from 63. 
 
 
 In order to generate test if a larger endcap may lead to less dethreading from 
slipping Compounds 64b and 64c were similarly threaded with α-CD in aqueous solution 
followed by endcapping via reaction of the terminal amines with TNBS. In this case, 
since two TNBS molecules may be present on each of the two polyrotaxane termini, it 




Scheme 4.6 Synthesis of TNB-capped polyrotaxanes from 64. 
The polyrotaxanes were characterized via 1H-NMR to determine the number of 
CD’s, threading efficiency and estimated molecular weight (Table 4.2). Yields were 
relatively low. It was also observed that during threading of PEG and α-CD precipitation 
of pseudopolyrotaxanes usually happens relatively quickly (less than 30 min) and 
generally happens quicker for lower PEG molecular weight. This suggests that lower 
weight PEG effectively presents more polymer termini present in solution on which a CD 
may become threaded. During threading of Compounds 63 and 64 pseudorotaxane 
formation was slow and the overall viscosity of the solution remained relatively low 
indicating that termini of Compounds 63 may be too bulky to be suitable for threading of 
α-CD. Threading efficiency for Compound 63b was extremely high while Compound 63c 
was comparable to other polyrotaxanes based on PEG of molecular weight of 10.0 kDa 
(Table 4.4). 
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Table 4.4 Characterization of TNB-Capped Polyrotaxanes from 63. 
 
 Overall, TNBS-capped polyrotaxanes were synthesized from three different PEG-
bis-amine constructs accessed through different synthetic methodologies. All three 
strategies successfully generated polyrotaxanes with PEG-bis-ethylenediamine showing 
the best yield likely due to greater overall amine-conversion in the PEG starting material. 
4.3.3 Modification of TNB-Capped Polyrotaxanes with NTA 
 
Scheme 4.7 Modification of TNB-Capped Polyrotaxane with NTA. 
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 Compound 66c was randomly conjugated modified with NTA via CDI-mediated 
coupling between the hydroxyl moieties of α-CD and Compound 15. This methodology 
yields a carbamate linkage which is expected to exhibit high stability for TFA-mediated 
deprotection and aqueous applications of the material (Scheme 4.7). Compound 69 was 
deprotected to yield the free acid groups of NT via treatment with TFA. Compound 70 
was purified via dialysis and size exclusion chromatography to remove small molecular 
contaminants and occult impurities. NMR and GPC revealed that Compound 70 was 
composed of approximately 17 CD’s with an average of 1.1 NTA/CD after the two step 
post-modification approach. One downside of this approach is that even after successive 
treatments with TFA, some t-butyl moieties were present in the NMR spectra. This 
observation is proposed to be due to O-alkylation by the reactive species (t-butyl cation) 
generated during deprotection. This side reaction could not be effectively avoided even 
via addition of scavengers commonly used in peptide synthesis (triethylsilane, phenol, 
etc.). 
In an effort to avoid the associated side-reactions of deprotection of t-butyl-
protected-NTA-modified polyrotaxanes, a small library of NTA and tris-NTA derivatives 
was synthesized with (2-trimethylsilyl)ethyl ester protecting groups. These esters employ 
mild fluoride-mediated ester deprotection, generating the carboxylic acid, ethene, and 
trimethylsilyl fluoride. Any O-silylation of hydroxyl groups of polyrotaxanes modified 
with these derivatives during deprotection should be hydrolysable during the subsequent 
aqueous dialytic purification. 
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Scheme 4.8 Synthesis of (2-trimethylsilyl)ethyl-Protected NTA. 
 Starting from Compound 18, EDC and DMAP were utilized to esterify the free 
carboxyl groups of Compound 18 with (2-trimethylsilyl)ethanol in a mixture of pyridine 
and DCM to give Compound 71 in 63.4 % yield. Hydrogenation on 10 Pd/C in isopropyl 
alcohol under 1 atm. hydrogen gave Compound 72 in 93.4 % yield. Compound 72 was 
further succinylated to give carboxylate derivative 73 in 92.0 % yield. Methyl ester NTA-
derivative 74 was also synthesized via acid-catalyzed esterification in MeOH. Sulfuric 
acid was found to be superior to p-toluenesulfonic acid (PTSA) for this purpose as the 
PTSA salt was difficult to remove. 
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Scheme 4.9 Synthesis of (2-trimethylsilyl)ethyl-Protected tris-NTA. 
 A (2-trimethylsilyl)ethyl derivative of tris-NTA was also synthesized. 
Compounds 18 and 72 were coupled to give Compound 75 in 47.2 % yield. Compound 
75 was hydrogenated to remove the Z-protecting group to give Compound 76 in 98.8 % 
yield. Compound 76 was further succinylated to give carboxylic acid derivative 77 in 
98.2 % yield (Scheme 4.9). 
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Scheme 4.10 Synthesis of NTA-Modified Polyrotaxanes Using (2-trimethylsilyl)ethyl 
Ester-Protected NTA. 
 Next, an attempt to synthesize NTA-modified polyrotaxanes using the post-
modification and fluoride-mediated deprotection was made. Polyrotaxane 67e was post-
modified with Compound 72 mediated by CDI in DMSO. The NTA-modified 
polyrotaxane 78 was isolated via dialysis. 1H-NMR indicated the presence of 29 CD’s, 
with approximately 6.2 NTA/CD and an associated estimated molecular weight of 110.0 
kDa. Compound 78 was then subjected to treatment with tetrabutylammonium fluoride 
(TBAF) in DMSO to effect deprotection of the (2-trimethylsilyl)ethyl ester groups of 
NTA. This strategy proved successful. After purification by dialysis and size-exclusion 
chromatography, 1H-NMR indicated the presence of NTA-modified polyrotaxane with 
approximately 24 CD’s and 2.8 NTA/CD after the two step post-modification sequence. 
The NMR spectra also indicated the presence of butyl groups, which could be from 
178 
tetrabutylammonium cation or possibly due to N-alkylation by TBAF, which has been 
reported.  
4.3.4 Screening of Aqueous Endcapping Methods 
 Due to the moderate success using the post-modification-deprotection strategy for 
synthesis of NTA-modified polyrotaxanes, a small screening study was performed to 
identify possible aqueous endcapping methodologies, which might be used to install 
bulkier endcaps than TNBS due to the observation of loss of CD (possibly from slippage) 
during previous strategies.  
 
 
Scheme 4.11 Synthesis of Z-Phenylalanine-Capped Polyrotaxanes. 
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 Compound 80 was synthesized from the pseudopolyrotaxane composed of PEG-
bis-amine (59c) and α-CD via amide-coupling between the terminal amino groups of the 
lyophilized pseudopolyrotaxane and free carboxylate of Z-phenylalanine mediated by 
EDC, HOBt, and N-methylmorpholine (NMM) in MeOH. The reaction was unsuccessful 
when the same process was repeated using ethanol in place of methanol. The 
polyrotaxane was purified via centrifugation and dialysis 1H-NMR indicated the presence 
of 16 CD’s. 
 
 
Scheme 4.12 Synthesis of POEGMA-Capped Polyrotaxanes. 
 An ATRP strategy30 was also utilized to grow a short poly(oligoethylene glycol) 
methacrylate (POEGMA) from tertiary-bromide terminal PEG 65c. This polyrotaxane 
was synthesized via threading of Compound 65c by α-CD in water followed by aqueous 
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ATRP as the rotaxanation reaction. The polyrotaxanes were isolated via centrifugation 
and dialysis. 1H-NMR revealed that the POEGMA polymer did not undergo a high 
degree of polymerization with only about 2.6 monomers incorporated on each terminus 
and approximately 22 CD’s threaded. In fact, the process was completely unsuccessful 
several times, which is attributed to no polymerization in those cases.  
4.3.5 Synthesis of Fluorescein-Capped Polyrotaxanes via CuAAC 
Next, we sought to design a small library of polyrotaxanes incorporating a larger 
endcap that could also impart fluorescence properties for imaging studies. Fluorescein is 
a water soluble heterocyclic compound commonly used as a dye31. Many derivatives 
have previously been synthesized.  
 




 The copper-catalyzed azide-alkyne cycloaddition32 (CuAAC) was chosen as an 
endcapping method since it is a very high efficiency reaction that is compatible with 
aqueous conditions and conjugation of large macromolecules. During the previous 
screening study, this strategy had been identified as a high-yielding strategy for aqueous 
polyrotaxane synthesis (data not shown). We sought to use bis-alkynyl-terminal PEG and 
an azido-derivative of fluorescein to synthesize these materials 
To utilize this strategy, a small library of bis-alkynyl-PEG derivatives was 
synthesized (Scheme 4.13) via direct coupling of propargylamine with Compounds 68a-
e. Since the Jones oxidation effectively oxidizes PEG termini in high efficiency, this two-
step protocol (also utilizing EDC coupling, another high-yielding reaction) is expected to 
yield polymers with high end group fidelity.  
 
Scheme 4.13 Synthesis of PEG-bis-alkyne. 
 Next, we sought to synthesize an azide derivative of fluorescein. Compound 84 
has previously been reported33 in 66.5 % yield via diazotization followed by substitution 
using sodium nitrite and sodium azide in methanol. However, this protocol suffers from 




Scheme 4.14 Synthesis of 5-Azidofluorescein. 
An alternative synthetic protocol was designed (Scheme 4.14) utilizing organic 
nitrite and azide derivatives whose by-product could be easily removed. The reaction was 
carried out with t-butyl nitrite and trimethylsilyl azide in a mixture of acetonitrile (ACN), 
methanol, and water. The product was purified chromatographically and isolated in 95.8 
% yield. 
 
Scheme 4.15 Synthesis of Isothiocyanate-NTA Derivative. 
 Since previous experiences with post modification usually resulted in loss of 
CD’s, which leads to a less rigid polyrotaxane, and harsh deprotection methodologies 
tended to lead to complications, a post modification strategy based around a two-step 
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protocol involving amine-functionalization of the polyrotaxane followed by direct 
conjugation of an isothiocyanate derivative of NTA was designed (Scheme 4.15).  
 4-Aminobenzoic acid (PABA, 85) was Boc-protected in 69.3 % yield and coupled 
with Compound 15 via EDC-coupling in the presence of HOBt and DIEA in DMF to 
give Compound 87 in 44.5 % yield. A global TFA-mediated deprotection was used to 
give NTA-derivative 88 in 71.1 % yield. Compound 88 was converted to an 
isothiocyanate derivative via thiophosgene in a biphasic mixture of DCM and water to 
give Compound 89 in 65.1 % yield. 
 
Scheme 4.16 Synthesis of Fluorescein-Capped Polyrotaxanes. 
 A small library of fluorescein-capped polyrotaxanes was synthesized from 
Compounds 82b-d, α-CD and Compound 84 under aqueous conditions. Pseudorotaxane 
formation was carried out followed by aqueous CuAAC via addition of a DMSO solution 
of 84, CuSO4 and sodium-l-ascorbate. The heterogeneous rotaxanation reaction was 
allowed to proceed for 48 hours The polyrotaxanes were purified via centrifugation 
process utilizing water and aqueous solutions of EDTA to remove Cu(II) followed by 
dialysis against water to remove CD and unthreaded polymer. 
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Table 4.5 Characterization of Fluorescein-Capped Polyrotaxanes. 
 
 
 Yields for Compounds 90a-c were generally good, being superior in average yield 
and reproducibility than previous methods. Also, since fluorescein is a larger molecule 
than TNBS, it is anticipated that dethreading via slippage should be reduced in these 
materials. 1H-NMR (Figure 4.5 C) indicated the threading were relatively high in 





Figure 4.5 Characterization of Fluorescein-Capped Polyrotaxanes via NMR and GPC. 
(A) Physical appearance of 90a. (B) GPC Chromatogram of 90a. (C) 1H-NMR spectral 
characterization of fluorescein-capped polyrotaxane 90a. (D) 2D NOESY spectra of 
fluorescein-capped polyrotaxane 90a. 
 
 
 Since the pseudorotaxane is kept under equilibrium conditions during the 
rotaxanation reaction, even though the rotaxanation reaction is slow, high yields and 
threading are still possible. 2D NMR showed the presence of proximal interactions 
between PEG and CD protons. GPC analysis (Figure 4.5B) of Compounds 90a-c in 
DMSO yielded number average molecular weight data in relative agreement with NMR 
observation, but consistently lower, having greater difference with the higher weight PEG 
derivatives. This may be due to presence of dethreaded α-CD, which would not be 
differentiated from polyrotaxane-associated CD in NMR. 
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4.3.6 Modification of Fluorescein-Capped Polyrotaxanes with NTA 
 
Scheme 4.17 Modification of Fluorescein-Capped Polyrotaxanes with Isothiocyanate-
NTA Derivative. 
 Fluorescein-capped polyrotaxanes (90a-c) were modified with NTA via a two-
step post-modification sequence. First, Compounds 9a-c were modified with 2,2-
(ethylenedioxy)bis(ethylamine) (EBE) via CDI-coupling in DMSO in the presence of 
triethylamine. Compounds 91a-c were then conjugated with Compound 89 via thiourea 
formation in the presence of triethylamine in aqueous DMSO. The NTA-modified 
polyrotaxanes were purified between each step via dialysis against DMSO and water to 
remove unreacted starting materials, dethreaded CD’s, etc. 
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Table 4.6 Characterization of NTA-Modified Fluorescein-Capped Polyrotaxanes. 
 
 
 The NTA-modified polyrotaxanes 92a-c were characterized via 1H-NMR and 
GPC (Table 4.6). NMR revealed that the apparent number of threaded CD’s and 
molecular weight had decreased considerable relative to the unmodified polyrotaxanes. 
This observation could be attributable to slippage, or hydrolysis of threaded CD’s or 
removal of unthreaded CD’s during purification. GPC showed good agreement with 
NMR for calculated molecular weight, although it was slightly higher than the calculated 
molecular weights from NMR. Mw/Mn was also observed to increase after post 
modification. 
4.4 Evaluation of NTA-Modified Polyrotaxanes 
To quantify the Ni2+ chelation capacity of 70, the total Ni2+ content bound to NTA 
was analyzed by ICP-MS. A solution of 20 mM NiSO4 was added to 70 and the metal 
bound PRTx isolated and purified by size exclusion chromatography using Sephadex G-
25M. ICP-MS analysis of the purified material revealed a Ni2+ content corresponding to 
approximately 19 NTA units per polyrotaxane (assuming a 1:1 Ni2+:NTA stoichiometry), 
a finding that is consistent with the 1H-NMR data for this compound.  
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Figure 4.6. Fluorescence Microscopy Analysis of His6-GFP Complexation with Ni2+-
Activated 70 (Olympus BX51, 10 X objective, DP71 CCD camera). (a) His6-GFP (3.0 
μM) in 10 mM HEPES buffer at pH 8.0. (b) Ni2+:70 complex (176 nM), (control). (c) 
Mixture of 3.0 µM his6-GFP and 176 nM Ni2+:70 complex at a 1:1 his6-GFP:α-CD 
stoichiometry. (d) Same as (c), except that 500 mM imidazole solution was added to (c) 
to strip the unbound Ni2+ from the 70:Ni complex. (e) Fluorescence intensities of samples 
(a)-(d), with the average intensity (black bar), minimum intensity (striped bar) and 
maximum intensity (dotted bar) reported for the CCD counts collected over randomly 




Fluorescence microscopy was used to evaluate the protein adsorption properties 
of Ni2+-activated 70 using his6-green fluorescent protein (his6-GFP). Figure 4.6A shows a 
3.0 µM solution of his6-GFP mounted between two glass slides and viewed by 
fluorescence microscopy. The appearance of a uniform fluorescence emission across the 
field of view indicates that GFP does not aggregate under these conditions. Figure 4.6B 
confirms that Ni2+-activated 70 has no appreciable fluorescence emission under these 
189 
conditions. When 10 µL of a 176 nM Ni2+-activated 70 solution was added to 3.0 µM 
his6-GFP to produce a 1:1 GFP:α-CD ratio and imaged under identical conditions, many 
intensely fluorescent spots surrounded by zones of depleted fluorescence intensity were 
observed (Figure 4.6C). We infer from these observations that the regions of high 
emission intensity are due to locally high GFP concentrations that have been facilitated 
by the Ni2+:70 complex since GFP does not aggregate under the same conditions in the 
absence of the polyrotaxane additive. When a 500 mM imidazole solution was added to 
disrupt the Ni2+:his6-GFP complexation interaction, a rehomogenization of the 
fluorescence intensity was observed. This observation is consistent with the expectation 
that excess imidazole should outcompete the his-tags for Ni2+ binding, thereby disrupting 




Figure 4.7 Tapping Mode AFM Analysis of His6-GFP on NTA-Modified Polyrotaxane 
Scaffolds. Tapping mode AFM analysis of: (A, B) 176 nM Ni2+:70 complex; (C, D) his6-
GFP:Ni2+:70 complex, prepared by mixing 176 nM Ni2+:70 complex solution with a 3.0 
µM his6-GFP solution in 10 mM HEPES buffer at pH 8.0 to attain a 1:1 his6-GFP:α-CD 
stoichiometry. (E, F) Sample C after addition of 500 mM imidazole solution. Samples 
were visualized on a Veeco Multimode AFM with a Nanoscope IIIa controller in air at 
22 °C. The line scans in B, D & F correspond to the image areas shown in the insets of A, 
C, & E, respectively. 
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AFM studies were then performed to provide greater insight into the his6-GFP 
aggregation phenomena in the presence of Ni2+:70 complex.  AFM images of Ni2+:70 
complexes deposited onto mica (Figure 4.7A) reveal the presence of features with an 
average long dimension of 60 nm and an average height of 1.2 nm. After addition of 3.0 
µM his6-GFP at a 1:1 GFP:α-CD molar ratio, these objects were transformed into rod-
shaped structures with an average length of ~100 nm (Figure 4.7B) and an average height 
of 3.7 nm, consistent with the adsorption of his6-GFP (GFP is a -barrel structure that is 
approximately 4.2 nm high x 2.4 nm in diameter) onto the 1.4 nm diameter polyrotaxane 
scaffold. Addition of 500 mM imidazole to this solution, followed by incubation for 1 h 
prior to AFM imaging (Figure 4.7C), produced samples that had reverted back to the 
original morphology with an average diameter of ~40 nm and average height of 1.1 nm. 
These observations are consistent with our fluorescence microscopy observations and the 
expected reversible complexation of his6-GFP with the Ni2+:70 complex. 
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Figure 4.8 Cryo-EM Imaging of His6-GFP adsorbed to NTA-Modified Polyrotaxane 
Scaffolds. Cryo-EM imaging of: (A) 1 mM Ni2+:70 complex; (B) 1 mM his6-GFP:Ni2+:70 
complex at a 1:1 his6-GFP:α-CD stoichiometry. A gallery of Ni2+:70 complex features 
observed at higher magnification appear to the right for samples in the absence (A) and 
presence (B) of his6-GFP.  Samples were spread onto C-FlatTM grids and plunge-frozen in 
liquid ethane. Images were recorded using a Gatan 4k × 4k CCD camera on a Philips 




In order to evaluate the potential of Ni2+:70 complexes for SPA applications, 
cryo-EM imaging was performed using a small protein target (his6-GFP) that would 
otherwise be difficult to visualize with this technique due to the combined effects of low 
EM contrast and extensive protein dispersion. Cryo-EM imaging of his6-GFP:Ni2+:70 
complexes showed the presence of similar rod-like structures, however, these structures 
were noticeably larger in diameter and exhibited greater electron density than the protein-
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free control. These observations are in agreement with our fluorescence microscopy and 
AFM data, providing further support for the hypothesis that his6-GFP chelation to Ni2+-
activated 70 leads to protein concentration onto the polyrotaxane scaffold. Taking the 
AFM and cryo-EM imaging data together, our results suggest that a thin protein layer 
surrounding the polyrotaxane is formed, although the lateral and rotational organization 
of this adsorbate is still unclear. 
 
Figure 4.9. TEM Analysis of His6-gp10 Adsorbed to NTA-Modified Polyrotaxane 
Scaffolds. (A) 3Dstructure of gp10 from the top and side. (B) Negative-stain TEM 
imaging of his6-gp10:Ni2+:70 complexes. Images were taken with FEI/Philips CM-10 
Bio-Twin instrument using glow discharged carbon-coated formvar copper 400 mesh 
grids (80 kV accelerating voltage) stained with a 2% UO2(OAc)2 solution. 
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In order to evaluate the ability of large protein assemblies to specifically adsorb to 
Ni2+-activated NTA-polyrotaxanes, we performed negative stain TEM imaging of Ni2+:70 
complexes treated with his-tagged bacteriophage phi29 connector protein assemblies 
(his6-gp10) at a 1:1 his6-gp10:-CD ratio. This 440 kD protein dodecamer of gp10 
connects the phage head to the ATP-driven motor that is responsible for DNA 
translocation and packaging during the formation of mature virion particles34. TEM 
images (Figure 4.9B) revealed the presence of many round pore-containing objects whose 
dimensions are consistent with phi29 connector protein assemblies; these features were 
presented in the same roughly linear arrangement seen for the Ni2+-activated NTA-
polyrotaxane control. We infer from these observations that his6-gp10 is binding to the 
Ni2+:70 scaffold in a manner similar to his6-GFP, except that the protein is not as densely 
packed along the polyrotaxane scaffold due to the spatial demands of the much larger 
phi29 connector array. 
 
Figure 4.10. UV-Vis Analysis of Azidofluorescein (84) and Compounds 92a-c in PBS. 
(Inset) Appearance of 92a-c Solutions. 
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 Ni2+ complexes of Compounds 92a-c were prepared in a similar fashion to 
Compound 70, Ni2+ complexes of 92a-c were dialyzed to remove excess Ni2+ followed by 
lyophilization. Complexes were then analyzed by ICP-MS to determine the relative 
number of NTA’s per polyrotaxane. UV-Vis spectra (Figure 4.10) were recorded for 
Compounds 92a-c and Compound 84, which is the endcap for the polyrotaxanes. All four 
solutions exhibited strong absorptions at 494 nm, which is characteristic of fluorescein35. 
All three polyrotaxanes 92a-c exhibited absorption maxima characteristic of fluorescein 
and their color was also very similar to that of solutions of Compound 84. This spectral 
evidence further illustrates the successful endcapping of polyrotaxanes by fluorescein and 
shows that the spectral properties of fluorescein can be utilized in experimentation with 
the fluorescein-capped polyrotaxane derivatives 92a-c.  
 
Figure 4.11. UV-Vis Spectra of (A) His6-GroEL Lysate and (B) His6-GFPuv Lysate. 
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 Figure 4.11 shows the UV-Vis spectra of his6-GroEL lysate and purified his6-
GFPuv. The GroEL lysate exhibits broad absorption from 200-400 nm characteristic of a 
crude lysate. The his6-GFPuv exhibited spectral properties consistent with other GFP 
variants.  
 
Figure 4.12. Centrifugal Isolation of 92a-c Complexes with His6-GFPuv and His6-GroEL 
Lysate. (A) solutions of Compounds 92a-c. (B) Appearance of his6-GFP-uv and his6-
GroELlysate. (C) Appearance of sediments generated from 92a-c and his6-GFPuv. (D) 




 From our previous fluorescence microscopy results, there was good evidence that 
the NTA-modified polyrotaxanes were forming complexes of very high molecular weight 
which were large enough to be visible by fluorescence microscopy. We developed a 
method to isolate these complexes via centrifugation of mixtures of 92a-c with his-tagged 
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proteins. These complexes were isolated after 30 minute incubation via centrifugation at 
12,000 g for 30 minutes. These pellets could then be resuspended and dispersed via 
sonication to generate samples suitable for imaging. This process is a variation on the 
monolayer purification approach15, 36 that may be useful for cryo-EM sample preparation. 
Figure 4.12 visually shows the appearance of solutions of 92a-c, his6-Gro-EL, his6-
GFPuv and sediments generated via incubation of each PR and his-tagged protein, 
respectively. 
 
Figure 4.13. Centrifugal Isolation of His6-GFPuv Complexed with 92a-c.  
 In order to further demonstrate the capacity for isolation of his-tagged proteins 
from purified solution and crude cell lysate using NTA-modified polyrotaxanes, UV-Vis 
198 
spectra were recorded of various solutions subjected to the centrifugal isolation protocol 
used for isolation of his-tagged proteins (Figure 4.13). The controls where either protein 
only or polyrotaxane only showed relatively low fluorescence intensity because no 
sedimentation was observed. Residual spectra properties are attributed to some solution 
being left in the tube. However, UV-Vis spectra of the resuspended lysates all exhibited 
spectra similar to his6-GFPuv with trace characteristics of 92a-c. 
 
Figure 4.14. Centrifugal Isolation of His6-GroEL Complexed with 92a-c. 
 Similarly, UV-Vis spectra were recorded of various solutions subjected to the 
centrifugal isolation protocol used for isolation of his-tagged proteins (Figure 4.14) with 
his6-GroEL lysate. The results are similar to those with his6-GFP, the controls showed 
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low absorption and no visible sedimentation was observed. Residual absorption is 
attributed to solution left in the tube after decantation. All the Compounds 92a-c with 
his6-GroEL visible formed sediments and after resuspension, the UV-Vis spectra were 
similar to spectra of his6-GroEL.  
 
Figure 4.15. SDS-PAGE Analysis of Isolation of His6-GroEL from Cell Lysate. Lane 1: 
Molecular weight ladder (BLUEStain). Lanes 2-4: his6-GroEL lysate. Lanes 5-7: 
Compound 92c + his6-GroEL lysate. Lanes 8-10: Ni:NTA beads (Talon resin) + his6-
GroEL isolated via centrifugation protocol. 
 
 SDS-PAGE was used to evaluate the purity of pellets isolated via centrifugation 
and using a commercial Ni:NTA resin using the centrifugation protocol used to isolate 
his-tagged proteins with NTA-modified polyrotaxanes (Figure 4.15). Results indicate that 
the protein composition of the sediments resembles the lysate with a possible modest 
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degree of purification. The centrifugation process was modified slightly to use 
commercial Ni:NTA resin in place of Compounds 92a-c. The protein composition of the 
material isolated also resembles the lysate. This shows that it may be possible to further 
modify the protocol to generate higher quality protein solutions via addition of washing 
steps or flow-based methods.  
 
Figure 4.16. TEM Analysis of His6-GroEL Isolated via Centrifugal Purification. (A) 
representative negatively-stained TEM image. (B) 4.2 Å reconstruction of native GroEL 
with D7 symmetry with a single subunit highlighted in red reported by Ludtke et al.37 (C) 
4.7 Å reconstruction of native GroEL with C7 symmetry reported by Ludtke et al.37 A 
single subunit in the A ring is colored blue while a single subunit in the B ring is colored 
yellow. 
 In order to further evaluate the ability of Compounds 92a-c for isolation and cryo-
EM of his-tagged protein from cell lysate, GroEL cell lysate was subjected to the 
centrifugal isolation protocol detailed above and resuspended sediment was qualitatively 
evaluated by TEM. Figure 4.16 depicts a representative image from this dataset. The 
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image appears to show his6-GroEL adsorbed to the tubular polyrotaxane scaffold. These 
particles are confirmed to be his6-GroEL as reported in cryo-EM efforts previously by 
Ludtke37. The appearance of the adsorbed particles is concurrent with results from UV-
Vis and SD-PAGE that his6-GroEL is present in complex with Compounds 92a-c via 
affinity interaction. Efforts are currently directed toward generation of 3D reconstruction 
from cryo-EM datasets generated using this isolation method. 
4.5 Conclusions 
A library of polyrotaxanes based on PEG, α-CD and various endcaps and 
rotaxanation methods was synthesized. Several of these compounds were further 
modified with NTA moieties to impart affinity interactions on the tubular polyrotaxane 
templates which might be used for isolation of proteins and assisted cryo-EM via 
homogenization of orientational distribution from lateral and rotational mobility of the 
CD’s upon which the protein is adsorbed. The laterally- and rotationally-mobile NTA-CD 
ligating groups enabled the capture of two his-tagged proteins of substantially different 
size and facilitated their imaging via AFM, cryo-TEM, and TEM. This material may 
greatly facilitate the cryo-EM analysis of his-tagged proteins by concentrating them into 
large and readily detectable clusters that enables projection images of the protein 
structure in all possible 3D orientations. It is anticipated that these NTA-modified 
polyrotaxane materials may be an important new tool for facilitating SPA by reducing 
both the amount of purified protein necessary for SPA and the time required for 
acquisition of the large particle counts needed for high-resolution analysis. 
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4.6 Experimental Methods 
All reactions were carried out under a blanket of N2 or argon gas. Reaction 
progress was monitored by thin-layer chromatography (TLC) analysis. TLC spots were 
visualized either by UV light (254nm), exposure by ninhydrin staining, staining with 
phosphomolybdic acid (PMA), staining by bromocresol green, or by staining with I2. 
Flash column chromatography was carried out using 230-400 mesh silica gel and 
analytical grade solvents. Solvents were purchased from Mallinckrodt/Baker and used 
without further purification unless noted. Toluene was purchased from Fisher. PEG 
polymers were from Sigma-Aldrich and were purified before use via precipitation from a 
solution in DCM into diethyl ether. 2,4,6-trinitrobenzenesulfonic acid (1.0 M in H2O) 
was purchased from Aldrich. Sodium 2,4,6-Trinitrobenzenesulfonate (TNBS) was 
obtained by neutralization of 2,4,6-trinitrobenzenesulfonic acid solution with NaHCO3. 
α-Cyclodextrin (α-CD) was purchased from Tokyo Kasei Inc. Dichloromethane (DCM), 
and toluene were distilled from CaH2. Triethylamine (TEA) was distilled from CaH2 and 
stored over BaO. Tetrahydrofuran (THF) was distilled from sodium-benzophenone ketyl. 
Dimethyl sulfoxide (DMSO) was distilled from CaH2. N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC) was purchased from Advanced Chemtech. All 
other chemicals were purchased from Sigma Aldrich and used without further 
purification. 
1H and 13C nuclear magnetic resonance (NMR) spectra were recorded on either a 
Bruker AV500HD (500MHz) or a Bruker ARX400 spectrometer (400 MHz). Chemical 
shifts are reported in ppm relative to the residual solvent peaks as internal standard 
203 
4.6.1 Synthesis of Homobifunctional PEG Derivatives 
PEG-bis-mesylate (57a-e). PEG was dried azeotropically with toluene several times and 
dried in vacuo for 18 hours. As a representative reaction, PEG (3.00 g) was dissolved in 
DCM (85 mL) and triethylamine (3.00 equiv.) was added. The solution was cooled to 0 
°C in an ice bath and methansulfonyl chloride (MsCl, 2.2 equiv.) was added dropwise 
over 10 minutes. The reaction was stirred for an additional 30 minutes at 0 °C. The 
solution was transferred to a separatory funnel with an additional 50 mL DCM. The 
solution was washed with 100 mL ice water followed by 100 mL 5 % HCl solution. The 
organic solution was dried with anhydrous sodium sulfate and concentrated in vacuo. The 
oily residue was precipitated into cold diethyl ether (500-800 mL), filtered and dried in 
vacuo to give 57a-e as white powders. Yield: (89-95 %). 
PPEG-bis-azide (58a-e). PEG-bis-mesylate 57a-e (3.00 g) was dissolved in DMF (150 
mL) and sodium azide (20.0 equiv.) was added. The solution was stirred for 90 °C for 48 
hours. DMF was evaporated in vacuo. The residue was dissolved in DCM (200 mL), 
filtered and washed with deionized water (150 mL) twice. The aqueous washes were 
extracted with DCM (100 mL) twice each and the organic extracts were combined with 
the original organic solution and concentrated in vacuo. The oily residue was precipitated 
into cold diethyl ether (500-800 mL), filtered and dried in vacuo to give 58a-e as white 
powders. Yield: (90-98 %). 
PEG-bis-amine (59a-e). PEG-bis-azide 58a-e (3.00 g) was dissolved in ethyl acetate (50 
mL) and 10% palladium on carbon (wet type) was added via spatula. The flask was 
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equipped with a three-way adapter and a hydrogen balloon. The flask was evacuated and 
purged with hydrogen three times and stirred vigorously under 1 atm hydrogen 
atmosphere for 24 hours at ambient temperature. The solution was gravity filtered 
through Celite and concentrated in vacuo. The oily residue was precipitated into cold 
diethyl ether (500-800 mL), filtered and dried in vacuo to give 59a-e as white powders. 
Yield: (88-96 %). 
PEG-bis-carboxylic acid (60a-e). Jones oxidation was used to produce carboxylic acid-
terminal PEG.  As a representative reaction, PEG (2.50 g) was dissolved in 280 mL 
acetone. Jones’ Reagent (2.2 equiv) was added to a 500 mL round bottom flask and the 
mPEG solution was added to this flask dropwise over 1 hour via addition funnel. The 
resulting solution was stirred at 20 C for 1 hour before quenching the excess Jones 
reagent with a few mL of iPrOH. The resulting green precipitate was removed by 
decantation of the liquid solution. The volatiles were removed under reduced pressure 
and the residue dissolved in 150 mL H2O. The aqueous phase was extracted with DCM (4 
x 120 mL). Depending of PEG molecular weight, it may be necessary to add MeOH 
(100-200 mL) to effect phase separation. The organic layers were combined and dried 
over anhydrous Na2SO4, filtered, and evaporated under reduced pressure. The oily 
residue was precipitated into cold diethyl ether (500-800-mL), filtered and dried in vacuo 
to give 60a-e as white powders.  TLC analysis was used to verify conversion using 
bromocresol green stain. Yield: (88-94 %). 
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PEG-bis-aldehyde (61a-e). Albright-Goldman oxidation was used to oxidize terminal 
hydroxyl-moieties of PEG to aldehyde groups. PEG 56a-e was dissolved in a mixture of 
dimethyl sulfoxide (DMSO) and acetic anhydride (Ac2O) (5 mL of 3:2 DMSO:Ac2O for 
every 1 mmol of alcohol). This solution is prepared beforehand at least 24 hours before 
reaction. The solution was stirred for 24 hours at ambient temperature. The solution was 
concentrated in vacuo. The oily residue was precipitated into cold diethyl ether (500-800 
mL) 2-3 times, filtered and dried in vacuo to give 61a-e as white powders. Yield: (89-94 
%). 
PEG-bis-amine (62a-e). An alternative synthesis of amine-terminal PEG was developed 
utilizing reductive amination. PEG-aldehyde 61a-e (3.00 g), ammonium chloride (10.0 
equiv) and potassium hydroxide (3.3 equiv) were dissolved in anhydrous MeOH (25 mL). 
This solution was stirred for 30 min. A solution of sodium cyanoborohydride (10.0 equiv) 
in anhydrous MeOH (10 mL) was added. And the solution was stirred under argon at 
ambient temperature for 24 hours. The solution was poured into 100 mL of deionized 
water and extracted with DCM (100 mL) four times. The organic extracts were dried over 
anhydrous sodium sulfate and concentrated in vacuo. The oily residue was precipitated 
into cold diethyl ether (500-800 mL), filtered and dried in vacuo to give 62a-e as white 
powders. Yield: (91-97 %). 
PEG-bis-ethylenediamine (63a-e). An alternative synthesis of amine-terminal PEG was 
developed direct CDI coupling of ethylenediamine to PEG. PEG 56a-e (2.00 g) was 
dissolved in DCM (100 mL), cooled down to 0 °C in an ice bath and triethylamine (10.00 
equiv) was added followed by CDI (5.00 equiv). The solution was stirred for 2 hours 
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warming to room temperature and ethylenediamine (20.0 equiv) was added via syringe. 
The solution was stirred for an additional 24 hours at ambient temperature. The solution 
was transferred to a separatory funnel and washed with 100 mL 5 % HCl twice followed 
by deionized water. The organic phase was dried over sodium sulfate, concentrated and 
precipitated into diethyl ether (600-800 mL), filtered and dried in vacuo to give 63a-e as 
a white powders. Yield: (91-97 %). 
PEG-bis-(tris-2-aminoethyl)amine) (64a-e). An alternative synthesis of amine-terminal 
PEG was developed direct CDI coupling of tris-(2-aminoethyl)amine to PEG. PEG 56a-e 
(2.00 g) was dissolved in DCM (100 mL), cooled down to 0 °C in an ice bath and 
triethylamine (10.00 equiv) was added followed by CDI (5.00 equiv). The solution was 
stirred for 2 hours warming to room temperature and tris-(2-aminoethyl)amine (20.0 
equiv) was added via syringe. The solution was stirred for an additional 24 hours at 
ambient temperature. The solution was transferred to a separatory funnel and washed 
with 100 mL 5 % HCl twice followed by deionized water. The organic phase was dried 
over sodium sulfate, concentrated and precipitated into diethyl ether (600-800 mL), 
filtered and dried in vacuo to give 63a-e as a white powders. Yield: (89-95 %). 
PEG-bis-(2-methyl-2-bromopropionamide) (65a-e). PEG-bis-amine (59a-e) (2.00 g), 
2-methyl-2-bromopropionic acid (20.0 equiv), and HOBt (16.0 equiv) were dissolved in 
20 mL DCM. DIEA (30.0 equiv) was added via syringe and the solution was cooled to 0 
°C in an ice bath. EDC was added and the solution was stirred for 48 hours warming to 
room temperature. The solution was diluted with 50 mL DCM and washed with % % HCl 
(50 mL) twice then deionized water (50 mL). The organic solution was dried over 
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anhydrous sodium sulfate, filtered and precipitated into diethyl ether (600-800 mL), 
filtered and dried in vacuo to give 65a-e as white solids. Yield: (92-88 %). 
4.6.2 Synthesis of TNBS-Capped Polyrotaxanes 
TNBS-capped-PEG-bis-amine-α-CD polyrotaxanes (66a-d). α-CD (10.0 g, 10.28 
mmol) was fully dissolved in 120 mL of deionized H2O before addition of PEG-bis-
amine (1.50 g). The mixture was sonicated for 30 min at 20 °C and the resulting white 
gel-like substance stored at 20 °C for 12 h. TNBS was neutralized to pH of 9.0 via 
addition of solid NaHCO3 to generate sodium 2,4,6-trinitrobenznesulfonate. Sodium 
2,4,6-trinitrobenznesulfonate (4.00 equiv per mol polymer) was then added as an aqueous 
slurry and stirred at 20 °C for 12 hours. The reaction mixture was washed via 
centrifugation sequentially with water 8 times before dialyzing the product (molecular 
weight cut-off 6,000-8,000) against DMSO for 3 d, then water for 3 d. The retained 
dialysate was then lyophilized to give polyrotaxane 66a-d as yellow powders. Yield: (92-
88 %). Yield: a: 5.068 g, b: 1.605 g, c: 1.029 g, d: 0.653 g; 1H NMR (400 MHz, DMSO-
d6) δ 8.73-8.97 (s, TNB-C-H), δ 5.51 (d, α-CD-OH), 5.43 (s, α-CD-OH), 4.79 (s, α-CD-
OH), 4.47 (t, α-CD-C1-H), 3.87 – 3.06 (m, α-CD and PEG). 
TNBS-capped-PEG-bis-ethylenediamine α-CD polyrotaxanes (67a,c,e). α-CD (10.0 g, 
10.28 mmol) was fully dissolved in 120 mL of deionized H2O before addition of PEG-
bis-ethylenediamine (1.50 g). The mixture was sonicated for 30 min at 20 °C and the 
resulting white gel-like substance stored at 20 °C for 12 h. TNBS was neutralized to pH 
of 9.0 via addition of solid NaHCO3 to generate sodium 2,4,6-trinitrobenznesulfonate. 
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Sodium 2,4,6-trinitrobenzenesulfonate (4.00 equiv per mol polymer) was then added as 
an aqueous slurry and stirred at 20 °C for 12 hours. The reaction mixture was washed via 
centrifugation sequentially with water 8 times before dialyzing the product (molecular 
weight cut-off 6,000-8,000) against DMSO for 3 d, then water for 3 d. The retained 
dialysate was then lyophilized to give polyrotaxanes 67a,c,e as yellow powders. Yield: 
(92-88 %). Yield: a: 3.017 g, c: 4.434 g, e: 4.687 g. 1H NMR (400 MHz, DMSO-d6) δ 
8.73-8.97 (s, TNB-C-H), δ 5.51 (d, α-CD-OH), 5.43 (s, α-CD-OH), 4.79 (s, α-CD-OH), 
4.47 (t, α-CD-C1-H), 3.87 – 3.06 (m, α-CD and PEG). 
TNBS-capped PEG- bis-(tris-2-aminoethyl)amine) α-CD polyrotaxanes (68b,c). α-
CD (10.0 g, 10.28 mmol) was fully dissolved in 120 mL of deionized H2O before 
addition of PEG- bis-(tris-2-aminoethyl)amine) (1.50 g). The mixture was sonicated for 
30 min at 20 °C and the resulting white gel-like substance stored at 20 °C for 12 h. TNBS 
was neutralized to pH of 9.0 via addition of solid NaHCO3 to generate sodium 2,4,6-
trinitrobenzenesulfonate. Sodium 2,4,6-trinitrobenzenesulfonate (8.00 equiv per mol 
polymer) was then added as an aqueous slurry and stirred at 20 °C for 12 hours. The 
reaction mixture was washed via centrifugation sequentially with water 8 times before 
dialyzing the product (molecular weight cut-off 6,000-8,000) against DMSO for 3 d, then 
water for 3 d. The retained dialysate was then lyophilized to give polyrotaxanes 68b,c as 
yellow powders. Yield: (92-88 %). Yield: b: 0.266 g, c: 0.170; 1H NMR (400 MHz, 
DMSO-d6) δ 8.73-8.97 (s, TNB-C-H), δ 5.51 (d, α-CD-OH), 5.43 (s, α-CD-OH), 4.79 (s, 
α-CD-OH), 4.47 (t, α-CD-C1-H), 3.87 – 3.06 (m, α-CD and PEG). 
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4.6.3 NTA-Modification of TNBS-Capped Polyrotaxanes 
t-Butyl-NTA-Modified-TNBS-capped-PEG-bis-amine-α-CD polyrotaxane (69). 
Polyrotaxane 66c (200 mg, 7.42 µmol) was dried in a 100 mL round bottom flask at 40 
°C under vacuum for 48 h before adding dry DMSO (20 mL) and stirring until the 
material dissolved. N,N'-Carbonyldiimidazole (CDI, 1.328 g, 8.19 mmol) was added to 
the polyrotaxane solution and the reaction allowed to proceed for 24 h at 20 °C under a 
N2 atmosphere. The reaction mixture was precipitated using a mixed ethereal solution 
(160 mL dry Et2O and 50 mL dry THF). The precipitate was added to NTA intermediate 
15 (0.485 g, 1.13 mmol) in 10 mL dry DMSO and triethylamine (0.181 mL, 1.30 mmol) 
and the reaction stirred for 24 h at 20 °C under N2. The product was dialyzed (molecular 
weight cut-off 6.0-8.0 kDa) against DMSO for 48 hours then deionized water for 48 
hours. The retained material was lyophilized to give t-butyl-NTA-modified polyrotaxane 
69 as a yellow powder. Yield: 0.150 g. 
NTA-Modified-TNBS-capped-PEG-bis-amine-α-CD polyrotaxane (70). Compound 
69 (0.276 g) was dissolved in DMSO (20 mL). TFA (20 mL) was added with stirring for 
6 hours to deprotect the NTA t-butyl esters. The solution was concentrated in vacuo to 
remove TFA. The residue was dialyzed (molecular weight cut-off 6.0-8.0 kDa) against 
DMSO for 72 hours followed by deionized water for 72 hours. The material was further 
purified by Sephadex G-25 gel filtration chromatography using water as eluent. 
Polyrotaxane 70 was recovered by lyophilization. Yield: 0.103 g. 
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Bis(2-(trimethylsilyl)ethyl) 2,2'-((14,14-dimethyl-3,10-dioxo-1-phenyl-2,11-dioxa-4-
aza-14-silapentadecan-9-yl)azanediyl)diacetate (71). Compound 18 (10.62 g, 26.8 
mmol), 2-(trimethylsilyl)ethanol (19.01 g, 160.8 mmol) and DMAP (2.45 g, 20.1 mmol) 
were added to an oven dried 250 mL round bottom flask equipped with a magnetic stir 
bar and a rubber septum. The contents were dissolved in a 3:1 DMF: pyridine solution 
(250 mL) and cooled down to 0 °C in an ice bath. EDC (16.22 g, 84.6 mmol) was added. 
The solution was stirred for 18 hours warming to room temperature. The solution was 
concentrated and redissolved in Et2O (300 mL) and filtered. The filtrate was transferred 
to a separatory funnel and washed with 5 % HCl (100 mL) twice then deionized water 
(100 mL). The organic phase was dried over anhydrous sodium sulfate, concentrated and 
purified by flask chromatography using 4:1 hexane: EtOAc as eluent. The pure fractions 
were combined, concentrated and dried in vacuo to give 71 as a clear oil. Yield: 11.726 g 
(62.8 %).; TLC: Rf= 0.33 (4:1 Hex: EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.29 
(m, 4H), 5.08 (s, 2H), 4.93 (s, 1H), 4.33 – 3.96 (m, 6H), 3.60 (s, 4H), 3.39 (t, J = 7.5 Hz, 
1H), 3.26 – 2.99 (m, 2H), 1.80 – 1.60 (m, 2H), 1.60 – 1.43 (m, 4H), 1.43 – 1.33 (m, 1H), 
1.33 – 1.04 (m, 1H), 0.98 (q, J = 8.4 Hz, 6H), 0.03 (d, J = 6.1 Hz, 28H). 
Bis(2-(trimethylsilyl)ethyl) 2,2'-((6-amino-1-oxo-1-(2-(trimethylsilyl)ethoxy)hexan-2-
yl)azanediyl)diacetate (72). Compound 71 (12.136 g, 17.4 mmol) was dissolved in 
MeOH (80 mL) in a 250 mL round bottom flask equipped with a stir bar and a three-way 
adapter with 90 ͦ stopcock equipped with a balloon. A spatula tip of 10 % palladium on 
carbon (wet type) was added and the flask was evacuated and purged with hydrogen 5 
times. The heterogeneous mixture was stirred for 12 hours at ambient temperature. The 
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solution was gravity filtered through a pad of Celite and activated carbon and the filtrate 
was concentrated in vacuo to give Compound 72 as a clear oil. Yield: 9.156 g (93.4 %).; 
TLC: Rf= 0.01 (4:1 Hex: EtOAc); 1H NMR (400 MHz, CDCl3) δ 4.47 (s, 3H), 4.21 – 
3.99 (m, 6H), 3.53 (s, 4H), 3.33 (t, J = 7.5 Hz, 1H), 2.74 (t, J = 7.0 Hz, 2H), 1.63 (dd, J = 
14.6, 7.9 Hz, 2H), 1.52 (tt, J = 17.2, 9.3 Hz, 3H), 1.37 – 1.27 (m, 1H), 1.06 – 0.70 (m, 
5H), -0.03 (d, J = 4.2 Hz, 25H). 
2,2-Dimethyl-6,15-dioxo-8-(2-oxo-2-(2-(trimethylsilyl)ethoxy)ethyl)-9-((2-
(trimethylsilyl)ethoxy)carbonyl)-5-oxa-8,14-diaza-2-silaoctadecan-18-oic acid (73). 
Compound 72 (0.743 g, 1.31 mmol) was dissolved in DCM (30 mL). DIEA was added 
via syringe (0.171 g, 1.32 mmol) followed by succinic anhydride (0.198 g, 1.98 mmol). 
The solution as stirred for 18 hours under nitrogen at ambient temperature. The solution 
was concentrated and redissolved in Et2O (150 mL). The solution was transferred to a 
separatory funnel and washed with 0.1 M HCl (50 mL) twice. The organic phase was 
dried over anhydrous sodium sulfate, concentrated and purified using a gradient of 10 % 
MeOH/DCM to 15 % MeOH/DCM. The pure fractions were combined, concentrated and 
dried in vacuo to give Compound 73 as a clear oil. Yield: 0.805 g (92.0 %).; TLC: Rf= 
0.58 (15 % MeOH/DCM); 1H NMR (400 MHz, CDCl3) δ 9.22 (s, 1H), 6.70 (s, 1H), 4.13 
(dd, J = 11.1, 5.6 Hz, 6H), 3.73 – 3.62 (m, 1H), 3.56 (d, J = 12.5 Hz, 3H), 3.38 (t, J = 7.5 
Hz, 1H), 3.21 (dd, J = 12.0, 5.5 Hz, 2H), 2.61 (dd, J = 13.9, 7.0 Hz, 3H), 2.52 (d, J = 6.3 
Hz, 2H), 1.79 – 1.60 (m, 2H), 1.58 – 1.34 (m, 4H), 1.32 – 1.10 (m, 1H), 0.95 (q, J = 8.1 
Hz, 6H), -0.00 (d, J = 4.7 Hz, 25H). 
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Dimethyl 2,2'-((6-(((benzyloxy)carbonyl)amino)-1-methoxy-1-oxohexan-2-
yl)azanediyl)diacetate (74). Compound 18 (8.353 g, 21.1 mmol) was dissolved in 
anhydrous MeOH in an oven-dried 500 mL round bottom flask equipped with a magnetic 
stir bar and rubber septum. The solution was cooled to 0 °C in an ice bath and sulfuric 
acid (4.28 mL) was added dropwise via Pasteur pipette. A reflux condenser was attached 
and the solution was heated to reflux and stirred for 60 hours. The solution was 
concentrated in vacuo and redissolved in Et2O (250 mL). The solution was washed with 5 
% NaHCO3 solution (80 mL) twice followed by deionized water (80 mL) and brine (80 
mL). The organic phase was dried over anhydrous sodium sulfate, concentrated and 
purified via flash chromatography using a gradient of 4:1 hexane: EtOAc to 1:1 hexane: 
EtOAc. The pure fractions were combined, concentrated and dried in vacuo to give 
Compound 74 as a clear oil. Yield: 6.711 g (72.6 %).; TLC: Rf= 0.37 (1:1 hexane: 
EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.09 (s, 5H), 5.52 (s, 1H), 4.85 (s, 2H), 3.42 (s, 
13H), 3.19 (s, 1H), 2.93 (s, 2H), 1.45 (s, 2H), 1.27 (s, 3H), 1.14 (s, 1H). 13C NMR (101 
MHz, CDCl3) δ 172.64, 171.42, 156.28, 136.73, 128.11, 127.66, 77.81, 77.49, 77.17, 
65.89, 64.19, 52.01, 51.16, 50.97, 40.44, 32.72, 29.60, 29.05, 22.64. 
Z-Lys-tris-NTA-(Otmse) (75). Compound 18 (1.61 g, 4.06 mmol) and Compound 72 
(9.156 g, 16.3 mmol) and HOBt (1.98 g, 14.7 mmol) were added to an oven-dried 500 
mL round bottom flask equipped with a magnetic stir bar and rubber septum. The 
contents were dissolved in DMF (90 mL) and cooled to 0 °C in an ice bath. EDC (3.00 g, 
14.7 mmol) was added and the solution was stirred for 48 hours warming to room 
temperature. The solution was concentrated in vacuo and redissolved into EtOAc (200 
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mL). the solution was washed with 5% HCl (80 mL) three times. The organic solution 
was dried over anhydrous sodium sulfate, concentrated and purified via flash 
chromatography using a gradient of 1:1 hexane:EtOAc to 100 % EtOAc. The pure 
fractions were combined, concentrated and dried in vacuo to give Compound 75 as a 
clear viscous oil. Yield: 3.894 g (47.2 %).; TLC: Rf= 0.77 (100 % EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.45 (s, 1H), 7.33 (s, 4H), 5.13 (s, 1H), 5.07 (s, 2H), 4.37 – 3.90 (m, 
19H), 3.58 (s, 11H), 3.37 (q, J = 10.2, 7.2 Hz, 6H), 3.28 – 2.89 (m, 10H), 1.84 – 1.61 (m, 
7H), 1.50 (s, 12H), 1.35 (dp, J = 21.8, 6.9 Hz, 5H), 0.98 (q, J = 8.8 Hz, 18H), 0.03 (d, J = 
5.1 Hz, 76H). 
H2N-Lys-tris-NTA-(Otmse) (76). Compound 75 (1.00 g, 0.49 mmol) was dissolved in 
MeOH (50 mL) in a 250 mL round bottom flask equipped with a magnetic stir bar and a 
three-way adapter equipped with a balloon and a 90°stopcock. A spatula tip of 10 % 
palladium on carbon was added and the flask was evacuated and purged with hydrogen 
three times and the heterogeneous mixture was stirred at ambient temperature under 1 
atm hydrogen for 18 hours. The mixture was gravity filtered through a pad of Celite and 
activated carbon. The filtrate was concentrated and dried in vacuo to give Compound 76 
as a clear oil. Yield: 0.922 g (98.8 %).; TLC: Rf= 0.02 (100 % EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.90 (s, 1H), 6.28 (s, 1H), 4.37 – 3.88 (m, 18H), 3.67 – 3.43 (m, 12H), 
3.39 (s, 3H), 3.32 (s, 3H), 3.26 – 3.02 (m, 9H), 2.95 (s, 1H), 1.62 (s, 9H), 1.37 – 1.13 (m, 
4H), 0.94 (q, J = 8.4 Hz, 17H), -0.02 (d, J = 4.7 Hz, 74H). 
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HO2C-Lys-tris-NTA-(Otmse) (77). Compound 76 (0.488 g, 0.26 mmol) was dissolved 
in DCM (50 mL) in an oven-dried 250 mL round bottom flask equipped with a stir bar 
and rubber septum. DIEA (183 µL, 1.03 mmol mmol) was added followed by succinic 
anhydride (0.155 g, 1.55 mmol). The solution was stirred for 18 hours at ambient 
temperature. The solution was concentrated in vacuo and redissolved in 120 mL Et2O. 
The solution was transferred to a separatory funnel and washed with 0.1 M HCl (50 mL) 
twice then deionized water (50 mL). The organic phase was dried over anhydrous sodium 
sulfate, concentrated and purified via flash chromatography using 10 % MeOH/DCM as 
eluent. The pure fractions were combined, concentrated and dried in vacuo to give 
Compound 77 as a clear viscous soil. Yield: 0.492 g (97.4 %).; TLC: Rf= 0.29 (10 % 
MeOH/DCM); 1H NMR (400 MHz, CDCl3) δ 7.65 (s, 1H), 4.26 – 3.94 (m, 18H), 3.61 (d, 
J = 30.5 Hz, 11H), 3.50 – 3.40 (m, 3H), 3.34 (s, 4H), 3.23 (d, J = 22.1 Hz, 10H), 2.98 (s, 
1H), 2.62 (d, J = 10.1 Hz, 6H), 1.83 (d, J = 11.7 Hz, 1H), 1.75 – 1.58 (m, 6H), 1.58 – 1.36 
(m, 12H), 1.36 – 1.27 (m, 4H), 1.25 – 1.14 (m, 5H), 1.11 (d, J = 6.4 Hz, 1H), 0.96 (q, J = 
8.0 Hz, 17H), 0.00 (d, J = 4.9 Hz, 72H). 
Tmse-NTA-Modified-TNBS-capped-PEG-bis-ethylenediamine-α-CD polyrotaxane 
(78). Polyrotaxane 67e (400 mg) was dried in a 100 mL round bottom flask at 40 °C 
under vacuum for 48 h before adding dry DMSO (25 mL) and stirring until the material 
dissolved. N,N'-Carbonyldiimidazole (CDI, 1.909 g) was added to the polyrotaxane 
solution and the reaction allowed to proceed for 24 h at 20 °C under a N2 atmosphere. 
The reaction mixture was precipitated using a mixed ether solution (160 mL dry Et2O and 
50 mL dry THF). The precipitate was added to NTA intermediate 72 (0.633 g, 1.12 
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mmol) in 10 mL dry DMSO and triethylamine (0.476 µL) and the reaction stirred for 24 
h at 20 °C under N2. The product was dialyzed (molecular weight cut-off 6.0-8.0 kDa) 
against DMSO for 48 hours then deionized water for 48 hours. The retained material was 
lyophilized to give t-butyl-NTA-modified polyrotaxane 69 as a yellow powder. Yield: 
0.600 g. 
NTA-Modified-TNBS-capped-PEG-bis-ethylenediamine-α-CD polyrotaxane (79). 
1.0 M TBAF in THF (6.6. mL) was added to 15 mL DMSO and THF was stripped in 
vacuo. Compound 78 (0.400 g) was dissolved in this solution. The solution was stirred at 
ambient temperature for 3 hours. The solution was dialyzed (molecular weight cut-off 
6.0-8.0 kDa) against DMSO for 72 hours followed by deionized water for 72 hours. 
Polyrotaxane 79 was recovered by lyophilization. Yield: 0.267 g. 
4.6.4 Screening of Aqueous Endcapping Methods 
Nα-Cbz-l-Phenylalanine-capped-PEG-bis-carboxylate-α-CD polyrotaxane (80). α-
CD (8.0 g, 10.28 mmol) was fully dissolved in 60 mL of deionized H2O before addition 
of PEG-bis-carboxylate 52c (0.750 g). The mixture was sonicated for 30 min at 20 °C 
and the resulting white gel-like substance stored at 20 °C for 12 h. The slurry was 
transferred to two 50 mL centrifuge tubes and pelleted. The water supernatant was 
decanted and the pseudorotaxane was lyophilized. A solution of Nα-Z-l-phenylalanine 
(0.434 g, 1.50 mmol), NMM (0.379 g, 3.75 mmol) and HOBt (36.5 mg, 0.27 mmol) in 
MeOH (30 mL). This solution was added to the lyophilized pseudorotaxane and EDC 
(0.288 g, 1.50 mmol) was added. The heterogeneous slurry was stirred for 48 hours at 
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ambient temperature. The reaction mixture was washed via centrifugation sequentially 
with water 8 times before dialyzing the product (molecular weight cut-off 6,000-8,000) 
against DMSO for 3 d, then water for 3 d. The retained dialysate was then lyophilized to 
give polyrotaxane 80 as a white powder. Yield: 0.285 g. 
Poly(oligoethyene glycol) methacrylate-capped-PEG-bis-(2-methyl-2-
bromopropionamide)-α-CD polyrotaxane (81). All deionized water was degassed via 
sonication followed by bubbling nitrogen for 30 min. α-CD (8.00 g) was dissolved in 
deionized water (60 mL). PEG-bis-(2-methyl-2-bromopropionamide) 65c (0.750 g) was 
dissolved in 10 mL deionized water. The two aqueous solutions were combined in a 125 
mL flask. The mixture was sonicated for 30 min at 20 °C and the resulting white gel-like 
substance stored at 20 °C for 12 hours under nitrogen. mPEG-methacrylate (avg. Mn = 
500 Da, 7.652 mL, 16.5 mmol) was added via syringe. Copper(II) bromide solution (1.45 
mL, 1.0 M in deionized water, 1.46 mmol) and 2,2-bypyridine solution (bpy, 2.0 mL, 125 
mg/mL in DMSO, 1.60 mmol) were combined and added to the pseudorotaxane solution 
via syringe. Sodium-l-ascorbate solution (145.6 µL, 0.1 M in deionized water, 14.6 µmol) 
was added via syringe and the slurry was stirred for 48 hours at ambient temperature. The 
reaction mixture was washed via centrifugation sequentially with water 8 times before 
dialyzing the product (molecular weight cut-off 6,000-8,000) against DMSO for 3 d, then 
water for 3 d. The retained dialysate was then lyophilized to give polyrotaxane 81 as a 
white powder. Yield: 0.878 g. 
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4.6.5 Synthesis of Fluorescein-Capped Polyrotaxanes 
PEG-bis-alkyne (82a-e). mPEG-bis-carboxylate 60a-e (2.50 g) were dissolved in DCM 
(20 mL) in an oven dried 100 mL round bottom flask equipped with a magnetic stir bar 
and rubber septum. HOBt (5.00 equiv), DIEA (10.00 equiv) and propargylamine (20.0 
equiv) were added. The solution was cooled to 0 °C in an ice bath. EDC (10.0 equiv) was 
added and the solution was stirred warming to ambient temperature for 48 hours. The 
solution was diluted with 60 mL DCM. The solution was transferred to a separatory 
funnel and washed with 5 % HCl (70 mL) twice then deionized water (70 mL) twice. The 
aqueous washes were combined and extracted with DCM (50 mL) three times. The 
organic extract was combined with the original DCM solution and dried over anhydrous 
sodium sulfate. The solution was filtered, concentrated and precipitated into 400 mL 
diethyl ether twice, filtered and dried in vacuo to give Compounds 82a-e as white 
powders. Yield: (86-90 %). 
5-Azido-3',6'-dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (84). 5-
aminofluorescein (.100 g, 0.29 mmol) was dissolved in a mixture of 1:1:2 (water:MeOH: 
acetonitrile) (8 mL) in a 50 mL round bottom flask. The flask was filled with nitrogen 
and stirred at 0 °C for 10 min. tert-Butyl nitrite (51.3 µL, 0.40 mmol) was added by 
syringe, followed by trimethylsilyl azide (47.8 µL, 0.36 mmol) over 5 min. The flask was 
covered with foil and stirred for 3 hours at ambient temperature. The solution was 
concentrated in vacuo and purified by flash chromatography on silica with 85:15 
(DCM:MeOH). Yield: 0.206 g (95.8 %).; TLC: Rf= 0.53 (15 % MeOH/DCM); 1H NMR 
(400 MHz, Methanol-d4) δ 7.79 – 7.57 (m, 1H), 7.44 – 7.26 (m, 1H), 7.26 – 7.04 (m, 1H), 
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6.95 – 6.73 (m, 2H), 6.72 – 6.62 (m, 2H), 6.59 (dd, J = 12.1, 2.3 Hz, 1H), 6.56 – 6.50 (m, 
1H). 13C NMR (101 MHz, DMSO) δ 171.40, 167.83, 156.22, 143.49, 131.14, 129.19, 
124.88, 117.83, 117.15, 113.30, 103.75, 49.64, 49.43, 49.22, 49.00, 48.79, 48.58, 48.37. 
ESI+: expected 373.32, found 374.2 (M+H). 
4-((tert-Butoxycarbonyl)amino)benzoic acid (86). 4-Aminobenzoic acid (4.00 g, 29.17 
mmol) was dissolved in dioxane (100 mL) and deionized water (50 mL) in an oven-dried 
250 mL round bottom flask equipped with a magnetic stir bar and rubber septum. Di-tert-
butyl-dicarbonate (12.720 g, 58.28 mmol) was added followed by triethylamine (8.16 
mL, 58.28 mmol). The solution was stirred for 24 hours at ambient temperature. The 
solution was concentrated in vacuo and the crude product was precipitated via addition of 
3.0 M HCl (15 mL). The crude product was filtered and recrystallized from 
MeOH/deionized water to give Compound 86 as an off white crystalline solid. Yield: 
4.799 g (69.3 %); 1H NMR (400 MHz, DMSO-d6) δ 12.59 (s, 1H), 9.72 (s, 1H), 7.82 (d, J 
= 8.6 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 1.46 (s, 9H). 13C NMR (101 MHz, DMSO) δ 
189.46, 167.90, 153.41, 144.66, 131.91, 124.82, 121.23, 118.80, 117.71, 117.37, 117.34, 
80.53, 76.15, 41.00, 40.80, 40.59, 40.38, 40.17, 39.96, 39.75. 
Di-tert-butyl 2,2'-((1-(tert-butoxy)-6-(4-((tert-butoxycarbonyl)amino)benzamido)-1-
oxohexan-2-yl)azanediyl)diacetate (87). Compound 86 (0.896 g, 3.78 mmol), 
Compound 15 (1.626 g, 3.78 mmol) and HOBt (0.567 g, 4.34mmol) were combined in an 
oven dried 250 mL round bottom flask equipped with a stir bar and rubber septum. The 
contents were dissolved in DMF (38 mL). The solution was cooled to 0 °C in an ice bath 
and EDC (0.833 g, 4.34 mmol) was added. The solution was stirred for 48 hours warming 
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to ambient temperature. The solution was concentrated in vacuo and the residue was 
dissolved in DCM (120 mL). The solution was transferred to a separatory funnel and 
washed with 0.1 M HCl (80 mL) twice and deionized water (80mL). The organic solution 
was dried over anhydrous sodium sulfate, filtered, concentrated and purified via flash 
chromatography using 5 % MeOH/DCM as eluent. The pure fractions were combined, 
concentrated and dried in vacuo to give Compound 87 as a clear oil. Yield: 1.090 g (44.5 
%).; TLC: Rf= 0.35 (5 % MeOH/DCM); 1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.7 
Hz, 2H), 7.39 (d, J = 8.6 Hz, 2H), 7.18 (s, 1H), 6.74 (t, J = 5.2 Hz, 1H), 3.69 (t, J = 6.6 
Hz, 2H), 3.53 – 3.32 (m, 7H), 3.32 – 3.17 (m, 1H), 1.90 – 1.52 (m, 11H), 1.43 (d, J = 
26.5 Hz, 25H), 1.37 (s, 15H). 13C NMR (126 MHz, CDCl3) δ 172.41, 170.75, 167.11, 
152.50, 141.41, 128.78, 128.12, 117.57, 81.10, 80.71, 77.35, 77.10, 76.84, 67.89, 64.97, 
53.95, 39.68, 29.94, 28.57, 28.28, 28.18, 28.07, 25.57, 23.03. 
2,2'-((5-(4-Aminobenzamido)-1-carboxypentyl)azanediyl)diacetic acid (88). 
Compound 87 (1.090 g, 1.68 mmol) was dissolved in DCM (15 mL) in an oven-dried 100 
mL round bottom flask equipped with a magnetic stir bar and rubber septum. 
Triethylsilane (0.195 g, 1.68 mmol) was added via syringe and the solution was cooled to 
0 °C in an ice bath. TFA (15 mL) was added slowly and the solution was stirred for 2 
hours warming to room temperature. The solution was concentrated and rotovapped 
together with DCM (60 mL) three times. The residue was recrystallized twice from 
Et2O/MeOH, filtered and dried in vacuo to give Compound 88 as a white crystalline 
solid. Yield: 1.090 g (44.5 %); 1H NMR (500 MHz, Methanol-d4) δ 7.72 (d, J = 8.0 Hz, 
2H), 6.93 (d, J = 7.9 Hz, 2H), 3.82 – 3.59 (m, 5H), 3.55 – 3.44 (m, 2H), 3.36 (t, J = 6.5 
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Hz, 2H), 3.30 (s, 2H), 1.83 (d, J = 13.5 Hz, 1H), 1.64 (d, J = 13.2 Hz, 3H), 1.57 – 1.38 
(m, 4H). 13C NMR (126 MHz, MeOD) δ 174.04, 168.46, 145.48, 128.63, 126.51, 116.58, 
65.35, 53.87, 48.11, 47.94, 47.77, 47.60, 47.43, 47.26, 47.09, 39.22, 29.18, 28.73, 26.96, 
23.45, 14.04. 
2,2'-((1-carboxy-5-(4-isothiocyanatobenzamido)pentyl)azanediyl)diacetic acid (89). 
Compound 88 (0.786 g, 2.06 mmol) was dissolved in deionized water (46.2 mL). The 
slightly cloudy solution was cooled to 0 °C in an ice bath. Thiophosgene (355 mg, 3.09 
mmol) was dissolved in DCM (12.73 mL) in an oven-dried 20 mL scintillation vial. The 
thiophosgene solution was added to the aqueous solution of Compound 88 slowly. The 
biphasic solution was stirred vigorously for 2 hours warming to ambient temperature. The 
solution was stirred for an additional 30 min at 45 °C. The solution was concentrated to 
remove DCM and the remaining aqueous solution was lyophilized to give Compound 89 
as a white solid. Yield: 0.568 g (65.1 %); 1H NMR (500 MHz, DMSO-d6) δ 8.52 (t, J = 
5.4 Hz, 1H), 7.87 (d, J = 8.7 Hz, 2H), 7.48 (d, J = 8.6 Hz, 2H), 3.62 – 3.42 (m, 5H), 3.38 
(t, J = 7.3 Hz, 1H), 3.21 (q, J = 6.8 Hz, 2H), 1.70 – 1.59 (m, 1H), 1.56 (d, J = 10.2 Hz, 
1H), 1.53 – 1.44 (m, 2H), 1.45 – 1.20 (m, 5H). 13C NMR (126 MHz, DMSO) δ 174.14, 
173.32, 165.26, 135.20, 134.12, 132.74, 129.23, 126.29, 64.78, 53.74, 40.47, 40.31, 
40.14, 39.97, 39.80, 39.64, 39.47, 29.62, 29.19, 28.18, 23.64. 
Fluorescein-capped-PEG-bis-alkyne α-CD polyrotaxanes (90a-c). Alpha-cyclodextrin 
(α-CD) (5.33 g) was dissolved in 35 mL water. PEG-bis alkyne (82b-d, a = 0.500 g, 0.15 
mmol; b = 0.500 g, 0.05 mmol; c = 0.500 g, 0.025 mmol) was dissolved in 11.66 mL 
water. The solutions were combined flushed with nitrogen and sonicated for 1 hour. After 
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several minutes the materials formed a white gel. The solutions were stirred at ambient 
temperature for 12 hours. 5-Azidofluorescein 84 (a = 219 mg, 0.587 mmol; b = 75 mg, 
0.200 mmol; c = 38 mg, 0.102 mmol) was added as a solution in 2 mL DMSO and the 
solutions were stirred for 10 min. 1.0 M CuSO4 solution (a = 148 μL, 0.148 mmol; b = 50 
μL, 0.052 mmol; c = 25 μL, 0.025 mmol) and 1.0 M sodium-l-ascorbate solution (a = 294 
μL, 0.293 mmol; b = 100 μL, 0.010 mmol 0.100 mmol, c = 50 μL, 0.050 mmol) were 
added via syringe and the heterogeneous solution was stirred for 48 hours at ambient 
temperature. The material was centrifuged, the supernatant was decanted, and the 
centrifugate resuspended in 5% EDTA solution and centrifuged. This process was 
repeated twice more to remove the remaining copper(II) and copper(I). The material was 
dialyzed against DMSO (MWCO = 6-8 kDa, Fisher) to remove unreacted materials for 3 
days and deionized water for 3 days with regeneration of the dialysate 2-3 times/day. The 
material remaining was lyophilized to obtain the unmodified Fluorescein-capped 
polyrotaxanes 90a-c as yellow powders. Yield: a = 2.408 g, b = 2.939 g, c = 1.691 g. 
4.6.6 NTA-Modification of Fluorescein-Capped Polyrotaxanes 
EBE-modified-fluorescein-capped-PEG-bis-alkyne α-CD polyrotaxanes (91a-c). 
Compounds 90a,b,c (0.500 g) were dissolved in DMSO (15 mL). The solutions were 
sonicated to obtain complete dissolution. TEA (a,b,c = 414 μL, 0.003 mmol) was added 
followed by CDI (a = 0.196 g, 1.21 mmol; b = 0.204 g, 1.26 mmol, c = 0.192 g, 1.18 
mmol). The solutions were flushed with nitrogen and stirred for 24 hours at ambient 
temperature. 2,2’-(Ethylenedioxy)bis(ethylamine) (EBE, a = 4.33 mL, 29.70 mmol, b = 
4.58 g, 30.23 mmol; c = 4.38 g, 29.55 mmol) was added by syringe and the solutions 
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were stirred for an additional 24 hours. The material was dialyzed against DMSO 
(MWCO = 6-8 kDa, Fisher) to remove unreacted materials for 3 days and deionized 
water for 3 days with regeneration of the dialysate 2-3 times/day. The material remaining 
was lyophilized to obtain the EBE-modified-fluorescein-capped polyrotaxanes 91a-c as 
yellow powders. Yield: a = 0.259 g, b = 0.215 g, c = 0.302 g. 
NTA-modified-fluorescein-capped-PEG-bis-alkyne α-CD polyrotaxanes (92a-c). 
EBE-modified-fluorescein-capped-PEG-bis-alkyne α-CD polyrotaxanes (91a-c: a: 0.125 
g, b: 0.103 g, c; 0.156 g) were dissolved in DMSO (4 mL) and deionized water (3 mL) in 
oven-dried 100 mL round bottom flasks equipped with magnetic stir bars and rubber 
septa. Compound 89 (a-c: 70 mg) was added followed by DIEA (a-c: 100 µL). The 
solutions were stirred for 18 hours at ambient temperature. The material was dialyzed 
against deionized water (MWCO = 6-8 kDa, Fisher) to remove unreacted materials for 8 
days with regeneration of the dialysate 2-3 times/day. The material remaining was 
lyophilized to obtain the EBE-modified-fluorescein-capped polyrotaxanes 91a-c as 
yellow powders. Yield: a = 0.095 g, b = 0.092 g, c = 0.132 g. 
4.6.7 Ni-Activation of NTA-Modified Polyrotaxanes 
NTA-modified polyrotaxane 70 (100 mg) was dissolved in 1 mL of 20 mM Ni2+ 
solution and the excess Ni2+ removed by gel filtration using Sephadex G-25M. After 
lyophilization, the Ni2+:70 complex was obtained as a solid (60 mg). 
NTA-modified polyrotaxanes 92a-c (50 mg) were dissolved in 1mL of 20 mM 
Ni2+ solution and the excess Ni2+ was removed via dialysis against deionized water 
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(MWCO = 2.0 kDa) to remove free Ni2+. After the dialysate contained to Ni2+, the 
solutions were flash frozen and lyophilized. 
4.6.8 Gel-Permeation Chromatography (GPC) 
GPC was performed using an Agilent 1200 Series GPC equipped with a Wyatt 
Dawn Heleos-II multi-angle light scattering (MALS) detector, Wyatt Optilab rEX 
refractive index (RI) detector and Wyatt quasi-elastic light scattering (QELS) detector 
using a single Shodex OHpakSB-803 HQ (8.0x3000 mm, 6 µm) column preceded by a 
Shodex OHpak SB807G (8.0x50.0 mm, 35 µm) guard column using DMSO as eluent. 
dn/dc was determined for each sample using a five-point calibration curve (0.5-2.5 
mg/mL) generated using Optilab rEX detector in flow mode in combination with ASTRA 
software. Samples were dissolved at 1.8 mg/mL in DMSO and run at 0.2 mL/min. Mn 
and Mw/Mn were calculated using ASTRA software. 
4.6.9 Preparation of ICP-MS Samples 
Ni2+:70 or Ni2+:92a-c complex (2.6 mg) was digested in 1 mL 70% HNO3 (Aristar 
Ultra, VWR, West Chester, PA) solution for 3 days. The solution was diluted with double 
deionized water until reaching a concentration of 2% HNO3 (35 mL, 2.25 µM) and then 
further diluted 103-fold with 2% HNO3 solution. Standard solutions of Ni2+ were 
prepared by diluting a NiSO4 standard solution (Exaxol, Clearwater, FL) with 2% HNO3 
solution until reaching a final concentration of 10 ppb. Blank 2% HNO3 solutions were 
prepared by diluting 70% HNO3 (Aristar Ultra) with double deionized water. 
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4.6.10 Fluorescence Microscopy 
A 3.0 µM his6-GFP solution in 10 mM HEPES buffer at pH 8.0 was prepared and 
a 10 µL aliquot transferred to a glass slide, covered with a cover slip and examined by 
fluorescence microscopy (Figure 2A).  In order to visualize the Ni2+:70 complex, a 
solution of Ni2+:70 complex without protein (control) was prepared by mixing a 20 mM 
NiSO4 solution and NTA-polyrotaxane in a 1:1 Ni2+:NTA ratio to yield a 176 nM 
solution which was then transferred to a glass slide, covered with a cover slip and 
examined by fluorescence microscopy (Figure 2B). In order to visualize the his6-
GFP:Ni2+:70 complex, a his6-GFP:Ni2+:70 solution was prepared by adding an aliquot of 
3.0 µM his6-GFP in 10 mM HEPES buffer at pH 8.0 to a 176 nM Ni2+:70 solution to 
attain 1:1 his6-GFP:α-CD stoichiometry. A 10 µL sample of this solution was transferred 
to a glass slide, covered with a cover slip and examined by fluorescence microscopy 
(Figure 2C). A 10 µL aliquot of 500 mM imidazole was added to the solution in Figure 
2C and a 10 µL sample of this mixture sealed with a cover slip and evaluated by 
fluorescence microscopy (Figure 2D). All measurements were made using a Olympus 
BX51 microscope with a 10 X objective and a DP71 CCD camera; the raw data were 
analyzed using Metavue Processing Software. Final images were converted to grayscale 
and the brightness and contrast adjusted equally in all images to enhance visualization. 
4.6.11 Atomic Force Microscopy 
AFM samples were prepared to further visualize the adsorption properties of the 
his6-GFP: Ni2+:70 complex (Figure 3A). A 176 nM solution of Ni2+:70 complex without 
protein (control) was prepared by mixing a 20 mM NiSO4 solution and NTA-
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polyrotaxane in a 1:1 Ni2+:NTA ratio to yield a 176 nM solution (Figure 3B). A 176 nM 
Ni2+:4 complex solution and a 3.0 µM his6-GFP solution in 10 mM HEPES buffer at pH 
8.0 were mixed to attain a 1:1 his6-GFP:α-CD stoichiometry on the mica surface (Figure 
3C). A third sample was prepared as described for Figure 3B, except that a 10µL aliquot 
of a 500 mM imidazole solution was added to a 10µL sample of the solution in Figure 3B 
to strip GFP from the polyrotaxane scaffold. The samples were visualized by tapping-
mode AFM using a Multimode AFM with a Nanoscope IIIa controller (Veeco) in air at 
22 °C. The AFM tips (NSC15/AlBS, MikroMasch, USA) used had a typical uncoated 
probe tip radius of 10 nm or less; the cantilevers had a spring constant of 40 N/m. 
4.6.12 Transmission Electron Microscopy 
TEM was performed using a FEI/Philips CM-10 Bio-Twin instrument and 
captured on Kodak electron image film (type so-163). Copper 400 mesh grids stabilized 
with formvar and carbon (Ted Pella INC. product No. 01814-F) were glow discharged 
under a plasma for 30 seconds prior to specimen loading. The imaging conditions were: 
spot size 3, accelerating voltage = 80kV, and apertures of 50 µm (AuF objective) and 200 
µm (condenser). All specimens were stained with an aqueous 2% uranyl acetate solution 
as described below.  
A 7.0 µL drop of the specimen was loaded onto the grid and left for 10 sec. Filter 
paper was used to wick away most of the 7.0 µL drop (leaving just enough to cover the 
surface of the grid) followed by 3 washing steps with 7.0 µL of double de-ionized water 
(wicking with filter paper after each wash). After the last washing step with water, 7.0 µL 
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of staining solution was applied to the grid, wicked away with filter paper, and repeated a 
second time.  The specimen was then allowed to dry before imaging.  
4.6.13 Cryogenic Electron Microscopy 
For cryo-EM imaging using Compound 70. A 176 nM Ni2+:70 solution (Figures 
4A & S2A) and a mixed solution of 176 nM Ni2+:70 complex + 3.0 µM his6-GFP (1:1 
his6-GFP:α-CD stoichiometry) in 10 mM HEPES buffer, pH 8.0 (Figures 4B & S2B) 
were concentrated to ∼1 mM, spread onto C-FlatTM grids then plunge-frozen in liquid 
ethane. Images were recorded using a Gatan 4k × 4k charge-coupled device camera on a 
Philips CM-200 TEM. 
For cryo-EM imaging using Compound 92c. Samples were prepared as detailed in 
SDS-PAGE and resuspended into 50 µL PBS, spread onto C-flatTM grids then plunge-
frozen in liquid ethane. Images were recorded using a Gatan 4k × 4k charge-coupled 
device camera on a Philips CM-200 TEM. 
4.6.14 Expression of His6-GroEL and His6-GFP 
The ASKA Library was used to express N-terminal His6-GroEL. Cells containing 
N-His6-GroEL gene overexpression vector were grown to OD = 0.6 (in 100 mL of LB 
broth using a 37 ˚C shaker/incubator) and induced with a final concentration of 1.0 mM 
IPTG, before allowing the cells to grow for an additional 4 h. After centrifugation and 
removal of the supernatant, the cell pellets were stored at -80 °C and split among 5 
different 50 mL tubes (200 mL broth equivalent). Each cell pellet was re-suspended in 
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lysis buffer (6.0 mL 50 mM PBS, 500 mM NaCl, pH = 7.4, 100 µg aprotinin, 174 µg 
phenylmethanesulfonyl fluoride (PMSF), and 500 µg of lysozyme) and allowed to sit for 
1.5 h (stirring every 30 min). Further disruption of the cell membranes was effected by 
110 W probe sonication (35 pulses at 1 second/pulse), followed by centrifugation at 
11,000 g for 30 min. The supernatant was removed and filtered through a 0.1 µm PVDF 
membrane and used for experiments immediately. 
His6-GFP was expressed from BL21 (DE3, MW 27.950.3 g/mol, ε280 = 22015, 
pI= 6.30)) E. coli containing the his6-GFPuv pT7-7plasmid with C-terminal his-tag. His6-
GFP gene overexpression vector were grown to OD = 0.6 (in 100 mL of LB broth using a 
37 °C shaker/incubator) and induced with a final concentration of 1.0 mM IPTG, before 
allowing the cells to grow for an additional 3 h. Cells were centrifuged at 4,000 g for 10 
minutes at 4 °C. The cell pellets were stored at -80 ᵒC. The pellet was resuspended in 
25.0 mL PBS containing 1mM PMSF. The cell suspension was vortexed and sonicated 
and a spatula tip of lysozyme was added. The suspension was incubated for 1.5 h (mixing 
every 30 min.). The suspension was probe sonicated and for 15 minutes using microtip 
(pulsed, 30 % duty cycle) and centrifuged at 11,000 rpm for 30 min at 4 °C. The 
supernatant was removed and filtered through a 0.1 µm PVDF membrane and further 
purified by FPLC. 
4.6.15 SDS-PAGE 
 A solution of 92 (450 µg/mL) in PBS 20 mM, 500 mM NaCl) was made and any 
undissolved material was removed by centrifugation followed by filtration of the 
supernatant through a 0.1 µm PVDF membrane. 92:his6-GroEL solution was made by 
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mixing different volumes of GroEL lysate with 92 solution. The solution was allowed to 
sit for 30 min at 4 °C and was centrifuged at 12,000 g for 30 min. The supernatant was 
decanted and the pellet was resuspended in 50 µL PBS. 
4.6.16 UV-Vis Analysis of PR-NTA Interaction with His6-GroEL and His6-GFP 
 A solution of Compound 84 was made at 15 µg/mL in PBS (20 mM, 500 mM 
NaCl). Solutions of 92a-c were made at 350 µg/mL in PBS (20 mM, 500 mM NaCl). 
Any undissolved material was removed via centrifugation and filtration of the 
supernatant through a 0.1 µm PVDF membrane. Mixtures of 92 and his6-Gro-EL lysate 
and his6-GFP were made by mixing 1.0 mL of the protein solution with 100 µL of 92 
solution. Samples were centrifuged at 12,000 g for 30 min at 4 °C and samples were 
resuspended in 50 µL PBS (20mM, 500 mM NaCl) and analyzed via UV Vis 
spectroscopy. This process was scaled up to generate larger samples for UV-Vis analysis 
and visual analysis (e.g. the photos of the complex pellets). 
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DEVELOPMENT OF NOVEL BLOCK COPOLYMERS FROM 
ORGANOCATALYTIC RING-OPENING POLYMERIZATION FOR DRUG AND 
GENE DELIVERY 
5.1 Introduction 
 There has been considerably increased interest in the use of nanoparticle-based 
drug delivery systems in recent decades1. Nanoparticles2 are defined as colloidal-sized 
particles having diameters between 1 and 1000 nm. These materials may have drugs or 
other therapeutic agents dispersed passively or via chemical ligation to alter the 
pharmacokinetic and pharmacodynamics properties of the therapeutic agent3.  
 A wide variety of nanoparticles composed of a vast array of materials including 
lipids, polymers, biomolecules and inorganic materials have been investigated, resulting 
in diverse delivery systems that vary in their physicochemical properties and are suited to 
address a variety of challenges. Thus far, many different nanoparticle-based drug delivery 
systems have been developed including, but not limited to, liposomes4, micelles5, 
nanospheres6, niosomes7, nanocapsules8, solid lipid nanoparticles9, microemulsions, 




Figure 5.1 Classification of Nanoparticulate-Based Drug-Delivery Systems8b. 
5.1.1 Diblock Copolymers in Drug and Gene Delivery 
 Amphiphilic block copolymers have been one of the most extensively studied 
delivery platforms owing to their synthetic accessibility, modular properties, and the 
variety of nanoparticle types which may be formulated using these materials. The interest 
in amphiphilic polymer-based nanoparticles owes in part to several advantages they 
provide for delivering their payload. The nano-scale size of these materials allows for 
direct administration of the therapeutic agent to the bloodstream via intravenous 
injection. Nanoparticles under ~200 nm show increased circulation times, which may be 
attributed to increased radius of curvature, which smaller particles possess compared to 
larger particles and may prevent efficient binding of opsinins12. They also show 
decreased renal excretion if the particles are sufficiently large enough to avoid glomerular 
filtration. Furthermore, the extended circulation times of nanoparticle-based drug 
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delivery systems has also been shown to lead to increased accumulation of nanoparticle-
associated therapeutic agents in tissues with increased vascular permeability and impaired 
lymphatic drainage13. This principle, known as the enhanced permeability and retention 
(EPR) effect1b, has been proposed to allow for passive targeting of the therapeutic agent 
to its site of action while reducing accumulation in healthy tissue. This may allow for 
enhanced therapeutic efficacy in comparison to the therapeutic agent in the absence of the 
drug delivery system. Nanoparticles have also been used to increase the aqueous 
solubility of hydrophobic drugs via solubilization within the hydrophobic cores of the 
delivery system14.  
 
 
Figure 5.2 Amphiphilic Copolymer-Based Drug Delivery Platforms and Their General 
Characteristics8b. 
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Amphiphilic block copolymers have attracted a great deal of attention in terms of 
their ability to form many different types of nanoparticles (Figure 5.2). These compounds 
are typically prepared via polymerization of multiple monomers or the macroinitiation of 
a polymerization by an existing polymer. Amphiphilic copolymers typically consist of a 
hydrophilic block and a hydrophobic block. The amphiphilic detergent-like nature of the 
resulting copolymer enables access to many different nanoparticle structures.  
 
 
Figure 5.3 Architectures of Various Therapeutic Strategies Utilizing Amphiphilic Block 
Copolymers. 
Amphiphilic copolymers often consist of biocompatible, biodegradable 
hydrophobic blocks like polyesters15, poly(amino acids)16, polycarbonates17, 
polyphosphoesters18 and polysiloxanes19 conjugated to biocompatible hydrophilic blocks. 
Common hydrophobic blocks include poly(lactic acid) (PLA)20, polycaprolactone 
(PCL)15a, 21, polyvalerolactone (PVL), poly(lactide-co-glycolide) (PLGA)6, 15b, 22 among 
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many others. Amphiphilic copolymer-based systems often incorporate poly(ethylene 
glycol) (PEG) to act as a hydrophilic component and barrier to adhesion12a, 23. However, 
other hydrophilic polymers blocks like poly(N-vinyl-2-pyrrolidone), poly(2-ethyl-2-
oxazoline)19a and poly(acrylic acid)24 have also been used. Amphiphilic copolymers 
enable the design of complex multifunctional drug delivery platforms via the facile 
incorporation of targeting ligands, imaging agents, therapeutic agents and other cargo 
(Figure 5.3). These constructs may also be designed to undergo stimuli-sensitive 
degradation to achieve controlled release of their cargo. 
To date, many different block copolymers have been synthesized composed of 
varying block compositions and relative block lengths. By precisely controlling the 
composition and relative molecular weights of block copolymers, various nanoparticle 
structures such as micelles, nanospheres, core-shell nanoparticles, nanocapsules, and 
polymersomes may be obtained. Many different methods of formulation have been 
utilized for production of these materials including, but not limited to, emulsification25, 
nanoprecipitation, emulsion polymerization, or microfluidic strategies26. 
 
5.1.2 Organocatalytic ROP 
 In recent years, organic catalysis has become an increasingly attractive method for 
the synthesis of functional amphiphilic copolymers and has become a powerful 
alternative to traditional metal-based catalysis27. Since the first report of living 
polymerization of lactide using 4-dimethylamino-pyridine (DMAP) reported by 
Nederberg et al28, organocatalysis has progressed to the point that organic catalysts can 
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now offer many tangible advantages in comparison with their organometallic 
counterparts. Most organic catalysts are relatively inexpensive commercially-available 
chemicals, which are generally easily purified, have long shelf lives, and are well-suited 
for a range of reaction conditions, solvents and monomers. Generally, they are organic 
acids or bases, which simply require drying to allow for good control of molecular weight 
and end group fidelity. This is because water can typically act as an initiator, leading to 




Figure 5.4 Coordination-Insertion Mechanism for Metal-Catalyzed ROP. 
 Ring-opening polymerization (ROP) is the most common method for synthesis of 
well-defined biodegradable block copolymers. ROP may be used to generate many 
different polymers including polyesters, polycarbonates, etc., which are attractive for 
therapeutic applications. Traditional metal-based catalysts generally function via the 
coordination-insertion mechanism (Figure 5.4) as in the case of the polymerization of l-
lactide by tin(II) 2-ethylhexanoate. These catalysts have generated concerns related to 




Figure 5.5 Dual Activation Mechanism of Monomer and Initiator in ROP of δ-
Valerolactone by TBD. 
Common orgnanocatalysts for ROP include N-heterocyclic carbenes, organic 
“super base” catalysts29 and bifunctional catalysts. (-)-Sparteine has been used as an 
organocatalyst, but due to its low availability as a natural product, it has not been 
extensively studied. Tris[2-(dimethylamino)ethyl]amine (Me6TREN) has been shown to 
exhibit similar activity to (-)-sparteine. Bifunctional thiourea-amine catalysts were first 
applied to the polymerization of lactide30. These systems involve simultaneous activation 
of monomer by the thiourea (a Lewis acid) and the initiator (an alcohol) by the amine-
component. This strategy was applied to two-component systems of thiourea and organic 
base and bifunctional thiourea-amine (TU/A) catalysts30. However, these systems show 
relative sluggish polymerization kinetics for other monomers (caprolactones, carbonates, 
etc.). 
The most common super-base catalysts include 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU), 1,4,5-triazabicyclo[4.4.0]dec-5-ene (TBD), 7-methyl-3,5,7-
triazabicyclo[4.4.0]dec-5-ene (MTBD), and other phosphazene-based compounds27. 
These catalysts are more active than the TU/A system, display different activities (TBD > 
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MTBD > DBU) and have been applied for the polymerization of many different cyclic 
monomers31. TBD, in particular has been shown to exhibit very high reactivity for 
monomers with low ring strain or which exhibit low conversion with other catalysts. 
TBD functions via dual activation of the monomer and initiator in an analogous fashion 
to the TU/A-based catalysts (Figure 5.5). Alternatively, TBD has been shown to 
polymerize L-lactide via an H-bonding mechanism which does not involve acyl 
transfer32. 
 
5.1.3 Pendant Polymer-Based Gene Delivery 
 Gene delivery involves the treatment of human disease via the transfer of genetic 
material into specific cells of the patient33. Advances in biotechnology, along with the 
completion of the human genome project, have led to the identification of numerous 
disease-causing genes. Gene therapy may offer potential therapeutic benefit for genetic 
diseases that are currently untreatable or involve challenging treatment regimens. 
 Various approaches to gene delivery have been proposed, but gene delivery 
vectors are classified as being either viral or non-viral. Viruses like retrovirus, 
adenovirus, lentivirus, herpes simplex virus and pox virus may all be transformed into 
gene delivery vehicles by replacement of part of the viral genome with the therapeutic 
gene of interest. Viral vectors account for the majority of gene delivery studies in the 
literature and ongoing clinical trials. However, safety concerns associated with 
immunogenicity of viral vectors have been the primary bottleneck to progress on viral 
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gene delivery. There are also concerns associated with large scale production of viral-
based gene therapies. 
 Non-viral gene therapy34 offers the potential for improved safety, greater 
flexibility, and more facile and robust design and production strategies. Non-viral gene 
delivery vectors function to electrostatically bind the nucleic acid cargo, condense the 
cargo into particles, protect the cargo from degradation and mediate cellular entry. Many 
different material strategies have been proposed as non-viral gene-delivery vectors11, 35. 
 
 
Figure 5.6 Pendant Polymer-Based Gene Delivery Strategies. (A) Fabrication of Chol-
PVA-PEG pendant polymer-based transfection complexes and transfection. (B) Chemical 
structures of Chol-PVA-PEG and cationic β-CD derivatives36. (C) Structures of 
hyaluronic acid (HA)-based pendant polymers and β-CD -PEI. 
Kulkarni et al.36-37 first introduced the concept of pendant-polymer-based gene 
delivery with the system composed of poly(vinyl alcohol) (PVA) grafted with PEG and 
also grafted with cholesterol via acid-sensitive benzylidene acetal linkages, amine-
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modified-β-cyclodextrin and siRNA as a therapeutic agent (Figure 5.6A,B). These 
materials effectively formed transfection complexes in the 120-170 nm range via 
electrostatic interaction of siRNA and the cationic cyclodextrins, which are further held 
together via non-covalent interactions of cholesterol with the CD-cavities. β-CD has been 
shown to possess host-guest interactions with a wide variety of compounds with binding 
constants in the 100.5-105 M-1 in aqueous media38. Another approach, based on 
cyclodextrin-containing oligomers, has also been introduced by Davis3, 35b, 39. The 
pendant polymer concept was further applied to microfluidic assembly of transfection 
complexes composed of hyaluronic acid (HA)-modified with adamantine, β-CD-PEI 
conjugate and siRNA26a.  
Although these materials showed good performance, several issues related to the 
reproducibility of the PVA and HA-based material synthesis, and the limitations 
associated with working from pre-formed commercial materials, prompted the design of a 
second generation of pendant polymers. We sought to improve on the pendant polymer 
concept by utilizing organocatalytic ROP to synthesize a library of well-defined block-
copolymers, which could allow for tunable synthesis, the incorporation of targeting 
moieties and biodegradability.  
5.2 Organocatalytic ROP Synthesis of PEG-b-Polycarbonate Pendant Polymers 
 The oligocarbonate-based non-viral gene delivery introduced by Cooley et al31b 
prompted the design of pendant polymers based on PEG-polycarbonate diblock 
copolymers (Figure 5.7). These materials are designed for tunable synthesis via 
organocatalytic ROP mediated by various organic catalysts. Specifically, TBD and the 
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DBU/thiourea-based system30 were utilized due to their respective activities and abilities 
to generate well-defined copolymers with low polydispersity29a. Polycarbonate diblocks 
are also expected to show controlled and sustained degradation rates and degrade into 
non-acidic and non-toxic by-products, which are suitable for biomedical applications. In 
addition to homopolymerization of cyclic carbonate monomers initiated by mPEG 
(Figure 5.7A), copolymers where the cyclic carbonate monomer is blended with 
trimethylene carbonate (TMC) are also included in the library to evaluate the effect of 
pendant group density on nanoparticle formation and efficacy of transfection complexes 
derived from mPEG-b-polycarbonate materials (Figure 5.7B). 
 
Figure 5.7 Chemical Structures of Targeted mPEG-b-Polycarbonate Pendant Polymer 
Library. (A) Homopolymerization of carbonate monomers. (B) Copolymerization of 
carbonate monomers blended with trimethylene carbonate (TMC). 
We sought to synthesize a library of mPEG-b-polycarbonate diblock copolymers 
bearing various moieties, which exhibit affinity for the β-CD cavity, various overall 
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molecular weight and relative block length, and various densities of pendant group along 
the linear polycarbonate backbone. These materials were designed to form transfection 
complexes together with the β-CD-PEI conjugate introduced previously26a and the 
nucleic acid cargo to effect gene delivery (Figure 5.8). 
 
Figure 5.8 Schematic of Gene Delivery Using the mPEG-b-Polycarbonate:β-CD-PEI-
Based Gene Delivery Strategy. 
5.2.1 Synthesis of Cyclic Carbonate Monomers 
 In order to generate a library of mPEG-b-polycarbonate pendant polymers, a 
small library of cyclic carbonate monomers bearing ethyl, benzyl, cholesteryl, and 
adamantyl esters were synthesized following a modified method previously reported for 
synthesis of cyclic carbonates with various functionalities40. These pendant groups were 




Scheme 5.1 Synthesis of Cyclic Carbonate Monomers. 
 2,2-Bis(hydroxymethyl)propionic acid (BHMPA, 93) was chosen as the 
commercial feedstock for synthesis of cyclic carbonate pendant monomers. BHMPA is a 
cheap, commercially available common building block for synthesis of six-membered 
cyclic carbonates. Treatment of BHMPA with benzyl bromide in DMF after formation of 
the potassium salt of BHMPA gave Compound 94 in 83.2 % yield after recrystallization. 
Compound 94 was treated with triphosgene in a solution of DCM and pyridine at -78 °C 
to yield the benzyl carbonate monomer 95 in 82.6 % yield after chromatographic 
purification. Carboxylate derivative 96 was obtained via benzyl ester hydrogenolysis with 
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10 % palladium on carbon to give 96 in 95.8% yield. Cholesteryl ester derivative 97 was 
synthesized via esterification of Compound 96 and cholesterol mediated by EDC and 
DMAP in a solution of DCM and THF in 68.1% yield after chromatographic purification 
and recrystallization. Adamantyl ester derivative 98 was synthesized via esterification of 
Compound 96 and 1-adamantanemethanol mediated by EDC and DMAP in THF in 
47.9% yield after chromatographic purification and recrystallization. 
 
Scheme 5.2 Syntheses of Trimethylene Carbonate. 
 Trimethylene carbonate (TMC) was synthesized as a spacing monomer in order to 
vary pendant group density along the linear polycarbonate backbone. TMC was initially 
synthesized using di-tert-butyl dicarbonate (Boc2O) and DMAP in acetonitrile to give 
102 in 74.2% yield after chromatographic purification and recrystallization. This method 
is very fast, but suffers from the use of large quantities of reagents and necessitates 
chromatographic purification. An alternative synthesis of TMC utilizing 3-bromo-1-
propanol under 1 atm of carbon dioxide in the presence of cesium carbonate in DMF was 
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used to give 104 in 89.0% yield after recrystallization. This method gives TMC in overall 
higher yield and only requires crystallization to yield monomer suitable for 
polymerization. However, this method requires extended reaction times to generate TMC 
in respectable yield.  
5.2.2 Homopolymerization of Carbonate Monomers by TBD 
 
 
Scheme 5.3 Synthesis of mPEG-b-PTMC Diblock Copolymers. 
 Initial polymerization studies focused on synthesis of mPEG-b-PTMC via 
organocatalytic ROP of TMC initiated by mPEG of various molecular weights catalyzed 
by TBD (Scheme 5.3). PEG and TMC were purified by precipitation and 
recrystallization, respectively, before polymerization. A molecular weight of 12.0 kDa 
was targeted for the PTMC blocks of the three diblock copolymers 105a-c. 
Polymerizations were carried out under nitrogen at 1.0 M initial TMC concentration in 
DCM with 5 mol % TBD as catalyst. Polymerizations were quenched after 12 hours with 
benzoic acid and purified via precipitation into diethyl ether. 
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Table 5.1 Characterization of mPEG-b-PTMC. 
 
 
 Compounds 105a-c were characterized via 1H-NMR and GPC. The results are 
summarized in Table 5.1. Mn was determined based on 1H-NMR and GPC. % Conversion 
was calculated based off of Mn from 1H-NMR. Overall, % conversions were high ranging 
from 94.8 % - 97.5 %, suggesting near complete conversion of monomer. Mn calculated 
from 1H-NMR all fall just below 12.0 kDa, while the average Mn calculated from GPC of 
the diblock copolymers in THF were consistently higher. Mw/Mn determined from GPC 
all fall around 1.2, suggesting that the diblock copolymers are relatively monodisperse. 
 
 
Figure 5.9 1H-NMR Spectra of mPEG-b-PTMC Diblock Copolymers. 
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 1H-NMR-spectra were used to determine Mn by integrating the PEG methylene 
regions according to the number of protons present for a monodisperse polymer of the 
reported average molecular weight of the commercial mPEG 1a-e. The sum of integrals 
of the TMC protons were used to calculate Mn and % conversion. NMR spectra also 
reveal that the isolated materials show no evidence of unreacted monomer or catalyst. 
 
 
Scheme 5.4 Homopolymerization of Carbonate Monomers by TBD. 
 Next, efforts were made to generate a small library of mPEG-b-polycarbonate 
homopolymers using ROP of Compounds 95, 97, 98, 100 and 104. Polymerizations were 
carried out under nitrogen for 12 hours in DCM solution. Monomers and PEG were 
purified immediately beforehand via recrystallization and precipitation into diethyl ether, 
respectively. Polymerizations were carried out at [M] of 1.0 M using either 5 or 10 mol % 
TBD as catalyst. A molecular weight of 10.0 kDa was targeted for the polycarbonate 
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block when 1e (mPEG5K) was used as an initiator and a molecular weight of 5.0 kDa 
was targeted for the polycarbonate block when 1d (mPEG2K) was used an initiator. 
Polymerizations were quenched via addition of benzoic acid and purified via 
precipitation into diethyl ether.  
Table 5.2 Characterization of TBD-catalyzed mPEG-b-Polycarbonate Homopolymers. 
 
 
 1H-NMR and GPC in THF were used to characterize the mPEG-b-polycarbonate 
homopolymers synthesized via TBD-catalyzed ROP of cyclic carbonate monomers. % 
Conversion and Mn calculated from 1H-NMR showed that there was a high degree of 
variability for homopolymers generated using TBD. % Conversions varied from very low 
(24.1%) to high (95.2%). Mn calculated from NMR roughly agreed with Mn calculated 
from GPC after taking into account the additional molecular weight due to mPEG. 
Mw/Mn varied greatly from 1.08-1.86 with most centered from 1.2-1.4. This indicates a 
relatively high degree of polydispersity which could be due to transesterification at 
extended reaction times, although no evidence was obtained from 13C-NMR. 
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5.2.3 Copolymerization of Carbonate Monomers by TBD 
 Next, a small library of copolymers was synthesized where carbonate monomers 
95, 97, or 98 were copolymerized with Compound 100 (Figure 5.5). Molecular weights 
of 12.0 kDa and n:m of 1:3 were targeted. Polymerizations were carried out in DCM 
solution at [M] = 1.0 M using 10 mol % TBD relative to [M]. Monomers and PEG were 
purified beforehand and polymerizations were run for 12 hours at ambient temperature. 
Polymerizations were quenched via addition of benzoic acid and purified via 
precipitation into diethyl ether.  
 
 
Scheme 5.5 Copolymerization of Carbonate Monomers by TDB. 
 1H-NMR and GPC in THF were used to characterize the copolymers generated 
via TBD catalyzed ROP. Total % conversions were moderate, indicating that the 
polymerizations only proceeded moderately efficiently. Calculated values for relative 
number of monomers incorporated into the polycarbonate polymers agreed with the 
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targeted ratio of 1:3, indicating that the different monomers did not likely differ greatly in 
their activities toward ROP. Mn from 1H-NMR agreed relatively well with GPC values, 
with a slightly higher value from GPC consistent with previous data. Mw/Mn ranged from 
1.35-1.42, which is comparable to values obtained from homopolymerizations (table 5.3). 
 




5.2.4 Homopolymerization of Carbonate Monomers by DBU/TU 
 Having obtained modest results for homopolymerizations and copolymerizations 
of carbonate monomers using TBD as catalyst, we sought to move to a milder ROP 
catalyst. We chose to go with the combination of DBU and thiourea Compound 110. This 
co-catalyst combination has been previously used to generate oligomers of similar 
monomers using various alcohols as catalysts31b, 41. This catalyst functions via activation 
of the monomer by the thiourea and activation of the initiator or propagating polymer 
terminus by the base (DBU). Interestingly, other thioureas have shown little or no 
activity. This observation has been attributed to the specific N-H acidity imparted on the 





Scheme 5.6 Synthesis of Thiourea (TU) Co-Catalyst. 
Compound 110 was synthesized via reaction between cyclohexylamine (108) and 
3,5-ditrifluoromethyl-phenyl isothiocyanate (109) in THF. A yield of 95.3 % was 
obtained after chromatographic purification.  
 
Scheme 5.7 Homopolymerization of Carbonate Monomers by DBU/TU. 
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 With Compound 110 in hand, a small library of mPEG-b-polycarbonate 
homopolymers was synthesized via organocatalytic ROP of cyclic carbonate monomers 
95, 97, 98, 100 and 104. All monomers and PEG were purified immediately beforehand 
by recrystallization and precipitation, respectively. Polymerizations were carried out 
under nitrogen at ambient temperature using 5 mol % each of DBU and TU (110) in 
DCM at a concentration where initial [M] = 1.0 M. Polymerizations were run for 24 or 48 
hours and quenched with benzoic acid before precipitation into diethyl ether to remove 
catalysts and unreacted monomers.  




 1H-NMR and GPC in THF were used to characterize mPEG-b-polycarbonate 
homopolymers (111a-o). % Conversion indicated that the DBU/TU co-catalyst system 
allowed for synthesis of higher molecular weight polycarbonate polymers and provided 
much better control and subsequent polydispersity. Interestingly, little difference between 
24- and 48-hour reaction times was observed, indicating that all monomers were 
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consumer by 24 hours. Mn as measured by NMR and GPC were in relative agreement 
with a slight bias for increased molecular weight for GPC measurements similar to the 
trend observed for previous compounds. Mw/Mn were significantly improved for 
DBU/TU relative to TBD ranging from 1.11-1.23. These observations are consistent with 
other materials synthesized using this co-catalyst system.  
 
Figure 5.10 Monitoring of 95 Polymerization using DBU/TU by 1H-NMR. 
 A brief kinetic experiment was used to monitor monomer consumption via 1H-
NMR in order to determine optimal reaction times for polymerization of the carbonate 
monomers using DBU/TU and the conditions outlined above for homopolymerization of 
carbonate monomers (Figure 5.10). Conditions used for synthesis of 111c were used and 
aliquots were removed at pre-determined time points, quench with benzoic acid and 
analyzed via 1H-NMR after drying. During polymerization, the carbonate monomers 
become decyclized, leading to a homogenization of the methylene protons on either side 
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of the carbonate functional group. In the monomer, these protons give two distinct 
doublets at 4.2 and 4.7 ppm. This is due to interaction of these methylene protons with 
the carbonyl of the ester moiety through space. Upon polymerization, these proton signals 
become homogenized in NMR due to the flexibility of the carbonate backbone. The ratios 
of integrals of these two sets of protons were used to determine the relative % monomer 
consumption at various time points. Results indicated that polymerizations reached a 
maximum of ~94 % monomer conversion by approximately 1 hour after initiation of 
polymerization. These results indicate that extended reaction times are not necessary for 
polymerization of cyclic carbonate monomers using the DBU/TU system. This also 
suggests that low % conversion, and high polydispersity of diblock copolymers generated 
using TBD as catalyst, may be due to side reactions associated with extended reaction 
times and possible transesterification of the pendant ester moieties, although no evidence 
of this was observed via 13C-NMR.  
5.2.5 Copolymerization of Carbonate Monomers by DBU/TU 
 Having obtained positive results for homopolymerization of carbonate monomers 
using the DBU/TU system, we synthesized a small library of diblock copolymers where 
the polycarbonate block consisted of the pendant carbonate monomers blended with 
TMC. The purpose of these materials was to evaluate the effect of pendant group density 
along the linear polycarbonate backbone on material performance. Since the monomers 
are expected to show similar activities for ROP using DBU/TU, we can expect relatively 
homogenous distributions of pendant moieties in the resultant polymer. If one monomer 
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has increased reactivity, it will be present in greater proportion towards beginning of the 
polycarbonate block.  
 
 
Scheme 5.8 Copolymerization of Carbonate Monomers by DBU/TU. 
 Copolymerizations were carried out under nitrogen using 10 mol % DBU/TU in 
DCM such that the total [M] was 1.0 M, initially. Reactions were allowed to proceed for 
24 hours before quenching with benzoic acid followed by precipitation into diethyl ether 
to remove catalysts and unreacted monomers. Total polycarbonate molecular weights of 
10.0 kDa were targeted with various ratios of 95 to TMC (2:1, 1:1, 1:2, 1:4). 




 1H-NMR and GPC were used to characterize copolymers generated via DBU/TU-
catalyzed ROP of cyclic monomers, 95 and TMC initiated by 1e. 1H-NMR indicated high 
% conversion of monomers and good control of monomer incorporation ratios via control 
of monomer feed ratios. Mn calculated from 1H-NMR and GPC were in good agreement. 
Mw/Mn as determined from GPC measurements ranged from 1.14-1.22, indicating 
relatively monodisperse copolymer formation. 
5.3 Performance of mPEG-b-Polycarbonate Pendant Polymers 
 Next, some of the homopolymers generated via TBD-catalyzed ROP were tested 
for their abilities to effectively form nanoparticles in combination with β-cyclodextrin-
poly(ethyleneimine) (β-CD-PEI) conjugate (as described by Kulkarni, et al.26a) and 
pDNA.  
5.3.1 Formulation of mPEG-b-Polycarbonate Pendant Polymer-Based Transfection 
Complexes 
 
 Transfection complexes composed of various mPEG-b-polycarbonate diblock 
copolymers, β-CD-PEI and pDNA were prepared via precomplexation of β-CD-PEI and 
the pDNA before addition of the diblock copolymer, which acts as a polymeric coating 
via host:guest interaction of the pendant groups with cyclodextrin cavities and 




Figure 5.11 Size Analysis of Transfection Complexes at Various N/P Ratios by DLS. 
 Dynamic light scattering (DLS) was used to determine size and polydispersity of 
transfection complexes generated using Compounds 106e-g and 106j-l (Figure 5.11). 
Transfection complexes ranged in size from approximately 100-250 nm in size. This size 
regime is highly amenable to gene delivery applications. Transfection complexes formed 
from lower weight diblock copolymers showed relatively larger sizes compared to those 
of higher weight polymers. Particle sizes generally decreased with increasing N/P and 
little correlation in particle size and pendant group was observed. Polydispersity indices 




Figure 5.12 Surface Zeta (ζ) Potential Analysis of Transfection Complexes at Various 
N/P Ratios. 
 Zeta potential analysis revealed slightly positive zeta potentials in the range of 5-
10 mV. This slightly positive surface charge is generally preferred in order to promote 
internalization via electrostatic interaction of the positively-charged nanoparticle surface 
and the negatively-charged cellular surface. N/P of 10, 20, and 30 resulted in similar 
surface charges. β-CD-PEI alone exhibited an elevated positive surface charge. 
Copolymers 106e and 106j both exhibited neutral charge in solution while mixtures of 
the copolymer with β-CD-PEI resulted in positive surface charges that were lower in 
magnitude than β-CD-PEI alone, indicating that the diblock copolymers effectively 
screen the positive surface charge of β-CD-PEI. Furthermore, β-CD-PEI in combination 
with the diblock copolymers showed similar zeta potential to the transfection complexes. 
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Figure 5.13 Gel Retardation Analysis of Transfection Complexes at Various N/P Ratios. 
Next, a gel retardation assay was performed to determine the ability of the mPEG-
b-polycarbonate:β-CD-PEI-based materials to condense pDNA at various N/P ratios. 
Higher molecular weight diblock copolymers resulted in the need for high N/P ratios (e.g. 
>20) to effectively condense pDNA, while lower molecular weight diblock copolymers 
effectively condensed pDNA at N/P =5 in two of three cases with the other effectively 




5.3.2 Transfection Efficiency in HeLa Cells 
 
 
Figure 5.14 % GFP Positive HeLa Cells Treated with Transfection Complexes 
Containing AcGFP pDNA. 
 Transfection complexes prepared from mPEG-b-polycarbonates 106e, 106f, 106j, 
or 106l in combination with β-CD-PEI and AcGFP pDNA were evaluated for their 
transfection efficiencies in HeLa cells (Figure 5.14). Transfection complexes showed 
similar efficiency in terms of positive cells to Lipofectamine (L2K). Overall, transfection 
complexes prepared from mPEG-b-polycarbonates with different pendant groups showed 
similar transfection efficiencies. Polymer molecular weight also seemed to have little 
correlation to transfection efficiency. Higher N/P tended to give higher transfection 
efficiency. This observation may be due to higher overall surface charge for particles at 




Figure 5.15 % Mean Fluorescence of HeLa Cells Treated with Transfection Complexes 
Containing AcGFP pDNA. 
 When transfection efficiency is evaluated in terms of % mean fluorescence 
(Figure 5.15), similar trends are revealed. All the transfection complexes performed with 
similar efficiency to L2K. Transfection efficiencies were consistent for different 
transfection complexes with no clear correlation between transfection efficiency and 
polymer molecular weight, or pendant group. N/P ratios of 20-30 tended to show highest 
transfection efficiency.  
 
5.4 Organocatalytic ROP Synthesis of mPEG-b-PCL and SILY-PEG-b-PCL 
 In an effort to design and evaluate a novel microparticle-based drug delivery 
system for delivery of hydrophobic anti-inflammatory compounds to the GI tract, and 
utilizing a novel collagen-binding peptide (SILY) pioneered by Paderi and Panitch43 for 
specific targeting of exposed collagen, a small library of mPEG-b-PCL diblock 




 Scheme 5.9 ROP of ε-Caprolactone by TBD Using mPEG as Macroinitiator. 
 Polymerizations were performed under nitrogen in DCM, yielding [M] of 2.0 M 
and 5 mol % TBD relative to [M]. Molecular weights of 15.0 kDa were targeted for each 
polymer so as to yield diblock copolymers possessing similar PCL blocks (~15.0 kDa) 
and PEG blocks of various molecular weight (550 Da, 2.0 kDa, 5.0 kDa).  Polymerization 
reactions were allowed to run for 72 hours before quenching with benzoic acid to yield 
the catalyst inactive and precipitation into ether to remove catalyst and unreacted 
monomer.  
 
Table 5.6 Characterization of mPEG-b-PCL Copolymers. 
 
 
 1H-NMR and GPC in THF were used to characterize the small family of mPEG-
b-PCL diblock copolymers synthesized via organocatalytic ROP mediated by TBD in 
DCM. Relative % conversion and Mn calculated from 1H-NMR indicated that nearly all 
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of the monomer was incorporated into polymer for all three cases with % conversions 
upwards of 95 %. Mn calculated by 1H-NMR was just below 15.0 kDa for all three 
polymers, while Mn calculated from GPC was very consistent with the expected 
molecular weights after taking into account the molecular weight of the macroinitiator in 
addition to the PCL block. Mw/Mn calculated from GPC were surprisingly low, indicating 
well-controlled living polymerization of ε-caprolactone under these conditions. 
 
 
Figure 5.16 1H-NMR Spectra of mPEG-b-PCL Diblock Copolymers. 
 1H-NMR spectra of Compounds 113a-c revealed that the compounds were 
isolated in high purity with no traces of catalyst, unreacted monomers or other occult 




Scheme 5.10 Synthesis of Collagen-Binding SILY-PEG-b-PCL Conjugate. 
 A novel strategy for synthesis of conjugates between thiol-containing peptides 
and PEG-b-PCL diblock copolymers was used to generate the SILY-PEG-b-PCL 
conjugate 117 via a two-step post-modification process after organocatalytic ROP of ε-
caprolactone by heterobifunctional PEG derivative 114 (Scheme 5.10).  
SILY peptide (H2N-RRANAALKAGELYKSILYGC-CO2H) was first developed 
as a synthetic peptide used to synthesize a dermatan sulfate-containing peptidoglycan 
based on decorin, a natural collagen-binding peptideglycan. The SILY peptide functions 
as a collagen binding motif. This synthetic peptidoglycan was shown to specifically bind 
collagen, delay fibrillogenesis and increase collagen gel stiffness in the same way decorin 
does. 
Polymerization of ε-caprolactone catalyzed by TBD using heterobifunctional α-
carboxyl-ω-hydroxyl-PEG derivative 114 was performed using 5 mol % TBD relative to 
[M] with an additional 1.0 equivalent to account for deprotonation of the terminal 
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carboxyl group in DCM at ambient temperature. PCL block molecular weight of 15.0 
kDa was targeted. The reaction was allowed to proceed for 72 hours, then quenched with 
benzoic acid before precipitation into diethyl ether to remove catalysts and unreacted 
monomer to give Compound 115. Compound 115 was then coupled to N-(2-
aminoethyl)maleimide via EDC-mediated coupling in the presence of HOBt and DIEA in 
DCM to give maleimide-PEG-b-PCL (116). Compound 116 was then conjugated to SILY 
via Michael addition of the thiol group of the lone cysteine residue of SILY and the 
maleimide terminus of Compound 116 to give peptide-polymer conjugate 117.  
 
Table 5.7 Characterization of SILY-PEG-b-PCL and Precursors. 
 
 SILY-PEG-b-PCL and precursors were characterized via 1H-NMR and GPC in 
THF (Table 5.7). Compound 115 showed high monomer conversion and Mn from 1H-
NMR and GPC were consistent and suggested (note that n from NMR represents 
molecular weight of the PCL block, while Mn from GPC represents the molecular weight 
of the entire construct). Mw/Mn for Compound 115 was 1.14, suggesting a relatively 
monodisperse diblock copolymer. After coupling to N-(2-aminoethyl)maleimide, 
Compound 116 showed consistent Mn in comparison to Compound 115 indicating that 
the PCL block was retained with minimal degradation. After coupling to SILY, 
Compound 117 showed consisted Mn for the PCL block from and NMR and GPC 
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reflected the additional molecular weight of the peptide. Mw/Mn increased slightly after 




Figure 5.17 1H-NMR Analysis of SILY-PEG-b-PCL and Precursors. 
 1H-NMR analysis of SILY-PEG-b-PCL in combination with GPC was used to 
verify successful reaction efficiency for each step in the sequence (Figure 5.17). The 
terminal carboxyl group of Compound 115 is apparent as a broad singlet at 
approximately 10.2 ppm. Peaks consistent with maleimide protons were observed in the 
1H-NMR of Compound 116. SILY-PEG-b-PCL (117) displayed numerous alkyl and 
aromatic signals corresponding to various moieties of the peptide. This data, along with 
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the increased Mn observed from GPC verify that SILY-PEG-b-PCL conjugate was 
synthesized successfully. 
 
5.5 Organocatalytic ROP Synthesis of mPEG-b-PLGA 
 A small library of mPEG-b-PLGA diblock copolymers was synthesized via 
organocatalytic ROP mediated by DBU using a method pioneered by Qian et al.44 
involves controlled addition of glycolide, the more reactive monomer, to generate 
random copolymers of PLGA grown from macroinitiators via organocatalytic ROP. 
PLGA is a biodegradable hydrophobic polyester commonly used in a wide variety of 
biomedical applications, which is typically synthesized in bulk using tin-based 
organometallic catalysts. However, this method results in high polydispersities. The 










Scheme 5.11 Organocatalytic ROP Synthesis of mPEG-b-PLGA Catalyzed by DBU.  
 Lactide and glycolide were each recrystallized immediately beforehand allowed 
to dry until constant mass was observed and used for polymerization. Polymerizations 
were run in DCM using 1.0 equivalent of DBU relative to the macroinitiator. 
Polymerizations were carried out by constant addition of glycolide solution to the 
polymerization vessel containing PEG, lactide, and the catalyst. Polymerizations were 
run for 10 min before quenching with benzoic acid to cease catalyst activity. This 
strategy functions to effectively maintain a low concentration of glycolide relative to 
lactide to maintain random incorporation of either monomer into the growing polyester. 
This is necessary because glycolide is much more active toward ROP than lactide. This 
method allows for control of the relative ratios of lactide to glycolide (LA:GA) in the 






Table 5.8 Characterization of mPEG-b-PLGA Diblock Copolymers. 
 
 1H-NMR was used to determine the molecular weight of mPEG-b-PLGA diblock 
copolymers and relative lactide:glycolide ratios of monomer conversion (Table 5.8). 
Overall, obtained PLGA Mn from 1H-NMR was variable. Mn of 10.0 kDa was targeted 
for polymerizations using 1e as macroinitiator and 5.0 kDa was targeted when 1d was 
used. Variability between targeted and obtained molecular weights is attributable to slight 
differences in polymerization kinetics over the very short reaction period, which makes 
optimal quenching times difficult to predict in the absence of real-time monitoring of the 
polymerization. However, ratios of lactide to glycolide calculated from 1H-NMR 
suggested nearly 1:1 stoichiometry with some variability for the polymers, which also 
showed decreased control of molecular weight. 
5.6 Synthesis of Cyclic Amino-Acid N-Carboxyanhydride Monomers 
 There has been significant interest in the chemical synthesis of polypeptides. Most 
polypeptides are synthesized via solid-phase peptide synthesis (SPPS) protocols 45. Solid-
phase peptide synthesis methodologies allow fast, efficient synthesis of short peptides of 
an exact determinable sequence. However, this method has several weaknesses including, 
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cost per amino acid, limitation of the maximum attainable molecular weight, and 
scalability. Today, medium sized peptides (30-50 residues) can be routinely synthesized 
via SPPS protocols using uronium-based coupling reagents and the standard orthogonal 
Fmoc-Boc methodology45a. The advantages of SPPS lie in its sequence specificity and 
relative standardization. Recently, the drug glatarimer acetate (Copaxone), which is a 
random synthetic copolymer of glutamic acid, lysine, alanine, and tyrosine with average 
Mn of 6.4 kDa, was approved for the treatment of multiple sclerosis. The drug is a 
myelin-basic protein biomimetic. Thus, glatarimer acetate may act as a decoy, averting an 
autoimmune response against myelin. 
 
 
Figure 5.18 Polymerization of Amino Acid N-Carboxyanhydride Monomers. (A) The 
“amine” mechanism of NCA polymerization. (B) “Active Monomer” mechanism of NCA 
polymerization. (C) NCA polymerization using ammonium salts. 
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An alternative strategy for the synthesis of polypeptides involves the ring opening 
polymerization of amino acid N-carboxyanhydrides (NCA). The NCA approach is the 
most commonly used approach for producing high molecular weight peptide homo- and 
copolymers on a gram or greater scale. NCA polymerization is the method of choice for 
synthesizing peptides like glatarimer acetate, where the exact sequence specificity is not 
required. By employing amine-terminal macroinitiators one can obtain block copolymers 
with a synthetic block and a polypeptide block or blocks. These so called “hybrid block 
copolymers” or “molecular chimeras” may be of particular utility in the fields of drug and 
gene delivery due to their inherent biocompatibility and programmable properties.  
NCA polymerization should preferentially proceed via the amine mechanism 
(Figure 5.18A). That is, nucleophillic attach of the NCA by an initiating primary amino 
group. This reaction is commonly run in dimethylformamide (DMF) at room 
temperature. However, using the amine mechanism, broad polydispersity indices in 
excess of 1.4-1.6 are commonly observed. This is due to side reactions involving 
deprotonation of weakly acidic N-H protons from an NCA monomer or an amide of the 
growing polypeptide chain (Figure 5.18B). This can lead to branching and contributes to 
an overall broadening of the polydispersity of the polymer46. 
Alternative strategies have sought to avoid the amine mechanism and thereby the 
active monomer side reaction by using catalytic systems. Deming, et al. used transition 
metal catalysts based on nickel (II) complexes47.  Since amines can act as effective 
nucleophiles and bases, an effective switching between the amine mechanism and active 
monomer mechanism will always occur in NCA polymerization. There is also evidence 
that these side reactions may depend heavily on the purity of the NCA monomers.. High 
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vacuum technique has also been utilized to speed the amine mechanism by fast 
degradation of the carbamic acid byproduct.  
Dimitrov and Schlaad48 found that by simply adding protons or using a 
hydrochloride salt to initiate the polymerization, polymers were obtained with PDIs near 
unity (Figure 5.18C). They used amine-hydrochloride-terminal polystyrene to initiate a 
polymerization of an NCA derivative of Nε-benzyloxycarbonyl-l-lysine (Z-L-Lys). The 
underlying hypothesis assumes that by keeping the propagating amine protonated when 
the active monomer is formed, it will be much more likely to be reprotonated rather than 
initiating acyl transfer. Polymer growth proceeds via the “amine” mechanism. These 
reactions were slow, taking several hours to complete due to decreased effective 
concentration of the propagating amine. The desirability of this mode of NCA 
polymerization comes from the accessibility of primary amine hydrochlorides and the 
simplicity of the reaction conditions. 
Several different amino acid-based N-carboxyanhydride monomer synthesis 
methods have been previously described. Initially NCA’s were synthesized via 
suspension of the amino acid in a dry solvent (dioxane, EtOAc) at elevated temperature 
before passing phosgene through the mixture until a homogeneous solution is obtained49. 
The resulting solution must then be evaporated or purged for extended periods to remove 
excess phosgene before purification by recrystallization. This procedure is potentially 
unsafe due to the use of phosgene. Nα-Cbz-protected amino acids may also be converted 
to the corresponding NCA via treatment with phosphorus pentachloride. 
Later, the Fuchs-Farthing method50 was developed utilizing triphosgene as 
carbonylation reagent in place of phosgene using ethyl acetate (EtOAc) as solvent. This 
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method generally involved sequential crystallization to remove impurities. A method 
employing flash chromatographic purification of NCA’s was also introduced. Numerous 
NCA’s have been reported via this method including NCA’s derived from γ-benzyl-L-
glutamate, L-alanine, Nε-benzyloxycarbonyl-L-lysine, O-benzyl-L-threonine, O-benzyl-
L-serine, β-benzyl-L-aspartate, L-leucine, L-tyrosine, and glycine. 
During the course of experimentation into applying the pendant polymer concept 
to peptide copolymers derived from NCA’s, we attempted to use the Fuchs-Farthing 
method to numerous amino-acid NCA’s but found that it was not applicable to many 
amino acids due to their inability to become dissolved in ethyl acetate as solvent even at 
elevated temperatures in excess of 80 °C. In particular, L-alanine proved non-amenable to 
NCA synthesis. Thus, several solvents were screened to determine a solvent for 
triphosgene-based NCA synthesis with broad applicability for a wide variety of amino 
acid starting materials. 
Tetrahydrofuran (THF) was found to be a suitable solvent for every amino acid 
that we attempted to convert to the corresponding NCA at relatively mild temperatures. 
Since THF is easily dried, readily evaporated after NCA synthesis and miscible with 
water, it is especially amenable to previous purification strategies applied to NCA’s. In 
order to test the utility of the modified Fuchs-Farthing method in THF, we synthesized a 
small library of NCA monomers, including some previously reported NCA’s and some 
novel NCA’s. The lowest temperature required to effect solubilization of the starting 





Scheme 5.12 Synthesis of Amino Acid-NCA Monomers. 
 NCA’s were obtained in high yield (87.1% - 97.1%) and in high purity based on 
NMR. Relatively hydrophilic amino acids (L-alanine, S-benzyl-L-cysteine) required the 
highest temperature (70 °C) to effect conversion while L-phenylalanine was solubilized 
at 60 °C. Nε-Cbz-L-lysine, and γ-methyl-L-glutamic acid were converted at 50 °C. 
Relatively lipophilic amino acids (γ-benzyl-L-glutamate, L-isoleucine) were converted to 
the corresponding NCA’s at ambient temperature in THF. This modified synthetic 
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approach to NCA synthesis using THF as universal solvent for carbonylation of amino 
acids using triphosgene is expected to be applicable to a wide range of natural and 
synthetic amino acid derivatives. Since THF is a good solvent able to solubilize a wide 
variety of compounds, is easily evaporated and miscible with water, this synthetic 
procedure may extend the range of accessible NCA’s and the corresponding molecular 
architectures of polypeptides derived from NCA polymerization. 
5.7 Conclusions 
 The pendant polymer-based gene delivery concept has shown potential as a novel 
non-viral gene delivery strategy. However, we sought to address material-specific 
limitations of previously reported pendant polymer materials by using modern synthetic 
strategies to design and synthesize a more well-defined new generation of pendant 
polymers based on diblock copolymers derived from organocatalytic ROP. A family of 
mPEG-b-polycarbonate diblock pendant polymers was successfully synthesized from 
several novel and previously reported cyclic carbonate monomers via organocatalytic 
ROP using TBD and the bifunctional DBU/TU system. Several copolymerizations of the 
cyclic carbonate monomers were performed to generate materials having tunable pendant 
group density alone the polymer backbone. These materials were characterized by NMR 
and GPC. The diblock copolymers showed the ability to form nanoparticles, typically 
100-250 nm in size, with slightly positive surface zeta-potentials, effectively condensed 
pDNA at N/P ratios above 10, and showed comparable transfection efficiencies to 
Lipofectamine-2000 (L2K) in HeLa Cells.  
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 A small library of mPEG-b-PCL diblock copolymers was successfully 
synthesized via organocatalytic ROP of ε-caprolactone catalyzed by TBD using mPEG as 
a macroinitiator. A collagen binding peptide (SILY) conjugate (SILY-PEG-b-PCL) was 
also synthesized via organocatalytic ROP of ε-caprolactone catalyzed by TBD using α-
carboxyl-ω-hydroxyl-heterobifunctional PEG as a macroinitiator. DBU was used to 
synthesize a small library of mPEG-b-PLGA diblock copolymers having controlled 
random incorporation of lactide and glycolide into the PLGA backbone. These materials 
were characterized via 1H-NMR and GPC. 
A new synthetic method for preparation of amino acid N-carboxyanhydrides 
(NCA’s) was developed based on a modified method which was previously reported 
where THF was substituted as solvent for the reaction. This protocol showed broad 
applicability for synthesis of several NCA’s from amino acids having highly varied 
solubility properties, including L-alanine. This method may provide for synthesis of a 
wide variety of novel NCA’s in the future. 
5.8 Future Directions 
 Future efforts for the polycarbonate-based pendant polymers will focus on 
evaluation of the complete library for performance and investigation of the pendant group 
density on performance. Furthermore, a similar strategy to that used to synthesize SILY-
PEG-b-PCL may be applied to the polycarbonate system to generate targeted-PEG-b-
polycarbonate pendant polymers. This strategy could prove to be a powerful modular 
approach to actively-targeted gene delivery systems. The amino-acid-NCA’s may also be 
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used to generate a similar library of polypeptide-based pendant polymers, which may 
exhibit unique properties relative to other pendant polymer materials. 
5.9 Experimental Methods 
All reactions were carried out under a blanket of N2 or argon gas. Reaction 
progress was monitored by thin-layer chromatography (TLC) analysis. TLC spots were 
visualized either by UV light (254nm), exposure by ninhydrin staining, staining with 
phosphomolybdic acid (PMA), staining with p-anisaldehyde or by staining with I2. Flash 
column chromatography was carried out using 230-400 mesh silica gel and analytical 
grade solvents. Solvents were purchased from Mallinckrodt/Baker and used without 
further purification unless noted. Toluene was purchased from Fisher. α-Methoxy-
poly(ethylene glycol) (mPEG, 1a-e) having average molecular weights of 350 Da, 550 
Da, 750 da, 2.0 kDa, and 5.0 kDa were purchased from Sigma Aldrich and purified prior 
to polymerization by precipitation of a dichloromethane (DCM) solution into an excess of 
diethyl ether (Et2O) three times each followed by vacuum filtration and drying in vacuo 
for 24 hours. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) was purchased from Sigma 
Aldrich and stirred together with CaH2 for 48 hours, followed by distillation in vacuo. 
1,5,7-Triazabicyclo [4.4.0]dec-5-ene (TBD) was purchased from Sigma Aldrich and 
purified by stirring a DCM solution in the presence of CaH2 for 48 hours, followed by 
filtration and recrystallization from DCM/pentane. ε-Caprolactone was purchased from 
Sigma and purified via stirring with CaH2 for 48 hours, followed by vacuum distillation. 
Lactide was purchased from Sigma Aldrich and purified via recrystallization from 
toluene. Glycolide was purchased from Sigma Aldrich and purified via recrystallization 
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from toluene/THF. 2-Maleimidoethylamine hydrochloride was purchased from Santa 
Cruz Biotechnology and used without further purification. Benzoic acid was purchased 
from Sigma Aldrich and purified by recrystallization from aqueous ethanol. N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) and N-
hydroxybenzotriazole hydrate (HOBt) were purchased from Advanced Chemtech and 
used without purification. Dichloromethane (DCM) and toluene were purified by 
distillation from CaH2. Tetrahydrofuran (THF) was purified by distillation from sodium 
benzophenone ketyl. HPLC grade THF used for GPC was purchased from Fisher 
Scientific and used without further purification. Dialysis tubing (regenerated cellulose) 
was purchased from Spectrum Labs. NMR solvents were purchased from Cambridge 
Isotope Laboratories and used without further purification. Other reagents were 
purchased from Sigma Aldrich and used without further purification. Other solvents were 
purchased from Fisher Scientific and used without further purification. 
1H-NMR and 13C-NMR samples were prepared by dissolving ~10 mg of sample 
in CDCl3 and spectra were acquired using a Bruker AV-III-500-HD NMR spectrometer 
at 500 mHz for 1H and 125 mHz for 13C or a Bruker ARX-400 NMR spectrometer at 400 
mHz for 1H and 100 mHz for 13C using residual solvent as an internal standard. Monomer 
% conversion and number average molecular weight (Mn) were calculated relative to the 
theoretical number of protons associated with the initiator with respect to the average of 
polymer-associated protons. 
Gel permeation chromatography (GPC) was performed using an Agilent 1200 
Series GPC equipped with a Wyatt Dawn Heleos-II multi-angle light scattering (MALS) 
detector, Wyatt Optilab rEX refractive index (RI) detector and Wyatt quasi-elastic light 
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scattering (QELS) detector using a single Waters Styragel HR-3 5 µm 7.8x300 mm 
column preceded by a Waters Styragel 20 µm 4.6x30 mm guard column using THF as 
eluent. Flow rates of 0.2-0.5 mL/min were used and 100 µL injections of 1.8 mg/mL 
samples were used. dn/dc was determined for each sample using a five-point calibration 
curve (samples from 0.5-2.5 mg/mL, 2.0 mL total) generated using Optilab rEX detector 
in flow mode in combination with ASTRA software. Mn and Mw/Mn were calculated 
using ASTRA software. 
PEI (2.5kD) was purchased from Polysciences, Inc. Dialysis membranes 
(MWCO: 6000-8000) were purchased from Fisher Scientific. AcGFP1 plasmid vector 
and MTS reagent were purchased from Promega®. pDNA was amplified in E. coli and 
purified according to the supplier’s protocol (Qiagen, Hilden, Germany). The 
concentration and purity of the pDNA was determined by absorption at 260 and 280 nm 
and by agarose gel electrophoresis, respectively. The purified pDNA was re-suspended in 
TE buer (10 mM Tris-Cl, pH 7.5, 1 mM EDTA) and kept frozen in aliquots at a 
concentration of 0.5 mg/mL. Lipofectamine®2000 (L2K) transfection reagent was 
purchased from Invitrogen. Cell culture reagents such as DMEM and RPMI media, FBS, 







5.9.1 Synthesis of Cyclic Carbonate Monomers 
Benzyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate (94). Benzyl bromide was 
purified beforehand via shaking with conc. H2SO4, water, sat. NaHCO3, then water, 
followed by drying over anhydrous sodium sulfate and vacuum distillation. 2,2-
Dihydroxymethylpropionic acid (36.00 g, 268.4 mmol) was added to an oven dried 1L 
round bottom flask equipped with a magnetic stir bar and rubber septum. DMF (500 mL) 
was added and the solid was dissolved with stirring. Anhydrous potassium carbonate 
(55.64 g, 402.6 mmol) was added and the mixture was stirred for 30 min under ambient 
conditions to generate the potassium carboxylate salt. Benzyl bromide (68.86 g, 402.6 
mmol) was added via addition funnel dropwise over 30 min at ambient temperature. The 
mixture was stirred for an additional 18 hours at ambient temperature under nitrogen. The 
reaction mixture was poured into 1L deionized water and this solution was divided into 
three equal parts. Each part was extracted with EtOAc (170 mL) four times each. The 
combined extracts were dried over anhydrous sodium sulfate, concentrated in vacuo and 
the residue was crystallized from benzene to give Compound 94 as a white crystalline 
solid. Yield: 50.06 g (83.2 %); 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.28 (m, 5H), 5.21 
(s, 2H), 3.93 (dd, J = 11.2, 6.0 Hz, 2H), 3.73 (dd, J = 11.3, 5.6 Hz, 2H), 2.89 (t, J = 6.1 
Hz, 2H), 1.08 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 175.74, 135.66, 128.65, 128.33, 
127.87, 77.30, 77.05, 76.79, 68.34, 66.71, 49.26, 17.13. 
Benzyl 5-methyl-2-oxo-1,3-dioxane-5-carboxylate (95). Compound 94 (16.51 g, 73.6 
mmol) was dissolved in DCM (280 mL) and pyridine (45 mL) in an oven-dried 500 mL 
round bottom flask equipped with a magnetic stir bar and an addition funnel. Triphosgene 
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(11.36 g, 38.3 mmol) dissolved in DCM (45 mL) was added to the addition funnel. The 
solution of 94 was cooled to -78 °C and the triphosgene solution was added dropwise 
over 1 hour at -78 °C. The dry ice/acetone bath was removed and the solution was 
allowed to stir for an additional 2 hours while warming to ambient temperature. The 
reaction was quenched via addition of 75 mL sat. NH4Cl solution. The biphasic solution 
was transferred to a separatory funnel and the aqueous phase was removed. The organic 
phase was washed with 5% HCl (150 mL) three times, then deionized water (100 mL). 
The organic solution was dried over anhydrous sodium sulfate, concentrated and purified 
via flash chromatography using a gradient of 100 % DCM to 2.5 % MeOH/DCM. The 
pure fractions were combined, concentrated and recrystallized from toluene/hexane to 
give Compound 95 as a white crystalline solid. Yield: 15.22 g (82.6 %).; TLC: Rf= 0.47 
(2.5 % MeOH/DCM); 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.30 (m, 5H), 5.21 (s, 2H), 
4.70 (d, J = 10.9 Hz, 2H), 4.20 (d, J = 10.9 Hz, 2H), 1.32 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 170.93, 147.40, 134.77, 128.78, 128.75, 128.22, 77.31, 77.06, 76.81, 72.95, 
67.92, 40.25, 17.59. 
5-Methyl-2-oxo-1,3-dioxane-5-carboxylic acid (96). Compound 95 (5.00 g, 20.0 mmol) 
was added to an oven-dried 250 mL round bottom flask equipped with a magnetic stir bar 
and a rubber septum. The solid was dissolved in EtOAc (50 mL) and THF (70 mL) and a 
spatula tip of 10% palladium on carbon (wet type) was added. The flask was equipped 
with a three-way adapter attached to a balloon. The flask and balloon were evacuated and 
filled with hydrogen three times and stirred under 1 atm hydrogen for 16 hours. The 
catalyst was removed via gravity filtration through Celite, concentrated and recrystallized 
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from toluene/EtOAc to give Compound 96 as a white crystalline solid. The product is 
positive for staining with bromocresol green. Yield: 3.07 g (95.8 %).; TLC: Rf= 0.06 (5 
% MeOH/DCM); 1H NMR (400 MHz, DMSO-d6) δ 12.68 (s, 1H), 4.52 (d, J = 10.4 Hz, 
2H), 4.29 (d, J = 10.4 Hz, 2H), 1.14 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 178.44, 
152.46, 108.61, 77.79, 45.14, 44.93, 44.72, 44.51, 44.31, 44.10, 43.89, 21.50. 
Cholesteryl 5-methyl-2-oxo-1,3-dioxane-5-carboxylate (97). Compound 96 (3.066 g, 
19.1 mmol), cholesterol (8.144 g, 21.1 mmol) and DMAP (0.351 g, 2.9 mmol) were 
combined in an oven-dried 500 mL round bottom flask equipped with a stir bar and 
rubber septum. The contents were dissolved in DCM (50 mL), THF (50 mL) and pyridine 
(25 mL). The solution was cooled to 0 °C in an ice bath and EDC (4.405 g, 22.8 mmol) 
was added. The solution was stirred for 72 hours while warming to room temperature. 
The solution was concentrated in vacuo and the residue was dissolved in DCM (150 mL). 
The solution was washed with 5% HCl (150 mL) three times, saturated NaHCO3 (120 
mL) and brine (100 mL). The organic solution was dried over anhydrous sodium sulfate 
and purified via column chromatography using a gradient of 100 % DCM, 1.25 % 
MeOH/DCM and 2.5 % MeOH/DCM. The pure fractions were combined and 
recrystallized from toluene/MeOH to give Compound 97 as white crystalline flakes 
similar to cholesterol. Yield: 6.892 g (68.1 %).; TLC: Rf= 0.26 (100 % DCM); 1H NMR 
(400 MHz, CDCl3) δ 5.38 (d, J = 4.3 Hz, 1H), 4.70 (s, 1H), 4.67 (d, J = 10.6 Hz, 2H), 
4.18 (d, J = 10.8 Hz, 2H), 2.32 (d, J = 6.9 Hz, 2H), 2.08 – 1.97 (m, 2H), 1.95 (s, 1H), 1.92 
– 1.75 (m, 3H), 1.64 (s, 1H), 1.61 – 1.58 (m, 1H), 1.58 – 1.52 (m, 2H), 1.52 – 1.44 (m, 
3H), 1.44 – 1.38 (m, 1H), 1.32 (d, J = 10.1 Hz, 6H), 1.25 (d, J = 11.8 Hz, 1H), 1.14 (dtd, J 
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= 22.4, 12.9, 11.1, 6.5 Hz, 7H), 1.06 – 0.95 (m, 6H), 0.92 (dd, J = 14.6, 6.1 Hz, 4H), 0.85 
(d, J = 6.6 Hz, 6H), 0.67 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 170.37, 147.47, 138.82, 
123.18, 108.59, 77.25, 76.94, 76.62, 75.96, 72.97, 56.55, 56.02, 49.86, 42.20, 40.04, 
39.59, 39.41, 37.65, 36.71, 36.43, 36.07, 35.68, 31.79, 31.71, 28.11, 27.90, 27.41, 24.17, 
23.72, 22.72, 22.46, 20.93, 19.20, 18.62, 17.47, 11.75. 
((1s,3s)-Adamantan-1-yl)methyl 5-methyl-2-oxo-1,3-dioxane-5-carboxylate (98). 
Compound 96 (2.108 g, 13.2 mmol), 1-adamantanemethanol (2.19 g, 13.8 mmol) and 
DMAP (322 mg, 2.6 mmol) were added to an oven-dried 250 mL round bottom flask 
equipped with a magnetic stir bar and rubber septum. The contents were dissolved in 
THF (15 mL) and pyridine (10 mL) and cooled to 0 °C in an ice bath. EDC (3.280 g, 17.1 
mmol) was added. The solution was stirred for 72 hours while warming to ambient 
temperature. The solution was concentrated in vacuo and poured into 100 mL deionized 
water. The mixture was extracted with DCM (80 mL) four times. The DCM extracts were 
combined, dried over anhydrous sodium sulfate and purified via column chromatography 
using a gradient of 4:1, 7:3, 3:2, and 1:1 (v/v) mixtures of hexane:EtOAc. The pure 
fractions were combined, concentrated and recrystallized from toluene/hexane to give 
Compound 98 as a white crystalline solid. Yield: 1.943 g (47.9 %).; TLC: Rf= 0.43 (1:1 
Hex: EtOAc); 1H NMR (400 MHz, CDCl3) δ 4.75 – 4.57 (m, 2H), 4.28 – 4.10 (m, 2H), 
3.76 (s, 2H), 1.96 (s, 3H), 1.70 (d, J = 12.3 Hz, 3H), 1.61 (d, J = 12.4 Hz, 3H), 1.49 (d, J 
= 2.5 Hz, 6H), 1.30 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 171.06, 147.35, 108.60, 
77.33, 77.01, 76.69, 75.31, 72.94, 40.23, 39.01, 36.68, 33.28, 27.76, 17.57. 
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Ethyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate (99). Compound 93 (15.00 
g, 111.8 mmol) was dissolved in 125 mL 200 proof ethanol in an oven-dried 250 mL 
round bottom flask equipped with a magnetic stir bar and a rubber septum. Conc. H2SO4 
(5.00 mL) was added and the solution was stirred for 3 hours at reflux. Ethanol was 
evaporated in vacuo and the residue was redissolved into 200 mL EtOAc. The solution 
was washed with sat. NaHCO3 (100 mL), then deionized water (100 mL) twice. The 
organic solution was dried over anhydrous sodium sulfate, and concentrated in vacuo to 
give Compound 99 as a clear viscous oil. Yield: 15.729 g (86.7 %).; TLC: Rf= 0.64 (15 
% MeOH/DCM); 1H NMR (400 MHz, CDCl3) δ 4.04 (q, J = 7.1 Hz, 2H), 3.72 (d, J = 5.6 
Hz, 2H), 3.66 (d, J = 6.1 Hz, 2H), 3.54 (dd, J = 10.4, 5.3 Hz, 2H), 1.14 (t, J = 7.1 Hz, 
3H), 0.96 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 175.63, 77.42, 77.10, 76.78, 65.88, 
60.70, 49.09, 16.95, 13.84. 
Ethyl 5-methyl-2-oxo-1,3-dioxane-5-carboxylate (100). Compound 99 (5.564 g, 34.3 
mmol) was dissolved in DCM (75 mL) and pyridine (15 mL) in an oven-dried 250 mL 
round bottom flask equipped with a magnetic stir bar and an addition funnel. In a separate 
50 mL conical flask, triphosgene (5.294 g, 17.8 mmol) was dissolved in DCM (15 mL). 
The triphosgene solution was transferred to the addition funnel and the solution of 
Compound 99 was cooled to -78 °C in a dry ice/acetone bath. The triphosgene solution 
was added dropwise over 1 hour. The -78 °C bath was removed and the solution was 
stirred for an additional 3 hours while warming to ambient temperature. The reaction was 
quenched via addition of 100 mL sat. NH4Cl solution. The biphasic solution was 
transferred to a separatory funnel and the aqueous layer was removed. The organic 
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solution was washed with 5% HCl (100 mL) twice, deionized water (100 mL) and brine 
(80 mL). The organic phase was dried over anhydrous sodium sulfate, concentrated in 
vacuo, and purified via flash chromatography using a gradient of 100 % DCM to 2.5 % 
MeOH/DCM to give Compound 100 as a clear waxy solid. Yield: 3.509 g (54.4 %).; 
TLC: Rf= 0.47 (2.5 % MeOH/DCM); 1H NMR (400 MHz, CDCl3) δ 4.54 (d, J = 10.8 Hz, 
2H), 4.20 – 4.11 (m, 2H), 4.10 – 4.01 (m, 2H), 1.35 – 0.96 (m, 6H). 13C NMR (101 MHz, 
CDCl3) δ 171.10, 147.51, 77.55, 77.23, 76.90, 72.82, 61.93, 39.91, 16.99, 13.75. 
1,3-Dioxan-2-one (102). 1,3-Propanediol (0.930 g, 12.2 mmol) was added to an oven-
dried 500 mL round bottom flask equipped with a stir bar and rubber septum. Di-tert-
butyl dicarbonate (Boc2O, 8.00 g, 36.7 mmol) was dissolved in 100 mL acetonitrile 
(ACN) in a separate 125 mL flask. The Boc2O solution was added the 500 mL flask and 
DMAP (1.493 g, 12.2 mmol) immediately after. The solution was stirred at ambient 
temperature under nitrogen for 30 min. The solution was transferred to a separatory 
funnel together with 420 mL chloroform. The organic solution was washed with 1.0 M 
HCl (150 mL) twice, followed by deionized water (150 mL). The organic phase was 
dried over anhydrous sodium sulfate, concentrated and purified via flash chromatography 
using a gradient of 2.5 % MeOH/DCM to 5% MeOH/DCM. The pure fractions were 
combined and recrystallized from diethyl ether (Et2O) to give Compound 102 as a white 
crystalline solid. Yield: 0.926 g (74.2 %).; TLC: Rf= 0.35 (5 % MeOH/DCM); 1H NMR 
(400 MHz, CDCl3) δ 4.76 – 3.98 (m, 4H), 2.12 (t, J = 8.4 Hz, 2H). 13C NMR (101 MHz, 
CDCl3) δ 148.42, 77.32, 77.00, 76.69, 67.89, 21.61. 
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1,3-Dioxan-2-one (104). 3-Bromo-1-propanol (5.00 g, 36.0 mmol) was added to an oven-
dried 500 mL round bottom flask equipped with a magnetic stir bar. DMF was added 
(108 mL) followed by Cs2CO3 (12.893 g, 39.6 mmol). Carbon dioxide was bubbled 
through the solution vigorously for 5 min, then a three-way adapter equipped with a 
balloon was attached to the flask. The flask was evacuated and purged with carbon 
dioxide 5 times. The heterogeneous mixture was stirred vigorously under 1 atm carbon 
dioxide for 4 days. The mixture was filtered to remove Cs2CO3 and the cake was washed 
with DCM. The filtrate was concentrated in vacuo and redissolved in DCM (200 mL). 
The solution was washed with deionized water (80 mL) and the organic phase was dried 
over anhydrous sodium sulfate, concentrated and recrystallized from diethyl ether to give 
Compound 104 as a white crystalline solid. Yield: 3.259 g (89.0 %).; TLC: Rf= 0.34 (5 % 
MeOH/DCM; 1H NMR (500 MHz, CDCl3) δ 4.43 (d, J = 5.8 Hz, 4H), 2.13 (p, J = 5.8 
Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 148.49, 77.33, 77.08, 76.82, 67.96, 21.74. 
 
5.9.2 Polymerizations of Carbonate Monomers Using TBD 
mPEG-b-PTMC (105a-c). mPEG (a: 32.1 mg, b: 117mg, c: 292mg; 58.4µmmol) was 
added to an oven-dried 5.0 mL conical vial equipped with magnetic spin vane and PTFE 
septum. Trimethylene carbonate (104, 0.700 g, 6.86 mmol) was added and contents were 
dissolved in 5.5 mL DCM. TBD solution in DCM (35 mg/mL, 1.364 mL) was added via 
pipette and the vial was capped and filled with nitrogen. The solutions were stirred for 12 
hours at ambient temperature. The polymerization was quenched via addition of 80 mg 
benzoic acid. The solution was precipitated twice into 250 mL diethyl ether from DCM, 
filtered and dried in vacuo to give 105a-c as white powders. Yield: a: 723 mg, b: 808 mg, 
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c: 850 mg; 1H NMR (500 MHz, CDCl3) δ 4.63 – 3.90 (m, PTMC -C(=O)-O-CH2-), 3.62 
(PEG -CH2-), 2.15 – 1.76 (m, PTMC). 
TBD-catalyzed mPEG-b-polycarbonate diblock pendant copolymers (106a-q). 1d 
(mPEG2K) or 1e (mPEG5K) (100 mg) was added to an oven-dried 5.0 mL conical vial 
equipped with magnetic spin vane and PTFE septum. Carbonate monomer (95, 97, 98, 
100, or 104) (200 mg) was added and the contents were dissolved in DCM. TBD solution 
(35 mg/mL in DCM) was added (5 mol % relative to monomer). The amount of initial 
DCM used is equal to the volume required to give [M] = 1.0 M, taking into account the 
volume of the TBD solution. The vials were flushed with nitrogen and stirred for 12 
hours at ambient temperature. The polymers were isolated via precipitation into 40 mL 
Et2O plus 5 mL iPrOH in 50 mL centrifuge tubes. The precipitate was isolated via 
centrifugation and dried in vacuo to give Compounds 106a-q as white solids. Mn was 
calculated by comparing PEG methylene proton integrals with characteristic integrals 
from the respective monomers. Yield: a: 139 mg, b: 286 mg, c: 256 mg, d: 238 mg, e: 
263 mg, f: 242 mg, g: 212 mg, h: 261 mg, i: 176 mg, j: 224 mg, k: 252 mg, l: 197 mg, m: 
260 mg, n: 227 mg, o: 240 mg, p: 188 mg, q: 212 mg. 
TBD-catalyzed mPEG-b-polycarbonate diblock pendant polymers (107a-c). 1e (100 
mg, 0.02 mmol), Compound 100 and one of either Compound 95, 97, or 98 were added 
to an oven-dried 5.0mL conical vial containing a magnetic spin vane and a PTFE septum. 
The total mass of monomers is equal to 200 mg. The relative amounts of monomers were 
determined by solving a system of equations targeting total polycarbonate molecular 
weight of 12.0 kDa and a 3:1 ratio of 100 to either 95, 97, or 98. The DCM was added 
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and the solutions were stirred to dissolve mPEG and monomers. TBD solution was added 
next via syringe (35 mg/mL in DCM). The amounts of TBD solution and DCM were 
determined by targeting 10 mol % TBD relative to total [M]. The initial volume of DCM 
is equal to the total volume required to give [M] = 1.0 M minus the volume of the TBD 
solution. The vials were flushed with nitrogen and stirred at ambient temperature for 12 
hours. The polymers were isolated via precipitation into 40 mL Et2O plus 5 mL iPrOH in 
50 mL centrifuge tubes. The precipitate was isolated via centrifugation and dried in vacuo 
to give Compounds 107a-c as white solids. Mn was calculated by comparing PEG 
methylene proton integrals with characteristic integrals from the respective monomers. 
Yield: a: 232 mg, b: 216 mg, c: 208 mg. 
 
5.9.3 Polymerization of Carbonate Monomers Using DBU/TU 
1-(3,5-Bis(trifluoromethyl)phenyl)-3-cyclohexylthiourea (110). 3,5,-Bis-
(trifluoromethyl)phenyl isothiocyanate (1.01 g, 3.72 mmol) was added to an oven-dried 
25 mL round bottom flask equipped with a magnetic stir bar and a rubber septum. THF (5 
mL) was added followed by cyclohexylamine (427 µL, 3.72 mmol). The flask was 
flushed with nitrogen and stirred for 3 hours at ambient temperature. The solution was 
filtered through a pad of Celite with DCM (20 mL). The filtrate was concentrated and 
purified via flash chromatography using a gradient of 2.5 % MeOH/DCM to 5 % 
MeOH/DCM. The pure fractions were combined, concentrated and recrystallized from 
DCM/pet. Ether to give Compound 110 as a white powder. Yield: 1.314 g (95.3 %).; 
TLC: Rf= 0.75 (5 % MeOH/DCM); 1H NMR (500 MHz, CDCl3 δ 8.40 (s, 1H), 7.75 (s, 
2H), 7.70 (s, 1H), 6.08 (s, 1H), 4.20 (s, 1H), 2.06 (dd, J = 12.5, 3.4 Hz, 2H), 1.71 (d, J = 
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10.2 Hz, 2H), 1.63 (dd, J = 9.1, 4.1 Hz, 1H), 1.50 – 1.35 (m, 2H), 1.27 – 1.14 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 179.12, 138.86, 133.51, 133.24, 132.97, 132.68, 125.99, 
123.82, 121.65, 119.34, 77.28, 77.03, 76.77, 54.04, 32.36, 25.26, 24.56. 19F NMR (471 
MHz, DMSO-d6) δ -62.75. 
DBU/TU-catalyzed-mPEG-b-polycarbonate diblock pendant polymers (111a-n). 1d 
(mPEG2K) or 1e (mPEG5K) (100 mg) was added to an oven-dried 5.0 mL conical vial 
equipped with magnetic spin vane and PTFE septum. Carbonate monomer (95, 97, 98, 
100, or 104) (200 mg) was added and the contents were dissolved in DCM. TU (110) 
solution (0.125 M in DCM) was added via syringe, followed by DBU solution (1.0 M in 
DCM). The amounts of DBU and TU solution and DCM were determined by targeting 5 
mol % DBU and TU relative to total [M]. The initial volume of DCM is equal to the total 
volume required to give [M] = 1.0 M, minus the volume of the DBU and TU solution 
volumes. The vials were flushed with nitrogen and stirred for 12 hours at ambient 
temperature. The polymers were isolated via precipitation into 40 mL Et2O plus 5 mL 
iPrOH in 50 mL centrifuge tubes. The precipitate was isolated via centrifugation and 
dried in vacuo to give Compounds 111a-n as white solids. Mn was calculated by 
comparing PEG methylene proton integrals with characteristic integrals from the 
respective monomers. Yield: a: 251 mg, b: 256 mg, c: 263 mg, d: 277 mg, e: 214 mg, f: 
278 mg, g: 240 mg, h: 271 mg, i: 267 mg, j: 244 mg, k: 261 mg, l: 284 mg, m: 243 mg, 
n: 214 mg. 
DBU/TU-catalyzed-mPEG-b-polycarbonate diblock pendant copolymers (112a-d). 
1e (150 mg, 0.03 mmol), Compound 104 and Compound 95, were added to an oven-dried 
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5.0mL conical vial containing a magnetic spin vane and a PTFE septum. The total mass 
of monomers is equal to 300 mg. The relative amounts of monomers were determined by 
solving a system of equations targeting total polycarbonate molecular weight of 10.0 kDa 
and 1:2 (a), 1:1 (b), 2:1 (c), and 4:1 (d) ratios of 104:95. DCM was added and the 
solutions were stirred to dissolve mPEG and monomers. TU (110) solution (0.125 M in 
DCM) was added via syringe, followed by DBU solution (1.0 M in DCM). The amounts 
of DBU and TU solution and DCM were determined by targeting 5 mol % DBU and TU 
relative to total [M]. The initial volume of DCM is equal to the total volume required to 
give [M] = 1.0 M, minus the volume of the DBU and TU solution volumes. The vials 
were flushed with nitrogen and stirred at ambient temperature for 24 hours. The polymers 
were isolated via precipitation into 40 mL Et2O plus 5 mL iPrOH in 50 mL centrifuge 
tubes. The precipitate was isolated via centrifugation and dried in vacuo to give 
Compounds 112a-d as white solids. Mn was calculated by comparing PEG methylene 
proton integrals with characteristic integrals from the respective monomers. Yield: a: 418 
mg, b: 417 mg, c: 411 mg, d: 373 mg. 
 
5.9.4 pDNA-Pendant Polymer Transfection Complex Formation 
mPEG-b-polycarbonate pendant polymers solutions (1 mM equivalent of pendant 
groups) were vortex mixed with equal volumes of β-CD-PEI+ (1mM equivalent of PEI) 
solution in water to form mPEG-b-polycarbonate:β-CD-PEI+ complexes. Transfection 
complexes were formed by adding appropriate amount of mPEG-b-polycarbonate:β-CD-
PEI+ complexes to the 1 µg of pDNA (unmodified or FITC-labelled) dissolved in 30 µL 
of TE buffer in 1.5 mL centrifuge tubes. The amount of mPEG-b-polycarbonate:β-CD-
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PEI+ added to DNA varied from 1-3 µL so as to achieve final N/P ratios of 5, 10, 20 & 30. 
The above solution was incubated at 4 °C for 1 h before use in transfection experiments.   
 
5.9.5 Particle Size and Zeta (ζ) Potential Measurements 
The diameters, size distributions, and ζ-potentials of the materials were evaluated 
by dynamic light scattering (DLS) using a Zetasizer Nano S (Malvern Instruments Ltd.) 
at 20 °C with a scattering angle of 90°. At least 40 measurements were made and 
averaged for each sample. The particles were diluted to 1 mL with HEPES buffer prior to 
analysis.  
 
5.9.6 Gel Retardation Assay 
 The complexation ability of mPEG-b-polycarbonate:CD-PEI+ with pDNA was 
determined by low melting point 1% agarose gel electrophoresis. The agarose gels were 
precast in TBE buffer with GelRed® dye at 1:10,000 dilution. mPEG-b-
polycarbonate:CD-PEI+:pDNA complexes containing 0.2 μg of pDNA at different N/P 
ratios were loaded onto the gel before addition of loading dye (1:5 dilution) to each well 
and electrophoresis at a constant voltage of 55 V for 2 h in TBE buffer. The pDNA bands 






5.9.7 In Vitro Transfection Assay in HeLa Cells 
 HeLa cells were cultured in complete DMEM medium with 10% FBS. All cells 
were incubated at 37 °C, 5% CO2, and 95% relative humidity, respectively, at a cell 
density of 75,000 cells/well in 24-well plates. After 24 h, the culture media was replaced 
with serum free media, with addition of mPEG-b-polycarbonate:CD-PEI+:pDNA 
complexes containing 1 μg of AcGFP, at N/P ratios of 5, 10, 20 and 30. The cells were 
incubated with the complexes for 4 h, after which the spent media was aspirated and fresh 
serum-supplemented media was added. After a total of 36 h incubation, the media was 
aspirated and the cells were washed with PBS, trypsinized, and analyzed by flow 
cytometry using a FC500. The % GFP mean fluorescence intensity was calculated 
relative to L2k controls, considered as 100%.  
 
5.9.8 Synthesis of mPEG-b-PCL and SILY-PEG-b-PCL 
mPEG-b-poly(ε-caprolactone) (113a-c). mPEG (a: 25.7 mg, b: 93.3 mg, c: 233.3 mg; 
46.7 µmmol) was added to an oven-dried 5.0 mL conical vial equipped with magnetic 
spin vane and PTFE septum. ε-Caprolactone (0.700 g, 6.13 mmol) was added and 
contents were dissolved in 1.166 mL DCM. TBD solution in DCM (35 mg/mL, 1.22 mL) 
was added ([M] = 2.0 M) via pipette and the vial was capped and filled with nitrogen. 
The solutions were stirred for 72 hours at ambient temperature. The polymerization was 
quenched via addition of 80 mg benzoic acid. The solution was precipitated twice into 
250 mL diethyl ether from DCM, filtered and dried in vacuo to give Compounds 113a-c 
as white powders. Yield: a: 670 mg, b: 716 mg, c: 867 mg; 1H NMR (500 MHz, CDCl3) 
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δ 4.05 (t, PCL-CH2), 3.64 (s, PEG-CH2), 2.30 (t, PCL-CH2), 1.64 (h, PCL-CH2CH2), 1.37 
(p, PCL-CH2). 13C NMR (126 MHz, CDCl3) δ 173.53, 77.29, 77.03, 76.78, 70.58, 64.15, 
34.12, 28.35, 25.54, 24.58. 
Carboxylate-PEG-b-poly(ε-caprolactone) (115). ε-Caprolactone (700 mg, 6.13 mmol) 
and HO2C-PEG5K-OH (233.3 mg, 46.65 mmol) were added to an oven dried 5.0 mL 
conical vial equipped with a magnetic spin vane and PTFE septum. The vial was then 
evacuated and purged with argon three times. DCM (1.66 mL) was added via syringe and 
solid components were allowed to dissolve followed by 1.41 mL TBD solution (35 
mg/mL in DCM) to produce [M] = 2.0 M. The solution was stirred for 72 hours and 
quenched with benzoic acid (1.2 equiv to TBD) at the end of the reaction period. 
Compound 115) was purified by precipitation twice from DCM into 200 mL cold Et2O, 
dried in vacuo for 24 hours and obtained as a white powder. Yield: 0.857 g (91.8 %).; 1H 
NMR (500 MHz, CDCl3) δ 10.13-10.27 (br, PEG-CO2H), δ 4.05 (t, PCL-CH2), 3.63 (s, 
PEG-CH2), 2.30 (t, PCL-CH2), 1.64 (dq, PCL-CH2CH2), 1.37 (p, PCL-CH2). 
Maleimide-PEG-b-poly(ε-caprolactone) (116). Compound 115 (250 mg, 12.6 µmol), 2-
maleimidoethylamine hydrochloride (46.0 mg, 0.260 mmol) and HOBt (35.2 mg, 0.260 
mmol) were added to an oven-dried 5.0 mL conical vial equipped with a magnetic spin 
vane and PTFE septum. DCM (3.0 mL) was added and solids were dissolved by stirring 
for 5 minutes and cooled to 4 °C in an ice bath. EDC (50.0 mg, 0.261 mmol) was added 
followed by diisopropylethylamine (DIEA, 116 µL, 0.651 mmol). The vial was evacuated 
and purged with argon three times and stirred for 48 hours warming to ambient 
temperature. At the end of the reaction period, the reaction mixture was combined with 
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50 mL DCM, 100 mL methanol (MeOH) and 50 mL deionized water in a 250 mL 
separatory funnel. The contents were shaken and allowed to separate. The lower organic 
phase was removed. The aqueous phase was extracted additionally with 50 mL DCM 
four times. Organic extracts were combined and dried with anhydrous sodium sulfate. 
The solution was concentrated to approximately 10 mL and the polymer was isolated via 
precipitation into 200 mL cold Et2O followed by vacuum filtration. The precipitation 
process was repeated once more and the product was dried in vacuo for 24 hours and 
obtained as a white powder. Yield: 0.221 g (88.4 %).; 1H NMR (500 MHz, CDCl3) δ 6.79 
(s, maleimide-CH2), δ 4.05 (t, PCL-CH2), 3.63 (s, PEG-CH2), 2.30 (t, PCL-CH2), 1.64 
(dq, PCL-CH2CH2), 1.37 (p, PCL-CH2). 
SILY-PEG-b-Poly(ε-caprolactone) (117). Compound 116 (100 mg, 0.0052 mmol) and 
lyophilized SILY peptide (20.7 mg, 9.40 µmol) were added to an oven-dried 5.0 mL 
conical vial equipped with a magnetic spin vane and PTFE septum. The vial was 
evacuated and purged with argon three times. The contents were solubilized in 1.0 mL 
dimethylformamide (DMF) and stirred at ambient temperature for 24 hours. At the end of 
the reaction period, the reaction mixture was combined with 50 mL DCM, 100 mL 
MeOH and 50 mL deionized water in a 250 mL separatory funnel. The contents were 
shaken and allowed to separate. The lower organic phase was removed. The aqueous 
phase was extracted additionally with 50 mL DCM four times. Organic extracts were 
combined and dried with anhydrous sodium sulfate. The solution was concentrated and 
dialyzed against 500 mL DMSO (MWCO 5,000 Da) for 8 hours four times, followed by 
deionized water for 2 hours four times. After dialysis the aqueous turbid solution was 
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transferred to a 50 mL centrifuge tube, frozen and lyophilized. The lyophilized powder 
was dissolved in minimal DCM and precipitated into 50 mL cold Et2O in a centrifuge 
tube, isolated via vacuum filtration and dried in vacuo for 24 hours to give Compound 
117 as a white powder. Yield: 92.3 mg (76.5 %). 1H NMR (500 MHz, DMSO-d6) δ 9.08 
(s, 9H), 8.12 (s, 9H), 8.04 (d, J = 23.1 Hz, 15H), 7.91 (d, J = 31.5 Hz, 30H), 7.85 – 7.62 
(m, 58H), 7.58 (s, 8H), 7.28 (s, 12H), 7.16 (s, 11H), 7.05 (s, 5H), 6.98 (t, J = 8.8 Hz, 
25H), 6.59 (s, 19H), 6.40 (s, 7H), 4.96 (d, J = 6.1 Hz, 3H), 4.47 (dd, J = 16.8, 9.8 Hz, 
5H), 4.32 (s, 24H), 4.25 – 4.02 (m, 61H), 3.95 (d, J = 6.5 Hz, 225H), 3.80 – 3.58 (m, 
41H), 3.50 (s, 454H), 3.39 (s, 14H), 3.30 (s, 126H), 3.08 (s, 36H), 2.92 (s, 15H), 2.74 (d, 
J = 11.6 Hz, 56H), 2.56 – 2.44 (m, 161H), 2.24 (t, J = 7.3 Hz, 241H), 1.62 – 1.40 (m, 
542H), 1.29 (q, J = 8.0 Hz, 303H), 0.99 (d, J = 7.2 Hz, 4H), 0.92 – 0.68 (m, 110H). 
 
5.9.9 Synthesis of mPEG-b-PLGA 
mPEG-b-poly(lactide-co-glycolide) (118a-h). Lactide and glycolide were recrystallized 
from toluene and toluene/THF, respectively, before polymerizations. 1d or 1e (675 mg) 
was added together with lactide (1.350 g, 9.37 mmol) to an oven-dried 100 mL round 
bottom flask equipped with a magnetic stir bar and rubber septum. The contents were 
dissolved in DCM (33 mL). In a separate round bottom flask, glycolide (0.675 g, 5.82 
mmol) was dissolved in THF (9 mL). The glycolide solution was added to the 
lactide/mPEG solution over 10 min via syringe pump. The polymerization was quenched 
via addition of 150 mg benzoic acid. The solution was concentrated and precipitated into 
500 mL diethyl twice, filtered and dried in vacuo to give Compounds 118a-h as white 
granular solids. Yield: a:  1.116 g, b: 0.809 g, c: 1.489 g, d: 1.675 g, e: 1.755 g, f: 1.131 
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g, g: 1.298 g; 1H NMR (400 MHz, CDCl3) δ 5.20 (m, PLA methine), 4.78 (m, PGA 
methylene), 4.43 – 4.22 (m, PEG), 3.62 (s, PEG methylene), 1.57 (m, PLA methyl). 13C 
NMR (101 MHz, CDCl3) δ 169.22, 166.25, 77.25, 76.94, 76.62, 70.46, 68.90, 60.72, 
16.54. 
 
5.9.10 Synthesis of Cyclic Amino Acid N-Carboxyanhydride Monomers 
(S)-4-Methyloxazolidine-2,5-dione (120). A mortar and pestle was used to grind 
commercial L-alanine before drying in vacuo overnight at 50 °C in a vacuum oven. The 
ground and dried L-alanine (2.033 g, 22.8 mmol) was added to an oven-dried 2-necked 
round bottom flask equipped with a magnetic stir bar, rubber septum and inlet adapter 
attached to a nitrogen line containing a 10 % NaOH scrubber. TFF (60 mL) was added 
via syringe. The solution was heated to 70 °C and stirred for 5 min. In a separate 50 mL 
conical flask, triphosgene (3.047 g, 10.3 mmol) was dissolved in THF (20 mL). The 
trisphosgene solution was added to the heterogeneous suspension via syringe pump over 
30 min. After the completion of the addition, the solution was nearly clear. The solution 
was stirred for an additional 1 hour at 70 °C. The solution was concentrated in vacuo and 
Compound 120 was recrystallized several times using THF/toluene/hexane, filtered and 
dried in vacuo at ambient temperature to give Compound 120 as a white crystalline solid. 
Yield: 2.288 g (87.1 %); 1H NMR (400 MHz, DMSO-d6) δ 9.00 (d, J = 20.1 Hz, 1H), 
4.45 (hept, J = 7.2 Hz, 1H), 1.64 – 1.00 (m, 3H). 13C NMR (101 MHz, DMSO) δ 221.66, 
173.28, 152.57, 76.17, 53.71, 41.03, 40.82, 40.61, 40.40, 40.20, 39.99, 39.78, 17.66. 
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(S)-4-((S)-Sec-butyl)oxazolidine-2,5-dione (122). L-Isoleucine was dried beforehand in 
a vacuum over at 50 °C for 24 hours. L-Isoleucine (2.00 g, 15.2 mmol) was added to an 
oven-dried 2-necked round bottom flask equipped with a magnetic stir bar, rubber septum 
and inlet adapter attached to a nitrogen line containing a 10 % NaOH scrubber. THF (40 
mL) was added via syringe. Triphosgene (1.719 g, 5.8 mmol) was dissolved in THF (8 
mL) in a separate 20 mL conical round bottom flask. The triphosgene solution was added 
over 30 min via syringe pump. The solution was stirred for an additional 2 hours at 
ambient temperature. The solution became clear during the 2 hour stir. The solution was 
concentrated and purified via recrystallization from toluene/DCM/hexane to give 122 as a 
white crystalline solid. Yield: 2.268 g (94.8 %); 1H NMR (400 MHz, CDCl3) δ 7.10 (s, 
1H), 4.28 (s, 1H), 2.26 – 1.76 (m, 1H), 1.74 – 1.44 (m, 1H), 1.37 (d, J = 6.5 Hz, 1H), 1.05 
(d, J = 6.0 Hz, 3H), 0.95 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 168.79, 
153.48, 77.27, 76.95, 76.64, 62.40, 37.24, 24.16, 14.72, 11.27. 
Benzyl (S)-3-(2,5-dioxooxazolidin-4-yl)propanoate (124). L-Glutamic acid benzyl ester 
was dried beforehand in a vacuum over at 50 °C for 24 hours. L-glutamic acid benzyl 
ester (3.50 g, 14.8 mmol) was added to an oven-dried 2-necked round bottom flask 
equipped with a magnetic stir bar, rubber septum and inlet adapter attached to a nitrogen 
line containing a 10 % NaOH scrubber. THF (36 mL) was added via syringe and the 
solution became clear. Triphosgene (1.66 g, 5.6 mmol) was dissolved in THF (9 mL) in a 
separate 20 mL conical round bottom flask. The triphosgene solution was added over 30 
min via syringe pump. The solution was stirred for an additional 2 hours at ambient 
temperature. The solution was concentrated and purified via recrystallization from 
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toluene/DCM/hexane to give 124 as a white crystalline solid. Yield: 3.689 g (95.0 %); 1H 
NMR (400 MHz, DMSO-d6) δ 12.37 (s, 2H), 7.59 (d, J = 8.1 Hz, 1H), 7.46 – 7.14 (m, 
5H), 5.02 (s, 2H), 3.98 (td, J = 9.4, 4.9 Hz, 1H), 2.39 – 2.16 (m, 2H), 1.96 (tt, J = 13.0, 
6.4 Hz, 1H), 1.83 – 1.60 (m, 1H). 13C NMR (101 MHz, DMSO) δ 174.61, 174.47, 
157.06, 137.87, 129.24, 128.60, 76.16, 66.31, 53.93, 41.04, 40.62, 40.41, 40.21, 39.79, 
30.98, 26.97. 
Methyl (S)-3-(2,5-dioxooxazolidin-4-yl)propanoate (126). L-Glutamic acid methyl 
ester was dried beforehand in a vacuum over at 50 °C for 24 hours. L-glutamic acid 
benzyl ester (3.00 g, 18.6 mmol) was added to an oven-dried 2-necked round bottom 
flask equipped with a magnetic stir bar, rubber septum and inlet adapter attached to a 
nitrogen line containing a 10 % NaOH scrubber. THF (50 mL) was added via syringe and 
the solution was heated to 50 °C and stirred for 5 min. Triphosgene (2.430 g, 8.2 mmol) 
was dissolved in THF (10 mL) in a separate 20 mL conical round bottom flask. The 
triphosgene solution was added over 30 min via syringe pump. The solution was stirred 
for an additional 2 hours at 50 °C during which the solution became clear. The solution 
was concentrated and purified via recrystallization from THF/hexane to give Compound 
126 as a white crystalline solid. Yield: 3.312 g (95.1 %); 1H NMR (400 MHz, DMSO-d6) 
δ 9.08 (s, 1H), 4.57 – 4.35 (m, 1H), 3.59 (s, 3H), 2.48 – 2.31 (m, 2H), 2.11 – 1.97 (m, 
1H), 1.89 (dq, J = 14.9, 7.4 Hz, 1H). 13C NMR (101 MHz, DMSO) δ 173.15, 172.21, 
152.74, 107.93, 57.07, 52.41, 41.05, 40.84, 40.63, 40.42, 40.21, 40.01, 39.80, 29.75, 
27.29. 
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Benzyl (S)-(4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate (128). H-Lys(Z)-OH was 
dried beforehand in a vacuum over at 50 °C for 24 hours. H-Lys(Z)-OH (4.00 g, 14.3 
mmol) was added to an oven-dried 2-necked round bottom flask equipped with a 
magnetic stir bar, rubber septum and inlet adapter attached to a nitrogen line containing a 
10 % NaOH scrubber. THF (50 mL) was added via syringe and the solution was heated 
to 50 °C and stirred for 5 min. Triphosgene (1.867 g, 6.3 mmol) was dissolved in THF 
(10 mL) in a separate 20 mL conical round bottom flask. The triphosgene solution was 
added over 30 min via syringe pump. The solution was stirred for an additional 2 hours at 
50 °C during which the solution became clear. The solution was concentrated and 
purified via recrystallization from THF/hexane to give 128 as a white crystalline solid. 
Yield: 4.214 g (96.4 %); 1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 5.1 Hz, 5H), 7.15 (s, 
1H), 5.09 (s, 2H), 5.01 (s, 1H), 4.25 (s, 1H), 3.18 (s, 2H), 2.05 – 1.87 (m, 1H), 1.86 – 
1.71 (m, 1H), 1.53 (s, 3H), 1.34 (d, J = 63.9 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 
169.85, 156.81, 152.47, 152.43, 136.26, 128.49, 128.13, 127.92, 77.25, 76.94, 76.62, 
66.82, 57.40, 40.06, 30.75, 29.03, 21.25. 
(R)-4-((Benzylthio)methyl)oxazolidine-2,5-dione (130). S-Benzyl-L-cysteine was dried 
beforehand in a vacuum over at 50 °C for 24 hours. S-benzyl-L-cysteine (3.00 g, 14.2 
mmol) was added to an oven-dried 2-necked round bottom flask equipped with a 
magnetic stir bar, rubber septum and inlet adapter attached to a nitrogen line containing a 
10 % NaOH scrubber. THF (45 mL) was added via syringe and the solution was heated 
to 70 °C and stirred for 5 min. Triphosgene (1.601 g, 5.4 mmol) was dissolved in THF 
(11 mL) in a separate 20 mL conical round bottom flask. The triphosgene solution was 
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added over 30 min via syringe pump. The solution was stirred for an additional 2 hours at 
70 °C during which the solution became clear. The solution was concentrated and 
purified via recrystallization from THF/hexane to give Compound 130 as a white 
crystalline solid. Yield: 3.273 g (97.1 %); 1H NMR (400 MHz, DMSO-d6) δ 9.20 (s, 1H), 
7.48 – 6.97 (m, 5H), 4.76 (t, J = 4.1 Hz, 1H), 3.93 – 3.62 (m, 2H), 3.05 – 2.63 (m, 2H). 
13C NMR (101 MHz, DMSO) δ 171.38, 152.90, 138.76, 129.83, 129.38, 127.98, 58.83, 
41.04, 40.83, 40.62, 40.41, 40.21, 40.00, 39.79, 36.94, 32.58. 
(S)-4-Benzyloxazolidine-2,5-dione (132). L-Phenylalanine was dried beforehand in a 
vacuum over at 50 °C for 24 hours. L-phenylalanine (3.50 g, 21.2 mmol) was added to an 
oven-dried 2-necked round bottom flask equipped with a magnetic stir bar, rubber septum 
and inlet adapter attached to a nitrogen line containing a 10 % NaOH scrubber. THF (70 
mL) was added via syringe and the solution was heated to 60 °C and stirred for 5 min. 
Triphosgene (2.389 g, 8.1 mmol) was dissolved in THF (14 mL) in a separate 20 mL 
conical round bottom flask. The triphosgene solution was added over 30 min via syringe 
pump. The solution was stirred for an additional 2 hours at 60 °C during which the 
solution became clear. The solution was concentrated and purified via recrystallization 
from THF/hexane to give Compound 132 as a white crystalline solid. Yield: 3.809 g 
(94.0 %); 1H NMR (400 MHz, DMSO-d6) δ 9.09 (s, 1H), 7.29 (tt, J = 12.8, 6.2 Hz, 3H), 
7.22 – 7.00 (m, 2H), 4.91 – 4.62 (m, 1H), 3.17 – 2.90 (m, 2H). 13C NMR (101 MHz, 
DMSO) δ 171.69, 152.52, 135.65, 130.55, 129.29, 128.02, 59.11, 41.03, 40.82, 40.62, 
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ABSTRACT: We report the preparation and performance of
TEM grids bearing stabilized nonfouling lipid monolayer
coatings. These films contain NTA capture ligands of
controllable areal density at the distal end of a flexible
poly(ethylene glycol) 2000 (PEG2000) spacer to avoid
preferred orientation of surface-bound histidine-tagged (His-
tag) protein targets. Langmuir−Schaefer deposition at 30 mN/m of mixed monolayers containing two novel synthetic lipids
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(5-amido-1-carboxypentyl)iminodiacetic acid]polyethylene glycolamide
2000) (NTA-PEG2000-DSPE) and 1,2-(tricosa-10′,12′-diynoyl)-sn-glycero-3-phosphoethanolamine-N-(methoxypolyethylene
glycolamide 350) (mPEG350-DTPE)in 1:99 and 5:95 molar ratios prior to treatment with a 5 min, 254 nm light exposure was
used for grid fabrication. These conditions were designed to limit nonspecific protein adsorption onto the stabilized lipid coating
by favoring the formation of a mPEG350 brush layer below a flexible, mushroom conformation of NTA-PEG2000 at low surface
density to enable specific immobilization and random orientation of the protein target on the EM grid. These grids were then
used to capture His6-T7 bacteriophage and RplL from cell lysates, as well as purified His8-green fluorescent protein (GFP) and
nanodisc solubilized maltose transporter, His6-MalFGK2. Our findings indicate that TEM grid supported, polymerized NTA lipid
monolayers are capable of capturing His-tag protein targets in a manner that controls their areal densities, while efficiently
blocking nonspecific adsorption and limiting film degradation, even upon prolonged detergent exposure.
■ INTRODUCTION
Cryogenic electron microscopy (cryoEM) single particle
reconstruction is a rapidly advancing method of protein
structure elucidation that is now capable of producing
structures with resolutions approaching 2.2 Å, provided that
thousands of single particle images can be collected.1 At
present, this is achieved by collecting and class averaging images
from many different carbon-coated grid preparations that
randomly adsorb and present the protein target in multiple
orientations for cryoEM imaging. Since many protein target
candidates exist in low copy number, may be highly labile, and/
or are derived from infectious agents that are in low supply,
there is significant motivation for the development of new
sample preparation methods to improve the throughput and
predictability of this technique.
Lipid monolayers have been used to concentrate proteins at
interfaces for structure determination, as first described by
Uzgiris and Kornberg.2 Subsequent affinity monolayer develop-
ments explored a variety of affinity lipid−ligand interactions
such as biotin−streptavidin, ATP lipid−ATP binding protein,
Ni2+:nitrilotriacetic acid (NTA)-hexahistidine-tagged (His6-tag)
protein, or Cu2+:iminodiacetic acid-His6-tag protein.
3 Many of
these efforts were focused on the development of two-
dimensional crystallization methods using nitrilotriacetic acid
(NTA)-modified lipid conjugates,4−9 with some cases showing
the potential of NTA lipids for structure elucidation with
resolutions in the 10−25 Å regime.5,8,9 NTA lipid monolayers
were extended to the realm of cryoEM single particle
reconstruction by Walz and co-workers, with the structures
for 50S ribosomal subunits,10 transferrin−transferrin receptor
complex,11,12 and human RNA polymerase II13 reported using a
commercially available NTA lipid conjugate, 1,2-dioleoyl-sn-
glycero-3-[((N-(5-amino-1-carboxypentyl)iminodiacetic acid)-
succinyl] (DGS-NTA), in mixed monolayers with DLPC.
They also extended this technique to the retrieval of protein
targets from cell lysates;11,13 however, the potential of the
approach is currently limited by the low stability,10 nonspecific
fouling,11 and preferred orientation14 limitations of DGS-
NTA:DLPC monolayers.
We report our attempts to address these challenges by
depositing nonfouling PEG-lipid15−17 coatings containing
common affinity ligands like NTA3,8,9,18,19 onto TEM grids.20
These coatings are prepared by compression of lipid films
whose NTA surface density and PEG mushroom-brush
conformational state can be controlled by initial film
composition and applied surface pressures prior to Langmuir−-
Schaefer (LS) deposition onto the EM grid. Brush
conformation methoxypoly(ethylene glycol) (mPEG) coatings
are highly nonfouling,21−23 thereby enabling the application of
cell lysates directly onto the grid and removal of the
Received: September 12, 2015
Revised: November 19, 2015
Published: January 4, 2016
Article
pubs.acs.org/Langmuir
© 2016 American Chemical Society 551 DOI: 10.1021/acs.langmuir.5b03445
Langmuir 2016, 32, 551−559
517
nonspecifically bound material in subsequent buffer washing
steps. In addition to the reduced sample quantity demands
required for cryoEM analysis, the shortened sample processing
times also limit the opportunities for proteolytic degradation
and/or protein unfolding of the His6-target that may occur
during standard sample processing protocols. LS deposition of





iminodiacetic acid]polyethylene glycolamide 2000) (NTA-
PEG2000-DTPE)prior to treatment with a 5 min, 254 nm
light exposure was used to prepare stabilized affinity
monolayers supported on carbon coated EM grids. These
grids were then used to capture His6-T7 bacteriophage and
His6-RplL from cell lysates, as well as purified histidine-tagged
green fluorescent protein (His8-GFP) and nanodisc embedded
His6-MalFGK2 (Figure 1). Our findings indicate that
polymerized NTA lipid monolayers are capable of capturing
His6-protein targets in a manner that controls their areal
densities, while efficiently blocking nonspecific adsorption and
limiting film degradation upon prolonged detergent exposure.
■ EXPERIMENTAL METHODS
Synthesis of mPEG350-DTPE, NTA-PEG2000-DSPE, and NTA-
PEG2000-DTPE. The detailed synthesis procedures for mPEG350-
DTPE, NTA-PEG2000-DSPE, and NTA-PEG2000-DTPE (Figure 2)
are reported in Supporting Information.
Figure 1. Conceptual diagram showing stabilized monolayer affinity grid fabrication and utilization. (top left) A fluid-phase mixed lipid monolayer
comprised of Ni2+:NTA-PEG2000-DSPE and mPEG350-DTPE (1:99 or 5:95 mol:mol) was compressed until the mPEG350-DTPE component
entered the brush regime and the diyne lipid chains were fully condensed; (top center) the condensed lipid monolayer film was deposited onto
carbon-coated TEM grids via Langmuir−Schaefer (LS) transfer; (top right) photopolymerization of the LS film, followed by Ni2+ activation,
produces a grid with a stable affinity capture coating; (bottom right) solutions containing the His-tag protein of interest are deposited onto the
coated grids, either as a clarified cell lysate or as a purified protein sample; (bottom center) blotting and rinsing of the sample removes nontarget
material prior to (bottom left) cryofixation (or negative staining) and sample imaging.
Figure 2. Structures of (A) mPEG350-DTPE and (B) NTA-PEG2000-DSPE.
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Cell Lysate Preparations. The ASKA library, a complete E. coli K-
12 ORF archive in which over 4000 bacterial proteins have been
cloned into pCA24N expression vectors, was used. Each protein
coding ORF has an N-terminal His6 and a C-terminal green
fluorescence protein (GFP); each protein coding ORF is also available
without the GFP fusion (which are the strains used in these studies).
Cells containing the RplL gene overexpression vector were grown to
OD = 0.6 in 100 mL of LB broth using a 37 °C shaker/incubator and
induced with a final concentration of 1.0 mM IPTG before allowing to
grow for an additional 4 h. After centrifugation, the supernatant was
discarded before resuspending the cell pellet in lysis buffer (20 mM
Tris, 10 mM MgCl2, 100 mM KCl, pH = 7.4, 100 μg aprotinin, 174 μg
PMSF, 500 μg lysozyme) and incubation for 20 min. The cell
membranes were disrupted by sonication (35 pulses, 1 s/pulse at 75
W) before centrifugation of the suspension at 11 000 g for 10 min. The
supernatant containing His6-RplL was diluted 10-fold before
application to the TEM grid for analysis.
Purified C-terminal His8-tag gp10 (capsid protein) of T7
bacteriophage was typically produced at concentrations of ∼1 × 1012
particles/mL. BL21 bacteria cells in 1 mL of LB media were grown to
OD = 0.8 before addition of T7 bacteriophage (1.0 μL, 1.0 × 1012
particles/mL) to the culture and shaking at 37 °C for 1 h. After
centrifugation of the cells, the supernatant was used directly for TEM
grid analysis.
His8-GFP Purification. A glycerol stock of E. coli cells, transformed
with the His8-GFPuv pT7−7 plasmid, was shaken at 37 °C overnight
before addition to 250 mL of LB media with shaking at 37 °C until an
OD600 of 0.7 was reached. Then, a 1.0 M stock solution of isopropyl-β-
D-thiogalactopyranoside (IPTG) was added, bringing the final
concentration to 1.0 mM, before shaking continually at 37 °C for an
additional 5 h. The cells were then centrifuged at 11 000 g for 10 min,
the supernatant discarded, and the pellet resuspended in 10 mL of lysis
buffer (50 mM NaH2PO4, 100 mM NaCl, pH = 8.0, 100 μg aprotinin,
174 μg phenylmethanesulfonyl fluoride (PMSF), and 500 μg of
lysozyme). The suspension was allowed to stand for 20 min before the
cell membranes were disrupted using 3 rounds of sonication (35 pulses
of probe sonication, 1 s/pulse at 75 W with 1 s rest/pulse) and the
debris pelleted by centrifugation at 11 000 g for 30 min. The
supernatant was incubated with 100 μL of Ni-NTA agarose beads and
gently rotated for 4 h. The beads were pelleted using a benchtop
centrifuge operating at 5000 g for 2 min. The supernatant was
discarded and the pellet was washed with PBS buffer containing
imidazole (50 mM NaH2PO4, 100 mM NaCl, 10 mM imidazole, pH =
8.0). The same spin and wash sequence was repeated with 15 mM, 20
mM, and 30 mM imidazole in PBS. The protein was eluted from the
resin after removal of the supernatant and incubation of the beads with
500 mM imidazole in PBS for 4 h. The removal of imidazole from the
eluted protein was achieved by dialysis against PBS (50 mM
NaH2PO4, 100 mM NaCl, 10 mM imidazole, pH = 8.0) overnight
using a 10 000 MWCO Slide-A-Lyzer. The protein was characterized
using 12.5% acrylamide SDS-PAGE gel electrophoresis.
Purified Maltose Transporter Solubilized in Lipid Nanodisc.
The methods used to purify and insert His6-MalFGK2 maltose
transporter in lipid nanodiscs derived from membrane scaffolding
proteins (MSP) followed those described in a previously reported
protocol.24
Langmuir−Schaefer Film Deposition onto TEM Grids. Stock
solutions of two lipid mixtures (1:99 Ni2+:NTA-PEG2000-DTPE:m-
PEG350-DTPE and 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE) were prepared in CHCl3 at 2.0 mg/mL and stored at −80
°C. Each of these were spread via 10 μL microsyringe at the air−water
interface of a Kibron μTrough and compressed to a final surface
pressure of 30 mN/m (i.e., ∼59 Å2/molecule for 1:99 Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE monolayers and ∼66 Å2/molecule
for 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayers).
The compressed lipid monolayers were deposited onto TEM grids by
Langmuir−Schaefer transfer using tabbed TEM grids (Ted Pella) to
enable grid approach at 180° (and the transfer forceps at 90°) relative
to the air−water interface. The LS film was immediately blotted with
filter paper. (n.b.: Standard TEM grids and forceps produced extensive
disruption of the interface during the LS transfer step, making it
impossible to determine accurate grid transfer ratios under these
conditions.) The supported monolayer films were then polymerized
for 10 min using a hand-held 8 W/m2 254 nm lamp that was placed
6−8 cm above the grid surface before transfer to a standard TEM grid
box for later use.
Fluorescence Microscopy. Sessile drops of His8-GFPuv solution
(3.5 μL, 2.0 mg GFP/mL in PBS) were deposited onto 1:99
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE, 5:95 Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE, 100% mPEG350-DTPE, or bare
carbon coated grid surfaces for 2 min, followed by removal of excess
sample using a microsyringe. Grids were then washed 3 times with 20
μL drops of Tris buffer before removal of the excess solution via
microsyringe. For elution of Ni2+:NTA-bound T7 bacteriophage from
the surface of the grid, 500 mM imidazole was deposited on the grid
surface for 5 min before washing twice with 20.0 μL of PBS. After
preparation, the TEM grid was sandwiched between a microscope
slide and coverslip and sealed with nail polish before recording the
fluorescence images.
Negative-Staining Procedure. T7 bacteriophage and RplL cell
lysate samples were prepared by incubating a 5.0 μL drop of cell lysate
on the grid surface for 2.0 min before gentle removal by microsyringe.
The grids were then washed 6 times with 20 μL drops of Tris buffer
followed by a final wash with 20 μL of distilled water. A 5 μL drop of
2% uranyl acetate was placed on the grid for 1 min before removal of
the excess solution with a wedge of filter paper. Ni2+:NTA-
immobilized samples were eluted from the grids by adding 5 μL of
500 mM imidazole in Tris buffer immediately after sample deposition
(i.e., instead of 6 Tris buffer washes). Nanodisc solubilized MalFGK2
and purified T7 bacteriophage samples were prepared in the same
manner as the cell lysate samples, except that the incubation time of
the samples on DLPC and mPEG350-DTPE modified grids was
increased to 3 min. Negatively stained samples were imaged using a
Tecnai TF20 transmission electron microscope operating at 200 kV.
Preparation of Frozen Hydrated Samples for Cryo-TEM.
TEM grids modified with stabilized 5:95 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE monolayers were treated with His-tag protein
samples as described above for negative-staining. After application of
the protein solution, the excess sample was removed by blotting the
grids twice for 3 s with an offset of −1 at 80% humidity using a
Vitrobot (FEI Company). The grids were then cryo-fixed by plunging
into liquid ethane and imaged at 200 kV on an FEI CM200
transmission electron microscope using low-dose techniques. Images
were recorded using a Gatan Ultrascan CCD.
■ RESULTS AND DISCUSSION
mPEG350-DTPE was prepared in 24% yield by treatment of
commercially available 1,2-(tricosa-10′,12′-diynoyl)-sn-glycero-
3-phosphoethanolamine (DTPE) with the N-hydroxysuccini-
midyl (NHS) active ester form of mPEG350 (Supporting
Information, Scheme S1). NTA-PEG2000-DSPE was prepared
in 40% yield by sequential modification of doubly activated
NHS-PEG2000-maleimide with 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine (DSPE) and a thiol-modified lysine-
NTA derivative (Figure 2; Supporting Information, Schemes
S2−S4). NTA-PEG2000-DTPE was prepared in 13% yield in a
similar manner as NTA-PEG2000-DSPE, except that DTPE
was used for NHS displacement instead of DSPE.
CHCl3 stock solutions of the lipid mixtures were prepared,
spread at the air−water interface at 20 °C, a 5 min incubation
period allowed for evaporation of the solvent, and the films
compressed at a rate of 10 Å2/molecule until collapse at 30−35
mN/m for the mixed monolayers and 40 mN/m for pure
mPEG350-DTPE monolayers. The pressure−area isotherms
shown in Figure S1 for 1:99 and 5:95 NTA-PEG2000-
DTPE:mPEG350-DTPE lipid mixtures displayed gradually
increasing surface pressures upon film compression, except
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that the onset of surface pressure occurred at larger molecular
areas as the NTA-PEG2000-DTPE composition in the film
increased. We attribute this observation to the displacement of
surface-adsorbed NTA-PEG2000 from the air−water interface
as previously described25 for mixed mPEG2000-lipid mono-
layers. As this desorption process progresses, the majority
component, mPEG350, undergoes a mushroom−brush regime
transition upon compression to 30 mN/m while the NTA-
PEG2000 fraction remains in the mushroom configuration. The
extension of the PEG2000 polymer mushroom conformation
from the surface of the film can be calculated by Lo = αN(α/
D)2/3, where Lo = the length of PEG graft, α = length of PEG
monomer (3.5 Å), N = number of ethylene glycol units in the
PEG chain (i.e., 45), and D = the distance between grafting
sites. For a lipid film containing 1% NTA-PEG2000-DTPE, the
grafting site separation is estimated to be 47 Å and the Lo = 2.8
nm. Fully compressed 5:95 NTA-PEG2000-DTPE:mPEG350-
DTPE monolayers are estimated to have a grafting site
separation of 9.4 Å and a NTA-PEG2000 graft extension of
8.2 nm. As the lipid film is compressed below 113 Å2/molecule,
the mPEG350 fraction enters the brush regime, while the NTA-
PEG2000 polymer chain accommodates further compression
by extending farther away from the air−water interface in a
concentration-dependent manner. Consequently, a longer
NTA-PEG was prepared for these studies since it would confer
greater conformational freedom to the immobilized histidine-
tagged target and present it in a greater diversity of possible
orientations for cryoEM single particle analysis.
Since the lipid films typically collapsed at surface pressures
above 30 mN/m, the monolayers were compressed to 30 mN/
m prior to Langmuir−Schaefer (LS) transfer onto carbon-
coated grids that were not subjected to glow discharge before
LS deposition. This method produced transfer ratios between
0.89 and 0.97 for the LS deposition step. Photopolymerization
of the lipid monolayer was initiated by placing the grids ∼6−8
cm from a hand-held UV lamp and irradiating for 10 min. Grid
performance as a function of varied irradiation time suggested
that a 10 min exposure was most favorable.
After monolayer film transfer onto 400 mesh grids and
staining with freshly prepared 1% UO2(OAc)2, TEM images
revealed the presence of large continuous areas exceeding 900
μm2 in size that were punctuated by much smaller zones of
higher contrast (Figure S2). We infer from these findings that
the large area regions were monolayer films with occasional,
interspersed domains of bilayer and trilayer films arising from
partial monolayer collapse during compression that were
preserved by the photopolymerization process. Sufficiently
large areas of the grid were coated by stabilized monolayer film
structures to make them suitable for negative stain and cryoEM
studies; however, the multilayer sections of the film were
helpful for monitoring the stability of the film in the presence of
detergents as described below.
The antifouling properties of the mPEG350 brush layer
within the stabilized monolayer coating was probed qualita-
tively using fluorescence microscopy analysis of His8-GFPuv
adsorption onto these modified surfaces. Wide field and line
scan fluorescence microscopy analysis revealed that glow
discharged bare amorphous carbon surfaces possessed nearly
20-fold greater fluorescence intensities after exposure to His8-
GFPuv than grids bearing mPEG350 brush regime coatings
(>8000 RFU and ∼400 RFU, respectively; Figure S3). Our data
shows that the fluorescence distribution was uniform over both
types of surfaces; however, in rare instances there were small
variations in fluorescence observed. In those cases, we attribute
the areas of decreased fluorescence to grid regions with an
incomplete carbon coating, whereas zones of substantially
increased fluorescence were ascribed to incomplete LS transfer
of the brush layer mPEG350-DTPE. We infer from these
findings that nonspecific binding of protein on the brush
regime mPEG350-DTPE coated grids is much lower than that
of glow discharged bare carbon films due to the combined
effects of molecular weight, polymer hydration, excluded
volume, elastic restoration, and grafting density on the surface
that enhance the antifouling properties of the mPEG
coating.22,26,27 In some cases, low molecular weight PEG
polymers such as mPEG350 display greater antifouling
properties than their higher molecular weight counterparts
since the shorter PEG chains are better able to form a more
densely packed layer.28,29 Based on these findings, we
concluded that brush regime mPEG350-DTPE monolayers,
deposited onto a carbon coated surface by LS transfer, would
be a good candidate for blocking nonspecific adsorption of
macromolecules onto EM grid surfaces. To test this
assumption, we conducted a comparative study between
DLPC monolayers and mPEG350-DTPE stabilized mono-
layers, both deposited via LS transfer, using bare carbon grids as
a control.
His8-GFPuv capture on grids bearing stabilized 1:99 and 5:95
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayers was
first demonstrated by fluorescence microscopy. Wide-field
fluorescence images (Figure S4) of Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE modified grids reveal a nonuniform,
concentration-dependent GFP fluorescence. Some spots of
bright fluorescence, suggestive of GFP aggregation, were also
observed. The observed pixel intensities in the fluorescence line
scan analyses were higher for the grids bearing a 5:95
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE coating than
the grids coated with a 1:99 monolayer. In both cases, the
bound His8-GFPuv could be removed from the grid surface
after a brief 5 min exposure to either 500 mM imidazole or 150
mM EDTA to remove Ni2+ from the His8:Ni
2+:NTA complex
to enable elution of the immobilized protein target from
stabilized, Ni2+ activated 1:99 and 5:95 Ni2+:NTA-PEG2000-
DTPE:mPEG350-DTPE monolayers. These findings indicate
that His-tag targets can be captured in an NTA concentration-
dependent manner, with higher NTA loadings producing
greater target protein concentrations on TEM grids coated with
stabilized, Ni2+-activated NTA-PEG2000-DTPE:mPEG350-
DTPE monolayers.
Purified His6-T7 bacteriophage (10
11−1012 particles/mL)
was used to probe the nonspecific adsorption properties of
DLPC and mPEG350-DTPE stabilized monolayer-coated grids
at higher resolution, with carbon coated, glow-discharged grids
serving as a control. The sample aggregated on grids lacking
modified DLPC or mPEG350 monolayers (Figure 3A). We
identified virus-like particles on these grids, as shown in Figure
3A (inset); however, the poor sample quality produced on
unmodified, glow-discharged grids made accurate quantification
of adsorbed virus particles impossible. Therefore, we only
quantified virus adsorption onto DLPC and mPEG350
modified grids, as discrete particles could be discerned in
both cases. DLPC coated grids were found to decrease the
amount of T7 that was adsorbed to the grid relative to bare
carbon grids (Figure 3B), indicating that interactions between
T7 bacteriophage and the DLPC monolayer are not as
favorable. Nonetheless, a significant amount of occult debris
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remained on the DLPC monolayer coated grids. Grids coated
with mPEG350-DTPE stabilized monolayers, however, dis-
played a greatly reduced accumulation of both T7 and debris
(Figure 3C). The appearance of the virus particles in these
samples included round-like objects as well as more familiar
hexagonal projection of the mature icosahedral form of the
virus. The T7 phage particles in these images represent the
immature form where an absence of mature capsid shell protein
gives results in the rounded appearance of these particles.30 The
low abundance of T7 phage particles highlights the antifouling
opportunities of these PEGylated surfaces. Quantitative
comparisons of the T7 particle densities on DLPC and
mPEG350 monolayers revealed an accumulation of ∼110
particle/1 μm2, and 5 particle/1 μm2, respectively. We infer
from these findings that mPEG350-DTPE stabilized mono-
layers are the most effective toward blocking nonspecific
adsorption of T7 bacteriophage (Figure 3D). Low magnifica-
tion images of purified T7 deposited onto both DLPC and
mPEG-DTPE stabilized monolayer coated grids reveal a
substantially lower background in the case of mPEG350-
DTPE coated grids (Figure 3E,F).
After evaluating the capacity of these grids to inhibit
nonspecific adsorption, we next turned our attention to their
ability to direct affinity-guided interactions with NTA-modified
grids. First, we used fluorescence microscopy to monitor His8-
GFPuv capture on grids bearing stabilized 1:99 and 5:95
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayers.
Wide-field fluorescence images (Figure S4) of Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE modified grids reveal a
nonuniform, concentration-dependent GFP fluorescence. Occa-
sional spots of bright fluorescence, suggestive of GFP
aggregation, were also observed. The observed average pixel
intensities in the fluorescence line scan analyses were higher for
the grids bearing a 5:95 Ni2+:NTA-PEG2000-DTPE:m-
PEG350-DTPE coating than the grids coated with a 1:99
monolayer. In both cases, the bound His8-GFPuv could be
removed from the grid surface after a brief 5 min exposure to
either 500 mM imidazole or 150 mM EDTA to remove Ni2+
from the His8:Ni
2+:NTA complex to enable elution of the
immobilized protein target from stabilized, Ni2+ activated 1:99
and 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE mono-
layers. These findings indicate that histidine-tagged targets can
be captured in an NTA concentration-dependent manner, with
higher NTA loadings producing greater target protein
concentrations on TEM grids coated with stabilized, Ni2+-
activated NTA-PEG2000-DTPE:mPEG350-DTPE monolayers.
Affinity capture of His6-T7 bacteriophage from cell lysates
was then tested by negative stain and cryoelectron microscopy
using grids modified with mPEG350-DTPE stabilized mono-
layers, Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabilized
monolayers, and Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE
stabilized monolayers rinsed with 500 mM imidazole after
lysate exposure (Figure 4). In the presence of mPEG350-DTPE
stabilized monolayers, we observed minimal binding of His6-T7
bacteriophage and very low levels of debris from the lysate onto
the grid (Figure 4A). In some cases, T7 particles were not
observed on the brush polymer surface even at low
Figure 3. Comparative performance of uncoated (bare carbon, glow-
discharge), DLPC, and mPEG350-DTPE coated grids toward
nonspecific protein adsorption (i.e., lacking NTA groups to promote
specific binding). The capacity of these grids to reject nonspecific
protein adsorption was tested by negative stain TEM analysis using
His6-T7 bacteriophage in purified form or within cell lysates. (A)
Purified His6-T7 bacteriophage on glow-discharged bare carbon grid;
(B) purified His6-T7 bacteriophage on 100% DLPC monolayer coated
grid; (C) His6-T7 bacteriophage on stabilized 100% mPEG350-DTPE
monolayer coated grid; (D) number of nonspecific contaminants
adsorbed from purified His6-T7 bacteriophage solution onto bare
carbon grids (blue), DLPC coated grids (red), and mPEG350-DTPE
coated grids (green) as determined by counting 60 randomly selected
fields across 3 different grids for each grid type; (E) His6-T7
bacteriophage in cell lysate applied to 100% DLPC coated grid; and
(F) His6-T7 bacteriophage in cell lysate applied to stabilized 100%
mPEG350-DTPE coated grid.
Figure 4. Effect of NTA surface density on His-T7 bacteriophage
captured from cell lysates using negative stain and cryoEM analysis.
(A) Negative stain TEM appearance of grid coated with stabilized
100% mPEG350-DTPE monolayer after 2 min exposure to cell lysate
containing His-T7 bacteriophage; (B) same as in (A), except that the
grid was coated with stabilized 1:99 Ni2+:NTA-PEG2000-DSPE:m-
PEG350-DTPE monolayer; (C) same as in (B), except that the grid
was rinsed with 500 mM imidazole, pH = 7.4, after the 2 min lysate
exposure step; and (D) cryoEM appearance of grid coated with
stabilized 5:95 Ni2+:NTA-PEG2000-DSPE:mPEG-350-DTPE mono-
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magnification, suggesting a complete blockage of nonspecific
adsorption. Grids bearing Ni2+-charged 1:99 NTA-PEG2000-
DTPE:mPEG350-DTPE stabilized monolayers were capable of
capturing His6-T7 bacteriophage from cell lysate while limiting
the background adsorption of undesired nontarget cellular
components (Figure 4B). It is worth noting that T7 viral
particles often give mixed results of negative-stain and positive-
stained particles since UO2
2+ salts may positively stain packaged
nucleic acid within the capsid structure.31 Exposure of these
samples to 500 mM imidazole led to greatly decreased surface
adsorption of His6-T7 bacteriophage, suggesting that the
interaction of phage particles with the supported NTA-lipid
monolayer is Ni2+ specific (Figure 4C). We attribute the
occurrence of the few remaining particles to either nonspecific
adsorption to uncoated grid regions or particles that are avidly
bound due to multivalent interactions between the phage
particles and the NTA-PEG grafted surface. To compensate for
particle capture efficiency limitations in samples prepared for
cryogenic imaging10 due to unfavorable kinetics and/or modest
ligand−receptor affinities,32 we examined 1:99 and 5:95
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabilized mono-
layer coated grids to determine whether the areal density of
NTA ligands had a detectable influence on His6-T7
bacteriophage capture efficiency. Using identical sample
processing methods and incubation times, we qualitatively
observed an increase in particle surface density with increasing
Ni2+:NTA-PEG2000-DTPE composition (unpublished data).
Since this comparison was not performed in a side-by-side
manner between 1:99 and 5:95 Ni2+:NTA-PEG2000-DTPE:m-
PEG350-DTPE stabilized monolayers with the same lysate, it is
conceivable that these findings may be the result of different
virus titers in the His6-T7 bacteriophage preparations. None-
theless, these findings are consistent with the His8-GFPuv
experiments described above (Figure S4) showing that higher
surface concentrations of affinity capture lipid produces greater
areal densities of immobilized target on the NTA-modified
surface, with the 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE stabilized monolayer coated grids being more suitable
for cryoEM sample preparation (Figure 4D). The immobiliza-
tion of both mature and immature T7 phage from lysate
samples (Figure S8) highlights the potential of rapid
purification using affinity grids toward studying dynamic
processes, which may not be possible when visualizing purified
samples generated using standard TEM sample preparations.
We next demonstrated the capture of the 50S E. coli
ribosomal subunit,10 His6-RplL, directly from cell lysates onto
grids coated with Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE stabilized monolayers. Negative stain EM images of
His6-RplL lysate deposited onto grids coated with mPEG350-
DTPE stabilized monolayers showed no appreciable target-
specific adsorption onto the grid (Figure 5A). After LS
deposition of 20:80 Ni2+:NTA-PEG2000-DTPE:mPEG350-
DTPE stabilized monolayers onto the grids, particles consistent
with the size and various shapes of the 50S subunit were
observed on the grid surface (Figure 5B). When 500 mM
imidazole was added to samples containing the captured
ribosomal particles on 20:80 Ni2+:NTA-PEG2000-DTPE:m-
PEG350-DTPE stabilized monolayers, the previously adsorbed
particles were eluted from the surface of the TEM grid (Figure
5C), consistent with the expectation that the interaction of
His6-RplL with the surface of the grid is Ni
2+ specific. Using the
same sample preparation procedure, cryoEM analysis revealed
the capture of His6-RplL from E. coli lysates (Figure 5D) as
crown-like projections in some images (Figure 5D). These have
frequently been reported and are attributed to the 50S
ribosomal subunit. The earliest reported TEM images of
ribosomes were small, featureless bumps on the grid surface;33
however, more powerful tools eventually led to the revelation
of several features in the ribosomal units such as “crown-like”
and “duck-like” projections for the 50S and 30S subunits,
respectively.34,35 Since the RplL protein carries the hexahisti-
dine tag on the 50S subunit in our construct, we identified
many more of these particles bound to the grid than the 30S
subunit. Crown-like projections are clearly seen from the side
view of the 50S particle with a central protuberance, a ridge, a
stalk, and two groove-like features.
A key design feature of these stabilized affinity coatings is
their utilization of two different types of poly(ethylene glycol)-
modified lipids, one high molar ratio brush layer short segment
to block nonspecific adsorption and facilitate stabilization via
photopolymerization (i.e., mPEG350-DTPE) and a second low
molar ratio component to enable multiple orientations of the
captured protein target to avoid preferred orientations at the
monolayer interface and provide a more representative single
particle reconstruction analysis data set. We tested this
hypothesis by preparing dozens of TEM grids bearing stabilized
Ni2+:NTA-PEG2000-DSPE:mPEG350-DTPE coatings that had
been treated with His6-RplL containing lysates. CryoEM
evaluation of these grids confirmed that the NTA-PEG2000
tether is capable of both capturing and presenting multiple
orientations of the bound His6-RplL target as demonstrated by
the overlay of the known 50S subunit and 70S complex
structures in different rotational configurations (data not
shown).
MSP have become an increasingly popular tool for stabilizing
membrane protein dispersions since it provides a platform in
Figure 5. Affinity capture of His-RplL from cell lysates onto stabilized
Ni2+:NTA-PEG2000-DTPE:mPEG-350-DTPE monolayer coated
grids. (A) Negative stain TEM of grid coated with stabilized 100%
mPEG350-DTPE after 2 min exposure to cell lysate containing His-
RplL; (B) negative stain TEM of grid coated with 20:80 Ni2+:NTA-
PEG2000-DSPE:mPEG350-DTPE after 2 min exposure to cell lysate
containing His-RplL; (C) same as in (B), except that the grid was
rinsed with 500 imidazole, pH = 7.4, after the 2 min exposure to cell
lysate containing His-RplL; and (D) cryoEM image of grid coated with
stabilized 5:95 Ni2+:NTA-PEG2000-DSPE:mPEG-350-DTPE mono-
layer after 2 min exposure to cell lysate containing His-RplL.
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which the local environment of solubilized membrane proteins
resemble the natural environment of the lipid bilayer in cells.36
MSP are used to corral lipids and membrane proteins within
disk-like structures containing a lipid bilayer interior that can
host reconstituted membrane proteins for structure analysis by
electron microscopy,37,38 protein modification studies,39 and
protein activation analysis.40 We used the purified hexahisti-
dine-tagged maltose transporter, His6-MalFGK2, solubilized in
MSP lipid nanodisc, for evaluating their affinity capture
properties on NTA-modified stabilized affinity grids. Although
His-tag MSP can be used for affinity purification,41 we used a
His6-MalFGK2 construct for nanodisc reconstitution to ensure
that only nanodisc containing His6-MalFGK2 are surface
immobilized. We found that mPEG350-DTPE stabilized
monolayer coated grids treated with His6-MalFGK2 nanodisc
appeared to have fewer particles bound to the grid surface
(Figure 6A) than the grids coated with 1:99 Ni2+:NTA-
PEG2000-DTPE:mPEG350-DTPE stabilized monolayers (Fig-
ure 6B). Treatment of the His6-MalFGK2-immobilized grids
with 500 mM imidazole produced a decrease in MSP nanodisc
binding to the surface (Figure 6C), further suggesting that the
interaction between nanodisc solubilized His6-MalFGK2 and
the NTA-modified surface is Ni2+ specific. High magnification
images of nanodisc solubilized His6-MalFGK2 immobilized
onto 5:95 Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE stabi-
lized monolayers (Figure 6D) reveal a set of disc-like features in
the size range of other lipid nanodisc dispersions (7−13 nm in
diameter).42 Although the His6-MalFGK2 within the MSP
nanodiscs is not directly observed due to its small size relative
to the nanodiscs, the fact that these features elute with 500 mM
imidazole strongly corroborates the assumption that they
contain His6-MalFGK2. In addition, our images show
predominantly top/bottom views of the particles, i.e., a disk-
like appearance in TEM micrographs (Figure 6D), suggesting
that a longer PEG spacer is needed to collect a greater number
of side views for this solubilized target.
In order to test the durability of the stabilized monolayers
toward detergent exposure, the modified grids were treated
with either 0.03% Triton X-100 (CAC = 0.015%), 0.014%
Tween 20 (CAC = 0.0072%), and 0.5% CHAPS (CMC =
0.49%) solutions for varying periods of time before TEM
observation. Lipid monolayers adsorbed to solid substrates
display better detergent resistance than lipid bilayers that are
prone to disruption via lipid flip-flop.43,44 Initial encounter of
detergents with the outer bilayer leaflet results in fluidization
and lipid flip-flop from the inner leaflet to the outer leaflet,
eventually leading to complete solubilization of the bilayer
structure.44 Inhibition of flip-flop due to adsorption of a highly
compressed monolayer onto the solid carbon substrate inhibits
flip-flop processes, leading to improved detergent resistance.
Despite some evidence of enhanced detergent resistant of
supported DLPC monolayers, prior attempts to produce TEM
grids coated with mixed Ni2+:NTA-DSG:DPLC monolayers
showed that their exposure to harsher detergents such as Triton
X-100, Tween-20, and CHAPS led to monolayer solubiliza-
tion.10 We tested the detergent resistance of our stabilized
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayer coat-
ings under conditions where DLPC monolayers failed by using
0.03% Triton X-100, 0.014% Tween 20, and 0.5% CHAPS at 5,
15, and 30 min exposures to the detergent solutions. Negative
stain TEM observation of the coatings after detergent exposure
indicated that stabilized Ni2+:NTA-PEG2000-DTPE:m-
PEG350-DTPE monolayer coatings remain intact after 30
min of incubation with Triton X-100, Tween-20, and CHAPS
(Figure S6). In the case of Triton X-100, some holes in the
monolayer were occasionally observed, but none were apparent
in grids treated with Tween 20 or CHAPS. The capacity of
these coatings to immobilize purified His6-T7 bacteriophage
after detergent exposure for 20 min indicated that a modest
reduction in phage binding to the grid occurred; however, the
immobilized His6-T7 bacteriophage particles were bound
specifically as indicated by their ability to be removed by
elution with 500 mM imidazole (unpublished data).
Fluorescence microscopy analysis of detergent-treated
Ni2+:NTA-PEG2000-DTPE:mPEG350-DTPE monolayers re-
vealed that the stabilized Ni2+ lipid monolayer coatings retained
their ability to capture His8-GFPuv. Pixel intensity data was
collected over the entire fluorescence image (Figure 7) to best
represent the overall specific capture capacity of the coating,
regardless of whether it had been detergent compromised or
not. In the case of Triton X-100 exposed samples, the
fluorescence was occasionally enhanced near the grid edges,
possibly as a result of solubilized or damaged monolayer near
the center of the grid holes that were unable to capture His8-
GFPuv in those regions. We did not see this phenomenon with
either CHAPS- or Tween 20-treated surfaces. These grids
exhibited a uniform distribution of His8-GFPuv fluorescence
over the grid holes until the surfaces were treated with 500 mM
imidazole to displace the immobilized protein. Despite the
limitations of these stabilized Ni2+:NTA-PEG2000-DTPE:m-
PEG350-DTPE monolayer coatings toward prolonged Triton
X-100 exposure, our data indicates that histidine-tagged
proteins can be reversibly immobilized even after detergent
exposure. We infer from these findings that both the integrity of
the stabilized lipid monolayer and the specific affinity capture of
Figure 6. Affinity capture of MSP nanodisc containing purified His-
MalFGK2. (A) Negative stain TEM of stabilized 100% mPEG350-
DTPE monolayer-coated grid after treatment with His-MalFGK2 in
nanodiscs; (B) negative stain TEM of His-MalFKG2 in nanodisc
captured on stabilized 1:99 Ni2+:NTA-PEG2000-DSPE:mPEG350-
DTPE monolayer-coated grid; (C) same as in (B), except that the grid
was rinsed with 500 mM imidazole, pH = 7.4, after the His-MalFGK2
in nanodisc exposure step; and (D) cryoEM of His-MalFGK2 in
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the grids remains intact after exposure to detergents that has
proven detrimental to previously reported mixed Ni2+:NTA-
DGS:DLPC monolayers.10
■ CONCLUSIONS
Langmuir−Schaefer transfer of compressed, mixed lipid
monolayers containing Ni2+:NTA-PEG2000:mPEG350 head-
groups in 1:99 and 5:95 molar ratios are capable of capturing
His-tag protein targets from cell lysates with controllable areal
densities and low degrees of nonspecific protein adsorption.
Photopolymerization of the mPEG350-DTPE component in
these monolayers by irradiating for 5 min at 254 nm produced
EM grids with stabilized lipid coatings that were used to then
used to capture His6-T7 bacteriophage and His6-RplL from cell
lysates, purified His8-GFPuv, and nanodisc embedded His6-
MalFGK2. Our data indicate that the cross-linked lipid coating
maintains the nonfouling properties of the monolayer and
provides multiple orientations of the captured target on the
surface, while also affording greater mechanical and detergent
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Single particle cryo-EM analysis (SPA) is a rapidly growing method for elucidating structure of biological mate-
rials at near atomic resolution1,2 due to recent advances in instrumentation and computational algorithms3. One 
aspect of the SPA process that is not well optimized, however, is sample preparation. Traditionally, proteins tar-
geted for structural analysis must be overexpressed and subjected to time-consuming purification and concen-
tration steps, sometimes under harsh conditions that disrupt protein-protein interactions of interest. Recently, 
there have been efforts reported that seek to address these limitations, either by improving grid rigidity to reduce 
beam-induced motion4–6 or by effecting on-grid purification with ‘affinity grids’7–10 that employ metal chelating 
lipids that were originally developed for two-dimensional protein crystallization at the lipid-water interface11–14. 
The latter approach seeks to selectively capture biological target molecules from complex mixtures such as cell 
lysates as an integral part of the TEM sample preparation process10,15.
Although lipid monolayer affinity grids have shown some success in producing samples for cryo-EM recon-
struction at 20 Å resolution7, robust performance of the reported grid coatings may be limited by film instability 
and non-uniformity under the evaporative casting methods that are often employed. Additionally, these lipid 
films require a thin polymer layer or a holey carbon substrate layer to provide mechanical support of the depos-
ited film. The electrical conductivity of monolayer graphene is six orders of magnitude higher than amorphous 
carbon, and although the level of conductivity in graphene decreases with the extent of oxidation, it has been 
shown to recover much of this conductivity upon reduction with H2 plasma9. Additionally, unlike unsupported 
lipid monolayers, the elasticity of graphene makes it ideal to resist permanent deformation due to mechanical 
transfer techniques from the material-water interface. Our interest in utilizing graphene-based affinity substrates 
is focused on exploiting the superior mechanical strength and conductivity it offers. By conferring better target 
specificity to this substrate, affinity graphenic substrates have the potential to offer both improved stability and 
resistance to non-specific adsorption such that direct capture from cell lysates may be feasible.
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We sought to address the limitations of lipid monolayer coated affinity grids by employing a GO derivative 
that minimizes background signal due to the single atom thickness and improved conductivity as a way to combat 
sample charging and instability during image capture16. Here we demonstrate the utility of affinity grids using 
Langmuir-Schaefer (L-S) transfer of GO monolayer sheets that have been functionalized with covalently linked 
Nα, Nα-dicarboxymethyllysine (GO-NTA). Using these affinity grids, we were able to selectively capture both 
His6-T7 bacteriophage and His6-GroEL. When the prepared grids were further modified with bovine serum 
albumin (BSA), a common antifouling agent that limits non-specific adsorption of non-targeted cellular debris, 
we were able to selectively capture these proteins directly from bacterial lysate while avoiding deposition of 
non-target proteins (Fig. 1).
Results and Discussion
GO was produced from graphene using Hummer’s 
method16. Activation of the GO carboxylic acid groups with SOCl2 prior to reaction with the tris-t-butyl ester of 
lysine NTA gave GO-NTA-(O-t-Bu)3. TFA deprotection of this intermediate gave GO-NTA (Fig. 2A). Fourier 
transfer infrared spectroscopy was used to monitor these reactions as shown in Fig. 2B 17. The spectra of GO 
displayed a broad absorption at 3236 cm−1 (O-H stretch) and a sharper absorption at 1648 cm−1 (C= O stretch)16. 
The NTA-GO tris-t-butyl ester displayed an additional absorption at 2933 cm−1 (C-H stretch) due to the incor-
poration of the lysine and t-butyl moieties. Following treatment of NTA-GO tris-t-butyl ester with TFA, the pres-
ence of the aliphatic C-H stretching was greatly reduced, indicating successful deprotection of the NTA chelator 
substituents18.
Previous work has shown that the typical GO sheet absorption band at ~240 nm is shifted to ~270 nm when 
the GO sheets are dispersed in aqueous solution. The origin of this hypsochromic shift is due to n-π * electronic 
transitions arising from the C= O bonds introduced by oxidation19. GO-NTA samples prepared in this manner 
exhibited a major absorption peak at ~280 nm (Figure S1), in good agreement with these reports.
Most reports of Langmuir dispersions of GO at the air-water interface 
focus on surfactant-assisted dispersion methods to stabilize GO sheets dispersed in water20. Treatment of GO 
with surfactants in these cases; however, biases the interfacial activity towards water-surfactant activity rather 
than GO-NTA activity due to their high relative abundance. The planar structure and functional group distri-
bution on GO-NTA confers edge amphiphilicity due to the distribution of hydrophilic carboxyl, ketone, alde-
hyde, amide, and alcohol groups around the periphery of the hydrophobic aryl GO-NTA core (Fig. 2A)21. Since 
GO-NTA becomes increasingly hydrophobic as displacement toward the core from the GO-NTA edge increases, 
larger sheets will tend to be more hydrophobic and migrate to the air-water interface, whereas smaller more 









Figure 1. Conceptual diagram of sample preparation using a GO-NTA modified TEM grid. (i) GO-NTA 
monolayer deposition onto TEM grid via L-S transfer; (ii) activation of NTA with Ni2+; (iii) blocking of non-
specific reaction and/or adsorption sites with 4-aminobenzoic acid (PABA) and bovine serum albumin (BSA); 





Previously, it was thought that the use of surface-active agents was needed to disperse GO sheets. More recent 
work; however, has shown that GO layers form at the air-water interface in the absence of surfactant molecules23. 
Brewster angle microscopy studies have shown that the interfacial refractive index of GO solutions change after a 
few hours of stirring pure GO dispersions in water24. This suggests a time-dependent mechanism for GO absorp-
tion at the air-water interface, with slower interfacial adsorption rates attributable to slower diffusion rates of large 
graphene sheets relative to typical surfactant molecules used for studies of the air-water interfaces. To increase 
the amount of surface-active graphene sheets present at the air-water interface while circumventing hours of 
stirring, studies using rising gas bubbles of CO2 and N2 as a way of transporting these sheets to the surface have 
proven successful22. These studies show that GO can migrate to the air-water interface, while other work suggests 
that the surface activity of GO sheets in water can be increased using volatile, polar protic solvents to enable their 
manipulation using Langmuir compression23.
Compression of the GO-NTA material at the interface gave a characteristic surface pressure-area isotherm 
(Fig. 3A), suggesting a progression from isolated GO-NTA sheets to close edge-to-edge packing of GO-NTA 
sheets, followed by folding, wrinkling, and sliding of the nearest neighbor GO-NTA sheets atop one another upon 
further compression25, in a manner analogous to pressure-induced collapse of Langmuir phospholipid monolayer 
films23. Repulsive electrostatic interactions and attractive van der Waals forces compete as GO-NTA sheets come 
into close contact. Previous work with GO monolayers has suggested that over-compression of GO causes irre-
versible coagulation above ~15 mN/m23 due to the increasing participation of attractive van der Waals interac-
tions once the repulsive electrostatic interactions between sheet edges has been overcome by lateral compression. 
Transfer of these films onto silicon substrates at multiple surface pressures enabled the transfer of single layer GO 








































































Figure 2. Synthesis and characterization of GO-NTA. (A) Reaction sequence for preparation of GO-NTA from 




Epifluorescence microscopy, AFM, and SEM was employed 
to determine the thickness and lateral distribution of GO-NTA sheets deposited onto solid substrates by L-S 
transfer from the air-water interface26. In particular, epifluorescence microscopy of F-PABA-GO-NTA monolay-
ers proved useful because opacity of the graphene-based sheet is directly related to its thickness as revealed by 
analysis of monolayer-coated grid and negative control bare Cu TEM grid samples that showed significantly 
greater fluorescence intensity for grids coated with F-PABA-GO-NTA (Figure S2).
We then evaluated drop casting and L-S transfer deposition methods for the production of the thinnest films 
possible, while yielding films with the highest density of NTA capture ligands. Drop casting26,27, followed by slow 
evaporation of solvent, resulted in a fluorescence signal that completely spanned the holes of Formvar-coated 400 
mesh Cu grids (data not shown). Slow solvent evaporation enables GO sheets to settle on top of one another to 
form a multi-layered film covering the TEM grid holes. Although successful, our findings suggest that drop cast-
ing typically yields sheets that are too thick and heterogeneous for protein structure elucidation applications by 
cryoEM. L-S transfer in the presence of 2-propanol (IPA) proved successful for depositions onto 1500 mesh grids, 
both with and without Formvar coating; however, L-S transfers with pure water resulted in thicker heterogeneous 
coatings over a limited area of the holes. L-S transfer onto Si wafers under identical conditions confirmed the pres-
ence of multilayered films (Fig. 3B,D). We were not able to fabricate functional coatings with 400 mesh grids using 
L-S transfer, a finding we attribute to the mismatch between the average GO-NTA sheet size of ~16 μ m × 16 μ m 
and the 37 μ m × 37 μ m grid holes of these grids. It is worth noting that the GO-NTA sheet size can vary as a func-
tion of oxidation reaction duration and sonication time employed during GO synthesis28.
To gain further insight into the structure of these GO-NTA films, SEM and AFM analyses were performed 
after compression to 15 mN/m and L-S transfer of GO-NTA monolayer sheets onto Si wafers. To prepare Si wafers 
for L-S transfer, ~2.25 cm2 wafers were cut and glued (bottom side) onto a transfer tube. The surface pressure was 
maintained until the Si wafer contacted the monolayer; the film was then recompressed to 15 mN/m after the L-S 
transfer step. The area difference before and after L-S transfer indicated transfer efficiencies of 75–85%. Image anal-
ysis of the coated Si wafers revealed the presence of GO-NTA monolayer sheets transferred from IPA-containing 
subphases with ~1.3 nm thicknesses that were relatively uniform (Fig. 3D,E), in good agreement with previously 
reported values for single layer GO29. In the absence of IPA; however, data from SEM and AFM experiments 
revealed GO-NTA films comprised of overlapping sheets and undesirable layer thickness variations (Fig. 3B,C).
Selected area electron diffraction analysis of GO-NTA L-S films, deposited onto bare 2000 mesh grids from 
the air-IPA/H2O interface, revealed a hexagonal diffraction pattern, indicative of a single layer of graphenic mate-
rial (Fig. 3F). The measured intensity of the inner and outer peaks confirms the presence of a single GO-NTA 
layer (Figure S3)27.
Figure 3. Characterization of GO-NTA surfaces. (A) Pressure-area isotherm for GO-NTA sheets at the air-
water interface, dispersed at 67 ng/mL in water at 20 °C. GO-NTA sheets compressed at a rate of 500 mm2/min. 
(B) SEM images taken 1.0 keV, with 5 μ m scale bar and (C) AFM images of GO-NTA after LS-transfer onto Si 
wafers from a subphase of pure H2O (5 μ m scale bar). (D) SEM images taken at 0.5 keV (5 μ m scale bar) and (E) 
AFM of GO-NTA after LS-transfer onto Si wafers from a subphase of IPA/H2O (5 μ m scale bar). (F) TEM image 
of GO-NTA monolayers after L-S transfer from a subphase of IPA/H2O onto TEM grids; Inset: Selected area 




E. coli  
and PABA + The capacity of GO-NTA coated grids to capture His6-T7 bac-
teriophage (His6-T7) by affinity interaction was examined first by negative-stain TEM. After a 2 min exposure 
of purified His6-T7 on GO-NTA modified 1500 mesh grids, dense clusters of phage particles were found on the 
GO-NTA surface in the absence of Ni2+ (Fig. 4A). Paradoxically, we observed fewer phage particles after charging 
the GO-NTA grids with Ni2+ (Fig. 4B). We attribute these findings to non-specific and random covalent coupling 
of lysine residues with epoxide and aldehyde residues on the GO sheets that are inactivated upon exposure to the 
metal ion30. To obviate this problem, we chemically deactivated these functional groups by treatment of GO-NTA 
with 4-aminobenzoic acid (PABA) after L-S transfer. The resulting PABA-GO-NTA grids showed a reduction in, 
but incomplete abrogation of, non-specific His6-T7 binding under the same incubation conditions (Fig. 4C). When 
activated with Ni2+, PABA-GO-NTA grids revealed a higher density of phage particles due to engagement of the 
NTA:Ni2+:His6 affinity interaction (Fig. 4D). To further enhance the anti-fouling properties of this material, we 
incubated the PABA-GO-NTA grids with BSA immediately before the affinity capture step. Under these condi-
tions, BSA appears to complete the blockade of non-specific viral particle adsorption (Fig. 4E), suggesting that BSA 
inhibits non-specific binding more effectively than PABA modification. After Ni2+ activation of the BSA-blocked 
PABA-GO-NTA surfaces, we observed a recovery in His6-T7 binding to the grids (Fig. 4F). To further demonstrate 
the Ni2+ dependence of this interaction, we treated the grid with 500 mM imidazole, leading to the elution of 
His6-T7 from the grid (data not shown). Taken together, these findings demonstrate the importance of deactivating 
highly reactive chemical functionalities on the surface of GO prior to use in affinity capture experiments.
Next, we sought to capture His6-T7 directly from clarified E. coli lysate. The engineered His-tag does not 
interfere with His6-T7 infectivity, thereby enabling the infection of BL21 cells and viral replication in vitro. A 
negative control experiment demonstrated that Ni2+-free BSA-PABA-GO-NTA grids resulted in little or no cap-
ture of phage and minimal background adsorption from non-targeted cellular material (Figure S4); however, 
Ni2+ activation prompted selective His6-mediated binding of bacteriophage to the grid surface (Fig. 4G). As an 
additional control, the grid was washed with 500 mM imidazole after Ni2+, but prior to incubation with lysate, 
to demonstrate that imidazole stripping of the metal ion results in the abrogation of His6-T7 binding (Fig. 4H). 
These results indicate that BSA-PABA-GO-NTA coated grids are able to effectively purify His6-T7 directly from 
clarified lysate on the grid using the reversible NTA:Ni2+:His6 affinity interaction.
E. coli  
The performance of antifouling BSA-PABA-GO-NTA coatings for high-resolution single particle reconstruction 
analysis was then evaluated by performing on-grid affinity capture of His6-GroEL from E. coli lysates. As observed 
for His6-T7 capture, specific binding of His6-GroEL occurred only with Ni2+-activated (Fig. 5B), but not Ni2+-free 
(Fig. 5A) or 500 mM imidazole treated grids (Fig. 5C). Next, we obtained cryo-EM images of His6-GroEL depos-
ited onto BSA-PABA-GO-NTA coated grids (Fig. 5D). Initial attempts at His6-GroEL capture and cryofixation on 
1500 mesh grids coated with BSA-PABA-GO-NTA generated unacceptably thick sample vitrification; however, 
high quality samples of His6-GroEL captured from lysate were afforded by BSA-PABA-GO-NTA films deposited 
by L-S transfer onto lacey carbon-supported 400 mesh copper grids.
Single Particle Analysis of His EMAN 2.131 was used for single particle analysis of His6-GroEL 
deposited onto BSA-PABA-GO-NTA coated grids since this protein target is often used for gauging workflow 
performance and data processing robustness32–34. The reconstruction effort followed the usual steps from within 
the application, except that the particles were manually picked. Background signal contributions by the BSA 
blocking layer may have contributed to the difficulties encountered during attempts at automated particle picking. 
Nonetheless, 5363 particles were hand-picked from 217 micrographs and the particles rapidly converged into 
coherent classes displaying high contrast (Fig. 6A).
Of 50 total class averages, 12 were chosen to produce an initial model with imposed D7 symmetry (Fig. 6A). 
After 12 refinement iterations with an angular sampling of 1.76 degrees, we were able to produce a gold standard 
(0.143 criteria) density map having 8.1 Å resolution using conservative masking (Fig. 6B–D). There were visible 
nodes in the FSC curve at regular intervals that resulted from an uneven distribution of micrograph defocuses.
To probe the accuracy of our model, we performed a comparison with published 4.2 Å resolution cryo-EM 
map EMD-500134 that was also produced by EMAN using D7 symmetry. Chimera35 was used to fit the volumes 
before calculating the FSC, yielding a 9 Å resolution using 0.5 criteria (Fig. 6D–F).
A substantial difference between our map and the published structure was observed, wherein additional elec-
tron density within the inner pore of the protein was found in the case of our His6-GroEL map. We attribute this 
finding to the extended amino acid sequences at the N- and C-termini (i.e., MRGSHHHHHHTDPALRA and 
GLCGR, respectively) of our His6-GroEL construct derived from the ASKA Library.
Wild type N- and C-termini of the protomers are located at the surface of the inner pore lining the assembled 
tetradecameric complex. Thus, the 14 engineered subunits comprising our His6-GroEL complex yield an addi-
tional 308 residues that occupy the pore, of which 84 are histidines. Given the large number of potential metal 
chelation regioisomers and topoisomers, as well as the high potential for conformational flexibility in the N- and 
C-terminal sequences, we believe that this density is unlikely to adopt a defined structure and instead appears as 
a filled “droplet” within each ring. Also, there is a noticeable decrease in density in the flexible apical region that 
suggests less structural coherency. We infer from these findings that the additional pore residues, along with NTA 
chelation, may create dynamic distortions to the structure of GroEL that could vary for each particle, reducing 
coherency and map density at the apical ends. Further experiments that vary the length and number of his-tag 
linkers per particle may allow for a better model convergence with improved resolution, and potentially improved 




Figure 4. Micrographs of negatively stained his6-T7 bacteriophage using various TEM grid coatings: (A,B) 
GO-NTA; (C,D) PABA-GO-NTA; and (E–H) BSA-PABA-GO-NTA. Negative controls (A,C,E) demonstrate 
no capture of purified phage when Ni2+ is absent, whereas coatings treated with Ni2+ (B,D,F) show capture of 
purified phage. Affinity capture of phage from lysate (G) can be reversed by incubation of (G) with 500 mM 
imidazole (H) that removes the Ni2+ from the coating and abrogates the affinity interaction between the phage 





Our findings show that a new functionalized GO-NTA monolayer sheet can be used as a coating to facilitate 
on-grid affinity purification from clarified cell lysates for negative stain TEM and cryo-EM single particle recon-
struction analysis. GO sheets were successfully functionalized with lysine-NTA affinity ligands and compressed 
monolayer films at the air-water interface were prepared by employing an IPA/H2O mixture to lower surface 
tension before L-S transfer onto EM grids. SEM, AFM, fluorescence spectroscopy, and TEM analysis of these films 
suggests that single monolayer sheets of GO-NTA can be transferred onto Si wafers, bare copper grids, and holey 
carbon grids using this method. Since GO films are thinner than amorphous carbon substrates and offer better 
electron dissipation than lipid-based affinity grids, we believe these two benefits will yield improved contrast for 
cryo-EM image acquisition of biological molecules.
Two blocking techniques, PABA coupling and BSA adsorption, were needed to deactivate the reactive GO 
surface towards non-specific adsorption of occult impurities present in complex samples such as cell lysates. 
Our data shows that further investigations into blocking agents that minimize background noise and improve 
cryofixation reliability are needed. Nonetheless, this grid coating approach showed good specificity for capture of 
His-tagged T7 bacteriophage and GroEL from highly complex cell lysates, while limiting background adsorption 
of non-targeted cellular material.
The utility of these grids for on-grid purification from cell lysates and single particle reconstruction was 
demonstrated using His6-GroEL. Capture of this target onto the surface of GO-NTA affinity grids from clarified 
cell lysates was then used as the key step to enable selection of 5363 particles for reconstruction analysis, yielding 
a map with a gold standard resolution of 8.1 Å. The presence of additional His-tag and linker amino acids in our 
Figure 5. Micrographs of his6-GroEL lysate affinity capture using BSA-PABA-GO-NTA TEM grid coating. 
Micrographs (A–C) are negatively stained. (A) Negative control showing no capture of his6-GroEL when Ni2+ is 
absent. (B) Affinity coating activated with Ni2+ displays specific capture of his6-GroEL from lysate. Treatment of 
the grid in (B) with 500 mM imidazole (C) leads to Ni2+ stripping from the coating and abrogation of his6-GroEL 




engineered GroEL was distinctly visible in our density map, but our final map could still be fit to a published 
high-resolution EM map to 9 Å resolution using 0.5 criteria. We conclude based on these findings that affinity 
capture-based graphenic materials offer great potential for simplified and accelerated cryo-EM sample prepara-
tion for high-resolution structure elucidation. These coatings possess many advantages over NTA-lipid-modified 
grids7,8 or other grid coatings that lack protection from non-specific binding4–6, thereby offering substantial 
improvements in sample preparation time and reduced sample volumes needed to acquire high resolution struc-
tural information of a given protein target and, potentially, its interaction partners.
GO was synthesized as described by Marcano et al.16. This interme-
diate (335 mg) was stirred in a mixture of SOCl2 (60 mL) and DMF (1.5 mL) at 70 °C for 3 d before evaporating 
the SOCl2 and DMF and washing the residue with dry DCM (3 × 50 mL). ACN (50 mL) and Et3N (3 mL) were 
then added and the mixture stirred for 30 min. Tris(O-t-butyl)-Nα,Nα-dicarboxymethyllysine ester (533 mg) was 
then added and the mixture stirred at 100 °C for 3 d before washing with THF and H2O (9,000 rpm for 15 min, 
3 times for each solvent), and vacuum drying at 60 °C for 24 h. TFA (10 mL) in THF (30 mL) was added to the 
dried t-butyl-NTA ester intermediate (180 mg) and stirred at 60 °C for 5 h before washing with THF and H2O 
(11,000 rpm × 15 min, 3 times for each solvent)29,36.
The GO-NTA sheets were ultrasonically exfoliated at 1 mg/mL by suspension of the 
powder in 5:1 MeOH:H2O using probe sonication at 150 watts for five cycles (45 s sonication followed by 45 s of 
rest in each cycle). The product was centrifuged at 1200 g for 10 min, after which the supernatant of exfoliated 
GO-NTA sheets was removed from the sediment of aggregated sheets and subjected to another 5 rounds of son-
ication. A final centrifugation at 1200 g for 10 min was performed prior to removal of the supernatant to yield a 
GO-NTA solution that was stored for subsequent grid coating experiments.
Exfoliated GO-NTA was deposited at the air-water interface of a Kibron μ Trough 
via a syringe pump fitted with a 20 mL syringe. The GO-NTA dispersion was loaded into the syringe and slowly 
introduced at the air-water interface at a rate of 100 μ L/min until the surface pressure reached 15 mN/m. The film 
was then allowed to relax for 5 min, followed by slow compression of the film to 15 mN/m. IPA was then added 
Figure 6. SPA of his6-GroEL captured from lysate. (A) Class averages of his6-GroEL images captured from 
BSA-PABA-GO-NTA coated grids that were used to build the initial model; (B) Top and (C) side views of 
refined his6-GroEL EM map at 8.1 Å resolution (gold standard, 0.143 criteria); (D) Fourier Shell Correlations: 
gold standard using conservative masking (black), and cross-validation between published GroEL map EMD-





to the subphase and the film transferred to either Si wafers, bare 1500 mesh TEM grids, or holey carbon grids by 
Langmuir-Schaefer (L-S) transfer.
GO-NTA (1 mg/mL) was partially deactivated 
by adding PABA (30 mg) to a 10 mL GO-NTA dispersion. This mixture was probe sonicated at 150 W for 30 sec of 
continuous sonication, followed by shaking for 24 h on a rotary mixer. The PABA-GO-NTA was then exfoliated 
and washed as described above for GO-NTA exfoliation.
Fluorescein modification of GO-NTA was performed by adding 2 mg of 
aminofluorescein to an aqueous solution of PABA-GO-NTA (10 mL at 1 mg/mL). This mixture was probe son-
icated for 30 s at 150 W of continuous sonication and then placed on a rotary mixer in the dark for another 
24 h. The material was then centrifuged to pellet the GO species before re-suspending in water, addition of 5:1 
MeOH:H2O, re-pelleted, and decanted a total of 10 times before exfoliation of the Fluorescein-PABA-GO-NTA 
(F-PABA-GO-NTA) product as described above for GO-NTA.
Following L-S transfer of GO-NTA or PABA-GO-NTA 
onto EM grids and overnight drying in a desiccator, the grids were placed on a strip of Teflon before addition of 
BSA (10 μ L of 0.1 mg/mL) and incubation for 5 min, followed by 3 × 20 μ L double deionized H2O washes. The 
modified grids were then stored in a desiccator until use.
F-PABA-GO-NTA was deposited onto 1500 mesh grids 
in the dark by L-S transfer as described above. After transfer, the grids were allowed to dry in the dark for 1 d 
before sandwiching them between a glass and cover slip with 5 μ L of double deionized H2O and the sandwich 
sealed with nail polish. The glass slide was then mounted on a light microscope for epifluorescence imaging.
The concentrations of the GO-NTA dispersions were measured at 
different steps of the synthesis by monitoring the UV-vis spectra of the products. The extinction coefficient data 
used for one batch of GO-NTA is shown (Fig. S1A). Since each batch of GO-NTA has minor differences in 
concentration, each preparation was evaluated for its own experimentally determined extinction coefficient for 
subsequent concentration measurements. Standard solutions used to determine the extinction coefficients were 
prepared by dispersing a weighed amount of dry GO-NTA into known volumes of 5:1 MeOH:H2O and measuring 
the absorbance at 280 nm across a series of dilutions with 5:1 MeOH:H2O. The extinction coefficient was derived 
from the slope of these concentration-dependent absorption plots.
Purified C-terminal gp10 His6-T7 
bacteriophage was initially prepared at a concentration of 1012 particles/mL, with dilution to 1010 particles/mL in 
HEPES buffer (pH = 7.4), before application to the affinity grid surface. GO-NTA modified grids were placed on 
a Teflon strip, 1 mM NiSO4 (10 μ L) added, and the grids incubated for 5 min before washing with double deion-
ized H2O (2 × 20 μ L) and HEPES buffer (1 × 20 μ L). Purified phage (3.5 μ L) was then applied to the surface and 
incubated for 2 min before washing with HEPES (2 × 20 μ L), double deionized H2O (1 × 20 μ L), and staining with 
2% uranyl acetate (5 μ L).
BL21 bacterial cells in 1 mL of LB 
media were grown to an OD of 0.8 before adding 1.0 μ L of His6-T7 bacteriophage (1 × 1012 particles/mL) to the 
media and shaking the culture for 1 h. After bench top centrifugation of the cells, the supernatant was withdrawn 
for use in His6-T7 bacteriophage particle capture studies. The grids were Ni2+-activated as described above, except 
that His6-T7 lysate (5 μ L) was applied to the surface before incubation for 2 min. The grids were then washed with 
HEPES (2 × 20 μ L), double deionized H2O (1 × 20 μ L), and then stained with 2% uranyl acetate (5 μ L).
The ASKA Library was used to express N-terminal 
His6-GroEL. Cells containing N-His6-GroEL gene overexpression vector were grown to OD = 0.6 (in 100 mL of 
LB broth using a 37 °C shaker/incubator) and induced with a final concentration of 1.0 mM IPTG, before allowing 
the cells to grow for an additional 4 h. After centrifugation and removal of the supernatant, the cell pellet was 
re-suspended in lysis buffer (20 mM HEPES, 100 mM NaCl, pH = 7.4, 100 μ g aprotinin, 174 μ g phenylmethanesul-
fonyl fluoride (PMSF), and 500 μ g of lysozyme) and allowed to sit for 20 min. Further disruption of the cell mem-
branes was effected by 110 W probe sonication (35 pulses at 1 second/pulse), followed by centrifugation at 11,000 g 
for 10 min. The supernatant containing His6-GroEL was diluted 10-fold and assayed for affinity binding using the 
Ni2+-activation procedure described above, except that N-His6-GroEL lysate (5 μ L) was applied to the surface and 
incubated for 2 min. The grids were then washed and stained with 2% uranyl acetate as described above.
-GroEL from E. coli  
Samples were prepared as described above for negative stain TEM imaging, except that 
BSA-PABA-GO-NTA modified grids were exposed to His6-GroEL lysate, after which the excess solution was 
removed by blotting twice for 6 s per blot using an offset setting of − 1 at 80% humidity using a Vitrobot device 
(FEI Company). The grids were then plunged into liquid ethane for cryofixation and imaged at 300 kV on an 
FEI Titan Krios equipped with a Gatan K2 Summit direct electron detection camera using low-dose techniques. 
Integrated microscope automation software (Leginon)37 was used to acquire a large set of micrographs at 11,000x 




Single Particle Analysis of His Direct electron detector movie frames were processed in Appion38  
to produce a set of averaged, motion-compensated micrographs to be used in subsequent steps. The micrographs 
had a 1.32 Å2/pixel resolution across a 4096 Å × 4096 Å array. EMAN 2.1 software31 was used for reconstruction 
of 5363 particles that were manually picked from 217 micrographs using a box size of 256. Automatic contrast 
transfer function (CTF) estimation and structure factor were determined from the incoherent sum of particles 
using e2ctf and phase-flipped to generate high-pass CTF-corrected particle stacks. Defocus was estimated to 
range between 0.4 μ m–4 μ m, but 55% of the particles were defocused between 2 μ m–3 μ m which resulted in a 
somewhat jagged CTF slope. Particles were binned 2X for class averaging and 12 classes were chosen to create an 
initial model with imposed D7 symmetry. The classes contained a mix of top and side views. In the refinement 
steps, the input set of particles was divided into even/odd halves, each containing 2682 particles. Two independ-
ent refinements were generated, producing a gold standard of 8.1 Å (using 0.143 criteria) after 12 iterations over 
two refinements with an angular sampling of 1.76 degrees. Additionally, we performed Fourier shell correlation 
against an existing high-resolution cryo-EM map, EMD-500134. The maps were rotated and translated using 
Chimera35 to fit the volumes together. The correlation of our model against EMD-5001 (4.2 Å) gave an approxi-
mate resolution of 9 Å.
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